data_2lb0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lb0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 109.63 -0.508 . . . . 15.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.692 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.4 Cg_exo -69.65 150.65 69.14 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.732 1.622 . . . . 15.0 108.961 163.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.83 141.87 53.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.551 0.691 . . . . 15.0 110.905 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.78 -22.74 6.8 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.21 -0.904 . . . . 15.0 112.334 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.7 m-85 -95.85 138.53 33.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 110.049 -0.352 . . . . 15.0 110.049 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.7 145.2 32.3 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.776 -0.824 . . . . 15.0 108.776 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.67 102.65 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -112.65 135.24 53.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 15.0 111.047 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -131.1 135.13 47.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.61 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -112.4 150.1 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.272 -0.422 . . . . 15.0 110.383 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.07 -16.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.705 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.712 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.5 tp60 -52.96 -18.91 2.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.188 -0.915 . . . . 15.0 111.232 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.63 2.47 67.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.999 -0.619 . . . . 15.0 112.169 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.502 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 33.3 mt-30 -124.07 150.03 45.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.465 -0.568 . . . . 15.0 109.465 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.22 138.07 30.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.067 -0.346 . . . . 15.0 110.067 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -126.07 123.24 37.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.145 0.498 . . . . 15.0 110.036 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.725 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 17.9 m-85 -89.57 111.8 22.83 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 115.626 -0.716 . . . . 15.0 111.188 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.055 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.95 133.36 53.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.913 1.34 . . . . 15.0 113.986 -176.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.593 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.0 t-80 -144.49 96.87 2.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 112.474 -2.148 . . . . 15.0 107.779 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.492 HG22 ' HA2' ' A' ' 258' ' ' GLY . 5.1 p -96.09 87.69 4.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.256 -2.177 . . . . 15.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 45.4 tt0 -101.73 -53.21 3.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.151 -1.84 . . . . 15.0 106.597 150.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.1 p -120.47 26.82 8.94 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 112.322 -2.217 . . . . 15.0 111.01 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.492 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.1 74.04 0.35 Allowed Glycine 0 C--N 1.273 -2.953 0 CA-C-N 111.262 -2.699 . . . . 15.0 113.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.599 ' O ' HD11 ' A' ' 253' ' ' LEU . 53.0 t -90.03 115.58 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 117.286 0.543 . . . . 15.0 111.655 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.952 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.7 p -128.32 105.4 8.31 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.774 1.296 . . . . 15.0 108.863 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.4 p -141.42 150.19 42.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.502 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 32.6 m95 -75.55 -32.49 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.449 -0.796 . . . . 15.0 111.009 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -85.35 140.49 30.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.171 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.725 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 11.2 t70 -59.51 123.79 72.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.485 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 12.2 Cg_exo -71.38 -14.47 31.07 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.965 1.777 . . . . 15.0 113.622 -172.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.692 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 12.4 tpt180 . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 108.526 -0.916 . . . . 15.0 108.526 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.664 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.3 m-20 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 114.278 1.214 . . . . 15.0 114.278 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.055 ' HG3' HD13 ' A' ' 253' ' ' LEU . 55.6 Cg_endo -99.44 160.57 0.58 Allowed 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.542 2.828 . . . . 15.0 112.559 -171.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 N-CA-C 110.133 -1.187 . . . . 15.0 110.133 175.408 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.404 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 5.3 Cg_exo . . . . . 0 N--CA 1.463 -0.319 0 CA-C-O 121.562 0.567 . . . . 15.0 113.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.004 179.398 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.642 HD23 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.806 -0.442 . . . . 15.0 109.806 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.63 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 14.3 Cg_exo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.588 1.525 . . . . 15.0 109.971 166.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.7 122.28 18.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.838 0.828 . . . . 15.0 111.645 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.82 -18.47 2.98 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.039 -1.437 . . . . 15.0 111.329 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.634 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 85.0 m-85 -100.91 138.89 37.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 15.0 110.53 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -112.27 137.89 49.75 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.314 -0.625 . . . . 15.0 109.314 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 97.93 11.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.606 HH11 ' HG2' ' A' ' 243' ' ' ARG . 2.3 ttt-85 -94.53 120.49 34.84 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.527 -0.761 . . . . 15.0 111.612 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -108.25 106.41 16.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 15.0 110.118 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.911 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -90.11 150.29 22.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.952 -0.567 . . . . 15.0 109.622 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.5 t -50.9 -24.41 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.377 0.608 . . . . 15.0 110.703 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.911 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.1 tp-100 -45.72 -34.74 3.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.837 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.01 -15.31 44.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.328 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 1.3 mp0 -97.64 132.19 43.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.976 0.417 . . . . 15.0 111.021 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.26 127.77 43.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.026 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.606 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 14.9 p90 -122.02 130.41 53.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.921 0.391 . . . . 15.0 110.741 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.684 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 30.8 m-85 -89.74 107.13 18.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.461 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.006 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -109.11 133.75 52.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.866 1.317 . . . . 15.0 113.674 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.634 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -140.2 104.04 4.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 112.451 -2.158 . . . . 15.0 108.042 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.9 p -98.13 87.73 4.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.386 -2.126 . . . . 15.0 110.918 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -101.43 -53.04 3.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.529 -1.656 . . . . 15.0 106.529 147.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -121.69 25.79 9.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 112.536 -2.12 . . . . 15.0 111.369 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 51.87 75.99 0.2 Allowed Glycine 0 C--N 1.27 -3.105 0 CA-C-N 111.144 -2.753 . . . . 15.0 113.431 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 253' ' ' LEU . 59.1 t -89.71 113.97 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.315 0.558 . . . . 15.0 111.678 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.878 ' HA ' HD21 ' A' ' 253' ' ' LEU . 8.1 p -125.35 107.05 10.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.265 -1.334 . . . . 15.0 109.069 173.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 150.45 31.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.173 0.805 . . . . 15.0 113.173 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 3.8 m95 -75.78 -21.35 57.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.946 -1.025 . . . . 15.0 112.018 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -95.61 135.49 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.556 -0.458 . . . . 15.0 111.116 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.684 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t0 -56.73 124.19 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.563 -0.903 . . . . 15.0 108.563 170.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.642 ' HD2' HD23 ' A' ' 236' ' ' LEU . 10.3 Cg_exo -71.61 -14.78 30.51 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.363 2.042 . . . . 15.0 113.591 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.63 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 9.8 tpt180 . . . . . 0 C--N 1.309 -1.155 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 56.6 m-20 . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 112.958 0.725 . . . . 15.0 112.958 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.006 ' HG3' HD11 ' A' ' 253' ' ' LEU . 19.4 Cg_endo -97.94 160.57 0.85 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.004 2.469 . . . . 15.0 111.635 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.908 0 N-CA-C 110.416 -1.074 . . . . 15.0 110.416 177.745 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.494 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.463 -0.28 0 N-CA-C 113.798 0.653 . . . . 15.0 113.798 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.545 173.742 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.51 HD11 ' HD2' ' A' ' 265' ' ' PRO . 2.1 mm? . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.941 -0.392 . . . . 15.0 109.941 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.739 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.1 Cg_exo -69.42 147.71 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.561 1.508 . . . . 15.0 109.172 161.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.51 116.07 9.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.453 0.644 . . . . 15.0 111.83 -167.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 147.87 -16.91 1.4 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.844 -1.071 . . . . 15.0 112.122 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 92.6 m-85 -94.9 132.48 39.68 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.722 -0.281 . . . . 15.0 110.567 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.68 142.87 35.62 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.509 -0.552 . . . . 15.0 109.509 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -90.0 119.59 30.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -124.77 137.21 54.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.481 0.658 . . . . 15.0 111.123 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 m -129.4 126.16 38.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.276 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.806 HG21 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -93.11 150.15 20.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.246 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.3 m -54.52 -21.21 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.559 0.695 . . . . 15.0 110.599 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.806 ' HB3' HG21 ' A' ' 245' ' ' THR . 3.4 tp-100 -47.66 -32.61 5.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.582 -1.19 . . . . 15.0 111.488 170.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.3 19.18 21.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.036 -0.602 . . . . 15.0 112.635 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.68 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.2 mt-30 -127.14 147.83 50.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.43 136.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.336 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -134.51 125.71 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.67 -0.492 . . . . 15.0 109.67 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.688 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -89.65 112.63 23.92 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.58 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.081 HD12 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -107.44 133.42 51.97 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.804 1.288 . . . . 15.0 113.494 -177.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -145.35 103.17 3.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.587 -2.097 . . . . 15.0 108.424 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.9 t -99.21 87.79 3.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 116.162 -2.215 . . . . 15.0 111.005 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 59.4 tt0 -101.27 -51.73 3.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.31 -1.768 . . . . 15.0 106.597 149.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 44.8 p -121.66 24.81 9.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.425 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.2 0.34 Allowed Glycine 0 C--N 1.27 -3.138 0 CA-C-N 111.278 -2.692 . . . . 15.0 113.7 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.605 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.1 t -89.97 119.54 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 117.253 0.526 . . . . 15.0 111.622 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.951 ' HA ' HD22 ' A' ' 253' ' ' LEU . 4.6 p -131.76 109.11 9.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.396 -1.275 . . . . 15.0 108.677 169.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.0 t -150.17 150.11 31.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.098 0.777 . . . . 15.0 113.098 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.463 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 33.8 m95 -71.06 -29.64 65.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.011 -0.995 . . . . 15.0 111.917 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 265' ' ' PRO . 4.3 p80 -90.61 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.597 -0.441 . . . . 15.0 111.271 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.688 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 12.3 t70 -56.65 120.43 36.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.02 -1.104 . . . . 15.0 108.02 168.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.533 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 Cg_exo -69.72 -14.61 36.47 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.247 1.965 . . . . 15.0 113.72 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.739 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.0 tpt180 . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.668 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 5.7 p-10 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.081 ' HG3' HD12 ' A' ' 253' ' ' LEU . 82.0 Cg_endo -94.3 160.59 2.03 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.292 2.661 . . . . 15.0 112.014 -170.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.978 0 C-N-CA 119.286 -1.435 . . . . 15.0 110.052 174.154 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.407 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 6.1 Cg_exo . . . . . 0 N--CA 1.46 -0.484 0 CA-C-O 121.6 0.583 . . . . 15.0 112.817 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 121.591 0.71 . . . . 15.0 109.385 175.372 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.499 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.516 -0.363 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.46 144.93 57.29 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.947 1.765 . . . . 15.0 110.182 172.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.6 124.75 24.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.716 0.77 . . . . 15.0 111.875 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.36 -20.19 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.477 -1.238 . . . . 15.0 111.884 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.542 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.5 m-85 -91.12 126.23 36.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 7.8 pt-20 -97.87 129.04 44.84 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.68 103.54 16.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.502 0.668 . . . . 15.0 109.347 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -105.15 139.65 39.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.915 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 m -131.23 108.91 10.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.687 HG22 ' HB3' ' A' ' 247' ' ' GLN . 2.8 t -94.78 150.25 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.418 -0.355 . . . . 15.0 110.728 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.3 -18.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.885 0.85 . . . . 15.0 111.074 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.687 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.6 tp-100 -48.67 -23.59 1.08 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.043 -1.435 . . . . 15.0 111.534 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.67 10.46 61.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.754 -0.538 . . . . 15.0 111.754 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.497 HE21 ' HG3' ' A' ' 247' ' ' GLN . 28.1 mt-30 -129.83 139.79 51.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.6 m -100.68 124.07 54.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.029 0.442 . . . . 15.0 110.385 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -109.58 127.52 54.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.132 0.491 . . . . 15.0 110.092 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.728 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 22.5 m-85 -89.54 107.57 19.16 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.591 -0.731 . . . . 15.0 111.116 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.106 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -106.83 133.96 50.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.734 1.254 . . . . 15.0 113.551 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 11.1 t-80 -142.91 102.76 4.08 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 112.703 -2.044 . . . . 15.0 107.865 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 25.1 m -102.1 88.06 3.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 115.874 -2.331 . . . . 15.0 110.931 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.562 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.8 tt0 -101.17 -47.78 4.62 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.415 -1.721 . . . . 15.0 107.027 146.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 36.0 p -124.83 25.11 7.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 113.521 -1.672 . . . . 15.0 111.399 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.23 74.49 0.31 Allowed Glycine 0 C--N 1.272 -2.984 0 CA-C-N 111.137 -2.756 . . . . 15.0 113.552 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 253' ' ' LEU . 56.1 t -89.83 120.25 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 117.239 0.519 . . . . 15.0 110.982 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.918 ' HA ' HD23 ' A' ' 253' ' ' LEU . 6.3 p -135.84 105.68 6.21 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 124.519 1.137 . . . . 15.0 109.244 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.46 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.2 150.35 31.48 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.479 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 18.6 m95 -68.81 -30.97 69.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.204 -0.907 . . . . 15.0 111.264 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.46 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.6 p80 -86.15 137.11 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.992 0.425 . . . . 15.0 111.173 -170.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.728 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 10.7 t0 -58.41 125.3 75.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.586 -0.894 . . . . 15.0 108.586 171.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 23.1 Cg_exo -68.3 -14.72 41.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 122.543 2.162 . . . . 15.0 113.865 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.563 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpt180 . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 23.0 t70 . . . . . 0 CA--C 1.554 1.108 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.106 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.3 Cg_endo -97.18 160.26 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.671 2.247 . . . . 15.0 111.919 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.881 0 C-N-CA 119.626 -1.273 . . . . 15.0 110.566 176.038 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.415 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.2 Cg_exo . . . . . 0 CA--C 1.531 0.332 0 CA-C-O 121.628 0.595 . . . . 15.0 113.334 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.516 -0.765 . . . . 15.0 109.552 174.697 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.2 mm? . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.28 0.562 . . . . 15.0 110.927 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.714 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.7 Cg_exo -69.28 159.28 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.254 1.969 . . . . 15.0 109.701 161.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -69.49 123.95 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.542 0.686 . . . . 15.0 111.547 -172.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.47 4.64 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.775 -1.102 . . . . 15.0 113.203 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 78.2 m-85 -97.4 130.77 44.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.319 0.56 . . . . 15.0 111.004 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.5 140.06 43.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.532 ' NE2' ' HB ' ' A' ' 250' ' ' VAL . 8.9 tp60 -89.66 143.76 26.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.615 -0.883 . . . . 15.0 108.615 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.445 ' H ' HE21 ' A' ' 242' ' ' GLN . 8.9 ttt180 -139.84 131.61 27.45 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.802 -0.636 . . . . 15.0 110.886 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 p -115.01 111.58 21.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.719 -1.128 . . . . 15.0 110.185 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.88 HG22 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.9 150.22 22.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.027 -0.533 . . . . 15.0 109.667 176.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.51 -24.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.381 0.61 . . . . 15.0 110.533 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.88 ' HB3' HG22 ' A' ' 245' ' ' THR . 4.1 tp-100 -47.58 -38.91 15.37 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.622 -1.172 . . . . 15.0 111.931 170.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.17 5.02 35.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.752 -0.737 . . . . 15.0 113.526 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.688 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.5 mt-30 -113.58 137.71 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.196 0.498 . . . . 15.0 111.037 -175.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.532 ' HB ' ' NE2' ' A' ' 242' ' ' GLN . 10.3 m -90.05 121.26 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.579 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -121.16 130.1 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.882 -0.327 . . . . 15.0 110.605 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 23.6 m-85 -89.82 110.18 21.13 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.505 -174.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.085 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -108.97 132.58 53.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.776 1.274 . . . . 15.0 114.086 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -140.75 101.24 4.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.702 -2.044 . . . . 15.0 107.884 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.4 t -99.07 87.54 3.71 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 116.087 -2.245 . . . . 15.0 110.667 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.472 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 47.5 tt0 -101.28 -50.66 3.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.142 -1.844 . . . . 15.0 106.753 149.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 32.0 p -124.19 25.19 7.89 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 112.794 -2.003 . . . . 15.0 111.142 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.78 75.15 0.25 Allowed Glycine 0 C--N 1.273 -2.942 0 CA-C-N 111.014 -2.812 . . . . 15.0 113.554 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.67 ' O ' HD11 ' A' ' 253' ' ' LEU . 41.1 t -89.72 117.26 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-N 117.287 0.543 . . . . 15.0 111.23 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.915 ' HA ' HD22 ' A' ' 253' ' ' LEU . 7.6 p -127.72 108.82 11.08 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 124.326 1.016 . . . . 15.0 109.061 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.5 t -150.16 150.33 31.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.596 0.591 . . . . 15.0 112.596 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 77.1 m95 -76.52 -25.68 54.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.578 -0.737 . . . . 15.0 111.054 174.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -90.49 132.21 35.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 15.0 111.072 -171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.563 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 8.9 t70 -53.26 122.12 28.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 169.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 236' ' ' LEU . 10.1 Cg_exo -71.65 -14.52 30.26 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 122.113 1.875 . . . . 15.0 113.924 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.714 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.7 tpt180 . . . . . 0 C--N 1.31 -1.114 0 CA-C-O 121.77 0.795 . . . . 15.0 109.105 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 28.2 m-20 . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 114.117 1.154 . . . . 15.0 114.117 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.085 ' HG3' HD13 ' A' ' 253' ' ' LEU . 35.6 Cg_endo -96.89 160.85 1.08 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 123.091 2.527 . . . . 15.0 111.9 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.982 0 N-CA-C 109.434 -1.466 . . . . 15.0 109.434 173.114 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.41 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 5.6 Cg_exo . . . . . 0 N--CA 1.463 -0.293 0 CA-C-O 121.021 0.342 . . . . 15.0 112.85 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.332 0.587 . . . . 15.0 110.185 176.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 1.015 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 22.5 Cg_exo -69.56 159.15 54.64 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.062 1.841 . . . . 15.0 110.702 165.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.98 123.87 22.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.904 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.49 -14.46 6.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.548 -0.834 . . . . 15.0 112.837 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.658 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.8 m-85 -94.67 131.16 40.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.911 0.355 . . . . 15.0 110.334 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 131.35 44.12 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.43 -0.952 . . . . 15.0 108.43 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -89.72 99.11 12.18 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -106.97 119.32 39.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.004 -0.998 . . . . 15.0 111.379 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.9 m -115.77 111.04 19.94 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 15.0 109.337 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.852 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.8 150.06 22.42 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.42 -21.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.388 0.613 . . . . 15.0 111.561 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.852 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.499 -1.228 . . . . 15.0 111.58 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.4 -8.84 28.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.896 -0.669 . . . . 15.0 112.561 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 9.2 mt-30 -112.41 143.52 43.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.86 0.362 . . . . 15.0 110.483 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.51 135.03 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -126.66 125.29 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.971 0.415 . . . . 15.0 109.902 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.633 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 21.4 m-85 -89.78 109.92 20.88 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.111 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.984 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.38 131.07 54.02 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.727 1.251 . . . . 15.0 114.053 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.658 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 15.8 t-80 -141.38 93.72 2.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 112.768 -2.014 . . . . 15.0 107.7 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 29.9 m -93.85 87.78 5.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 115.99 -2.284 . . . . 15.0 110.09 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -101.38 -52.91 3.13 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.117 -1.856 . . . . 15.0 106.233 150.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 45.2 p -118.01 24.75 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.437 -2.165 . . . . 15.0 110.904 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.19 73.19 0.44 Allowed Glycine 0 C--N 1.27 -3.096 0 CA-C-N 110.965 -2.834 . . . . 15.0 113.836 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.671 ' O ' HD11 ' A' ' 253' ' ' LEU . 53.4 t -90.01 115.01 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 117.309 0.554 . . . . 15.0 112.037 175.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.902 ' HA ' HD23 ' A' ' 253' ' ' LEU . 5.8 p -127.46 107.87 10.33 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.37 1.043 . . . . 15.0 109.08 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -150.28 150.28 31.3 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.644 0.609 . . . . 15.0 112.644 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 79.6 m95 -75.11 -25.46 58.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.282 175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -87.63 142.09 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.065 0.459 . . . . 15.0 111.03 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.633 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.3 t70 -65.92 131.33 94.56 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.175 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.72 -14.57 8.88 Favored 'Trans proline' 0 CA--C 1.509 -0.737 0 C-N-CA 122.541 2.161 . . . . 15.0 113.855 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 1.015 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.1 tpm_? . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 122.076 0.941 . . . . 15.0 108.858 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.8 m-20 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 113.631 0.975 . . . . 15.0 113.631 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.984 ' HG3' HD13 ' A' ' 253' ' ' LEU . 16.4 Cg_endo -97.03 160.39 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.549 2.166 . . . . 15.0 112.303 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -0.772 0 N-CA-C 110.387 -1.085 . . . . 15.0 110.387 176.509 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.467 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo . . . . . 0 N--CA 1.464 -0.221 0 CA-C-O 121.91 0.713 . . . . 15.0 113.602 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.503 177.442 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.934 HD11 ' HD2' ' A' ' 265' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.343 0 CA-C-O 121.529 0.68 . . . . 15.0 111.119 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.46 158.98 55.37 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 122.831 2.354 . . . . 15.0 109.617 165.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.62 117.31 11.07 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.405 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.14 -2.1 2.87 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.759 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.519 ' CE1' ' HD2' ' A' ' 237' ' ' PRO . 69.6 m-85 -116.74 136.98 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.22 134.14 51.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.601 -0.518 . . . . 15.0 109.601 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.55 ' HG3' ' CE2' ' A' ' 252' ' ' PHE . 21.4 tt0 -89.72 97.98 11.51 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.546 -0.538 . . . . 15.0 109.546 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -95.49 119.47 34.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.767 -0.651 . . . . 15.0 110.598 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' THR . . . . . 0.584 ' HB ' HG11 ' A' ' 250' ' ' VAL . 5.0 t -104.0 150.07 24.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.286 -0.87 . . . . 15.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -135.31 150.46 50.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.972 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.93 -17.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.336 0.589 . . . . 15.0 110.983 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.77 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.3 tp-100 -54.36 -20.43 7.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.446 -0.797 . . . . 15.0 111.245 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.38 69.01 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.363 -0.446 . . . . 15.0 112.51 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.476 HE21 ' HG3' ' A' ' 247' ' ' GLN . 29.7 mt-30 -125.74 136.0 52.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.033 -0.358 . . . . 15.0 110.033 -175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.584 HG11 ' HB ' ' A' ' 244' ' ' THR . 20.8 m -89.99 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.716 0.293 . . . . 15.0 110.334 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -122.86 130.68 53.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 15.0 110.153 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 28.9 m-85 -89.76 108.51 19.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.871 -0.604 . . . . 15.0 111.698 -171.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.963 HD21 ' HA ' ' A' ' 260' ' ' SER . 0.4 OUTLIER -107.33 132.13 53.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.858 1.313 . . . . 15.0 113.558 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.1 OUTLIER -140.4 99.47 3.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 112.601 -2.091 . . . . 15.0 107.514 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.7 t -108.37 87.47 2.5 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 115.242 -2.583 . . . . 15.0 111.395 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 39.8 tt0 -101.47 -48.22 4.42 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.256 -2.247 . . . . 15.0 106.649 142.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -118.32 24.78 10.74 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 113.539 -1.664 . . . . 15.0 111.757 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.53 72.79 0.43 Allowed Glycine 0 C--N 1.271 -3.069 0 CA-C-N 110.961 -2.836 . . . . 15.0 114.495 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.634 ' O ' HD12 ' A' ' 253' ' ' LEU . 13.1 t -92.42 116.33 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 117.449 0.624 . . . . 15.0 111.631 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.963 ' HA ' HD21 ' A' ' 253' ' ' LEU . 6.1 p -126.63 110.08 12.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.167 0.917 . . . . 15.0 108.659 167.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -149.93 150.31 31.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.923 0.712 . . . . 15.0 112.923 -167.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 22.1 m95 -75.65 -29.65 59.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.353 -0.839 . . . . 15.0 111.479 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -93.53 140.16 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.624 -0.43 . . . . 15.0 111.27 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.582 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 16.2 t0 -50.61 126.22 22.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 N-CA-C 108.672 -0.862 . . . . 15.0 108.672 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.934 ' HD2' HD11 ' A' ' 236' ' ' LEU . 56.3 Cg_endo -70.55 -14.53 33.66 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 C-N-CA 122.471 2.114 . . . . 15.0 113.608 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 . . . . . 0 C--N 1.314 -0.974 0 CA-C-O 121.898 0.856 . . . . 15.0 108.963 174.567 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 10.3 m-20 . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 113.095 0.776 . . . . 15.0 113.095 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.933 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.4 Cg_endo -96.78 160.38 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.99 2.46 . . . . 15.0 112.759 -166.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.015 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 174.343 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 3.8 Cg_exo . . . . . 0 N--CA 1.46 -0.453 0 CA-C-O 121.839 0.683 . . . . 15.0 113.383 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 114.815 -1.084 . . . . 15.0 109.875 -179.522 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.218 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.401 ' HG3' HH11 ' A' ' 266' ' ' ARG . 13.4 Cg_exo -69.52 160.31 50.26 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 121.524 1.482 . . . . 15.0 110.579 168.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.89 120.16 15.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.281 -171.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 135.11 -27.16 3.18 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.597 -0.729 . . . . 15.0 113.068 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.648 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 45.1 m-85 -92.39 136.69 32.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.884 0.342 . . . . 15.0 110.62 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.82 141.4 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 167.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -89.82 99.37 12.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -93.47 130.22 39.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.81 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -119.76 110.41 16.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.312 -0.858 . . . . 15.0 110.142 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.06 150.26 22.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.789 -0.448 . . . . 15.0 109.789 176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 42.6 t -55.13 -18.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.65 0.738 . . . . 15.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.802 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.3 tp-100 -49.94 -29.21 7.95 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.817 -1.083 . . . . 15.0 111.429 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.36 -23.92 17.05 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.046 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.49 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.0 mp0 -89.88 148.39 23.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.253 0.549 . . . . 15.0 111.322 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 123.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.713 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -114.15 128.61 56.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.439 -0.505 . . . . 15.0 110.592 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.3 m-85 -89.69 110.34 21.24 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.419 -172.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.048 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.48 134.43 52.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.739 1.257 . . . . 15.0 113.852 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.648 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 20.4 t-80 -146.89 102.27 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 112.563 -2.108 . . . . 15.0 108.309 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.4 t -102.91 88.01 3.07 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 116.058 -2.257 . . . . 15.0 111.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 7.9 tt0 -101.15 -50.69 3.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.164 -1.835 . . . . 15.0 106.237 147.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.9 p -116.91 27.23 9.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.142 -1.845 . . . . 15.0 111.293 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.04 72.18 0.55 Allowed Glycine 0 C--N 1.277 -2.747 0 CA-C-N 111.133 -2.758 . . . . 15.0 113.974 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.635 ' O ' HD12 ' A' ' 253' ' ' LEU . 53.8 t -90.05 115.16 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-N 117.379 0.59 . . . . 15.0 111.807 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.939 ' HA ' HD21 ' A' ' 253' ' ' LEU . 5.1 p -127.89 100.09 5.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.956 170.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.5 p -141.25 150.27 42.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.223 0.823 . . . . 15.0 113.223 -167.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.626 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 1.7 m95 -70.87 -42.56 69.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.475 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -76.19 139.33 41.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.66 -0.7 . . . . 15.0 111.676 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.587 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 49.3 t0 -54.19 127.74 56.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 168.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.406 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 65.1 Cg_endo -74.13 -14.79 23.32 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 121.651 1.567 . . . . 15.0 112.916 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.44 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 13.6 tpt180 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 108.683 -0.858 . . . . 15.0 108.683 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.61 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.8 p-10 . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.048 ' HG3' HD11 ' A' ' 253' ' ' LEU . 56.3 Cg_endo -90.8 160.44 4.13 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.306 2.004 . . . . 15.0 111.629 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.158 0 N-CA-C 110.214 -1.154 . . . . 15.0 110.214 179.74 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.626 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.463 -0.289 0 CA-C-O 122.007 0.753 . . . . 15.0 113.832 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.121 -0.945 . . . . 15.0 110.236 178.025 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 108.922 -0.77 . . . . 15.0 108.922 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.801 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.6 Cg_exo -69.62 161.97 43.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.497 1.465 . . . . 15.0 110.332 167.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.53 124.37 23.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.112 -0.949 . . . . 15.0 111.256 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.98 -13.93 8.0 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.521 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.9 m-85 -94.29 131.89 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.365 0.583 . . . . 15.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.99 140.58 38.76 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 170.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.473 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.8 OUTLIER -89.85 102.09 14.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -109.02 145.95 34.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.24 -0.891 . . . . 15.0 111.413 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 m -136.47 124.77 23.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.019 -0.991 . . . . 15.0 109.664 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.719 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.1 t -89.86 150.43 22.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.923 -0.399 . . . . 15.0 109.923 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.3 m -51.5 -24.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.316 0.579 . . . . 15.0 110.979 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.719 ' HB3' HG22 ' A' ' 245' ' ' THR . 2.2 tp-100 -52.05 -33.29 38.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.037 -0.983 . . . . 15.0 111.703 172.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.8 12.16 28.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.995 -0.622 . . . . 15.0 112.512 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.593 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.4 mm-40 -99.1 142.32 30.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.241 -0.652 . . . . 15.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 m -102.78 106.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.013 0.435 . . . . 15.0 109.897 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -109.56 127.0 54.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.552 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.671 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.0 m-85 -89.54 108.4 19.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.593 -172.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.043 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.21 133.44 52.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.885 1.326 . . . . 15.0 113.503 -175.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.603 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 6.7 t-80 -143.93 104.73 4.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.427 -2.17 . . . . 15.0 107.866 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -104.36 87.81 2.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 115.768 -2.373 . . . . 15.0 111.125 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.6 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.4 tt0 -101.32 -49.32 4.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.137 -1.847 . . . . 15.0 106.798 148.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -124.84 27.34 6.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.272 -1.785 . . . . 15.0 111.623 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.26 73.97 0.35 Allowed Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.457 -2.611 . . . . 15.0 114.292 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 253' ' ' LEU . 38.0 t -89.91 120.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.09 0.445 . . . . 15.0 111.517 173.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.933 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.6 p -131.25 112.23 12.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.053 -0.976 . . . . 15.0 109.166 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 p -144.33 150.12 37.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.244 0.831 . . . . 15.0 113.244 -167.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.776 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.1 OUTLIER -73.26 -36.28 66.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.975 -1.011 . . . . 15.0 110.496 171.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -86.02 142.35 28.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.237 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.671 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 10.6 t70 -58.96 131.52 86.8 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.744 -0.836 . . . . 15.0 108.744 171.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.99 -14.8 16.81 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 C-N-CA 122.189 1.926 . . . . 15.0 113.619 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.801 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.4 tpt180 . . . . . 0 C--N 1.31 -1.146 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.793 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 19.8 t70 . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 113.735 1.013 . . . . 15.0 113.735 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.043 ' HG3' HD11 ' A' ' 253' ' ' LEU . 61.4 Cg_endo -101.41 160.31 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.742 2.961 . . . . 15.0 114.081 -162.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 N-CA-C 109.669 -1.372 . . . . 15.0 109.669 169.609 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.776 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.2 Cg_exo . . . . . 0 C--O 1.223 -0.247 0 CA-C-O 121.744 0.643 . . . . 15.0 113.439 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 15.0 109.764 174.755 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.735 HD11 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.404 0.621 . . . . 15.0 111.31 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.572 ' HG3' HH11 ' A' ' 266' ' ' ARG . 19.6 Cg_exo -69.41 167.21 24.62 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 122.977 2.451 . . . . 15.0 110.82 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.54 114.6 7.91 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.676 -1.147 . . . . 15.0 111.516 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.55 -18.78 2.43 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 114.821 -1.082 . . . . 15.0 113.112 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.607 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 43.5 m-85 -101.77 131.68 47.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.053 0.427 . . . . 15.0 111.107 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -101.59 138.66 38.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.98 110.08 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -112.09 128.78 56.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.235 0.54 . . . . 15.0 111.311 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -113.53 125.49 54.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.843 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.752 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -107.72 150.52 26.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.125 -0.488 . . . . 15.0 110.65 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -48.84 -20.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.314 0.646 . . . . 15.0 112.171 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.752 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.1 tp-100 -51.21 -21.76 2.25 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.336 -0.847 . . . . 15.0 111.666 171.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.14 60.92 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 15.0 111.916 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 34.1 mt-30 -130.72 149.73 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.662 -0.495 . . . . 15.0 109.662 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.73 138.66 26.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 15.0 109.975 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -125.25 128.16 47.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.351 0.596 . . . . 15.0 110.476 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 14.8 m-85 -89.73 109.66 20.62 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.028 -0.987 . . . . 15.0 111.453 -172.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.03 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.37 132.96 53.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.836 1.303 . . . . 15.0 114.039 -175.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.607 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.4 t-80 -140.38 97.09 3.15 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.535 -2.121 . . . . 15.0 107.447 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.2 p -90.51 88.22 7.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.439 -2.104 . . . . 15.0 110.424 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -101.29 -44.73 5.56 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.032 -1.895 . . . . 15.0 108.704 152.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 5.6 t -146.05 26.09 1.24 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 124.062 1.887 . . . . 15.0 108.775 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 59.45 75.96 0.25 Allowed Glycine 0 C--N 1.28 -2.581 0 CA-C-N 110.307 -3.133 . . . . 15.0 113.356 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.535 ' O ' HD22 ' A' ' 253' ' ' LEU . 79.6 t -89.27 115.8 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 118.833 -1.147 . . . . 15.0 110.841 164.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.864 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.9 p -129.31 106.15 8.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.481 -1.69 . . . . 15.0 108.571 173.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.994 0.739 . . . . 15.0 112.994 -167.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 43.3 m95 -77.84 -36.6 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 15.0 109.94 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -79.95 141.12 36.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.089 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.527 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 25.3 t0 -59.81 125.43 80.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.053 -1.091 . . . . 15.0 108.053 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.735 ' HD2' HD11 ' A' ' 236' ' ' LEU . 11.9 Cg_exo -70.55 -14.8 33.9 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.192 1.928 . . . . 15.0 112.897 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.572 HH11 ' HG3' ' A' ' 237' ' ' PRO . 18.7 tpt180 . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 121.677 0.751 . . . . 15.0 109.078 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.749 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 47.4 p-10 . . . . . 0 CA--C 1.556 1.185 0 N-CA-C 114.059 1.133 . . . . 15.0 114.059 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.03 ' HG3' HD13 ' A' ' 253' ' ' LEU . 57.4 Cg_endo -96.72 160.68 1.14 Allowed 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.057 2.505 . . . . 15.0 111.928 -175.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.969 0 C-N-CA 119.865 -1.16 . . . . 15.0 110.455 176.776 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.43 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.3 Cg_exo . . . . . 0 CA--C 1.53 0.301 0 CA-C-O 121.584 0.577 . . . . 15.0 113.146 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.015 -179.009 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 15.0 110.551 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.667 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.7 Cg_exo -69.34 155.94 65.86 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.3 2.0 . . . . 15.0 109.76 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.72 117.73 11.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.219 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 146.12 -13.55 1.67 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.38 -0.827 . . . . 15.0 112.949 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.564 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.9 m-85 -104.84 138.43 41.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.276 0.538 . . . . 15.0 110.848 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 170.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.92 104.59 17.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -109.05 130.71 55.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.49 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 125.71 53.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.789 . . . . 15.0 110.213 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.733 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -106.25 150.72 25.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.082 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.0 t -45.87 -23.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.611 0.569 . . . . 15.0 111.57 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.733 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.7 tp60 -50.94 -23.08 2.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.457 0.703 . . . . 15.0 111.53 173.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.15 65.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.248 -0.501 . . . . 15.0 112.275 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.484 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 35.5 mt-30 -106.73 142.47 36.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.835 0.35 . . . . 15.0 110.587 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.03 137.23 22.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.433 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -127.79 128.25 44.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.048 0.451 . . . . 15.0 110.081 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.2 m-85 -89.7 111.33 22.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.619 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.005 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.47 133.95 51.92 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.806 1.289 . . . . 15.0 113.985 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.564 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 t-80 -140.49 97.54 3.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 112.475 -2.148 . . . . 15.0 107.307 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.506 HG23 ' HA2' ' A' ' 258' ' ' GLY . 8.8 p -97.21 87.74 4.26 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 116.295 -2.162 . . . . 15.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 40.8 tt0 -101.29 -52.73 3.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.278 -1.783 . . . . 15.0 106.818 147.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 35.8 p -119.4 27.66 8.66 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 112.417 -2.174 . . . . 15.0 111.116 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.506 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 51.36 74.94 0.24 Allowed Glycine 0 C--N 1.274 -2.883 0 CA-C-N 111.464 -2.607 . . . . 15.0 113.692 -175.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.57 ' O ' HD21 ' A' ' 253' ' ' LEU . 55.7 t -89.59 111.11 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-N 117.452 0.626 . . . . 15.0 111.066 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.833 ' HA ' HD21 ' A' ' 253' ' ' LEU . 6.6 p -124.66 101.97 7.37 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.171 -1.377 . . . . 15.0 108.885 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -150.22 150.39 31.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -169.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.484 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 74.4 m95 -72.66 -38.32 67.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.012 174.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -74.86 136.32 41.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.165 -0.47 . . . . 15.0 111.563 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.623 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t0 -57.26 124.66 67.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.271 -0.877 . . . . 15.0 108.917 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.518 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 9.1 Cg_exo -73.38 -14.62 25.27 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.5 2.134 . . . . 15.0 113.879 -176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.667 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 26.2 tpt180 . . . . . 0 C--N 1.313 -1.016 0 N-CA-C 108.76 -0.83 . . . . 15.0 108.76 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.558 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 29.5 m-20 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 113.394 0.887 . . . . 15.0 113.394 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.005 ' HG3' HD13 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -92.04 160.19 3.26 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.191 1.927 . . . . 15.0 111.098 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 C-N-CA 119.904 -1.141 . . . . 15.0 110.295 -179.51 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.472 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 CA-C-O 122.082 0.784 . . . . 15.0 113.952 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.026 172.351 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.835 -0.431 . . . . 15.0 109.835 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.915 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.57 165.61 30.17 Favored 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.062 1.841 . . . . 15.0 110.92 166.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -69.48 126.93 31.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.304 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 121.52 -13.65 9.38 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 15.0 113.647 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.602 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 91.0 m-85 -95.06 128.58 41.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.471 0.636 . . . . 15.0 110.718 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -106.78 135.99 47.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 15.0 109.655 172.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.527 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -89.79 111.61 22.67 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.358 -0.979 . . . . 15.0 108.358 -178.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.675 HH11 ' HG2' ' A' ' 243' ' ' ARG . 6.1 ttt-85 -107.51 127.36 53.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.654 -0.703 . . . . 15.0 111.909 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.4 p -113.83 124.38 52.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.455 -1.248 . . . . 15.0 109.821 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -107.91 150.0 27.61 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.927 -0.397 . . . . 15.0 109.927 175.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.47 -18.67 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.516 0.674 . . . . 15.0 110.312 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.794 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.8 tp-100 -47.33 -40.99 18.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.877 -1.056 . . . . 15.0 111.198 171.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.91 21.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.779 -0.724 . . . . 15.0 112.881 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -104.48 150.11 24.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.1 0.476 . . . . 15.0 111.662 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.12 124.17 55.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.301 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.655 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 37.8 p90 -125.82 129.23 48.99 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.013 -0.675 . . . . 15.0 111.784 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 36.7 m-85 -90.06 111.28 22.34 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.678 -174.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.002 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -110.54 134.17 52.63 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.707 1.241 . . . . 15.0 113.211 176.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.602 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.9 t-80 -140.72 100.32 3.82 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.005 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.3 t -101.81 87.89 3.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 115.905 -2.318 . . . . 15.0 110.885 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 46.7 tt0 -101.08 -46.67 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.023 -1.899 . . . . 15.0 106.773 148.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.3 p -124.97 27.05 6.84 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.412 -1.722 . . . . 15.0 111.109 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.91 73.11 0.43 Allowed Glycine 0 C--N 1.278 -2.666 0 CA-C-N 111.281 -2.69 . . . . 15.0 114.212 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 253' ' ' LEU . 50.9 t -89.95 114.0 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 117.349 0.574 . . . . 15.0 112.066 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.946 ' HA ' HD21 ' A' ' 253' ' ' LEU . 6.7 p -121.63 106.86 11.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.786 -1.097 . . . . 15.0 108.596 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.3 p -142.41 150.13 40.22 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.257 0.836 . . . . 15.0 113.257 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.515 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 1.5 m95 -77.67 -34.81 52.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.652 172.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -82.79 137.81 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.003 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.656 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.9 t70 -57.14 133.41 80.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 171.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.21 -14.64 10.63 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.293 1.995 . . . . 15.0 113.986 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.915 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.3 tpt180 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 122.376 1.084 . . . . 15.0 108.396 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.553 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 5.3 p-10 . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 118.987 -0.53 . . . . 15.0 112.244 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.002 ' HG3' HD11 ' A' ' 253' ' ' LEU . 13.1 Cg_endo -96.42 160.37 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.941 2.427 . . . . 15.0 111.691 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 111.036 -0.825 . . . . 15.0 111.036 178.242 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.515 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo . . . . . 0 C--O 1.223 -0.226 0 N-CA-C 113.895 0.69 . . . . 15.0 113.895 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.663 -0.698 . . . . 15.0 109.54 172.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.594 -0.521 . . . . 15.0 109.594 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.639 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.45 159.39 53.82 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.986 1.791 . . . . 15.0 110.485 166.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.62 113.96 7.39 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.54 -0.755 . . . . 15.0 111.214 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 143.77 -16.43 2.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.49 -0.777 . . . . 15.0 112.729 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 66.4 m-85 -98.36 138.74 35.16 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.626 -0.338 . . . . 15.0 110.737 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -109.33 144.3 37.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -89.85 118.55 29.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 15.0 108.796 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.7 136.36 53.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.387 0.613 . . . . 15.0 111.536 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 m -129.45 115.61 17.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.931 -1.032 . . . . 15.0 109.592 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -90.15 150.62 21.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.536 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.48 -17.34 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.31 0.576 . . . . 15.0 110.617 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.803 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.5 tp60 -54.2 -22.7 12.13 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.012 170.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.43 16.65 48.9 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.009 -0.615 . . . . 15.0 112.78 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 18.1 mt-30 -131.47 146.81 52.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.773 0.321 . . . . 15.0 110.213 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.56 141.21 15.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.415 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.5 127.42 27.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.889 0.376 . . . . 15.0 110.098 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.674 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 25.1 m-85 -89.62 111.65 22.66 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.05 -0.523 . . . . 15.0 111.434 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.039 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.83 135.86 49.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.684 1.231 . . . . 15.0 113.619 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -148.74 107.44 3.82 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.678 -2.055 . . . . 15.0 108.292 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 11.9 m -103.42 87.58 2.89 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 116.17 -2.212 . . . . 15.0 110.625 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.593 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 43.7 tt0 -101.35 -48.19 4.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.071 -1.877 . . . . 15.0 107.253 149.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 43.6 p -125.11 25.17 7.31 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.099 -1.864 . . . . 15.0 111.201 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.27 75.38 0.23 Allowed Glycine 0 C--N 1.272 -2.983 0 CA-C-N 111.17 -2.741 . . . . 15.0 113.187 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' HD11 ' A' ' 253' ' ' LEU . 75.3 t -89.74 119.94 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.161 0.48 . . . . 15.0 111.604 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.911 ' HA ' HD23 ' A' ' 253' ' ' LEU . 6.4 p -134.21 107.32 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 124.817 1.323 . . . . 15.0 108.932 171.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -150.13 150.36 31.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.552 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 37.7 m95 -72.83 -28.69 62.7 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.114 174.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -87.65 134.62 33.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.97 0.414 . . . . 15.0 111.132 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.674 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t70 -52.73 126.97 42.27 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.444 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 252' ' ' PHE . 80.9 Cg_endo -76.96 -14.44 17.04 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.381 2.054 . . . . 15.0 114.052 -173.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.639 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 13.3 tpt180 . . . . . 0 C--N 1.312 -1.053 0 CA-C-O 122.108 0.956 . . . . 15.0 108.465 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.645 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 32.6 t70 . . . . . 0 CA--C 1.557 1.216 0 N-CA-C 113.798 1.036 . . . . 15.0 113.798 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.039 ' HG3' HD13 ' A' ' 253' ' ' LEU . 62.8 Cg_endo -93.04 160.33 2.63 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.513 2.142 . . . . 15.0 112.127 -169.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.088 0 C-N-CA 119.639 -1.267 . . . . 15.0 110.369 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.552 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo . . . . . 0 N--CA 1.462 -0.35 0 CA-C-O 121.887 0.703 . . . . 15.0 113.262 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.633 -0.712 . . . . 15.0 109.523 175.228 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 265' ' ' PRO . 6.4 mt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.456 ' HD3' ' CD ' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.62 160.6 49.14 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 121.925 1.75 . . . . 15.0 110.543 168.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.4 119.4 13.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.548 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 137.18 -17.89 3.55 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.481 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.566 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 67.0 m-85 -103.33 132.01 49.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.596 0.198 . . . . 15.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -108.97 139.29 44.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.78 105.0 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 243' ' ' ARG . 16.4 ttt85 -105.71 138.66 41.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.261 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 m -128.37 117.2 21.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.195 -0.912 . . . . 15.0 109.824 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.848 HG22 ' HB3' ' A' ' 247' ' ' GLN . 2.3 t -90.02 150.3 22.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.945 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 t -54.53 -18.06 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.575 0.702 . . . . 15.0 110.522 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.848 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.4 tp60 -53.02 -24.62 10.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.07 -0.968 . . . . 15.0 111.774 172.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.92 -2.96 52.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.627 -0.797 . . . . 15.0 112.824 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.586 ' NE2' ' HG3' ' A' ' 247' ' ' GLN . 1.2 mp0 -113.35 143.84 43.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.133 0.492 . . . . 15.0 111.486 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.83 136.81 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 15.0 110.161 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -130.68 130.95 44.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.054 0.454 . . . . 15.0 110.529 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.647 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 38.9 m-85 -89.66 109.16 20.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.691 -0.686 . . . . 15.0 111.297 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.009 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -109.37 134.62 51.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.682 1.23 . . . . 15.0 113.716 -176.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.5 t-80 -141.81 105.63 4.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.457 -2.156 . . . . 15.0 107.698 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 22.5 p -104.26 87.75 2.82 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.281 -2.168 . . . . 15.0 111.277 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.468 HE21 HG23 ' A' ' 257' ' ' THR . 16.5 tt0 -101.35 -49.1 4.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.367 -1.742 . . . . 15.0 106.89 146.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' THR . . . . . 0.468 HG23 HE21 ' A' ' 256' ' ' GLN . 24.9 p -126.09 30.92 5.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.006 -1.906 . . . . 15.0 111.557 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.02 76.01 0.17 Allowed Glycine 0 C--N 1.278 -2.685 0 CA-C-N 111.952 -2.385 . . . . 15.0 114.361 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.618 ' O ' HD12 ' A' ' 253' ' ' LEU . 55.6 t -89.81 118.32 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.247 0.524 . . . . 15.0 110.91 171.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.923 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.0 p -132.57 107.3 8.35 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.504 1.128 . . . . 15.0 109.51 172.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.6 t -150.16 150.24 31.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.307 0.855 . . . . 15.0 113.307 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.627 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -67.76 -32.38 72.94 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.901 173.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -87.97 135.74 33.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.582 -0.447 . . . . 15.0 111.351 -168.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.647 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.9 t0 -56.28 128.73 73.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 171.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 236' ' ' LEU . 73.3 Cg_endo -76.57 -14.91 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.834 1.69 . . . . 15.0 113.183 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.456 ' CD ' ' HD3' ' A' ' 237' ' ' PRO . 4.7 tpt180 . . . . . 0 C--N 1.31 -1.137 0 CA-C-O 121.975 0.893 . . . . 15.0 108.998 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.644 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 7.7 m-20 . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 113.855 1.057 . . . . 15.0 113.855 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.009 ' HG3' HD11 ' A' ' 253' ' ' LEU . 63.0 Cg_endo -95.7 160.19 1.48 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.822 2.348 . . . . 15.0 112.77 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.941 0 C-N-CA 119.973 -1.108 . . . . 15.0 111.308 174.622 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.627 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 6.5 Cg_exo . . . . . 0 CA--C 1.528 0.224 0 CA-C-O 121.486 0.536 . . . . 15.0 113.395 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.641 -0.708 . . . . 15.0 109.811 175.236 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.718 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.7 Cg_exo -69.67 161.92 44.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.418 1.412 . . . . 15.0 110.343 166.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -69.44 126.41 29.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.147 -0.933 . . . . 15.0 111.254 -170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 125.42 -14.99 7.25 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.773 -0.727 . . . . 15.0 113.671 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 63.2 m-85 -100.3 136.53 40.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.574 0.687 . . . . 15.0 110.78 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.43 146.18 29.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.716 -0.846 . . . . 15.0 108.716 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 17.4 tm0? -89.78 109.51 20.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -117.33 141.34 48.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.627 0.727 . . . . 15.0 111.096 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.9 m -139.34 117.38 11.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.879 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.822 HG22 ' HB3' ' A' ' 247' ' ' GLN . 3.7 t -89.91 150.29 22.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.06 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.33 -22.72 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.6 0.714 . . . . 15.0 111.085 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.822 ' HB3' HG22 ' A' ' 245' ' ' THR . 8.1 tp-100 -49.55 -24.34 2.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.409 -1.269 . . . . 15.0 111.746 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.5 58.68 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.224 -0.513 . . . . 15.0 111.876 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.584 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 4.5 mt-30 -100.83 135.94 41.48 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.741 -0.466 . . . . 15.0 109.741 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.97 143.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.638 -0.256 . . . . 15.0 110.464 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -135.47 123.47 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 15.0 110.424 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 39.1 m-85 -89.67 110.84 21.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.426 -0.806 . . . . 15.0 110.824 -171.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.03 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.57 132.84 52.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.724 1.25 . . . . 15.0 113.66 -175.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.633 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 4.1 t-80 -144.74 106.99 4.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 112.569 -2.105 . . . . 15.0 108.317 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 12.7 m -102.11 87.78 3.16 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 116.1 -2.24 . . . . 15.0 111.002 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.633 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.5 tt0 -101.38 -53.05 3.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.668 -1.604 . . . . 15.0 106.668 147.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 18.0 p -122.25 26.94 8.21 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 112.664 -2.062 . . . . 15.0 111.364 -174.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.29 75.97 0.2 Allowed Glycine 0 C--N 1.273 -2.931 0 CA-C-N 111.607 -2.542 . . . . 15.0 113.4 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.593 ' O ' HD11 ' A' ' 253' ' ' LEU . 45.4 t -89.81 114.98 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 O-C-N 122.484 -0.421 . . . . 15.0 111.257 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.962 ' HA ' HD21 ' A' ' 253' ' ' LEU . 5.2 p -129.87 108.32 10.05 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.699 1.249 . . . . 15.0 108.858 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.407 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.3 t -150.14 150.23 31.36 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.935 0.717 . . . . 15.0 112.935 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.584 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 56.1 m95 -70.86 -31.85 68.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.487 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.407 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.3 p80 -88.51 134.68 33.79 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.006 0.432 . . . . 15.0 110.937 -170.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.634 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 13.0 t0 -58.5 123.82 68.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.491 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.72 -14.76 36.69 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 C-N-CA 122.099 1.866 . . . . 15.0 112.194 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.718 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.8 tpt180 . . . . . 0 C--N 1.314 -0.974 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.938 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.773 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 29.1 t70 . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 114.021 1.119 . . . . 15.0 114.021 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.03 ' HG3' HD13 ' A' ' 253' ' ' LEU . 51.7 Cg_endo -102.43 160.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 123.667 2.911 . . . . 15.0 114.236 -165.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 110.323 -1.111 . . . . 15.0 110.323 171.867 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.498 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.9 Cg_exo . . . . . 0 CA--C 1.527 0.157 0 CA-C-O 121.37 0.488 . . . . 15.0 113.076 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.791 -0.641 . . . . 15.0 109.824 171.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.227 0 N-CA-C 109.301 -0.629 . . . . 15.0 109.301 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.637 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.39 164.85 32.62 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.328 2.019 . . . . 15.0 110.172 165.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.49 130.52 42.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.851 -172.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 124.9 -34.59 3.38 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.809 -1.087 . . . . 15.0 113.245 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.591 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 53.6 m-85 -83.89 149.45 26.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.165 0.482 . . . . 15.0 110.744 -175.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -116.49 147.27 41.91 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 166.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.474 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.46 102.49 15.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.611 ' HD3' ' CE1' ' A' ' 251' ' ' TYR . 13.6 ttt-85 -102.82 147.61 26.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.136 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.2 m -138.95 118.38 12.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.799 -1.092 . . . . 15.0 108.751 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.719 HG22 ' HB3' ' A' ' 247' ' ' GLN . 3.6 t -96.67 150.23 20.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.641 -0.254 . . . . 15.0 110.422 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.98 -21.63 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.267 0.556 . . . . 15.0 110.854 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.719 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.9 tp-100 -53.08 -23.71 8.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.273 -0.876 . . . . 15.0 111.523 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.25 17.58 39.45 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.154 -0.546 . . . . 15.0 112.318 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.711 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 5.2 mt-30 -125.13 147.43 49.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.01 -0.737 . . . . 15.0 109.01 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.2 130.56 50.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.162 -0.31 . . . . 15.0 110.162 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.611 ' CE1' ' HD3' ' A' ' 243' ' ' ARG . 34.9 p90 -126.99 129.13 47.5 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.531 -0.468 . . . . 15.0 110.626 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.697 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 27.5 m-85 -89.73 111.05 21.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.135 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.093 HD12 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.71 135.86 50.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.712 1.244 . . . . 15.0 113.928 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.661 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 16.1 t-80 -144.35 100.76 3.59 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 112.458 -2.156 . . . . 15.0 107.819 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.667 HG23 ' HA2' ' A' ' 258' ' ' GLY . 2.8 p -102.8 87.41 2.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 116.163 -2.215 . . . . 15.0 110.833 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.661 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.0 tt0 -101.25 -35.73 9.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 113.316 -1.765 . . . . 15.0 108.029 146.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.5 p -139.02 30.64 2.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.916 1.341 . . . . 15.0 111.362 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.667 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 54.5 73.78 0.38 Allowed Glycine 0 C--N 1.279 -2.591 0 CA-C-N 111.936 -2.393 . . . . 15.0 114.603 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.719 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -92.77 115.08 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 117.274 0.537 . . . . 15.0 111.406 171.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.993 ' HA ' HD21 ' A' ' 253' ' ' LEU . 5.4 p -135.49 104.36 5.8 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.573 1.171 . . . . 15.0 109.229 172.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.414 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.22 150.43 31.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 15.0 112.733 -169.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.462 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 39.0 m95 -66.98 -38.05 85.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.639 -0.71 . . . . 15.0 111.166 171.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.414 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.7 p80 -78.41 136.85 37.74 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.121 -0.491 . . . . 15.0 111.177 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.697 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.9 t70 -57.03 127.65 76.12 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.828 -0.805 . . . . 15.0 108.828 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.483 ' HD2' HD12 ' A' ' 236' ' ' LEU . 71.1 Cg_endo -75.87 -14.64 19.25 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.135 1.89 . . . . 15.0 113.039 -174.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.637 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.6 tpt180 . . . . . 0 C--N 1.315 -0.923 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.648 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 18.2 t70 . . . . . 0 CA--C 1.556 1.189 0 N-CA-C 113.322 0.86 . . . . 15.0 113.322 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.093 ' HG3' HD12 ' A' ' 253' ' ' LEU . 48.9 Cg_endo -91.88 160.25 3.37 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.529 2.153 . . . . 15.0 112.411 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.045 0 N-CA-C 110.442 -1.063 . . . . 15.0 110.442 175.409 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.462 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.401 0 CA-C-O 121.776 0.657 . . . . 15.0 112.53 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.0 179.198 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.748 0.309 . . . . 15.0 110.393 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.843 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.2 Cg_exo -69.58 157.24 61.43 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 121.945 1.763 . . . . 15.0 110.506 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.88 121.18 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.976 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 134.49 -14.33 4.5 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.741 -0.742 . . . . 15.0 113.105 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 79.4 m-85 -99.13 129.33 45.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.472 0.636 . . . . 15.0 111.048 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.79 137.13 43.05 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.91 119.32 30.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.179 -0.675 . . . . 15.0 109.179 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.39 132.81 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.559 0.695 . . . . 15.0 111.81 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -120.13 122.5 41.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.338 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.895 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -94.01 150.16 20.59 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.357 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -54.61 -19.28 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.529 0.681 . . . . 15.0 111.157 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.895 ' HB3' HG22 ' A' ' 245' ' ' THR . 4.6 tp-100 -50.1 -24.44 2.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.415 -1.266 . . . . 15.0 111.701 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.67 -1.75 55.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.151 -0.547 . . . . 15.0 112.196 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.673 HE21 ' HG2' ' A' ' 247' ' ' GLN . 5.1 mt-30 -111.29 138.49 47.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.879 0.371 . . . . 15.0 110.418 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.08 136.44 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.625 -0.509 . . . . 15.0 109.625 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -131.73 126.7 35.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.18 0.514 . . . . 15.0 110.957 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.7 m-85 -89.77 113.5 25.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.357 -173.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.126 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -111.82 134.75 53.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 122.842 1.306 . . . . 15.0 114.087 -176.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.556 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.5 t-80 -141.88 103.73 4.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.579 -2.1 . . . . 15.0 107.611 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.8 t -100.14 87.92 3.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 116.287 -2.165 . . . . 15.0 111.056 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.536 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 33.6 tt0 -101.62 -54.43 2.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.311 -1.768 . . . . 15.0 106.712 147.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 38.2 p -119.88 27.23 8.81 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.397 -2.183 . . . . 15.0 111.329 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.07 75.66 0.21 Allowed Glycine 0 C--N 1.274 -2.867 0 CA-C-N 111.315 -2.675 . . . . 15.0 113.698 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' HD12 ' A' ' 253' ' ' LEU . 53.5 t -89.58 114.89 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-N 117.395 0.598 . . . . 15.0 111.028 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.995 ' HA ' HD21 ' A' ' 253' ' ' LEU . 9.1 p -126.44 107.61 10.43 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.965 -1.471 . . . . 15.0 108.79 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.1 p -140.21 149.43 42.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.255 0.835 . . . . 15.0 113.255 -168.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.507 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 21.3 m95 -75.05 -38.52 61.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.457 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -79.11 143.92 35.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.943 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.694 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.6 t70 -62.61 130.16 93.34 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.903 -0.777 . . . . 15.0 108.903 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.7 -14.77 24.43 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 C-N-CA 122.044 1.829 . . . . 15.0 113.775 -173.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.843 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.2 tpt180 . . . . . 0 C--N 1.31 -1.145 0 CA-C-O 122.17 0.986 . . . . 15.0 108.792 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.5 m-20 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.126 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -98.17 160.32 0.81 Allowed 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.889 2.393 . . . . 15.0 112.832 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 N-CA-C 109.776 -1.33 . . . . 15.0 109.776 173.253 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.507 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.4 Cg_exo . . . . . 0 CA--C 1.529 0.239 0 CA-C-O 121.278 0.449 . . . . 15.0 112.202 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.5 -177.382 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.925 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 15.3 Cg_exo -69.62 154.46 68.28 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.095 1.863 . . . . 15.0 110.611 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.81 131.37 44.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.902 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 127.19 -16.47 6.35 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.564 -0.827 . . . . 15.0 112.921 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.6 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 90.2 m-85 -95.22 135.01 37.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.983 0.392 . . . . 15.0 110.267 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -113.7 138.55 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.196 0.522 . . . . 15.0 109.831 170.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.635 HE22 HG23 ' A' ' 244' ' ' THR . 1.1 tm0? -89.87 107.36 19.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.715 -0.846 . . . . 15.0 108.715 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -103.55 135.79 44.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.325 0.583 . . . . 15.0 111.816 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' THR . . . . . 0.635 HG23 HE22 ' A' ' 242' ' ' GLN . 0.9 OUTLIER -117.29 115.21 24.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.596 -1.184 . . . . 15.0 110.41 177.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.888 HG21 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -89.95 150.34 22.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 15.0 109.684 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.9 t -51.5 -24.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.4 0.619 . . . . 15.0 110.071 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.888 ' HB3' HG21 ' A' ' 245' ' ' THR . 4.4 tp-100 -50.2 -31.37 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.964 -1.016 . . . . 15.0 111.588 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.36 19.94 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.107 -0.568 . . . . 15.0 113.31 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.656 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.6 mt-30 -127.02 141.35 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.04 0.42 . . . . 15.0 110.26 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.9 m -92.39 127.33 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.483 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -128.51 130.35 47.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.881 0.372 . . . . 15.0 110.204 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.4 m-85 -89.9 110.48 21.42 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.488 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.053 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.13 133.21 52.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.711 1.243 . . . . 15.0 113.899 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.6 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.0 t-80 -143.64 95.23 2.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.655 -2.066 . . . . 15.0 107.918 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.3 m -90.4 87.91 6.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 116.512 -2.075 . . . . 15.0 110.141 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -101.15 -49.62 4.04 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 112.891 -1.959 . . . . 15.0 108.212 153.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.7 t -135.28 23.67 3.49 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-N 112.736 -2.029 . . . . 15.0 108.506 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 60.92 74.32 0.39 Allowed Glycine 0 C--N 1.279 -2.585 0 CA-C-N 109.785 -3.371 . . . . 15.0 112.909 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.558 ' O ' HD12 ' A' ' 253' ' ' LEU . 67.4 t -89.15 115.7 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 119.51 -0.876 . . . . 15.0 111.199 168.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.99 ' HA ' HD21 ' A' ' 253' ' ' LEU . 3.7 p -131.22 104.41 7.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.533 -1.667 . . . . 15.0 109.026 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.9 t -150.24 150.33 31.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.764 0.653 . . . . 15.0 112.764 -168.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 69.8 m95 -70.92 -34.34 71.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.136 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -81.59 136.27 35.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.11 -168.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.666 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 11.5 t70 -54.35 130.5 61.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 15.0 109.443 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.94 -14.79 16.92 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 C-N-CA 122.202 1.934 . . . . 15.0 114.179 -171.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.925 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpm_? . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 122.372 1.082 . . . . 15.0 108.645 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.591 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.555 1.151 0 N-CA-C 113.269 0.84 . . . . 15.0 113.269 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 1.053 ' HG3' HD11 ' A' ' 253' ' ' LEU . 42.2 Cg_endo -90.18 160.63 4.74 Favored 'Trans proline' 0 C--N 1.369 1.605 0 C-N-CA 122.882 2.388 . . . . 15.0 111.241 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.011 0 C-N-CA 119.334 -1.413 . . . . 15.0 110.699 179.276 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 5.7 Cg_exo . . . . . 0 N--CA 1.461 -0.4 0 CA-C-O 120.998 0.332 . . . . 15.0 112.694 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 15.0 110.049 179.332 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.633 HD13 ' HD2' ' A' ' 265' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.085 0.469 . . . . 15.0 110.242 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.696 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.6 Cg_exo -69.37 145.54 59.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.881 1.72 . . . . 15.0 108.561 161.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.54 96.44 0.92 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.128 0.966 . . . . 15.0 112.358 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 163.28 32.09 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 113.45 -1.705 . . . . 15.0 112.607 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 265' ' ' PRO . 82.7 m-85 -140.99 125.69 17.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 5.9 pt-20 -97.45 134.25 40.95 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.203 0.525 . . . . 15.0 109.986 175.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -89.7 111.6 22.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -120.3 129.78 54.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.345 0.593 . . . . 15.0 111.592 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.0 m -123.04 124.44 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.619 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.579 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 0.1 OUTLIER -89.86 150.46 22.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.433 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.57 -24.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.46 0.648 . . . . 15.0 110.283 174.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HG3' ' HG3' ' A' ' 249' ' ' GLN . 3.3 tp-100 -47.8 -35.52 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.823 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.16 31.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.039 -0.601 . . . . 15.0 112.798 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.701 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 9.0 mt-30 -107.19 149.77 27.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 15.0 110.69 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.04 136.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.323 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -131.57 126.76 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.3 m-85 -89.74 109.94 20.89 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.139 -172.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.952 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -104.96 133.16 50.22 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 122.925 1.345 . . . . 15.0 113.28 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.8 OUTLIER -142.18 96.35 2.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 112.571 -2.104 . . . . 15.0 107.833 -178.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 t -104.11 87.73 2.84 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 115.662 -2.415 . . . . 15.0 111.18 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 16.4 tt0 -100.93 -31.55 11.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 112.401 -2.181 . . . . 15.0 108.245 145.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.9 t -144.28 24.84 1.58 Allowed 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 123.655 1.693 . . . . 15.0 110.014 -166.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 50.73 70.38 0.86 Allowed Glycine 0 C--N 1.274 -2.904 0 CA-C-N 110.006 -3.27 . . . . 15.0 113.883 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 56.4 t -89.23 116.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 119.853 -0.739 . . . . 15.0 111.629 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.926 ' HA ' HD22 ' A' ' 253' ' ' LEU . 3.7 p -129.18 105.44 8.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.905 -1.498 . . . . 15.0 109.131 170.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 150.17 31.46 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.713 0.635 . . . . 15.0 112.713 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.517 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 55.8 m95 -69.02 -32.91 72.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 15.0 112.102 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -88.0 139.4 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 15.0 111.708 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.588 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.6 t0 -58.55 123.25 66.04 Favored Pre-proline 0 C--O 1.215 -0.745 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.633 ' HD2' HD13 ' A' ' 236' ' ' LEU . 16.8 Cg_exo -68.54 -14.48 39.76 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 121.983 1.789 . . . . 15.0 113.598 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.696 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.3 tpt180 . . . . . 0 C--N 1.309 -1.156 0 CA-C-O 122.095 0.95 . . . . 15.0 108.752 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.739 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.1 p-10 . . . . . 0 CA--C 1.555 1.16 0 N-CA-C 113.964 1.098 . . . . 15.0 113.964 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.952 ' HG3' HD13 ' A' ' 253' ' ' LEU . 95.7 Cg_endo -97.39 160.37 0.97 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.962 2.441 . . . . 15.0 112.664 -167.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.836 0 N-CA-C 109.8 -1.32 . . . . 15.0 109.8 173.478 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.517 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo . . . . . 0 N--CA 1.463 -0.267 0 CA-C-O 121.743 0.643 . . . . 15.0 113.414 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.422 -0.808 . . . . 15.0 109.257 173.803 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.482 HD21 ' N ' ' A' ' 236' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.325 0 N-CA-C 109.986 -0.375 . . . . 15.0 109.986 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 0.671 ' HG3' HH11 ' A' ' 266' ' ' ARG . 17.4 Cg_exo -69.51 154.32 68.88 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.566 1.51 . . . . 15.0 109.413 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.76 121.54 17.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.391 0.615 . . . . 15.0 110.869 -170.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.74 -21.57 2.86 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.095 -0.957 . . . . 15.0 111.853 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.609 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 75.8 m-85 -96.69 128.82 44.0 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.64 0.257 . . . . 15.0 110.413 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -102.19 130.83 48.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 172.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.75 116.02 27.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.154 0.502 . . . . 15.0 109.924 -174.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.502 ' HD3' ' CE2' ' A' ' 251' ' ' TYR . 0.0 OUTLIER -101.07 150.02 23.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.037 -173.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.0 p -129.26 98.02 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.311 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -89.93 150.07 22.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.517 -0.765 . . . . 15.0 112.148 -168.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.09 -20.45 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 15.0 110.521 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 247' ' ' GLN . 11.1 mm100 -57.65 -22.25 44.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.633 -1.167 . . . . 15.0 111.524 173.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.34 23.21 48.8 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.36 -1.096 . . . . 15.0 110.36 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.3 mm100 -130.3 150.36 51.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.482 -0.859 . . . . 15.0 108.938 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -110.67 107.55 23.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.15 0.5 . . . . 15.0 110.676 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.502 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 51.3 p90 -98.67 125.52 44.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.299 0.571 . . . . 15.0 111.076 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.733 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.1 m-85 -90.01 113.12 24.75 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.634 -0.712 . . . . 15.0 111.622 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 1.032 HD23 ' HA ' ' A' ' 260' ' ' SER . 0.3 OUTLIER -110.39 134.39 52.35 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.804 1.288 . . . . 15.0 113.45 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -141.75 99.38 3.53 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.534 -2.121 . . . . 15.0 108.05 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.1 t -92.44 87.87 6.16 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.068 -2.253 . . . . 15.0 110.425 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.79 -44.99 5.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 112.654 -2.066 . . . . 15.0 108.168 151.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 12.9 t -139.8 24.44 2.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.092 1.901 . . . . 15.0 108.424 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.18 0.37 Allowed Glycine 0 C--N 1.28 -2.546 0 CA-C-N 109.858 -3.337 . . . . 15.0 112.722 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 253' ' ' LEU . 62.9 t -89.29 115.5 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 119.757 -0.777 . . . . 15.0 111.882 169.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 1.032 ' HA ' HD23 ' A' ' 253' ' ' LEU . 10.4 p -126.36 112.02 15.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.652 -1.613 . . . . 15.0 108.014 168.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 12.8 t -149.93 150.43 31.86 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.646 0.98 . . . . 15.0 113.646 -167.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.591 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 4.0 m95 -75.15 -21.34 58.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.529 -1.214 . . . . 15.0 112.548 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.435 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.1 p80 -101.42 144.01 30.74 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.518 -0.473 . . . . 15.0 111.578 -172.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.733 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.1 t70 -60.46 123.32 73.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.455 -0.942 . . . . 15.0 108.455 170.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 8.7 Cg_exo -71.29 -14.68 31.43 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 121.863 1.709 . . . . 15.0 113.792 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 0.671 HH11 ' HG3' ' A' ' 237' ' ' PRO . 17.4 tpt180 . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 6.6 t70 . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 112.683 0.623 . . . . 15.0 112.683 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.972 ' HG3' HD11 ' A' ' 253' ' ' LEU . 39.7 Cg_endo -92.68 160.26 2.85 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.069 1.846 . . . . 15.0 112.244 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 178.852 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.591 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 8.1 Cg_exo . . . . . 0 C--O 1.223 -0.238 0 N-CA-C 114.719 1.007 . . . . 15.0 114.719 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 114.614 -1.175 . . . . 15.0 108.764 170.414 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.186 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . 1.02 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 10.4 Cg_exo -69.82 163.7 37.36 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.589 2.193 . . . . 15.0 110.822 165.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -69.81 124.31 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.817 -1.083 . . . . 15.0 112.137 -172.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 122.62 -2.12 10.22 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.583 -0.818 . . . . 15.0 114.7 170.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.1 m-85 -99.41 130.43 45.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.991 0.895 . . . . 15.0 110.581 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -104.65 138.35 41.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 173.54 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' GLN . . . . . 0.583 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -89.92 106.18 18.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 15.0 109.501 -179.327 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' ARG . . . . . 0.553 ' HB2' ' OE1' ' A' ' 241' ' ' GLU . 27.8 ttt85 -104.06 139.87 38.56 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.458 -0.792 . . . . 15.0 111.884 -174.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -130.6 103.12 6.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.55 -1.204 . . . . 15.0 110.078 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -90.01 150.34 22.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.942 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.08 -17.69 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.344 0.593 . . . . 15.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 247' ' ' GLN . . . . . 0.651 ' HB3' HG21 ' A' ' 245' ' ' THR . 6.2 tp-100 -55.45 -23.8 27.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.506 -0.77 . . . . 15.0 111.076 172.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.6 -0.62 65.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.044 -0.598 . . . . 15.0 112.92 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 15.8 mt-30 -115.24 149.27 38.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.054 -0.35 . . . . 15.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.2 m -97.49 135.0 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.786 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.433 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 47.3 p90 -131.36 125.28 32.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.104 0.478 . . . . 15.0 110.29 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.672 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.81 112.29 23.56 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.517 -0.765 . . . . 15.0 111.445 -173.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.961 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -109.34 134.16 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.943 1.354 . . . . 15.0 114.243 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 254' ' ' HIS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 13.5 t-80 -137.84 97.89 3.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 112.561 -2.108 . . . . 15.0 107.578 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 255' ' ' THR . . . . . 0.54 HG21 ' HA2' ' A' ' 258' ' ' GLY . 1.2 p -97.42 87.52 4.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.074 -2.25 . . . . 15.0 110.836 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.419 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 35.3 tt0 -101.52 -54.14 2.82 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.14 -1.8 . . . . 15.0 106.14 147.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 30.5 p -118.06 25.88 10.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.47 -2.15 . . . . 15.0 111.331 -177.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 258' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 255' ' ' THR . . . 51.99 76.6 0.17 Allowed Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.269 -2.696 . . . . 15.0 113.736 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 253' ' ' LEU . 43.5 t -90.1 115.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.157 0.479 . . . . 15.0 110.995 171.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.895 ' HA ' HD23 ' A' ' 253' ' ' LEU . 7.4 p -124.09 103.39 8.26 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 124.59 1.181 . . . . 15.0 109.025 172.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.6 p -138.03 150.08 46.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.881 0.697 . . . . 15.0 112.881 -169.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 262' ' ' TRP . . . . . 0.401 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 36.6 m95 -78.78 -29.03 44.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.307 -0.86 . . . . 15.0 110.288 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -88.29 141.17 28.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.671 . . . . 15.0 110.801 -173.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 264' ' ' ASP . . . . . 0.672 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.3 t70 -55.97 131.37 73.7 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.503 -0.925 . . . . 15.0 108.503 171.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -14.58 28.95 Favored 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.032 1.821 . . . . 15.0 113.996 -172.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 266' ' ' ARG . . . . . 1.02 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.0 tpm_? . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 122.124 0.964 . . . . 15.0 109.161 177.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 211' ' ' ASP . . . . . 0.58 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 113.965 1.098 . . . . 15.0 113.965 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 212' ' ' PRO . . . . . 0.961 ' HG3' HD11 ' A' ' 253' ' ' LEU . 29.4 Cg_endo -95.25 160.49 1.62 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.937 2.425 . . . . 15.0 112.218 -173.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.086 0 C-N-CA 119.925 -1.131 . . . . 15.0 110.906 179.906 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 215' ' ' PRO . . . . . 0.401 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo . . . . . 0 CA--C 1.532 0.39 0 N-CA-C 113.658 0.599 . . . . 15.0 113.658 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 15.0 109.945 175.117 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.113 -0.328 . . . . 15.0 110.113 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -119.32 163.51 26.49 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 15.0 109.63 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.692 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.4 Cg_exo -69.65 150.65 69.14 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.732 1.622 . . . . 15.0 108.961 163.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.83 141.87 53.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.551 0.691 . . . . 15.0 110.905 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.78 -22.74 6.8 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.21 -0.904 . . . . 15.0 112.334 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.593 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.7 m-85 -95.85 138.53 33.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 110.049 -0.352 . . . . 15.0 110.049 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.7 145.2 32.3 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.776 -0.824 . . . . 15.0 108.776 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.67 102.65 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -112.65 135.24 53.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 15.0 111.047 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -131.1 135.13 47.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.61 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.712 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -112.4 150.1 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.272 -0.422 . . . . 15.0 110.383 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.07 -16.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.705 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.712 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.5 tp60 -52.96 -18.91 2.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.188 -0.915 . . . . 15.0 111.232 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.63 2.47 67.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.999 -0.619 . . . . 15.0 112.169 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.502 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 33.3 mt-30 -124.07 150.03 45.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.465 -0.568 . . . . 15.0 109.465 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.22 138.07 30.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.067 -0.346 . . . . 15.0 110.067 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -126.07 123.24 37.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.145 0.498 . . . . 15.0 110.036 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.725 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 17.9 m-85 -89.57 111.8 22.83 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 115.626 -0.716 . . . . 15.0 111.188 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.055 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.95 133.36 53.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.913 1.34 . . . . 15.0 113.986 -176.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.593 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.0 t-80 -144.49 96.87 2.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 112.474 -2.148 . . . . 15.0 107.779 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.492 HG22 ' HA2' ' A' ' 258' ' ' GLY . 5.1 p -96.09 87.69 4.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.256 -2.177 . . . . 15.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 45.4 tt0 -101.73 -53.21 3.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.151 -1.84 . . . . 15.0 106.597 150.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.1 p -120.47 26.82 8.94 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 112.322 -2.217 . . . . 15.0 111.01 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.492 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.1 74.04 0.35 Allowed Glycine 0 C--N 1.273 -2.953 0 CA-C-N 111.262 -2.699 . . . . 15.0 113.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.599 ' O ' HD11 ' A' ' 253' ' ' LEU . 53.0 t -90.03 115.58 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 117.286 0.543 . . . . 15.0 111.655 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.952 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.7 p -128.32 105.4 8.31 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.774 1.296 . . . . 15.0 108.863 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.4 p -141.42 150.19 42.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.502 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 32.6 m95 -75.55 -32.49 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.449 -0.796 . . . . 15.0 111.009 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -85.35 140.49 30.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.171 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.952 ' HB3' HG12 ' A' ' 267' ' ' ILE . 11.2 t70 -59.51 123.79 72.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.485 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 12.2 Cg_exo -71.38 -14.47 31.07 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.965 1.777 . . . . 15.0 113.622 -172.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.692 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 12.4 tpt180 -78.68 -9.64 59.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.526 -0.916 . . . . 15.0 108.526 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.952 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.6 pt . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.22 -1.355 . . . . 15.0 110.744 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 121.468 0.652 . . . . 15.0 110.3 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.3 p -148.39 104.15 3.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.582 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.655 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.664 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.3 m-20 -102.21 -15.56 0.18 Allowed Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 114.278 1.214 . . . . 15.0 114.278 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.055 ' HG3' HD13 ' A' ' 253' ' ' LEU . 55.6 Cg_endo -99.44 160.57 0.58 Allowed 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.542 2.828 . . . . 15.0 112.559 -171.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.37 160.19 29.1 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.133 -1.187 . . . . 15.0 110.133 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.428 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.3 Cg_exo -89.02 147.72 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.964 3.109 . . . . 15.0 113.191 -170.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.07 10.35 34.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.004 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.523 -0.751 . . . . 15.0 110.39 -178.033 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.695 -0.484 . . . . 15.0 109.695 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.642 HD23 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mt -90.1 157.71 45.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.806 -0.442 . . . . 15.0 109.806 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.63 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 14.3 Cg_exo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.588 1.525 . . . . 15.0 109.971 166.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.7 122.28 18.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.838 0.828 . . . . 15.0 111.645 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.82 -18.47 2.98 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.039 -1.437 . . . . 15.0 111.329 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.634 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 85.0 m-85 -100.91 138.89 37.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 15.0 110.53 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.418 ' CD ' ' H3 ' ' B' ' 208' ' ' THR . 10.2 pt-20 -112.27 137.89 49.75 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.314 -0.625 . . . . 15.0 109.314 169.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 97.93 11.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.606 HH11 ' HG2' ' A' ' 243' ' ' ARG . 2.3 ttt-85 -94.53 120.49 34.84 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.527 -0.761 . . . . 15.0 111.612 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -108.25 106.41 16.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 15.0 110.118 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.911 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -90.11 150.29 22.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.952 -0.567 . . . . 15.0 109.622 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.5 t -50.9 -24.41 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.377 0.608 . . . . 15.0 110.703 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.911 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.1 tp-100 -45.72 -34.74 3.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.837 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.01 -15.31 44.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.328 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.549 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 1.3 mp0 -97.64 132.19 43.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.976 0.417 . . . . 15.0 111.021 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.26 127.77 43.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.026 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.606 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 14.9 p90 -122.02 130.41 53.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.921 0.391 . . . . 15.0 110.741 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.684 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 30.8 m-85 -89.74 107.13 18.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.461 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.006 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -109.11 133.75 52.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.866 1.317 . . . . 15.0 113.674 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.634 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -140.2 104.04 4.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 112.451 -2.158 . . . . 15.0 108.042 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.9 p -98.13 87.73 4.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.386 -2.126 . . . . 15.0 110.918 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -101.43 -53.04 3.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.529 -1.656 . . . . 15.0 106.529 147.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -121.69 25.79 9.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 112.536 -2.12 . . . . 15.0 111.369 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 51.87 75.99 0.2 Allowed Glycine 0 C--N 1.27 -3.105 0 CA-C-N 111.144 -2.753 . . . . 15.0 113.431 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.653 ' O ' HD12 ' A' ' 253' ' ' LEU . 59.1 t -89.71 113.97 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.315 0.558 . . . . 15.0 111.678 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.878 ' HA ' HD21 ' A' ' 253' ' ' LEU . 8.1 p -125.35 107.05 10.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.265 -1.334 . . . . 15.0 109.069 173.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 150.45 31.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.173 0.805 . . . . 15.0 113.173 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 3.8 m95 -75.78 -21.35 57.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.946 -1.025 . . . . 15.0 112.018 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -95.61 135.49 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.556 -0.458 . . . . 15.0 111.116 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.979 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t0 -56.73 124.19 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.563 -0.903 . . . . 15.0 108.563 170.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.642 ' HD2' HD23 ' A' ' 236' ' ' LEU . 10.3 Cg_exo -71.61 -14.78 30.51 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.363 2.042 . . . . 15.0 113.591 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.63 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 9.8 tpt180 -79.43 -10.06 59.73 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 174.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.979 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.6 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-N 114.398 -1.274 . . . . 15.0 110.305 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.418 ' H3 ' ' CD ' ' A' ' 241' ' ' GLU . 13.4 t . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 111.426 0.158 . . . . 15.0 111.426 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.8 m -116.15 105.15 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.658 0.265 . . . . 15.0 110.373 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.904 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 56.6 m-20 -84.51 -25.24 0.36 Allowed Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 112.958 0.725 . . . . 15.0 112.958 167.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.006 ' HG3' HD11 ' A' ' 253' ' ' LEU . 19.4 Cg_endo -97.94 160.57 0.85 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.004 2.469 . . . . 15.0 111.635 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.05 28.66 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.416 -1.074 . . . . 15.0 110.416 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.463 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.494 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo -89.11 128.27 1.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.827 3.018 . . . . 15.0 113.798 -170.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -89.35 91.38 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.545 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.706 -0.664 . . . . 15.0 110.156 -179.123 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.017 0.437 . . . . 15.0 110.473 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.51 HD11 ' HD2' ' A' ' 265' ' ' PRO . 2.1 mm? -94.16 171.73 6.56 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 15.0 109.941 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.739 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.1 Cg_exo -69.42 147.71 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.561 1.508 . . . . 15.0 109.172 161.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.51 116.07 9.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.453 0.644 . . . . 15.0 111.83 -167.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 147.87 -16.91 1.4 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.844 -1.071 . . . . 15.0 112.122 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 92.6 m-85 -94.9 132.48 39.68 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.722 -0.281 . . . . 15.0 110.567 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.68 142.87 35.62 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.509 -0.552 . . . . 15.0 109.509 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -90.0 119.59 30.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -124.77 137.21 54.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.481 0.658 . . . . 15.0 111.123 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 m -129.4 126.16 38.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.276 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.806 HG21 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -93.11 150.15 20.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.246 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.3 m -54.52 -21.21 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.559 0.695 . . . . 15.0 110.599 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.806 ' HB3' HG21 ' A' ' 245' ' ' THR . 3.4 tp-100 -47.66 -32.61 5.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.582 -1.19 . . . . 15.0 111.488 170.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.3 19.18 21.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.036 -0.602 . . . . 15.0 112.635 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.68 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.2 mt-30 -127.14 147.83 50.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.43 136.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.336 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -134.51 125.71 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.67 -0.492 . . . . 15.0 109.67 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.688 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -89.65 112.63 23.92 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.58 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.081 HD12 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -107.44 133.42 51.97 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.804 1.288 . . . . 15.0 113.494 -177.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -145.35 103.17 3.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.587 -2.097 . . . . 15.0 108.424 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.9 t -99.21 87.79 3.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 116.162 -2.215 . . . . 15.0 111.005 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 59.4 tt0 -101.27 -51.73 3.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.31 -1.768 . . . . 15.0 106.597 149.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 44.8 p -121.66 24.81 9.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.425 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.2 0.34 Allowed Glycine 0 C--N 1.27 -3.138 0 CA-C-N 111.278 -2.692 . . . . 15.0 113.7 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.605 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.1 t -89.97 119.54 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 117.253 0.526 . . . . 15.0 111.622 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.951 ' HA ' HD22 ' A' ' 253' ' ' LEU . 4.6 p -131.76 109.11 9.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.396 -1.275 . . . . 15.0 108.677 169.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.424 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.0 t -150.17 150.11 31.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.098 0.777 . . . . 15.0 113.098 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.463 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 33.8 m95 -71.06 -29.64 65.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.011 -0.995 . . . . 15.0 111.917 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.464 ' CE1' ' HA ' ' A' ' 265' ' ' PRO . 4.3 p80 -90.61 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.597 -0.441 . . . . 15.0 111.271 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.949 ' HB3' HG12 ' A' ' 267' ' ' ILE . 12.3 t70 -56.65 120.43 36.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.02 -1.104 . . . . 15.0 108.02 168.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.533 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 Cg_exo -69.72 -14.61 36.47 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.247 1.965 . . . . 15.0 113.72 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.739 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.0 tpt180 -78.63 -10.61 59.81 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.949 HG12 ' HB3' ' A' ' 264' ' ' ASP . 38.9 pt . . . . . 0 C--O 1.253 1.272 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.831 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 111.981 0.363 . . . . 15.0 111.981 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.6 p -137.5 116.79 12.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 110.808 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.763 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.668 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 5.7 p-10 -104.48 -14.65 0.16 Allowed Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.081 ' HG3' HD12 ' A' ' 253' ' ' LEU . 82.0 Cg_endo -94.3 160.59 2.03 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.292 2.661 . . . . 15.0 112.014 -170.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.4 160.05 28.95 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.286 -1.435 . . . . 15.0 110.052 174.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.435 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 6.1 Cg_exo -89.06 150.38 5.7 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.444 2.762 . . . . 15.0 112.817 -172.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -108.8 4.03 23.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.591 0.71 . . . . 15.0 109.385 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 115.02 -0.991 . . . . 15.0 110.193 -175.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.825 0.345 . . . . 15.0 110.541 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.499 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.3 OUTLIER -98.52 158.32 32.77 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.563 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.46 144.93 57.29 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.947 1.765 . . . . 15.0 110.182 172.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.6 124.75 24.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.716 0.77 . . . . 15.0 111.875 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.36 -20.19 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.477 -1.238 . . . . 15.0 111.884 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.542 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.5 m-85 -91.12 126.23 36.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.534 ' HB2' HG21 ' B' ' 208' ' ' THR . 7.8 pt-20 -97.87 129.04 44.84 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.68 103.54 16.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.502 0.668 . . . . 15.0 109.347 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -105.15 139.65 39.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.915 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 m -131.23 108.91 10.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.687 HG22 ' HB3' ' A' ' 247' ' ' GLN . 2.8 t -94.78 150.25 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.418 -0.355 . . . . 15.0 110.728 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.3 -18.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.885 0.85 . . . . 15.0 111.074 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.687 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.6 tp-100 -48.67 -23.59 1.08 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.043 -1.435 . . . . 15.0 111.534 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.67 10.46 61.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.754 -0.538 . . . . 15.0 111.754 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.497 HE21 ' HG3' ' A' ' 247' ' ' GLN . 28.1 mt-30 -129.83 139.79 51.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.6 m -100.68 124.07 54.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.029 0.442 . . . . 15.0 110.385 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -109.58 127.52 54.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.132 0.491 . . . . 15.0 110.092 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.728 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 22.5 m-85 -89.54 107.57 19.16 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.591 -0.731 . . . . 15.0 111.116 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.106 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -106.83 133.96 50.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.734 1.254 . . . . 15.0 113.551 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 11.1 t-80 -142.91 102.76 4.08 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 112.703 -2.044 . . . . 15.0 107.865 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 25.1 m -102.1 88.06 3.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 115.874 -2.331 . . . . 15.0 110.931 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.562 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.8 tt0 -101.17 -47.78 4.62 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.415 -1.721 . . . . 15.0 107.027 146.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 36.0 p -124.83 25.11 7.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 113.521 -1.672 . . . . 15.0 111.399 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.23 74.49 0.31 Allowed Glycine 0 C--N 1.272 -2.984 0 CA-C-N 111.137 -2.756 . . . . 15.0 113.552 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 253' ' ' LEU . 56.1 t -89.83 120.25 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 117.239 0.519 . . . . 15.0 110.982 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.918 ' HA ' HD23 ' A' ' 253' ' ' LEU . 6.3 p -135.84 105.68 6.21 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 124.519 1.137 . . . . 15.0 109.244 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.46 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.2 150.35 31.48 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.479 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 18.6 m95 -68.81 -30.97 69.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.204 -0.907 . . . . 15.0 111.264 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.46 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.6 p80 -86.15 137.11 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.992 0.425 . . . . 15.0 111.173 -170.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.949 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.7 t0 -58.41 125.3 75.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.586 -0.894 . . . . 15.0 108.586 171.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 23.1 Cg_exo -68.3 -14.72 41.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 122.543 2.162 . . . . 15.0 113.865 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.563 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpt180 -81.92 -6.64 59.27 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.949 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.9 pt . . . . . 0 C--O 1.248 1.023 0 CA-C-N 113.852 -1.522 . . . . 15.0 110.861 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.534 HG21 ' HB2' ' A' ' 241' ' ' GLU . 28.5 p . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.973 -0.381 . . . . 15.0 109.973 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 17.7 m -127.37 105.61 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.034 0.445 . . . . 15.0 109.836 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.698 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 23.0 t70 -90.55 -20.61 0.25 Allowed Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.106 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.3 Cg_endo -97.18 160.26 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.671 2.247 . . . . 15.0 111.919 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.57 158.02 27.09 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 119.626 -1.273 . . . . 15.0 110.566 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.496 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.2 Cg_exo -89.15 147.97 5.49 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 124.012 3.141 . . . . 15.0 113.334 -173.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.86 -4.19 21.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.516 -0.765 . . . . 15.0 109.552 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.161 -0.923 . . . . 15.0 110.528 -178.31 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.168 -0.308 . . . . 15.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.2 mm? -90.0 166.99 18.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.28 0.562 . . . . 15.0 110.927 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.714 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.7 Cg_exo -69.28 159.28 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.254 1.969 . . . . 15.0 109.701 161.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -69.49 123.95 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.542 0.686 . . . . 15.0 111.547 -172.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.47 4.64 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.775 -1.102 . . . . 15.0 113.203 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 78.2 m-85 -97.4 130.77 44.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.319 0.56 . . . . 15.0 111.004 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.5 140.06 43.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.532 ' NE2' ' HB ' ' A' ' 250' ' ' VAL . 8.9 tp60 -89.66 143.76 26.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.615 -0.883 . . . . 15.0 108.615 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.445 ' H ' HE21 ' A' ' 242' ' ' GLN . 8.9 ttt180 -139.84 131.61 27.45 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.802 -0.636 . . . . 15.0 110.886 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 p -115.01 111.58 21.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.719 -1.128 . . . . 15.0 110.185 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.88 HG22 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.9 150.22 22.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.027 -0.533 . . . . 15.0 109.667 176.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.51 -24.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.381 0.61 . . . . 15.0 110.533 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.88 ' HB3' HG22 ' A' ' 245' ' ' THR . 4.1 tp-100 -47.58 -38.91 15.37 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.622 -1.172 . . . . 15.0 111.931 170.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.17 5.02 35.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.752 -0.737 . . . . 15.0 113.526 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.688 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.5 mt-30 -113.58 137.71 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.196 0.498 . . . . 15.0 111.037 -175.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.532 ' HB ' ' NE2' ' A' ' 242' ' ' GLN . 10.3 m -90.05 121.26 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.579 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -121.16 130.1 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.882 -0.327 . . . . 15.0 110.605 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 23.6 m-85 -89.82 110.18 21.13 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.505 -174.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.085 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -108.97 132.58 53.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.776 1.274 . . . . 15.0 114.086 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.599 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -140.75 101.24 4.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.702 -2.044 . . . . 15.0 107.884 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.4 t -99.07 87.54 3.71 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 116.087 -2.245 . . . . 15.0 110.667 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.472 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 47.5 tt0 -101.28 -50.66 3.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.142 -1.844 . . . . 15.0 106.753 149.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 32.0 p -124.19 25.19 7.89 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 112.794 -2.003 . . . . 15.0 111.142 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.78 75.15 0.25 Allowed Glycine 0 C--N 1.273 -2.942 0 CA-C-N 111.014 -2.812 . . . . 15.0 113.554 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.67 ' O ' HD11 ' A' ' 253' ' ' LEU . 41.1 t -89.72 117.26 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-N 117.287 0.543 . . . . 15.0 111.23 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.915 ' HA ' HD22 ' A' ' 253' ' ' LEU . 7.6 p -127.72 108.82 11.08 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 124.326 1.016 . . . . 15.0 109.061 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.5 t -150.16 150.33 31.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.596 0.591 . . . . 15.0 112.596 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.41 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 77.1 m95 -76.52 -25.68 54.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.578 -0.737 . . . . 15.0 111.054 174.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -90.49 132.21 35.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 15.0 111.072 -171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.871 ' HB3' HG12 ' A' ' 267' ' ' ILE . 8.9 t70 -53.26 122.12 28.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 169.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 236' ' ' LEU . 10.1 Cg_exo -71.65 -14.52 30.26 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 122.113 1.875 . . . . 15.0 113.924 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.714 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.7 tpt180 -80.0 -7.33 58.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.77 0.795 . . . . 15.0 109.105 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.871 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.248 0.994 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.115 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.228 0.537 . . . . 15.0 110.262 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 m -136.68 115.37 12.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 15.0 110.772 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.625 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 28.2 m-20 -84.87 -18.04 0.24 Allowed Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 114.117 1.154 . . . . 15.0 114.117 172.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.085 ' HG3' HD13 ' A' ' 253' ' ' LEU . 35.6 Cg_endo -96.89 160.85 1.08 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 123.091 2.527 . . . . 15.0 111.9 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.37 29.13 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.434 -1.466 . . . . 15.0 109.434 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.436 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.6 Cg_exo -89.13 160.17 5.77 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 124.111 3.207 . . . . 15.0 112.85 -170.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -112.13 -2.39 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.332 0.587 . . . . 15.0 110.185 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.827 -176.686 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.43 -0.211 . . . . 15.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.445 HD21 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -121.67 173.74 3.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 1.015 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 22.5 Cg_exo -69.56 159.15 54.64 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.062 1.841 . . . . 15.0 110.702 165.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.98 123.87 22.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.904 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.49 -14.46 6.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.548 -0.834 . . . . 15.0 112.837 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.658 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.8 m-85 -94.67 131.16 40.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.911 0.355 . . . . 15.0 110.334 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 131.35 44.12 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.43 -0.952 . . . . 15.0 108.43 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -89.72 99.11 12.18 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -106.97 119.32 39.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.004 -0.998 . . . . 15.0 111.379 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.9 m -115.77 111.04 19.94 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 15.0 109.337 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.852 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.8 150.06 22.42 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.42 -21.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.388 0.613 . . . . 15.0 111.561 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.852 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.499 -1.228 . . . . 15.0 111.58 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.4 -8.84 28.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.896 -0.669 . . . . 15.0 112.561 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.528 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 9.2 mt-30 -112.41 143.52 43.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.86 0.362 . . . . 15.0 110.483 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.51 135.03 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -126.66 125.29 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.971 0.415 . . . . 15.0 109.902 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.633 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 21.4 m-85 -89.78 109.92 20.88 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.111 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.984 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.38 131.07 54.02 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.727 1.251 . . . . 15.0 114.053 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.658 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 15.8 t-80 -141.38 93.72 2.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 112.768 -2.014 . . . . 15.0 107.7 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 29.9 m -93.85 87.78 5.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 115.99 -2.284 . . . . 15.0 110.09 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -101.38 -52.91 3.13 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.117 -1.856 . . . . 15.0 106.233 150.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 45.2 p -118.01 24.75 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.437 -2.165 . . . . 15.0 110.904 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.19 73.19 0.44 Allowed Glycine 0 C--N 1.27 -3.096 0 CA-C-N 110.965 -2.834 . . . . 15.0 113.836 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.671 ' O ' HD11 ' A' ' 253' ' ' LEU . 53.4 t -90.01 115.01 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 117.309 0.554 . . . . 15.0 112.037 175.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.902 ' HA ' HD23 ' A' ' 253' ' ' LEU . 5.8 p -127.46 107.87 10.33 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.37 1.043 . . . . 15.0 109.08 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -150.28 150.28 31.3 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.644 0.609 . . . . 15.0 112.644 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.528 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 79.6 m95 -75.11 -25.46 58.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.282 175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -87.63 142.09 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.065 0.459 . . . . 15.0 111.03 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.702 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.3 t70 -65.92 131.33 94.56 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.175 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.72 -14.57 8.88 Favored 'Trans proline' 0 CA--C 1.509 -0.737 0 C-N-CA 122.541 2.161 . . . . 15.0 113.855 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 1.015 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.1 tpm_? -82.33 -4.31 57.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.076 0.941 . . . . 15.0 108.858 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.702 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.8 mm . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 113.326 -1.761 . . . . 15.0 110.67 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.291 0.567 . . . . 15.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 18.8 m -105.26 121.33 43.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.121 -0.49 . . . . 15.0 109.734 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.463 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.8 m-20 -73.83 -24.41 0.59 Allowed Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 113.631 0.975 . . . . 15.0 113.631 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.984 ' HG3' HD13 ' A' ' 253' ' ' LEU . 16.4 Cg_endo -97.03 160.39 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.549 2.166 . . . . 15.0 112.303 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.23 161.04 29.92 Favored Glycine 0 C--N 1.312 -0.772 0 N-CA-C 110.387 -1.085 . . . . 15.0 110.387 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.843 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 2.9 Cg_exo -88.99 148.54 5.67 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 124.303 3.335 . . . . 15.0 113.602 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.66 8.75 31.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.503 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.625 -178.245 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.408 -0.589 . . . . 15.0 109.408 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.934 HD11 ' HD2' ' A' ' 265' ' ' PRO . 0.0 OUTLIER -95.06 151.38 38.79 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 121.529 0.68 . . . . 15.0 111.119 -168.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.46 158.98 55.37 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 122.831 2.354 . . . . 15.0 109.617 165.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.62 117.31 11.07 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.405 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.14 -2.1 2.87 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.759 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.519 ' CE1' ' HD2' ' A' ' 237' ' ' PRO . 69.6 m-85 -116.74 136.98 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.22 134.14 51.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.601 -0.518 . . . . 15.0 109.601 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.55 ' HG3' ' CE2' ' A' ' 252' ' ' PHE . 21.4 tt0 -89.72 97.98 11.51 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.546 -0.538 . . . . 15.0 109.546 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -95.49 119.47 34.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.767 -0.651 . . . . 15.0 110.598 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' THR . . . . . 0.584 ' HB ' HG11 ' A' ' 250' ' ' VAL . 5.0 t -104.0 150.07 24.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.286 -0.87 . . . . 15.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.77 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -135.31 150.46 50.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.972 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.93 -17.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.336 0.589 . . . . 15.0 110.983 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.77 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.3 tp-100 -54.36 -20.43 7.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.446 -0.797 . . . . 15.0 111.245 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.38 69.01 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.363 -0.446 . . . . 15.0 112.51 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.476 HE21 ' HG3' ' A' ' 247' ' ' GLN . 29.7 mt-30 -125.74 136.0 52.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.033 -0.358 . . . . 15.0 110.033 -175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.584 HG11 ' HB ' ' A' ' 244' ' ' THR . 20.8 m -89.99 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.716 0.293 . . . . 15.0 110.334 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -122.86 130.68 53.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 15.0 110.153 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 28.9 m-85 -89.76 108.51 19.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.871 -0.604 . . . . 15.0 111.698 -171.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.963 HD21 ' HA ' ' A' ' 260' ' ' SER . 0.4 OUTLIER -107.33 132.13 53.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.858 1.313 . . . . 15.0 113.558 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.1 OUTLIER -140.4 99.47 3.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 112.601 -2.091 . . . . 15.0 107.514 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.7 t -108.37 87.47 2.5 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 115.242 -2.583 . . . . 15.0 111.395 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 39.8 tt0 -101.47 -48.22 4.42 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.256 -2.247 . . . . 15.0 106.649 142.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -118.32 24.78 10.74 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 113.539 -1.664 . . . . 15.0 111.757 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.53 72.79 0.43 Allowed Glycine 0 C--N 1.271 -3.069 0 CA-C-N 110.961 -2.836 . . . . 15.0 114.495 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.634 ' O ' HD12 ' A' ' 253' ' ' LEU . 13.1 t -92.42 116.33 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 117.449 0.624 . . . . 15.0 111.631 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.963 ' HA ' HD21 ' A' ' 253' ' ' LEU . 6.1 p -126.63 110.08 12.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.167 0.917 . . . . 15.0 108.659 167.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -149.93 150.31 31.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.923 0.712 . . . . 15.0 112.923 -167.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 22.1 m95 -75.65 -29.65 59.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.353 -0.839 . . . . 15.0 111.479 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.514 ' HD1' ' HB ' ' A' ' 267' ' ' ILE . 5.5 p80 -93.53 140.16 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.624 -0.43 . . . . 15.0 111.27 -170.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.911 ' HB3' HG12 ' A' ' 267' ' ' ILE . 16.2 t0 -50.61 126.22 22.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 N-CA-C 108.672 -0.862 . . . . 15.0 108.672 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.934 ' HD2' HD11 ' A' ' 236' ' ' LEU . 56.3 Cg_endo -70.55 -14.53 33.66 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 C-N-CA 122.471 2.114 . . . . 15.0 113.608 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.24 -9.58 59.28 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.898 0.856 . . . . 15.0 108.963 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.911 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.3 mm . . . . . 0 C--O 1.247 0.967 0 CA-C-N 114.186 -1.37 . . . . 15.0 110.328 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 121.364 0.602 . . . . 15.0 109.834 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 24.2 m -135.33 115.03 12.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.208 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.864 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.556 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 10.3 m-20 -81.44 -30.01 0.53 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.095 0.776 . . . . 15.0 113.095 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.933 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.4 Cg_endo -96.78 160.38 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.99 2.46 . . . . 15.0 112.759 -166.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.23 160.42 29.44 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.433 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 3.8 Cg_exo -89.08 136.66 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.312 2.674 . . . . 15.0 113.383 -169.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -98.03 1.04 47.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.815 -1.084 . . . . 15.0 109.875 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.402 ' HG3' ' HE1' ' A' ' 262' ' ' TRP . 3.5 pt20 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.559 -0.734 . . . . 15.0 110.353 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.151 -0.315 . . . . 15.0 110.151 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -115.44 177.82 1.11 Allowed Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.401 ' HG3' HH11 ' A' ' 266' ' ' ARG . 13.4 Cg_exo -69.52 160.31 50.26 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 121.524 1.482 . . . . 15.0 110.579 168.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.89 120.16 15.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.281 -171.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 135.11 -27.16 3.18 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.597 -0.729 . . . . 15.0 113.068 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.648 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 45.1 m-85 -92.39 136.69 32.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.884 0.342 . . . . 15.0 110.62 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.467 ' CD ' ' H2 ' ' B' ' 208' ' ' THR . 5.3 pt-20 -109.82 141.4 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 167.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -89.82 99.37 12.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.446 ' HD3' ' OG ' ' B' ' 210' ' ' SEP . 2.4 ttt-85 -93.47 130.22 39.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.81 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -119.76 110.41 16.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.312 -0.858 . . . . 15.0 110.142 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.06 150.26 22.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.789 -0.448 . . . . 15.0 109.789 176.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 42.6 t -55.13 -18.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.65 0.738 . . . . 15.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.843 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 3.3 tp-100 -49.94 -29.21 7.95 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.817 -1.083 . . . . 15.0 111.429 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.36 -23.92 17.05 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.046 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.49 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.0 mp0 -89.88 148.39 23.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.253 0.549 . . . . 15.0 111.322 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 123.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.713 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -114.15 128.61 56.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.439 -0.505 . . . . 15.0 110.592 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.3 m-85 -89.69 110.34 21.24 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.419 -172.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.048 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.48 134.43 52.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.739 1.257 . . . . 15.0 113.852 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.648 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 20.4 t-80 -146.89 102.27 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 112.563 -2.108 . . . . 15.0 108.309 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.4 t -102.91 88.01 3.07 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 116.058 -2.257 . . . . 15.0 111.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 7.9 tt0 -101.15 -50.69 3.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.164 -1.835 . . . . 15.0 106.237 147.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.9 p -116.91 27.23 9.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.142 -1.845 . . . . 15.0 111.293 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.04 72.18 0.55 Allowed Glycine 0 C--N 1.277 -2.747 0 CA-C-N 111.133 -2.758 . . . . 15.0 113.974 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.635 ' O ' HD12 ' A' ' 253' ' ' LEU . 53.8 t -90.05 115.16 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-N 117.379 0.59 . . . . 15.0 111.807 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.939 ' HA ' HD21 ' A' ' 253' ' ' LEU . 5.1 p -127.89 100.09 5.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.956 170.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.5 p -141.25 150.27 42.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.223 0.823 . . . . 15.0 113.223 -167.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.626 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 1.7 m95 -70.87 -42.56 69.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.475 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -76.19 139.33 41.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.66 -0.7 . . . . 15.0 111.676 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.013 ' HB3' HG12 ' A' ' 267' ' ' ILE . 49.3 t0 -54.19 127.74 56.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 168.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.406 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 65.1 Cg_endo -74.13 -14.79 23.32 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 121.651 1.567 . . . . 15.0 112.916 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.44 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 13.6 tpt180 -81.92 -5.93 58.68 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.683 -0.858 . . . . 15.0 108.683 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.013 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.5 mm . . . . . 0 C--O 1.25 1.128 0 CA-C-N 113.911 -1.495 . . . . 15.0 110.141 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.467 ' H2 ' ' CD ' ' A' ' 241' ' ' GLU . 11.8 p . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.44 0.162 . . . . 15.0 111.257 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 27.4 m -121.86 117.84 27.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.652 0.263 . . . . 15.0 110.474 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.851 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.61 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.8 p-10 -120.08 -17.21 0.08 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.048 ' HG3' HD11 ' A' ' 253' ' ' LEU . 56.3 Cg_endo -90.8 160.44 4.13 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.306 2.004 . . . . 15.0 111.629 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.32 160.44 29.35 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.214 -1.154 . . . . 15.0 110.214 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.843 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.626 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo -88.64 127.44 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.72 2.947 . . . . 15.0 113.832 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -94.25 5.8 50.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.121 -0.945 . . . . 15.0 110.236 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.724 -0.655 . . . . 15.0 109.607 178.411 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.04 0.447 . . . . 15.0 110.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.85 -179.79 0.88 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.922 -0.77 . . . . 15.0 108.922 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.801 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.6 Cg_exo -69.62 161.97 43.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.497 1.465 . . . . 15.0 110.332 167.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.53 124.37 23.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.112 -0.949 . . . . 15.0 111.256 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.98 -13.93 8.0 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.521 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.603 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.9 m-85 -94.29 131.89 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.365 0.583 . . . . 15.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.527 ' CD ' ' H3 ' ' B' ' 208' ' ' THR . 10.8 pt-20 -105.99 140.58 38.76 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 170.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.473 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.8 OUTLIER -89.85 102.09 14.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -109.02 145.95 34.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.24 -0.891 . . . . 15.0 111.413 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 m -136.47 124.77 23.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.019 -0.991 . . . . 15.0 109.664 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.719 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.1 t -89.86 150.43 22.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.923 -0.399 . . . . 15.0 109.923 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.3 m -51.5 -24.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.316 0.579 . . . . 15.0 110.979 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.719 ' HB3' HG22 ' A' ' 245' ' ' THR . 2.2 tp-100 -52.05 -33.29 38.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.037 -0.983 . . . . 15.0 111.703 172.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.8 12.16 28.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.995 -0.622 . . . . 15.0 112.512 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.593 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.4 mm-40 -99.1 142.32 30.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.241 -0.652 . . . . 15.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 m -102.78 106.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.013 0.435 . . . . 15.0 109.897 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -109.56 127.0 54.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.552 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.671 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.0 m-85 -89.54 108.4 19.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.593 -172.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.043 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.21 133.44 52.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.885 1.326 . . . . 15.0 113.503 -175.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.603 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 6.7 t-80 -143.93 104.73 4.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.427 -2.17 . . . . 15.0 107.866 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -104.36 87.81 2.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 115.768 -2.373 . . . . 15.0 111.125 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.6 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.4 tt0 -101.32 -49.32 4.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.137 -1.847 . . . . 15.0 106.798 148.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -124.84 27.34 6.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.272 -1.785 . . . . 15.0 111.623 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.26 73.97 0.35 Allowed Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.457 -2.611 . . . . 15.0 114.292 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.614 ' O ' HD12 ' A' ' 253' ' ' LEU . 38.0 t -89.91 120.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.09 0.445 . . . . 15.0 111.517 173.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.933 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.6 p -131.25 112.23 12.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.053 -0.976 . . . . 15.0 109.166 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 p -144.33 150.12 37.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.244 0.831 . . . . 15.0 113.244 -167.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.776 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.1 OUTLIER -73.26 -36.28 66.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.975 -1.011 . . . . 15.0 110.496 171.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -86.02 142.35 28.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.237 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.914 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.6 t70 -58.96 131.52 86.8 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.744 -0.836 . . . . 15.0 108.744 171.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.99 -14.8 16.81 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 C-N-CA 122.189 1.926 . . . . 15.0 113.619 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.801 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.4 tpt180 -80.56 -7.43 59.23 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.914 HG12 ' HB3' ' A' ' 264' ' ' ASP . 44.4 mm . . . . . 0 C--O 1.25 1.125 0 CA-C-N 113.803 -1.544 . . . . 15.0 109.917 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.527 ' H3 ' ' CD ' ' A' ' 241' ' ' GLU . 6.2 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.581 0.229 . . . . 15.0 111.397 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.2 p -123.86 106.32 10.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 15.0 110.883 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.793 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 19.8 t70 -99.39 -14.35 0.18 Allowed Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.735 1.013 . . . . 15.0 113.735 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.043 ' HG3' HD11 ' A' ' 253' ' ' LEU . 61.4 Cg_endo -101.41 160.31 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.742 2.961 . . . . 15.0 114.081 -162.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.63 160.37 28.92 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 109.669 -1.372 . . . . 15.0 109.669 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.593 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.776 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.2 Cg_exo -88.86 139.1 3.73 Favored 'Trans proline' 0 C--N 1.333 -0.279 0 C-N-CA 123.582 2.855 . . . . 15.0 113.439 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -95.41 9.59 39.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 15.0 109.764 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.308 -0.853 . . . . 15.0 110.571 -179.345 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.735 HD11 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER -92.01 154.96 43.47 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.404 0.621 . . . . 15.0 111.31 -169.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.572 ' HG3' HH11 ' A' ' 266' ' ' ARG . 19.6 Cg_exo -69.41 167.21 24.62 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 122.977 2.451 . . . . 15.0 110.82 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.54 114.6 7.91 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.676 -1.147 . . . . 15.0 111.516 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.55 -18.78 2.43 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 114.821 -1.082 . . . . 15.0 113.112 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.607 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 43.5 m-85 -101.77 131.68 47.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.053 0.427 . . . . 15.0 111.107 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.561 ' CD ' ' H1 ' ' B' ' 208' ' ' THR . 3.7 pt-20 -101.59 138.66 38.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 169.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.98 110.08 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -112.09 128.78 56.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.235 0.54 . . . . 15.0 111.311 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -113.53 125.49 54.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.843 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.752 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -107.72 150.52 26.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.125 -0.488 . . . . 15.0 110.65 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -48.84 -20.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.314 0.646 . . . . 15.0 112.171 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.752 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.1 tp-100 -51.21 -21.76 2.25 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.336 -0.847 . . . . 15.0 111.666 171.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.14 60.92 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 15.0 111.916 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.512 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 34.1 mt-30 -130.72 149.73 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.662 -0.495 . . . . 15.0 109.662 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.73 138.66 26.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 15.0 109.975 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -125.25 128.16 47.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.351 0.596 . . . . 15.0 110.476 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 14.8 m-85 -89.73 109.66 20.62 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.028 -0.987 . . . . 15.0 111.453 -172.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.03 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.37 132.96 53.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.836 1.303 . . . . 15.0 114.039 -175.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.607 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.4 t-80 -140.38 97.09 3.15 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.535 -2.121 . . . . 15.0 107.447 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.2 p -90.51 88.22 7.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.439 -2.104 . . . . 15.0 110.424 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -101.29 -44.73 5.56 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.032 -1.895 . . . . 15.0 108.704 152.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 5.6 t -146.05 26.09 1.24 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 124.062 1.887 . . . . 15.0 108.775 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 59.45 75.96 0.25 Allowed Glycine 0 C--N 1.28 -2.581 0 CA-C-N 110.307 -3.133 . . . . 15.0 113.356 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.535 ' O ' HD22 ' A' ' 253' ' ' LEU . 79.6 t -89.27 115.8 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 118.833 -1.147 . . . . 15.0 110.841 164.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.864 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.9 p -129.31 106.15 8.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.481 -1.69 . . . . 15.0 108.571 173.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.994 0.739 . . . . 15.0 112.994 -167.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.512 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 43.3 m95 -77.84 -36.6 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 15.0 109.94 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -79.95 141.12 36.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.089 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.941 ' HB3' HG12 ' A' ' 267' ' ' ILE . 25.3 t0 -59.81 125.43 80.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.053 -1.091 . . . . 15.0 108.053 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.735 ' HD2' HD11 ' A' ' 236' ' ' LEU . 11.9 Cg_exo -70.55 -14.8 33.9 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.192 1.928 . . . . 15.0 112.897 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.572 HH11 ' HG3' ' A' ' 237' ' ' PRO . 18.7 tpt180 -75.05 -10.26 59.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.677 0.751 . . . . 15.0 109.078 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.941 HG12 ' HB3' ' A' ' 264' ' ' ASP . 47.6 mm . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.448 -1.251 . . . . 15.0 109.739 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.561 ' H1 ' ' CD ' ' A' ' 241' ' ' GLU . 19.3 m . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.411 0.148 . . . . 15.0 110.976 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.2 p -150.09 114.94 5.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.709 0.29 . . . . 15.0 110.364 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.697 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.749 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 47.4 p-10 -120.19 -14.47 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 114.059 1.133 . . . . 15.0 114.059 173.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.03 ' HG3' HD13 ' A' ' 253' ' ' LEU . 57.4 Cg_endo -96.72 160.68 1.14 Allowed 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.057 2.505 . . . . 15.0 111.928 -175.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.27 160.21 29.23 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 119.865 -1.16 . . . . 15.0 110.455 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.454 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.3 Cg_exo -89.1 151.14 5.69 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 123.722 2.948 . . . . 15.0 113.146 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -115.11 63.99 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.015 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.061 -0.971 . . . . 15.0 110.822 -176.93 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.495 HD21 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER -89.73 156.55 47.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 15.0 110.551 -173.022 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.667 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.7 Cg_exo -69.34 155.94 65.86 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.3 2.0 . . . . 15.0 109.76 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.72 117.73 11.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.219 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 146.12 -13.55 1.67 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.38 -0.827 . . . . 15.0 112.949 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.564 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.9 m-85 -104.84 138.43 41.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.276 0.538 . . . . 15.0 110.848 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 170.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.92 104.59 17.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -109.05 130.71 55.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.49 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 125.71 53.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.789 . . . . 15.0 110.213 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.733 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -106.25 150.72 25.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.082 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.0 t -45.87 -23.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.611 0.569 . . . . 15.0 111.57 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.733 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.7 tp60 -50.94 -23.08 2.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.457 0.703 . . . . 15.0 111.53 173.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.15 65.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.248 -0.501 . . . . 15.0 112.275 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.484 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 35.5 mt-30 -106.73 142.47 36.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.835 0.35 . . . . 15.0 110.587 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.03 137.23 22.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.433 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.467 ' OH ' ' O2P' ' B' ' 210' ' ' SEP . 28.1 p90 -127.79 128.25 44.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.048 0.451 . . . . 15.0 110.081 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.623 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.2 m-85 -89.7 111.33 22.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.619 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.005 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.47 133.95 51.92 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.806 1.289 . . . . 15.0 113.985 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.564 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 t-80 -140.49 97.54 3.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 112.475 -2.148 . . . . 15.0 107.307 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.506 HG23 ' HA2' ' A' ' 258' ' ' GLY . 8.8 p -97.21 87.74 4.26 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 116.295 -2.162 . . . . 15.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 40.8 tt0 -101.29 -52.73 3.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.278 -1.783 . . . . 15.0 106.818 147.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 35.8 p -119.4 27.66 8.66 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 112.417 -2.174 . . . . 15.0 111.116 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.506 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 51.36 74.94 0.24 Allowed Glycine 0 C--N 1.274 -2.883 0 CA-C-N 111.464 -2.607 . . . . 15.0 113.692 -175.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.57 ' O ' HD21 ' A' ' 253' ' ' LEU . 55.7 t -89.59 111.11 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-N 117.452 0.626 . . . . 15.0 111.066 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.833 ' HA ' HD21 ' A' ' 253' ' ' LEU . 6.6 p -124.66 101.97 7.37 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.171 -1.377 . . . . 15.0 108.885 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -150.22 150.39 31.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -169.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.484 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 74.4 m95 -72.66 -38.32 67.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.012 174.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -74.86 136.32 41.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.165 -0.47 . . . . 15.0 111.563 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.826 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t0 -57.26 124.66 67.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.271 -0.877 . . . . 15.0 108.917 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.518 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 9.1 Cg_exo -73.38 -14.62 25.27 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.5 2.134 . . . . 15.0 113.879 -176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.667 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 26.2 tpt180 -76.66 -9.62 58.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.76 -0.83 . . . . 15.0 108.76 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.826 HG12 ' HB3' ' A' ' 264' ' ' ASP . 51.3 mm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 113.906 -1.497 . . . . 15.0 109.591 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.037 0.446 . . . . 15.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -131.82 129.53 40.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.858 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.558 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 29.5 m-20 -95.65 -19.39 0.22 Allowed Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 113.394 0.887 . . . . 15.0 113.394 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.005 ' HG3' HD13 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -92.04 160.19 3.26 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.191 1.927 . . . . 15.0 111.098 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.24 160.24 29.3 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.904 -1.141 . . . . 15.0 110.295 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.452 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.472 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo -88.99 137.7 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.341 2.694 . . . . 15.0 113.952 -169.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.15 7.36 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.026 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.025 -0.989 . . . . 15.0 110.014 -177.532 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 5.3 mm-40 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.578 0.228 . . . . 15.0 110.439 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.86 171.83 5.08 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.835 -0.431 . . . . 15.0 109.835 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.915 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.57 165.61 30.17 Favored 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.062 1.841 . . . . 15.0 110.92 166.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -69.48 126.93 31.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.304 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 121.52 -13.65 9.38 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 15.0 113.647 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.602 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 91.0 m-85 -95.06 128.58 41.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.471 0.636 . . . . 15.0 110.718 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -106.78 135.99 47.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 15.0 109.655 172.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.527 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -89.79 111.61 22.67 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.358 -0.979 . . . . 15.0 108.358 -178.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.675 HH11 ' HG2' ' A' ' 243' ' ' ARG . 6.1 ttt-85 -107.51 127.36 53.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.654 -0.703 . . . . 15.0 111.909 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.4 p -113.83 124.38 52.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.455 -1.248 . . . . 15.0 109.821 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.794 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -107.91 150.0 27.61 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.927 -0.397 . . . . 15.0 109.927 175.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.47 -18.67 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.516 0.674 . . . . 15.0 110.312 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.892 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 3.8 tp-100 -47.33 -40.99 18.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.877 -1.056 . . . . 15.0 111.198 171.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.91 21.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.779 -0.724 . . . . 15.0 112.881 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.518 ' HB2' ' O2P' ' B' ' 214' ' ' SEP . 1.7 mp0 -104.48 150.11 24.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.1 0.476 . . . . 15.0 111.662 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.12 124.17 55.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.301 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.655 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 37.8 p90 -125.82 129.23 48.99 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.013 -0.675 . . . . 15.0 111.784 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 36.7 m-85 -90.06 111.28 22.34 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.678 -174.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.002 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -110.54 134.17 52.63 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.707 1.241 . . . . 15.0 113.211 176.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.602 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.9 t-80 -140.72 100.32 3.82 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.005 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.3 t -101.81 87.89 3.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 115.905 -2.318 . . . . 15.0 110.885 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.59 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 46.7 tt0 -101.08 -46.67 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.023 -1.899 . . . . 15.0 106.773 148.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.3 p -124.97 27.05 6.84 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.412 -1.722 . . . . 15.0 111.109 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.91 73.11 0.43 Allowed Glycine 0 C--N 1.278 -2.666 0 CA-C-N 111.281 -2.69 . . . . 15.0 114.212 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.678 ' O ' HD12 ' A' ' 253' ' ' LEU . 50.9 t -89.95 114.0 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 117.349 0.574 . . . . 15.0 112.066 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.946 ' HA ' HD21 ' A' ' 253' ' ' LEU . 6.7 p -121.63 106.86 11.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.786 -1.097 . . . . 15.0 108.596 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.3 p -142.41 150.13 40.22 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.257 0.836 . . . . 15.0 113.257 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.515 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 1.5 m95 -77.67 -34.81 52.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.652 172.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -82.79 137.81 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.003 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.868 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t70 -57.14 133.41 80.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 171.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.21 -14.64 10.63 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.293 1.995 . . . . 15.0 113.986 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.915 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.3 tpt180 -83.81 -3.47 57.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.376 1.084 . . . . 15.0 108.396 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.868 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.1 mm . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 113.177 -1.829 . . . . 15.0 109.776 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.807 0.337 . . . . 15.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.2 p -109.36 107.78 18.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 15.0 110.158 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.962 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.553 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 5.3 p-10 -95.24 -24.12 0.25 Allowed Pre-proline 0 CA--C 1.549 0.911 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.244 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.002 ' HG3' HD11 ' A' ' 253' ' ' LEU . 13.1 Cg_endo -96.42 160.37 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.941 2.427 . . . . 15.0 111.691 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.29 160.31 29.29 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.036 -0.825 . . . . 15.0 111.036 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.892 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.515 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo -89.14 132.14 2.24 Favored 'Trans proline' 0 C--O 1.223 -0.226 0 C-N-CA 124.132 3.221 . . . . 15.0 113.895 -174.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -88.12 -2.1 58.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.663 -0.698 . . . . 15.0 109.54 172.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.102 -0.952 . . . . 15.0 110.682 -176.815 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.73 0.3 . . . . 15.0 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -122.87 172.69 5.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 15.0 109.594 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.639 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.45 159.39 53.82 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.986 1.791 . . . . 15.0 110.485 166.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.62 113.96 7.39 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.54 -0.755 . . . . 15.0 111.214 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 143.77 -16.43 2.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.49 -0.777 . . . . 15.0 112.729 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.597 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 66.4 m-85 -98.36 138.74 35.16 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.626 -0.338 . . . . 15.0 110.737 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -109.33 144.3 37.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -89.85 118.55 29.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 15.0 108.796 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.7 136.36 53.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.387 0.613 . . . . 15.0 111.536 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 m -129.45 115.61 17.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.931 -1.032 . . . . 15.0 109.592 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.803 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -90.15 150.62 21.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.536 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.48 -17.34 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.31 0.576 . . . . 15.0 110.617 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.803 ' HB3' HG22 ' A' ' 245' ' ' THR . 6.5 tp60 -54.2 -22.7 12.13 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.012 170.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.43 16.65 48.9 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.009 -0.615 . . . . 15.0 112.78 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 18.1 mt-30 -131.47 146.81 52.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.773 0.321 . . . . 15.0 110.213 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.56 141.21 15.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.415 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.5 127.42 27.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.889 0.376 . . . . 15.0 110.098 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.674 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 25.1 m-85 -89.62 111.65 22.66 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.05 -0.523 . . . . 15.0 111.434 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.039 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.83 135.86 49.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.684 1.231 . . . . 15.0 113.619 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -148.74 107.44 3.82 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.678 -2.055 . . . . 15.0 108.292 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 11.9 m -103.42 87.58 2.89 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 116.17 -2.212 . . . . 15.0 110.625 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.593 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 43.7 tt0 -101.35 -48.19 4.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.071 -1.877 . . . . 15.0 107.253 149.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 43.6 p -125.11 25.17 7.31 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.099 -1.864 . . . . 15.0 111.201 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.27 75.38 0.23 Allowed Glycine 0 C--N 1.272 -2.983 0 CA-C-N 111.17 -2.741 . . . . 15.0 113.187 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' HD11 ' A' ' 253' ' ' LEU . 75.3 t -89.74 119.94 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.161 0.48 . . . . 15.0 111.604 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.911 ' HA ' HD23 ' A' ' 253' ' ' LEU . 6.4 p -134.21 107.32 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 124.817 1.323 . . . . 15.0 108.932 171.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -150.13 150.36 31.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.552 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 37.7 m95 -72.83 -28.69 62.7 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.114 174.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -87.65 134.62 33.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.97 0.414 . . . . 15.0 111.132 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.766 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t70 -52.73 126.97 42.27 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.444 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 252' ' ' PHE . 80.9 Cg_endo -76.96 -14.44 17.04 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.381 2.054 . . . . 15.0 114.052 -173.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.639 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 13.3 tpt180 -79.5 -8.1 58.91 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.108 0.956 . . . . 15.0 108.465 174.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.766 HG12 ' HB3' ' A' ' 264' ' ' ASP . 50.3 mm . . . . . 0 C--O 1.246 0.911 0 CA-C-N 113.613 -1.631 . . . . 15.0 109.797 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.466 0.174 . . . . 15.0 111.028 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.8 p -140.61 104.54 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.436 . . . . 15.0 110.938 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.629 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.645 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 32.6 t70 -109.1 -15.23 0.12 Allowed Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.798 1.036 . . . . 15.0 113.798 172.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.039 ' HG3' HD13 ' A' ' 253' ' ' LEU . 62.8 Cg_endo -93.04 160.33 2.63 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.513 2.142 . . . . 15.0 112.127 -169.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.54 159.52 28.38 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.639 -1.267 . . . . 15.0 110.369 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.45 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.552 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo -89.05 126.1 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.515 2.81 . . . . 15.0 113.262 -173.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -87.16 88.44 7.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.633 -0.712 . . . . 15.0 109.523 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.432 -0.794 . . . . 15.0 109.875 -176.392 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.588 HD23 ' HD2' ' A' ' 265' ' ' PRO . 6.4 mt -100.5 166.23 12.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 -176.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.456 ' HD3' ' CD ' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.62 160.6 49.14 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 121.925 1.75 . . . . 15.0 110.543 168.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.4 119.4 13.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.548 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 137.18 -17.89 3.55 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.481 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.566 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 67.0 m-85 -103.33 132.01 49.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.596 0.198 . . . . 15.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -108.97 139.29 44.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.78 105.0 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 243' ' ' ARG . 16.4 ttt85 -105.71 138.66 41.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.261 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 m -128.37 117.2 21.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.195 -0.912 . . . . 15.0 109.824 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.848 HG22 ' HB3' ' A' ' 247' ' ' GLN . 2.3 t -90.02 150.3 22.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.945 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 t -54.53 -18.06 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.575 0.702 . . . . 15.0 110.522 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.848 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.4 tp60 -53.02 -24.62 10.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.07 -0.968 . . . . 15.0 111.774 172.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.92 -2.96 52.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.627 -0.797 . . . . 15.0 112.824 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.586 ' NE2' ' HG3' ' A' ' 247' ' ' GLN . 1.2 mp0 -113.35 143.84 43.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.133 0.492 . . . . 15.0 111.486 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.83 136.81 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 15.0 110.161 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -130.68 130.95 44.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.054 0.454 . . . . 15.0 110.529 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.647 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 38.9 m-85 -89.66 109.16 20.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.691 -0.686 . . . . 15.0 111.297 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.009 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -109.37 134.62 51.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.682 1.23 . . . . 15.0 113.716 -176.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.5 t-80 -141.81 105.63 4.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.457 -2.156 . . . . 15.0 107.698 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 22.5 p -104.26 87.75 2.82 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.281 -2.168 . . . . 15.0 111.277 178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.468 HE21 HG23 ' A' ' 257' ' ' THR . 16.5 tt0 -101.35 -49.1 4.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.367 -1.742 . . . . 15.0 106.89 146.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' THR . . . . . 0.468 HG23 HE21 ' A' ' 256' ' ' GLN . 24.9 p -126.09 30.92 5.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.006 -1.906 . . . . 15.0 111.557 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.02 76.01 0.17 Allowed Glycine 0 C--N 1.278 -2.685 0 CA-C-N 111.952 -2.385 . . . . 15.0 114.361 -177.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.618 ' O ' HD12 ' A' ' 253' ' ' LEU . 55.6 t -89.81 118.32 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.247 0.524 . . . . 15.0 110.91 171.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.923 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.0 p -132.57 107.3 8.35 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.504 1.128 . . . . 15.0 109.51 172.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.6 t -150.16 150.24 31.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.307 0.855 . . . . 15.0 113.307 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.627 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -67.76 -32.38 72.94 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.901 173.317 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -87.97 135.74 33.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.582 -0.447 . . . . 15.0 111.351 -168.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.9 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.28 128.73 73.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 171.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.588 ' HD2' HD23 ' A' ' 236' ' ' LEU . 73.3 Cg_endo -76.57 -14.91 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.834 1.69 . . . . 15.0 113.183 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.456 ' CD ' ' HD3' ' A' ' 237' ' ' PRO . 4.7 tpt180 -80.66 -6.2 58.03 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.975 0.893 . . . . 15.0 108.998 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.9 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.1 mm . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 114.044 -1.435 . . . . 15.0 109.885 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.241 0.543 . . . . 15.0 110.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 20.3 m -150.07 110.45 4.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.042 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.747 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.644 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 7.7 m-20 -103.62 -14.95 0.17 Allowed Pre-proline 0 CA--C 1.555 1.163 0 N-CA-C 113.855 1.057 . . . . 15.0 113.855 170.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.009 ' HG3' HD11 ' A' ' 253' ' ' LEU . 63.0 Cg_endo -95.7 160.19 1.48 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.822 2.348 . . . . 15.0 112.77 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.76 158.63 27.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.973 -1.108 . . . . 15.0 111.308 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.51 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.627 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 6.5 Cg_exo -88.88 146.88 5.67 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 123.558 2.839 . . . . 15.0 113.395 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -98.2 -1.14 42.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.641 -0.708 . . . . 15.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.15 -172.818 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.983 0.42 . . . . 15.0 110.411 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER -119.5 179.52 0.86 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 -176.841 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.718 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.7 Cg_exo -69.67 161.92 44.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.418 1.412 . . . . 15.0 110.343 166.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -69.44 126.41 29.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.147 -0.933 . . . . 15.0 111.254 -170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 125.42 -14.99 7.25 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.773 -0.727 . . . . 15.0 113.671 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.528 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 63.2 m-85 -100.3 136.53 40.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.574 0.687 . . . . 15.0 110.78 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.428 ' OE2' ' HB ' ' B' ' 208' ' ' THR . 9.9 pt-20 -105.43 146.18 29.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.716 -0.846 . . . . 15.0 108.716 168.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 17.4 tm0? -89.78 109.51 20.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -117.33 141.34 48.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.627 0.727 . . . . 15.0 111.096 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.9 m -139.34 117.38 11.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.879 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.822 HG22 ' HB3' ' A' ' 247' ' ' GLN . 3.7 t -89.91 150.29 22.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.06 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.33 -22.72 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.6 0.714 . . . . 15.0 111.085 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.822 ' HB3' HG22 ' A' ' 245' ' ' THR . 8.1 tp-100 -49.55 -24.34 2.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.409 -1.269 . . . . 15.0 111.746 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.5 58.68 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.224 -0.513 . . . . 15.0 111.876 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.584 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 4.5 mt-30 -100.83 135.94 41.48 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.741 -0.466 . . . . 15.0 109.741 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.97 143.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.638 -0.256 . . . . 15.0 110.464 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -135.47 123.47 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 15.0 110.424 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 39.1 m-85 -89.67 110.84 21.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.426 -0.806 . . . . 15.0 110.824 -171.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.03 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.57 132.84 52.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.724 1.25 . . . . 15.0 113.66 -175.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.633 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 4.1 t-80 -144.74 106.99 4.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 112.569 -2.105 . . . . 15.0 108.317 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 12.7 m -102.11 87.78 3.16 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 116.1 -2.24 . . . . 15.0 111.002 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.633 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.5 tt0 -101.38 -53.05 3.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.668 -1.604 . . . . 15.0 106.668 147.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 18.0 p -122.25 26.94 8.21 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 112.664 -2.062 . . . . 15.0 111.364 -174.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.29 75.97 0.2 Allowed Glycine 0 C--N 1.273 -2.931 0 CA-C-N 111.607 -2.542 . . . . 15.0 113.4 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.593 ' O ' HD11 ' A' ' 253' ' ' LEU . 45.4 t -89.81 114.98 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 O-C-N 122.484 -0.421 . . . . 15.0 111.257 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.962 ' HA ' HD21 ' A' ' 253' ' ' LEU . 5.2 p -129.87 108.32 10.05 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.699 1.249 . . . . 15.0 108.858 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.407 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.3 t -150.14 150.23 31.36 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.935 0.717 . . . . 15.0 112.935 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.584 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 56.1 m95 -70.86 -31.85 68.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.487 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.407 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.3 p80 -88.51 134.68 33.79 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.006 0.432 . . . . 15.0 110.937 -170.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 1.022 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.0 t0 -58.5 123.82 68.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.491 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.72 -14.76 36.69 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 C-N-CA 122.099 1.866 . . . . 15.0 112.194 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.718 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.8 tpt180 -76.14 -10.66 59.59 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.938 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 1.022 HG12 ' HB3' ' A' ' 264' ' ' ASP . 39.1 pt . . . . . 0 C--O 1.25 1.112 0 CA-C-N 114.731 -1.122 . . . . 15.0 111.458 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.428 ' HB ' ' OE2' ' A' ' 241' ' ' GLU . 56.6 m . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.435 -0.209 . . . . 15.0 110.435 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 12.0 t -131.44 99.96 5.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.393 0.616 . . . . 15.0 109.736 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.444 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.773 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 29.1 t70 -98.92 -14.99 0.19 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 114.021 1.119 . . . . 15.0 114.021 175.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.03 ' HG3' HD13 ' A' ' 253' ' ' LEU . 51.7 Cg_endo -102.43 160.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 123.667 2.911 . . . . 15.0 114.236 -165.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.52 160.53 29.18 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.323 -1.111 . . . . 15.0 110.323 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.464 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.498 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.9 Cg_exo -89.29 160.19 5.61 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 124.145 3.23 . . . . 15.0 113.076 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -120.94 1.51 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.791 -0.641 . . . . 15.0 109.824 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.252 -0.88 . . . . 15.0 110.73 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.779 0.323 . . . . 15.0 110.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.483 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.5 OUTLIER -113.96 168.11 8.44 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.301 -0.629 . . . . 15.0 109.301 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.637 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.39 164.85 32.62 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.328 2.019 . . . . 15.0 110.172 165.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.49 130.52 42.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.851 -172.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 124.9 -34.59 3.38 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.809 -1.087 . . . . 15.0 113.245 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.591 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 53.6 m-85 -83.89 149.45 26.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.165 0.482 . . . . 15.0 110.744 -175.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.654 ' OE2' ' HA ' ' B' ' 208' ' ' THR . 5.1 pt-20 -116.49 147.27 41.91 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.474 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.46 102.49 15.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.611 ' HD3' ' CE1' ' A' ' 251' ' ' TYR . 13.6 ttt-85 -102.82 147.61 26.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.136 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.2 m -138.95 118.38 12.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.799 -1.092 . . . . 15.0 108.751 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.719 HG22 ' HB3' ' A' ' 247' ' ' GLN . 3.6 t -96.67 150.23 20.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.641 -0.254 . . . . 15.0 110.422 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.98 -21.63 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.267 0.556 . . . . 15.0 110.854 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.719 ' HB3' HG22 ' A' ' 245' ' ' THR . 5.9 tp-100 -53.08 -23.71 8.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.273 -0.876 . . . . 15.0 111.523 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.25 17.58 39.45 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.154 -0.546 . . . . 15.0 112.318 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.711 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 5.2 mt-30 -125.13 147.43 49.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.01 -0.737 . . . . 15.0 109.01 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.2 130.56 50.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.162 -0.31 . . . . 15.0 110.162 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.611 ' CE1' ' HD3' ' A' ' 243' ' ' ARG . 34.9 p90 -126.99 129.13 47.5 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.531 -0.468 . . . . 15.0 110.626 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.697 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 27.5 m-85 -89.73 111.05 21.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.135 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.093 HD12 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.71 135.86 50.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.712 1.244 . . . . 15.0 113.928 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.661 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 16.1 t-80 -144.35 100.76 3.59 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 112.458 -2.156 . . . . 15.0 107.819 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.667 HG23 ' HA2' ' A' ' 258' ' ' GLY . 2.8 p -102.8 87.41 2.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 116.163 -2.215 . . . . 15.0 110.833 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.661 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.0 tt0 -101.25 -35.73 9.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 113.316 -1.765 . . . . 15.0 108.029 146.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.5 p -139.02 30.64 2.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.916 1.341 . . . . 15.0 111.362 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.667 ' HA2' HG23 ' A' ' 255' ' ' THR . . . 54.5 73.78 0.38 Allowed Glycine 0 C--N 1.279 -2.591 0 CA-C-N 111.936 -2.393 . . . . 15.0 114.603 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.719 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -92.77 115.08 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 117.274 0.537 . . . . 15.0 111.406 171.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.993 ' HA ' HD21 ' A' ' 253' ' ' LEU . 5.4 p -135.49 104.36 5.8 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.573 1.171 . . . . 15.0 109.229 172.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.414 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.22 150.43 31.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 15.0 112.733 -169.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.462 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 39.0 m95 -66.98 -38.05 85.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.639 -0.71 . . . . 15.0 111.166 171.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.414 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.7 p80 -78.41 136.85 37.74 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.121 -0.491 . . . . 15.0 111.177 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.901 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t70 -57.03 127.65 76.12 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.828 -0.805 . . . . 15.0 108.828 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.483 ' HD2' HD12 ' A' ' 236' ' ' LEU . 71.1 Cg_endo -75.87 -14.64 19.25 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.135 1.89 . . . . 15.0 113.039 -174.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.637 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.6 tpt180 -76.05 -9.77 58.88 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.901 HG12 ' HB3' ' A' ' 264' ' ' ASP . 47.1 mm . . . . . 0 C--O 1.244 0.774 0 CA-C-N 114.051 -1.431 . . . . 15.0 109.765 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.654 ' HA ' ' OE2' ' A' ' 241' ' ' GLU . 6.3 m . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.566 0.698 . . . . 15.0 110.23 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 62.4 m -150.19 121.91 8.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.579 -0.737 . . . . 15.0 109.566 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.849 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.648 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 18.2 t70 -111.51 -19.82 0.12 Allowed Pre-proline 0 CA--C 1.556 1.189 0 N-CA-C 113.322 0.86 . . . . 15.0 113.322 173.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.093 ' HG3' HD12 ' A' ' 253' ' ' LEU . 48.9 Cg_endo -91.88 160.25 3.37 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.529 2.153 . . . . 15.0 112.411 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.55 160.27 28.94 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.442 -1.063 . . . . 15.0 110.442 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.485 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 2.8 Cg_exo -88.79 126.77 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.852 2.368 . . . . 15.0 112.53 -175.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -98.03 114.39 26.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.0 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.71 -0.662 . . . . 15.0 110.022 -178.158 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.749 -0.463 . . . . 15.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.462 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -102.45 169.68 7.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.748 0.309 . . . . 15.0 110.393 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.843 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.2 Cg_exo -69.58 157.24 61.43 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 121.945 1.763 . . . . 15.0 110.506 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.88 121.18 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.976 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 134.49 -14.33 4.5 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.741 -0.742 . . . . 15.0 113.105 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 79.4 m-85 -99.13 129.33 45.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.472 0.636 . . . . 15.0 111.048 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.79 137.13 43.05 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.91 119.32 30.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.179 -0.675 . . . . 15.0 109.179 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 8.1 ttt-85 -122.39 132.81 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.559 0.695 . . . . 15.0 111.81 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -120.13 122.5 41.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.338 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.895 HG22 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -94.01 150.16 20.59 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.357 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -54.61 -19.28 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.529 0.681 . . . . 15.0 111.157 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.895 ' HB3' HG22 ' A' ' 245' ' ' THR . 4.6 tp-100 -50.1 -24.44 2.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.415 -1.266 . . . . 15.0 111.701 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.67 -1.75 55.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.151 -0.547 . . . . 15.0 112.196 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.673 HE21 ' HG2' ' A' ' 247' ' ' GLN . 5.1 mt-30 -111.29 138.49 47.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.879 0.371 . . . . 15.0 110.418 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.08 136.44 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.625 -0.509 . . . . 15.0 109.625 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -131.73 126.7 35.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.18 0.514 . . . . 15.0 110.957 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.694 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.7 m-85 -89.77 113.5 25.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.357 -173.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.126 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -111.82 134.75 53.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 122.842 1.306 . . . . 15.0 114.087 -176.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.556 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.5 t-80 -141.88 103.73 4.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.579 -2.1 . . . . 15.0 107.611 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.8 t -100.14 87.92 3.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 116.287 -2.165 . . . . 15.0 111.056 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.536 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 33.6 tt0 -101.62 -54.43 2.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.311 -1.768 . . . . 15.0 106.712 147.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 38.2 p -119.88 27.23 8.81 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.397 -2.183 . . . . 15.0 111.329 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.07 75.66 0.21 Allowed Glycine 0 C--N 1.274 -2.867 0 CA-C-N 111.315 -2.675 . . . . 15.0 113.698 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.587 ' O ' HD12 ' A' ' 253' ' ' LEU . 53.5 t -89.58 114.89 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-N 117.395 0.598 . . . . 15.0 111.028 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.995 ' HA ' HD21 ' A' ' 253' ' ' LEU . 9.1 p -126.44 107.61 10.43 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.965 -1.471 . . . . 15.0 108.79 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.1 p -140.21 149.43 42.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.255 0.835 . . . . 15.0 113.255 -168.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.507 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 21.3 m95 -75.05 -38.52 61.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.457 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -79.11 143.92 35.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.943 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.788 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.6 t70 -62.61 130.16 93.34 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.903 -0.777 . . . . 15.0 108.903 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.7 -14.77 24.43 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 C-N-CA 122.044 1.829 . . . . 15.0 113.775 -173.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.843 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.2 tpt180 -80.73 -5.55 57.25 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.17 0.986 . . . . 15.0 108.792 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.788 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.9 mm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 113.484 -1.689 . . . . 15.0 109.728 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.259 0.552 . . . . 15.0 110.104 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 20.9 m -150.1 100.8 2.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.928 -0.578 . . . . 15.0 109.654 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.449 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.5 m-20 -81.1 -18.04 0.26 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 172.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.126 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -98.17 160.32 0.81 Allowed 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.889 2.393 . . . . 15.0 112.832 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.4 160.32 29.16 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.776 -1.33 . . . . 15.0 109.776 173.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.485 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.507 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.4 Cg_exo -88.96 153.66 5.86 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.932 3.088 . . . . 15.0 112.202 -174.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -116.02 -2.15 12.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.5 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.562 -0.732 . . . . 15.0 110.116 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.792 0.329 . . . . 15.0 110.284 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.517 HD21 ' H ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -91.57 169.98 10.35 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -176.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.925 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 15.3 Cg_exo -69.62 154.46 68.28 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.095 1.863 . . . . 15.0 110.611 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.81 131.37 44.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.902 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 127.19 -16.47 6.35 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.564 -0.827 . . . . 15.0 112.921 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.6 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 90.2 m-85 -95.22 135.01 37.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.983 0.392 . . . . 15.0 110.267 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.645 ' CD ' ' H2 ' ' B' ' 208' ' ' THR . 5.0 pt-20 -113.7 138.55 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.196 0.522 . . . . 15.0 109.831 170.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.635 HE22 HG23 ' A' ' 244' ' ' THR . 1.1 tm0? -89.87 107.36 19.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.715 -0.846 . . . . 15.0 108.715 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -103.55 135.79 44.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.325 0.583 . . . . 15.0 111.816 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' THR . . . . . 0.635 HG23 HE22 ' A' ' 242' ' ' GLN . 0.9 OUTLIER -117.29 115.21 24.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.596 -1.184 . . . . 15.0 110.41 177.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.888 HG21 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -89.95 150.34 22.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 15.0 109.684 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.9 t -51.5 -24.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.4 0.619 . . . . 15.0 110.071 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.888 ' HB3' HG21 ' A' ' 245' ' ' THR . 4.4 tp-100 -50.2 -31.37 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.964 -1.016 . . . . 15.0 111.588 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.36 19.94 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.107 -0.568 . . . . 15.0 113.31 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.656 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.6 mt-30 -127.02 141.35 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.04 0.42 . . . . 15.0 110.26 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.9 m -92.39 127.33 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.483 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -128.51 130.35 47.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.881 0.372 . . . . 15.0 110.204 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.666 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.4 m-85 -89.9 110.48 21.42 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.488 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.053 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.13 133.21 52.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.711 1.243 . . . . 15.0 113.899 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.6 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.0 t-80 -143.64 95.23 2.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.655 -2.066 . . . . 15.0 107.918 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.3 m -90.4 87.91 6.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 116.512 -2.075 . . . . 15.0 110.141 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -101.15 -49.62 4.04 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 112.891 -1.959 . . . . 15.0 108.212 153.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.7 t -135.28 23.67 3.49 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-N 112.736 -2.029 . . . . 15.0 108.506 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 60.92 74.32 0.39 Allowed Glycine 0 C--N 1.279 -2.585 0 CA-C-N 109.785 -3.371 . . . . 15.0 112.909 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.558 ' O ' HD12 ' A' ' 253' ' ' LEU . 67.4 t -89.15 115.7 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 119.51 -0.876 . . . . 15.0 111.199 168.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.99 ' HA ' HD21 ' A' ' 253' ' ' LEU . 3.7 p -131.22 104.41 7.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.533 -1.667 . . . . 15.0 109.026 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.9 t -150.24 150.33 31.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.764 0.653 . . . . 15.0 112.764 -168.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 69.8 m95 -70.92 -34.34 71.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.136 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -81.59 136.27 35.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.11 -168.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.875 ' HB3' HG12 ' A' ' 267' ' ' ILE . 11.5 t70 -54.35 130.5 61.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 15.0 109.443 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.94 -14.79 16.92 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 C-N-CA 122.202 1.934 . . . . 15.0 114.179 -171.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.925 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpm_? -85.45 -2.76 58.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.372 1.082 . . . . 15.0 108.645 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.875 HG12 ' HB3' ' A' ' 264' ' ' ASP . 39.7 mm . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 112.96 -1.927 . . . . 15.0 109.827 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.645 ' H2 ' ' CD ' ' A' ' 241' ' ' GLU . 31.8 p . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.927 0.394 . . . . 15.0 110.823 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.5 p -132.82 110.12 10.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.408 -0.36 . . . . 15.0 110.59 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.859 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.591 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -108.02 -14.86 0.13 Allowed Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 113.269 0.84 . . . . 15.0 113.269 168.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 1.053 ' HG3' HD11 ' A' ' 253' ' ' LEU . 42.2 Cg_endo -90.18 160.63 4.74 Favored 'Trans proline' 0 C--N 1.369 1.605 0 C-N-CA 122.882 2.388 . . . . 15.0 111.241 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.46 159.57 28.5 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.334 -1.413 . . . . 15.0 110.699 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.45 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.7 Cg_exo -88.99 160.09 5.91 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.623 2.882 . . . . 15.0 112.694 -173.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -119.6 16.98 12.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 15.0 110.049 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.471 -0.776 . . . . 15.0 110.416 -177.571 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 2.0 mp0 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.758 -0.46 . . . . 15.0 109.758 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.633 HD13 ' HD2' ' A' ' 265' ' ' PRO . 0.8 OUTLIER -93.25 159.45 35.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.085 0.469 . . . . 15.0 110.242 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.696 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.6 Cg_exo -69.37 145.54 59.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.881 1.72 . . . . 15.0 108.561 161.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.54 96.44 0.92 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.128 0.966 . . . . 15.0 112.358 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 163.28 32.09 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 113.45 -1.705 . . . . 15.0 112.607 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.626 ' CD2' ' HG2' ' A' ' 265' ' ' PRO . 82.7 m-85 -140.99 125.69 17.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 5.9 pt-20 -97.45 134.25 40.95 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.203 0.525 . . . . 15.0 109.986 175.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -89.7 111.6 22.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -120.3 129.78 54.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.345 0.593 . . . . 15.0 111.592 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.0 m -123.04 124.44 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.619 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.579 ' CG2' ' HB3' ' A' ' 247' ' ' GLN . 0.1 OUTLIER -89.86 150.46 22.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.433 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.57 -24.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.46 0.648 . . . . 15.0 110.283 174.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HG3' ' HG3' ' A' ' 249' ' ' GLN . 3.3 tp-100 -47.8 -35.52 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.823 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.16 31.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.039 -0.601 . . . . 15.0 112.798 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.701 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 9.0 mt-30 -107.19 149.77 27.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 15.0 110.69 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.04 136.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.323 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -131.57 126.76 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.588 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.3 m-85 -89.74 109.94 20.89 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.139 -172.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.952 HD13 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -104.96 133.16 50.22 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 122.925 1.345 . . . . 15.0 113.28 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.555 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.8 OUTLIER -142.18 96.35 2.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 112.571 -2.104 . . . . 15.0 107.833 -178.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 t -104.11 87.73 2.84 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 115.662 -2.415 . . . . 15.0 111.18 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 16.4 tt0 -100.93 -31.55 11.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 112.401 -2.181 . . . . 15.0 108.245 145.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.9 t -144.28 24.84 1.58 Allowed 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 123.655 1.693 . . . . 15.0 110.014 -166.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 50.73 70.38 0.86 Allowed Glycine 0 C--N 1.274 -2.904 0 CA-C-N 110.006 -3.27 . . . . 15.0 113.883 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 56.4 t -89.23 116.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 119.853 -0.739 . . . . 15.0 111.629 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.926 ' HA ' HD22 ' A' ' 253' ' ' LEU . 3.7 p -129.18 105.44 8.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.905 -1.498 . . . . 15.0 109.131 170.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 150.17 31.46 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.713 0.635 . . . . 15.0 112.713 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.517 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 55.8 m95 -69.02 -32.91 72.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 15.0 112.102 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -88.0 139.4 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 15.0 111.708 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.988 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.6 t0 -58.55 123.25 66.04 Favored Pre-proline 0 C--O 1.215 -0.745 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.633 ' HD2' HD13 ' A' ' 236' ' ' LEU . 16.8 Cg_exo -68.54 -14.48 39.76 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 121.983 1.789 . . . . 15.0 113.598 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.696 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.3 tpt180 -80.7 -7.27 59.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.095 0.95 . . . . 15.0 108.752 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.988 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.3 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.742 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.403 ' HA ' ' OE1' ' A' ' 241' ' ' GLU . 12.5 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.985 0.421 . . . . 15.0 110.119 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 44.3 m -150.07 108.93 3.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.991 0.424 . . . . 15.0 110.398 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.527 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.739 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.1 p-10 -93.15 -15.47 0.21 Allowed Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 113.964 1.098 . . . . 15.0 113.964 174.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.952 ' HG3' HD13 ' A' ' 253' ' ' LEU . 95.7 Cg_endo -97.39 160.37 0.97 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.962 2.441 . . . . 15.0 112.664 -167.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.67 160.22 28.75 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.8 -1.32 . . . . 15.0 109.8 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.464 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.517 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo -89.2 153.61 5.62 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.805 3.004 . . . . 15.0 113.414 -169.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -117.61 -4.3 11.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.422 -0.808 . . . . 15.0 109.257 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.216 -0.897 . . . . 15.0 110.658 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.856 0.36 . . . . 15.0 110.214 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.482 HD21 ' N ' ' A' ' 236' ' ' LEU . 1.0 OUTLIER -109.04 172.39 3.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.213 -0.449 . . . . 15.0 109.986 -177.307 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.671 ' HG3' HH11 ' A' ' 266' ' ' ARG . 17.4 Cg_exo -69.51 154.32 68.88 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.566 1.51 . . . . 15.0 109.413 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.76 121.54 17.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.391 0.615 . . . . 15.0 110.869 -170.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.74 -21.57 2.86 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.095 -0.957 . . . . 15.0 111.853 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.609 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 75.8 m-85 -96.69 128.82 44.0 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.64 0.257 . . . . 15.0 110.413 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.5 ' CD ' ' H3 ' ' B' ' 208' ' ' THR . 8.8 pt-20 -102.19 130.83 48.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 172.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.75 116.02 27.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.154 0.502 . . . . 15.0 109.924 -174.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.502 ' HD3' ' CE2' ' A' ' 251' ' ' TYR . 0.0 OUTLIER -101.07 150.02 23.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.037 -173.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.0 p -129.26 98.02 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.311 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -89.93 150.07 22.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.517 -0.765 . . . . 15.0 112.148 -168.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.09 -20.45 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 15.0 110.521 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 247' ' ' GLN . 11.1 mm100 -57.65 -22.25 44.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.633 -1.167 . . . . 15.0 111.524 173.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.34 23.21 48.8 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.36 -1.096 . . . . 15.0 110.36 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.469 ' HB2' ' O3P' ' B' ' 214' ' ' SEP . 2.3 mm100 -130.3 150.36 51.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.482 -0.859 . . . . 15.0 108.938 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -110.67 107.55 23.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.15 0.5 . . . . 15.0 110.676 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.502 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 51.3 p90 -98.67 125.52 44.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.299 0.571 . . . . 15.0 111.076 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.733 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.1 m-85 -90.01 113.12 24.75 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.634 -0.712 . . . . 15.0 111.622 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 1.032 HD23 ' HA ' ' A' ' 260' ' ' SER . 0.3 OUTLIER -110.39 134.39 52.35 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.804 1.288 . . . . 15.0 113.45 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.609 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -141.75 99.38 3.53 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.534 -2.121 . . . . 15.0 108.05 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.1 t -92.44 87.87 6.16 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.068 -2.253 . . . . 15.0 110.425 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.79 -44.99 5.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 112.654 -2.066 . . . . 15.0 108.168 151.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 12.9 t -139.8 24.44 2.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.092 1.901 . . . . 15.0 108.424 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.18 0.37 Allowed Glycine 0 C--N 1.28 -2.546 0 CA-C-N 109.858 -3.337 . . . . 15.0 112.722 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 253' ' ' LEU . 62.9 t -89.29 115.5 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 119.757 -0.777 . . . . 15.0 111.882 169.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 1.032 ' HA ' HD23 ' A' ' 253' ' ' LEU . 10.4 p -126.36 112.02 15.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.652 -1.613 . . . . 15.0 108.014 168.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 12.8 t -149.93 150.43 31.86 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.646 0.98 . . . . 15.0 113.646 -167.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.591 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 4.0 m95 -75.15 -21.34 58.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.529 -1.214 . . . . 15.0 112.548 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.435 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.1 p80 -101.42 144.01 30.74 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.518 -0.473 . . . . 15.0 111.578 -172.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.973 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t70 -60.46 123.32 73.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.455 -0.942 . . . . 15.0 108.455 170.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 8.7 Cg_exo -71.29 -14.68 31.43 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 121.863 1.709 . . . . 15.0 113.792 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 0.671 HH11 ' HG3' ' A' ' 237' ' ' PRO . 17.4 tpt180 -79.95 -8.51 59.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.973 HG12 ' HB3' ' A' ' 264' ' ' ASP . 35.5 pt . . . . . 0 C--O 1.251 1.146 0 CA-C-N 113.947 -1.478 . . . . 15.0 111.158 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' THR . . . . . 0.5 ' H3 ' ' CD ' ' A' ' 241' ' ' GLU . 9.8 m . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.068 0.461 . . . . 15.0 110.497 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.413 ' HA ' ' NH2' ' A' ' 243' ' ' ARG . 63.4 m -124.19 150.54 45.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.765 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 6.6 t70 -99.49 -24.78 0.23 Allowed Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.383 -0.826 . . . . 15.0 112.683 172.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.972 ' HG3' HD11 ' A' ' 253' ' ' LEU . 39.7 Cg_endo -92.68 160.26 2.85 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.069 1.846 . . . . 15.0 112.244 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.65 160.49 28.98 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.469 ' O3P' ' HB2' ' A' ' 249' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.591 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 8.1 Cg_exo -89.04 136.4 2.95 Favored 'Trans proline' 0 C--O 1.223 -0.238 0 C-N-CA 124.039 3.159 . . . . 15.0 114.719 -170.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.94 10.62 38.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.614 -1.175 . . . . 15.0 108.764 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.842 -1.072 . . . . 15.0 110.438 -176.899 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 10.0 mm-40 . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.665 0.269 . . . . 15.0 110.506 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.7 OUTLIER -114.79 167.64 9.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -177.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 1.02 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 10.4 Cg_exo -69.82 163.7 37.36 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.589 2.193 . . . . 15.0 110.822 165.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -69.81 124.31 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.817 -1.083 . . . . 15.0 112.137 -172.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.499 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 122.62 -2.12 10.22 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.583 -0.818 . . . . 15.0 114.7 170.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.633 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.1 m-85 -99.41 130.43 45.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.991 0.895 . . . . 15.0 110.581 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.553 ' OE1' ' HB2' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -104.65 138.35 41.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 173.54 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . 0.583 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -89.92 106.18 18.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 15.0 109.501 -179.327 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' ARG . . . . . 0.553 ' HB2' ' OE1' ' A' ' 241' ' ' GLU . 27.8 ttt85 -104.06 139.87 38.56 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.458 -0.792 . . . . 15.0 111.884 -174.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 5.6 p -130.6 103.12 6.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.55 -1.204 . . . . 15.0 110.078 -177.603 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -90.01 150.34 22.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.942 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.08 -17.69 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.344 0.593 . . . . 15.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' GLN . . . . . 0.651 ' HB3' HG21 ' A' ' 245' ' ' THR . 6.2 tp-100 -55.45 -23.8 27.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.506 -0.77 . . . . 15.0 111.076 172.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.6 -0.62 65.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.044 -0.598 . . . . 15.0 112.92 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.411 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 15.8 mt-30 -115.24 149.27 38.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.054 -0.35 . . . . 15.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 31.2 m -97.49 135.0 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.786 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.433 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 47.3 p90 -131.36 125.28 32.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.104 0.478 . . . . 15.0 110.29 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.672 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.81 112.29 23.56 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.517 -0.765 . . . . 15.0 111.445 -173.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.961 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -109.34 134.16 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.943 1.354 . . . . 15.0 114.243 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' HIS . . . . . 0.633 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 13.5 t-80 -137.84 97.89 3.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 112.561 -2.108 . . . . 15.0 107.578 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' THR . . . . . 0.54 HG21 ' HA2' ' A' ' 258' ' ' GLY . 1.2 p -97.42 87.52 4.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.074 -2.25 . . . . 15.0 110.836 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.419 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 35.3 tt0 -101.52 -54.14 2.82 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.14 -1.8 . . . . 15.0 106.14 147.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 30.5 p -118.06 25.88 10.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.47 -2.15 . . . . 15.0 111.331 -177.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' GLY . . . . . 0.54 ' HA2' HG21 ' A' ' 255' ' ' THR . . . 51.99 76.6 0.17 Allowed Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.269 -2.696 . . . . 15.0 113.736 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.604 ' O ' HD12 ' A' ' 253' ' ' LEU . 43.5 t -90.1 115.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.157 0.479 . . . . 15.0 110.995 171.847 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.895 ' HA ' HD23 ' A' ' 253' ' ' LEU . 7.4 p -124.09 103.39 8.26 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 124.59 1.181 . . . . 15.0 109.025 172.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.6 p -138.03 150.08 46.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.881 0.697 . . . . 15.0 112.881 -169.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 262' ' ' TRP . . . . . 0.401 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 36.6 m95 -78.78 -29.03 44.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.307 -0.86 . . . . 15.0 110.288 173.105 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.455 ' HD1' ' HB ' ' A' ' 267' ' ' ILE . 4.4 p80 -88.29 141.17 28.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.671 . . . . 15.0 110.801 -173.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . 0.885 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.3 t70 -55.97 131.37 73.7 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.503 -0.925 . . . . 15.0 108.503 171.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -14.58 28.95 Favored 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.032 1.821 . . . . 15.0 113.996 -172.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 266' ' ' ARG . . . . . 1.02 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.0 tpm_? -85.93 -3.36 58.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.124 0.964 . . . . 15.0 109.161 177.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . 0.885 HG12 ' HB3' ' A' ' 264' ' ' ASP . 44.5 mm . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 113.357 -1.747 . . . . 15.0 109.916 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.247 0.546 . . . . 15.0 110.678 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 24.7 p -145.21 103.88 3.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.562 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 210' ' ' SEP . . . . . 0.582 ' HB2' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 211' ' ' ASP . . . . . 0.58 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -107.97 -19.12 0.15 Allowed Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.965 1.098 . . . . 15.0 113.965 171.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 212' ' ' PRO . . . . . 0.961 ' HG3' HD11 ' A' ' 253' ' ' LEU . 29.4 Cg_endo -95.25 160.49 1.62 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.937 2.425 . . . . 15.0 112.218 -173.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.27 157.94 27.34 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.925 -1.131 . . . . 15.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 214' ' ' SEP . . . . . 0.453 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 215' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 2.7 Cg_exo -89.15 150.12 5.61 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.827 3.018 . . . . 15.0 113.658 -171.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 216' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' B' ' 217' ' ' GLN . 92.0 m-85 -98.48 -9.18 25.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 15.0 109.945 175.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 217' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' B' ' 217' ' ' GLN . 19.0 mt-30 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 117.789 -1.101 . . . . 15.0 110.521 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 109.63 -0.508 . . . . 15.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.689 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.4 Cg_exo -69.65 150.65 69.14 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.732 1.622 . . . . 15.0 108.961 163.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.83 141.87 53.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.551 0.691 . . . . 15.0 110.905 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.78 -22.74 6.8 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.21 -0.904 . . . . 15.0 112.334 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.7 m-85 -95.85 138.53 33.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 110.049 -0.352 . . . . 15.0 110.049 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.7 145.2 32.3 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.776 -0.824 . . . . 15.0 108.776 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.67 102.65 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -112.65 135.24 53.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 15.0 111.047 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -131.1 135.13 47.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.61 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.662 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -112.4 150.1 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.272 -0.422 . . . . 15.0 110.383 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.07 -16.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.705 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.662 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -52.96 -18.91 2.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.188 -0.915 . . . . 15.0 111.232 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.63 2.47 67.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.999 -0.619 . . . . 15.0 112.169 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.516 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 33.1 mt-30 -124.07 150.03 45.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.465 -0.568 . . . . 15.0 109.465 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.22 138.07 30.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.067 -0.346 . . . . 15.0 110.067 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -126.07 123.24 37.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.145 0.498 . . . . 15.0 110.036 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.723 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 17.9 m-85 -89.57 111.8 22.83 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 115.626 -0.716 . . . . 15.0 111.188 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.95 133.36 53.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.913 1.34 . . . . 15.0 113.986 -176.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 41.9 t60 -144.49 96.87 2.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 112.474 -2.148 . . . . 15.0 107.779 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 258' ' ' GLY . 5.1 p -96.09 87.69 4.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.256 -2.177 . . . . 15.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -101.73 -53.21 3.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.151 -1.84 . . . . 15.0 106.597 150.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.1 p -120.47 26.82 8.94 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 112.322 -2.217 . . . . 15.0 111.01 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.1 74.04 0.35 Allowed Glycine 0 C--N 1.273 -2.953 0 CA-C-N 111.262 -2.699 . . . . 15.0 113.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.0 t -90.03 115.58 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 117.286 0.543 . . . . 15.0 111.655 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.84 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.7 p -128.32 105.4 8.31 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.774 1.296 . . . . 15.0 108.863 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.4 p -141.42 150.19 42.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 32.6 m95 -75.55 -32.49 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.449 -0.796 . . . . 15.0 111.009 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -85.35 140.49 30.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.171 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.723 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 11.2 t70 -59.51 123.79 72.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 12.2 Cg_exo -71.38 -14.47 31.07 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.965 1.777 . . . . 15.0 113.622 -172.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.689 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 12.4 tpt180 . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 108.526 -0.916 . . . . 15.0 108.526 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.679 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.3 m-20 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 114.278 1.214 . . . . 15.0 114.278 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 55.6 Cg_endo -99.44 160.57 0.58 Allowed 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.542 2.828 . . . . 15.0 112.559 -171.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 N-CA-C 110.133 -1.187 . . . . 15.0 110.133 175.408 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.402 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.3 Cg_exo . . . . . 0 N--CA 1.463 -0.319 0 CA-C-O 121.562 0.567 . . . . 15.0 113.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.004 179.398 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.668 HD22 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.806 -0.442 . . . . 15.0 109.806 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.628 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 14.3 Cg_exo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.588 1.525 . . . . 15.0 109.971 166.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.7 122.28 18.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.838 0.828 . . . . 15.0 111.645 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.82 -18.47 2.98 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.039 -1.437 . . . . 15.0 111.329 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 85.0 m-85 -100.91 138.89 37.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 15.0 110.53 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -112.27 137.89 49.75 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.314 -0.625 . . . . 15.0 109.314 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 97.93 11.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.653 HH11 ' HG2' ' A' ' 243' ' ' ARG . 2.3 ttt-85 -94.53 120.49 34.84 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.527 -0.761 . . . . 15.0 111.612 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -108.25 106.41 16.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 15.0 110.118 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -90.11 150.29 22.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.952 -0.567 . . . . 15.0 109.622 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.5 t -50.9 -24.41 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.377 0.608 . . . . 15.0 110.703 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.806 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.1 tp-100 -45.72 -34.74 3.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.837 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.01 -15.31 44.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.328 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.558 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 1.7 mp0 -97.64 132.19 43.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.976 0.417 . . . . 15.0 111.021 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.26 127.77 43.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.026 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.606 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 14.9 p90 -122.02 130.41 53.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.921 0.391 . . . . 15.0 110.741 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.671 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 30.8 m-85 -89.74 107.13 18.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.461 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.959 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -109.11 133.75 52.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.866 1.317 . . . . 15.0 113.674 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 34.1 t60 -140.2 104.04 4.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 112.451 -2.158 . . . . 15.0 108.042 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.9 p -98.13 87.73 4.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.386 -2.126 . . . . 15.0 110.918 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -101.43 -53.04 3.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.529 -1.656 . . . . 15.0 106.529 147.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -121.69 25.79 9.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 112.536 -2.12 . . . . 15.0 111.369 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 51.87 75.99 0.2 Allowed Glycine 0 C--N 1.27 -3.105 0 CA-C-N 111.144 -2.753 . . . . 15.0 113.431 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 253' ' ' LEU . 59.1 t -89.71 113.97 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.315 0.558 . . . . 15.0 111.678 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.766 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 8.1 p -125.35 107.05 10.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.265 -1.334 . . . . 15.0 109.069 173.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 150.45 31.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.173 0.805 . . . . 15.0 113.173 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.558 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 3.8 m95 -75.78 -21.35 57.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.946 -1.025 . . . . 15.0 112.018 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -95.61 135.49 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.556 -0.458 . . . . 15.0 111.116 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.671 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t0 -56.73 124.19 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.563 -0.903 . . . . 15.0 108.563 170.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.668 ' HD2' HD22 ' A' ' 236' ' ' LEU . 10.3 Cg_exo -71.61 -14.78 30.51 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.363 2.042 . . . . 15.0 113.591 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.628 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 9.8 tpt180 . . . . . 0 C--N 1.309 -1.155 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 56.6 m-20 . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 112.958 0.725 . . . . 15.0 112.958 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.959 ' HG3' HD11 ' A' ' 253' ' ' LEU . 19.4 Cg_endo -97.94 160.57 0.85 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.004 2.469 . . . . 15.0 111.635 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.908 0 N-CA-C 110.416 -1.074 . . . . 15.0 110.416 177.745 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.484 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.463 -0.28 0 N-CA-C 113.798 0.653 . . . . 15.0 113.798 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.545 173.742 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 265' ' ' PRO . 2.1 mm? . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.941 -0.392 . . . . 15.0 109.941 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.749 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.1 Cg_exo -69.42 147.71 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.561 1.508 . . . . 15.0 109.172 161.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.51 116.07 9.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.453 0.644 . . . . 15.0 111.83 -167.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 147.87 -16.91 1.4 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.844 -1.071 . . . . 15.0 112.122 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 92.6 m-85 -94.9 132.48 39.68 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.722 -0.281 . . . . 15.0 110.567 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.68 142.87 35.62 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.509 -0.552 . . . . 15.0 109.509 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -90.0 119.59 30.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -124.77 137.21 54.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.481 0.658 . . . . 15.0 111.123 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 m -129.4 126.16 38.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.276 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -93.11 150.15 20.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.246 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.3 m -54.52 -21.21 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.559 0.695 . . . . 15.0 110.599 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.4 tp-100 -47.66 -32.61 5.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.582 -1.19 . . . . 15.0 111.488 170.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.3 19.18 21.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.036 -0.602 . . . . 15.0 112.635 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.723 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 4.6 mt-30 -127.14 147.83 50.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.43 136.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.336 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -134.51 125.71 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.67 -0.492 . . . . 15.0 109.67 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -89.65 112.63 23.92 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.58 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.014 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -107.44 133.42 51.97 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.804 1.288 . . . . 15.0 113.494 -177.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 39.7 t60 -145.35 103.17 3.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.587 -2.097 . . . . 15.0 108.424 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.9 t -99.21 87.79 3.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 116.162 -2.215 . . . . 15.0 111.005 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -101.27 -51.73 3.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.31 -1.768 . . . . 15.0 106.597 149.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 44.8 p -121.66 24.81 9.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.425 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.2 0.34 Allowed Glycine 0 C--N 1.27 -3.138 0 CA-C-N 111.278 -2.692 . . . . 15.0 113.7 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.559 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.1 t -89.97 119.54 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 117.253 0.526 . . . . 15.0 111.622 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.821 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 4.6 p -131.76 109.11 9.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.396 -1.275 . . . . 15.0 108.677 169.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -150.17 150.11 31.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.098 0.777 . . . . 15.0 113.098 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -71.06 -29.64 65.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.011 -0.995 . . . . 15.0 111.917 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -90.61 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.597 -0.441 . . . . 15.0 111.271 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.678 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 12.3 t70 -56.65 120.43 36.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.02 -1.104 . . . . 15.0 108.02 168.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 Cg_exo -69.72 -14.61 36.47 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.247 1.965 . . . . 15.0 113.72 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.749 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.0 tpt180 . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.688 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 5.7 p-10 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.014 ' HG3' HD11 ' A' ' 253' ' ' LEU . 82.0 Cg_endo -94.3 160.59 2.03 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.292 2.661 . . . . 15.0 112.014 -170.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.978 0 C-N-CA 119.286 -1.435 . . . . 15.0 110.052 174.154 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.46 -0.484 0 CA-C-O 121.6 0.583 . . . . 15.0 112.817 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 121.591 0.71 . . . . 15.0 109.385 175.372 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.516 -0.363 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.589 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.46 144.93 57.29 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.947 1.765 . . . . 15.0 110.182 172.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.6 124.75 24.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.716 0.77 . . . . 15.0 111.875 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.36 -20.19 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.477 -1.238 . . . . 15.0 111.884 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.5 m-85 -91.12 126.23 36.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 7.8 pt-20 -97.87 129.04 44.84 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.405 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.68 103.54 16.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.502 0.668 . . . . 15.0 109.347 -175.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -105.15 139.65 39.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.915 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 m -131.23 108.91 10.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.8 t -94.78 150.25 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.418 -0.355 . . . . 15.0 110.728 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.3 -18.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.885 0.85 . . . . 15.0 111.074 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.6 tp-100 -48.67 -23.59 1.08 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.043 -1.435 . . . . 15.0 111.534 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.67 10.46 61.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.754 -0.538 . . . . 15.0 111.754 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.492 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 26.5 mt-30 -129.83 139.79 51.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.6 m -100.68 124.07 54.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.029 0.442 . . . . 15.0 110.385 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -109.58 127.52 54.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.132 0.491 . . . . 15.0 110.092 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.722 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 22.5 m-85 -89.54 107.57 19.16 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.591 -0.731 . . . . 15.0 111.116 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.052 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -106.83 133.96 50.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.734 1.254 . . . . 15.0 113.551 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 37.4 t60 -142.91 102.76 4.08 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 112.703 -2.044 . . . . 15.0 107.865 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 25.1 m -102.1 88.06 3.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 115.874 -2.331 . . . . 15.0 110.931 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -101.17 -47.78 4.62 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.415 -1.721 . . . . 15.0 107.027 146.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 36.0 p -124.83 25.11 7.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 113.521 -1.672 . . . . 15.0 111.399 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.23 74.49 0.31 Allowed Glycine 0 C--N 1.272 -2.984 0 CA-C-N 111.137 -2.756 . . . . 15.0 113.552 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 253' ' ' LEU . 56.1 t -89.83 120.25 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 117.239 0.519 . . . . 15.0 110.982 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.815 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.3 p -135.84 105.68 6.21 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 124.519 1.137 . . . . 15.0 109.244 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -150.2 150.35 31.48 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.492 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 18.6 m95 -68.81 -30.97 69.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.204 -0.907 . . . . 15.0 111.264 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -86.15 137.11 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.992 0.425 . . . . 15.0 111.173 -170.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.722 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 10.7 t0 -58.41 125.3 75.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.586 -0.894 . . . . 15.0 108.586 171.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 23.1 Cg_exo -68.3 -14.72 41.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 122.543 2.162 . . . . 15.0 113.865 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.589 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpt180 . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.585 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 23.0 t70 . . . . . 0 CA--C 1.554 1.108 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.052 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.3 Cg_endo -97.18 160.26 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.671 2.247 . . . . 15.0 111.919 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.881 0 C-N-CA 119.626 -1.273 . . . . 15.0 110.566 176.038 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.412 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.2 Cg_exo . . . . . 0 CA--C 1.531 0.332 0 CA-C-O 121.628 0.595 . . . . 15.0 113.334 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.516 -0.765 . . . . 15.0 109.552 174.697 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.2 mm? . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.28 0.562 . . . . 15.0 110.927 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.712 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.7 Cg_exo -69.28 159.28 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.254 1.969 . . . . 15.0 109.701 161.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -69.49 123.95 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.542 0.686 . . . . 15.0 111.547 -172.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.47 4.64 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.775 -1.102 . . . . 15.0 113.203 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.612 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 78.2 m-85 -97.4 130.77 44.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.319 0.56 . . . . 15.0 111.004 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.5 140.06 43.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 243' ' ' ARG . 2.5 tp-100 -89.66 143.76 26.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.615 -0.883 . . . . 15.0 108.615 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.427 ' N ' ' HG3' ' A' ' 242' ' ' GLN . 8.9 ttt180 -139.84 131.61 27.45 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.802 -0.636 . . . . 15.0 110.886 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 p -115.01 111.58 21.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.719 -1.128 . . . . 15.0 110.185 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.9 150.22 22.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.027 -0.533 . . . . 15.0 109.667 176.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.51 -24.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.381 0.61 . . . . 15.0 110.533 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.733 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -47.58 -38.91 15.37 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.622 -1.172 . . . . 15.0 111.931 170.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.17 5.02 35.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.752 -0.737 . . . . 15.0 113.526 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.653 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.8 mt-30 -113.58 137.71 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.196 0.498 . . . . 15.0 111.037 -175.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 m -90.05 121.26 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.579 177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -121.16 130.1 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.882 -0.327 . . . . 15.0 110.605 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 23.6 m-85 -89.82 110.18 21.13 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.505 -174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.013 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -108.97 132.58 53.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.776 1.274 . . . . 15.0 114.086 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 40.1 t60 -140.75 101.24 4.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.702 -2.044 . . . . 15.0 107.884 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.4 t -99.07 87.54 3.71 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 116.087 -2.245 . . . . 15.0 110.667 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -101.28 -50.66 3.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.142 -1.844 . . . . 15.0 106.753 149.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 32.0 p -124.19 25.19 7.89 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 112.794 -2.003 . . . . 15.0 111.142 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.78 75.15 0.25 Allowed Glycine 0 C--N 1.273 -2.942 0 CA-C-N 111.014 -2.812 . . . . 15.0 113.554 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 253' ' ' LEU . 41.1 t -89.72 117.26 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-N 117.287 0.543 . . . . 15.0 111.23 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.793 ' HA ' HD22 ' A' ' 253' ' ' LEU . 7.6 p -127.72 108.82 11.08 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 124.326 1.016 . . . . 15.0 109.061 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.5 t -150.16 150.33 31.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.596 0.591 . . . . 15.0 112.596 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 77.1 m95 -76.52 -25.68 54.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.578 -0.737 . . . . 15.0 111.054 174.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -90.49 132.21 35.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 15.0 111.072 -171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.551 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 8.9 t70 -53.26 122.12 28.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 169.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.608 ' HD2' HD12 ' A' ' 236' ' ' LEU . 10.1 Cg_exo -71.65 -14.52 30.26 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 122.113 1.875 . . . . 15.0 113.924 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.712 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.7 tpt180 . . . . . 0 C--N 1.31 -1.114 0 CA-C-O 121.77 0.795 . . . . 15.0 109.105 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 28.2 m-20 . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 114.117 1.154 . . . . 15.0 114.117 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.013 ' HG3' HD11 ' A' ' 253' ' ' LEU . 35.6 Cg_endo -96.89 160.85 1.08 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 123.091 2.527 . . . . 15.0 111.9 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.982 0 N-CA-C 109.434 -1.466 . . . . 15.0 109.434 173.114 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.401 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.6 Cg_exo . . . . . 0 N--CA 1.463 -0.293 0 CA-C-O 121.021 0.342 . . . . 15.0 112.85 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.332 0.587 . . . . 15.0 110.185 176.711 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 1.057 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 22.5 Cg_exo -69.56 159.15 54.64 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.062 1.841 . . . . 15.0 110.702 165.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.98 123.87 22.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.904 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.49 -14.46 6.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.548 -0.834 . . . . 15.0 112.837 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.673 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.8 m-85 -94.67 131.16 40.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.911 0.355 . . . . 15.0 110.334 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 131.35 44.12 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.43 -0.952 . . . . 15.0 108.43 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -89.72 99.11 12.18 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -106.97 119.32 39.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.004 -0.998 . . . . 15.0 111.379 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.9 m -115.77 111.04 19.94 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 15.0 109.337 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.8 150.06 22.42 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.42 -21.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.388 0.613 . . . . 15.0 111.561 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.743 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.499 -1.228 . . . . 15.0 111.58 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.4 -8.84 28.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.896 -0.669 . . . . 15.0 112.561 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 58.2 mt-30 -112.41 143.52 43.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.86 0.362 . . . . 15.0 110.483 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.51 135.03 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -126.66 125.29 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.971 0.415 . . . . 15.0 109.902 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 21.4 m-85 -89.78 109.92 20.88 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.111 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.38 131.07 54.02 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.727 1.251 . . . . 15.0 114.053 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.673 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 53.2 t60 -141.38 93.72 2.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 112.768 -2.014 . . . . 15.0 107.7 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 29.9 m -93.85 87.78 5.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 115.99 -2.284 . . . . 15.0 110.09 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -101.38 -52.91 3.13 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.117 -1.856 . . . . 15.0 106.233 150.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 45.2 p -118.01 24.75 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.437 -2.165 . . . . 15.0 110.904 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.19 73.19 0.44 Allowed Glycine 0 C--N 1.27 -3.096 0 CA-C-N 110.965 -2.834 . . . . 15.0 113.836 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.63 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -90.01 115.01 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 117.309 0.554 . . . . 15.0 112.037 175.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.801 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.8 p -127.46 107.87 10.33 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.37 1.043 . . . . 15.0 109.08 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -150.28 150.28 31.3 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.644 0.609 . . . . 15.0 112.644 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.575 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 79.6 m95 -75.11 -25.46 58.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.282 175.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 264' ' ' ASP . 7.0 p-80 -87.63 142.09 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.065 0.459 . . . . 15.0 111.03 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.634 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.3 t70 -65.92 131.33 94.56 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.175 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.72 -14.57 8.88 Favored 'Trans proline' 0 CA--C 1.509 -0.737 0 C-N-CA 122.541 2.161 . . . . 15.0 113.855 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 1.057 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.1 tpm_? . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 122.076 0.941 . . . . 15.0 108.858 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.8 m-20 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 113.631 0.975 . . . . 15.0 113.631 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HG3' HD11 ' A' ' 253' ' ' LEU . 16.4 Cg_endo -97.03 160.39 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.549 2.166 . . . . 15.0 112.303 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -0.772 0 N-CA-C 110.387 -1.085 . . . . 15.0 110.387 176.509 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.46 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo . . . . . 0 N--CA 1.464 -0.221 0 CA-C-O 121.91 0.713 . . . . 15.0 113.602 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.503 177.442 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.942 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.343 0 CA-C-O 121.529 0.68 . . . . 15.0 111.119 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.514 ' HD2' ' CE1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.46 158.98 55.37 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 122.831 2.354 . . . . 15.0 109.617 165.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.62 117.31 11.07 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.405 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.14 -2.1 2.87 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.759 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 237' ' ' PRO . 69.6 m-85 -116.74 136.98 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.22 134.14 51.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.601 -0.518 . . . . 15.0 109.601 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' A' ' 252' ' ' PHE . 21.4 tt0 -89.72 97.98 11.51 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.546 -0.538 . . . . 15.0 109.546 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -95.49 119.47 34.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.767 -0.651 . . . . 15.0 110.598 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.604 ' HB ' HG12 ' A' ' 250' ' ' VAL . 5.0 t -104.0 150.07 24.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.286 -0.87 . . . . 15.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.786 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -135.31 150.46 50.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.972 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.93 -17.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.336 0.589 . . . . 15.0 110.983 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.786 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.3 tp-100 -54.36 -20.43 7.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.446 -0.797 . . . . 15.0 111.245 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.38 69.01 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.363 -0.446 . . . . 15.0 112.51 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 28.0 mt-30 -125.74 136.0 52.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.033 -0.358 . . . . 15.0 110.033 -175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 244' ' ' THR . 20.8 m -89.99 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.716 0.293 . . . . 15.0 110.334 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -122.86 130.68 53.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 15.0 110.153 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 28.9 m-85 -89.76 108.51 19.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.871 -0.604 . . . . 15.0 111.698 -171.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.33 132.13 53.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.858 1.313 . . . . 15.0 113.558 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 0.3 OUTLIER -140.4 99.47 3.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 112.601 -2.091 . . . . 15.0 107.514 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.7 t -108.37 87.47 2.5 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 115.242 -2.583 . . . . 15.0 111.395 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.424 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 39.8 tt0 -101.47 -48.22 4.42 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.256 -2.247 . . . . 15.0 106.649 142.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -118.32 24.78 10.74 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 113.539 -1.664 . . . . 15.0 111.757 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.53 72.79 0.43 Allowed Glycine 0 C--N 1.271 -3.069 0 CA-C-N 110.961 -2.836 . . . . 15.0 114.495 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 253' ' ' LEU . 13.1 t -92.42 116.33 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 117.449 0.624 . . . . 15.0 111.631 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.799 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.1 p -126.63 110.08 12.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.167 0.917 . . . . 15.0 108.659 167.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -149.93 150.31 31.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.923 0.712 . . . . 15.0 112.923 -167.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.465 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 22.1 m95 -75.65 -29.65 59.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.353 -0.839 . . . . 15.0 111.479 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -93.53 140.16 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.624 -0.43 . . . . 15.0 111.27 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 16.2 t0 -50.61 126.22 22.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 N-CA-C 108.672 -0.862 . . . . 15.0 108.672 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.942 ' HD2' HD12 ' A' ' 236' ' ' LEU . 56.3 Cg_endo -70.55 -14.53 33.66 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 C-N-CA 122.471 2.114 . . . . 15.0 113.608 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 . . . . . 0 C--N 1.314 -0.974 0 CA-C-O 121.898 0.856 . . . . 15.0 108.963 174.567 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 10.3 m-20 . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 113.095 0.776 . . . . 15.0 113.095 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.4 Cg_endo -96.78 160.38 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.99 2.46 . . . . 15.0 112.759 -166.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.015 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 174.343 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.46 -0.453 0 CA-C-O 121.839 0.683 . . . . 15.0 113.383 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 114.815 -1.084 . . . . 15.0 109.875 -179.522 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.218 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.414 ' HG3' HH11 ' A' ' 266' ' ' ARG . 13.4 Cg_exo -69.52 160.31 50.26 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 121.524 1.482 . . . . 15.0 110.579 168.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.89 120.16 15.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.281 -171.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 135.11 -27.16 3.18 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.597 -0.729 . . . . 15.0 113.068 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 45.1 m-85 -92.39 136.69 32.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.884 0.342 . . . . 15.0 110.62 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.82 141.4 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 167.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -89.82 99.37 12.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -93.47 130.22 39.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.81 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -119.76 110.41 16.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.312 -0.858 . . . . 15.0 110.142 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.656 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.06 150.26 22.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.789 -0.448 . . . . 15.0 109.789 176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 42.6 t -55.13 -18.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.65 0.738 . . . . 15.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.656 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.3 tp-100 -49.94 -29.21 7.95 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.817 -1.083 . . . . 15.0 111.429 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.36 -23.92 17.05 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.046 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.505 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.5 mp0 -89.88 148.39 23.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.253 0.549 . . . . 15.0 111.322 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 123.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.713 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -114.15 128.61 56.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.439 -0.505 . . . . 15.0 110.592 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.3 m-85 -89.69 110.34 21.24 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.419 -172.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.48 134.43 52.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.739 1.257 . . . . 15.0 113.852 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 64.1 t60 -146.89 102.27 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 112.563 -2.108 . . . . 15.0 108.309 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.4 t -102.91 88.01 3.07 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 116.058 -2.257 . . . . 15.0 111.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -101.15 -50.69 3.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.164 -1.835 . . . . 15.0 106.237 147.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.9 p -116.91 27.23 9.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.142 -1.845 . . . . 15.0 111.293 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.04 72.18 0.55 Allowed Glycine 0 C--N 1.277 -2.747 0 CA-C-N 111.133 -2.758 . . . . 15.0 113.974 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.8 t -90.05 115.16 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-N 117.379 0.59 . . . . 15.0 111.807 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.839 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.1 p -127.89 100.09 5.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.956 170.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.5 p -141.25 150.27 42.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.223 0.823 . . . . 15.0 113.223 -167.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.624 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 1.7 m95 -70.87 -42.56 69.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.475 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -76.19 139.33 41.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.66 -0.7 . . . . 15.0 111.676 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.57 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 49.3 t0 -54.19 127.74 56.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 168.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.416 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 65.1 Cg_endo -74.13 -14.79 23.32 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 121.651 1.567 . . . . 15.0 112.916 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 13.6 tpt180 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 108.683 -0.858 . . . . 15.0 108.683 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 3.8 p-10 . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 253' ' ' LEU . 56.3 Cg_endo -90.8 160.44 4.13 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.306 2.004 . . . . 15.0 111.629 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.158 0 N-CA-C 110.214 -1.154 . . . . 15.0 110.214 179.74 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.624 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.463 -0.289 0 CA-C-O 122.007 0.753 . . . . 15.0 113.832 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.121 -0.945 . . . . 15.0 110.236 178.025 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 108.922 -0.77 . . . . 15.0 108.922 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.791 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.6 Cg_exo -69.62 161.97 43.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.497 1.465 . . . . 15.0 110.332 167.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.53 124.37 23.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.112 -0.949 . . . . 15.0 111.256 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.98 -13.93 8.0 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.521 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.9 m-85 -94.29 131.89 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.365 0.583 . . . . 15.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.99 140.58 38.76 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 170.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.492 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.8 OUTLIER -89.85 102.09 14.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -109.02 145.95 34.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.24 -0.891 . . . . 15.0 111.413 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 m -136.47 124.77 23.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.019 -0.991 . . . . 15.0 109.664 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.591 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.1 t -89.86 150.43 22.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.923 -0.399 . . . . 15.0 109.923 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.3 m -51.5 -24.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.316 0.579 . . . . 15.0 110.979 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.591 ' HB3' HG23 ' A' ' 245' ' ' THR . 2.2 tp-100 -52.05 -33.29 38.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.037 -0.983 . . . . 15.0 111.703 172.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.8 12.16 28.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.995 -0.622 . . . . 15.0 112.512 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 0.1 OUTLIER -99.1 142.32 30.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.241 -0.652 . . . . 15.0 109.241 179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 m -102.78 106.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.013 0.435 . . . . 15.0 109.897 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -109.56 127.0 54.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.552 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.0 m-85 -89.54 108.4 19.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.593 -172.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.992 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.21 133.44 52.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.885 1.326 . . . . 15.0 113.503 -175.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.617 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 24.1 t60 -143.93 104.73 4.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.427 -2.17 . . . . 15.0 107.866 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -104.36 87.81 2.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 115.768 -2.373 . . . . 15.0 111.125 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 34.4 tt0 -101.32 -49.32 4.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.137 -1.847 . . . . 15.0 106.798 148.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -124.84 27.34 6.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.272 -1.785 . . . . 15.0 111.623 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.26 73.97 0.35 Allowed Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.457 -2.611 . . . . 15.0 114.292 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.565 ' O ' HD13 ' A' ' 253' ' ' LEU . 38.0 t -89.91 120.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.09 0.445 . . . . 15.0 111.517 173.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.805 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.6 p -131.25 112.23 12.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.053 -0.976 . . . . 15.0 109.166 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 p -144.33 150.12 37.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.244 0.831 . . . . 15.0 113.244 -167.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.78 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.1 OUTLIER -73.26 -36.28 66.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.975 -1.011 . . . . 15.0 110.496 171.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -86.02 142.35 28.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.237 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.661 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 10.6 t70 -58.96 131.52 86.8 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.744 -0.836 . . . . 15.0 108.744 171.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.99 -14.8 16.81 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 C-N-CA 122.189 1.926 . . . . 15.0 113.619 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.791 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.4 tpt180 . . . . . 0 C--N 1.31 -1.146 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.811 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 19.8 t70 . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 113.735 1.013 . . . . 15.0 113.735 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.992 ' HG3' HD11 ' A' ' 253' ' ' LEU . 61.4 Cg_endo -101.41 160.31 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.742 2.961 . . . . 15.0 114.081 -162.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 N-CA-C 109.669 -1.372 . . . . 15.0 109.669 169.609 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.78 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.2 Cg_exo . . . . . 0 C--O 1.223 -0.247 0 CA-C-O 121.744 0.643 . . . . 15.0 113.439 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 15.0 109.764 174.755 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.404 0.621 . . . . 15.0 111.31 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.569 ' HG3' HH11 ' A' ' 266' ' ' ARG . 19.6 Cg_exo -69.41 167.21 24.62 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 122.977 2.451 . . . . 15.0 110.82 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.54 114.6 7.91 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.676 -1.147 . . . . 15.0 111.516 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.55 -18.78 2.43 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 114.821 -1.082 . . . . 15.0 113.112 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 43.5 m-85 -101.77 131.68 47.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.053 0.427 . . . . 15.0 111.107 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -101.59 138.66 38.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.98 110.08 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -112.09 128.78 56.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.235 0.54 . . . . 15.0 111.311 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -113.53 125.49 54.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.843 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -107.72 150.52 26.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.125 -0.488 . . . . 15.0 110.65 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -48.84 -20.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.314 0.646 . . . . 15.0 112.171 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.764 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.1 tp-100 -51.21 -21.76 2.25 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.336 -0.847 . . . . 15.0 111.666 171.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.14 60.92 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 15.0 111.916 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.525 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 32.7 mt-30 -130.72 149.73 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.662 -0.495 . . . . 15.0 109.662 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.73 138.66 26.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 15.0 109.975 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -125.25 128.16 47.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.351 0.596 . . . . 15.0 110.476 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 14.8 m-85 -89.73 109.66 20.62 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.028 -0.987 . . . . 15.0 111.453 -172.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.081 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.37 132.96 53.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.836 1.303 . . . . 15.0 114.039 -175.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.623 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 18.7 t60 -140.38 97.09 3.15 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.535 -2.121 . . . . 15.0 107.447 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.2 p -90.51 88.22 7.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.439 -2.104 . . . . 15.0 110.424 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -101.29 -44.73 5.56 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.032 -1.895 . . . . 15.0 108.704 152.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 5.6 t -146.05 26.09 1.24 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 124.062 1.887 . . . . 15.0 108.775 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 59.45 75.96 0.25 Allowed Glycine 0 C--N 1.28 -2.581 0 CA-C-N 110.307 -3.133 . . . . 15.0 113.356 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 79.6 t -89.27 115.8 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 118.833 -1.147 . . . . 15.0 110.841 164.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.822 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.9 p -129.31 106.15 8.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.481 -1.69 . . . . 15.0 108.571 173.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.994 0.739 . . . . 15.0 112.994 -167.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.525 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 43.3 m95 -77.84 -36.6 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 15.0 109.94 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -79.95 141.12 36.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.089 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 25.3 t0 -59.81 125.43 80.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.053 -1.091 . . . . 15.0 108.053 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.776 ' HD2' HD12 ' A' ' 236' ' ' LEU . 11.9 Cg_exo -70.55 -14.8 33.9 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.192 1.928 . . . . 15.0 112.897 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 237' ' ' PRO . 18.7 tpt180 . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 121.677 0.751 . . . . 15.0 109.078 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.588 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 47.4 p-10 . . . . . 0 CA--C 1.556 1.185 0 N-CA-C 114.059 1.133 . . . . 15.0 114.059 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.081 ' HG3' HD11 ' A' ' 253' ' ' LEU . 57.4 Cg_endo -96.72 160.68 1.14 Allowed 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.057 2.505 . . . . 15.0 111.928 -175.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.969 0 C-N-CA 119.865 -1.16 . . . . 15.0 110.455 176.776 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.427 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.3 Cg_exo . . . . . 0 CA--C 1.53 0.301 0 CA-C-O 121.584 0.577 . . . . 15.0 113.146 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.015 -179.009 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 15.0 110.551 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.665 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.7 Cg_exo -69.34 155.94 65.86 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.3 2.0 . . . . 15.0 109.76 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.72 117.73 11.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.219 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 146.12 -13.55 1.67 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.38 -0.827 . . . . 15.0 112.949 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.9 m-85 -104.84 138.43 41.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.276 0.538 . . . . 15.0 110.848 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 170.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.92 104.59 17.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -109.05 130.71 55.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.49 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 125.71 53.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.789 . . . . 15.0 110.213 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -106.25 150.72 25.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.082 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.0 t -45.87 -23.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.611 0.569 . . . . 15.0 111.57 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.756 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.7 tp60 -50.94 -23.08 2.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.457 0.703 . . . . 15.0 111.53 173.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.15 65.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.248 -0.501 . . . . 15.0 112.275 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 34.5 mt-30 -106.73 142.47 36.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.835 0.35 . . . . 15.0 110.587 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.03 137.23 22.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.433 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -127.79 128.25 44.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.048 0.451 . . . . 15.0 110.081 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.2 m-85 -89.7 111.33 22.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.619 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.47 133.95 51.92 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.806 1.289 . . . . 15.0 113.985 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 43.4 t60 -140.49 97.54 3.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 112.475 -2.148 . . . . 15.0 107.307 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.533 HG22 ' HA2' ' A' ' 258' ' ' GLY . 8.8 p -97.21 87.74 4.26 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 116.295 -2.162 . . . . 15.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -101.29 -52.73 3.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.278 -1.783 . . . . 15.0 106.818 147.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 35.8 p -119.4 27.66 8.66 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 112.417 -2.174 . . . . 15.0 111.116 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.36 74.94 0.24 Allowed Glycine 0 C--N 1.274 -2.883 0 CA-C-N 111.464 -2.607 . . . . 15.0 113.692 -175.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.7 t -89.59 111.11 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-N 117.452 0.626 . . . . 15.0 111.066 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.813 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.6 p -124.66 101.97 7.37 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.171 -1.377 . . . . 15.0 108.885 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -150.22 150.39 31.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -169.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 74.4 m95 -72.66 -38.32 67.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.012 174.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.86 136.32 41.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.165 -0.47 . . . . 15.0 111.563 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.614 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t0 -57.26 124.66 67.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.271 -0.877 . . . . 15.0 108.917 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 9.1 Cg_exo -73.38 -14.62 25.27 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.5 2.134 . . . . 15.0 113.879 -176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.665 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 26.2 tpt180 . . . . . 0 C--N 1.313 -1.016 0 N-CA-C 108.76 -0.83 . . . . 15.0 108.76 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.558 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 29.5 m-20 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 113.394 0.887 . . . . 15.0 113.394 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -92.04 160.19 3.26 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.191 1.927 . . . . 15.0 111.098 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 C-N-CA 119.904 -1.141 . . . . 15.0 110.295 -179.51 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.461 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 CA-C-O 122.082 0.784 . . . . 15.0 113.952 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.026 172.351 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.835 -0.431 . . . . 15.0 109.835 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.925 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.57 165.61 30.17 Favored 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.062 1.841 . . . . 15.0 110.92 166.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -69.48 126.93 31.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.304 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 121.52 -13.65 9.38 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 15.0 113.647 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.628 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 91.0 m-85 -95.06 128.58 41.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.471 0.636 . . . . 15.0 110.718 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -106.78 135.99 47.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 15.0 109.655 172.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.547 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -89.79 111.61 22.67 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.358 -0.979 . . . . 15.0 108.358 -178.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.708 HH11 ' HG2' ' A' ' 243' ' ' ARG . 6.1 ttt-85 -107.51 127.36 53.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.654 -0.703 . . . . 15.0 111.909 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.4 p -113.83 124.38 52.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.455 -1.248 . . . . 15.0 109.821 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -107.91 150.0 27.61 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.927 -0.397 . . . . 15.0 109.927 175.126 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.47 -18.67 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.516 0.674 . . . . 15.0 110.312 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.724 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.8 tp-100 -47.33 -40.99 18.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.877 -1.056 . . . . 15.0 111.198 171.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.91 21.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.779 -0.724 . . . . 15.0 112.881 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -104.48 150.11 24.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.1 0.476 . . . . 15.0 111.662 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.12 124.17 55.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.301 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 37.8 p90 -125.82 129.23 48.99 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.013 -0.675 . . . . 15.0 111.784 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.645 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 36.7 m-85 -90.06 111.28 22.34 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.678 -174.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.953 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -110.54 134.17 52.63 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.707 1.241 . . . . 15.0 113.211 176.103 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 42.2 t60 -140.72 100.32 3.82 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.005 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.3 t -101.81 87.89 3.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 115.905 -2.318 . . . . 15.0 110.885 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.452 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 46.7 tt0 -101.08 -46.67 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.023 -1.899 . . . . 15.0 106.773 148.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.3 p -124.97 27.05 6.84 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.412 -1.722 . . . . 15.0 111.109 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.91 73.11 0.43 Allowed Glycine 0 C--N 1.278 -2.666 0 CA-C-N 111.281 -2.69 . . . . 15.0 114.212 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.644 ' O ' HD13 ' A' ' 253' ' ' LEU . 50.9 t -89.95 114.0 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 117.349 0.574 . . . . 15.0 112.066 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.776 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.7 p -121.63 106.86 11.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.786 -1.097 . . . . 15.0 108.596 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.3 p -142.41 150.13 40.22 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.257 0.836 . . . . 15.0 113.257 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 1.5 m95 -77.67 -34.81 52.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.652 172.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -82.79 137.81 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.003 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.645 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.9 t70 -57.14 133.41 80.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 171.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.405 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 87.8 Cg_endo -81.21 -14.64 10.63 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.293 1.995 . . . . 15.0 113.986 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.925 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.3 tpt180 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 122.376 1.084 . . . . 15.0 108.396 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.553 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 5.3 p-10 . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 118.987 -0.53 . . . . 15.0 112.244 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.953 ' HG3' HD11 ' A' ' 253' ' ' LEU . 13.1 Cg_endo -96.42 160.37 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.941 2.427 . . . . 15.0 111.691 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 111.036 -0.825 . . . . 15.0 111.036 178.242 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.508 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo . . . . . 0 C--O 1.223 -0.226 0 N-CA-C 113.895 0.69 . . . . 15.0 113.895 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.663 -0.698 . . . . 15.0 109.54 172.759 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.594 -0.521 . . . . 15.0 109.594 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.647 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.45 159.39 53.82 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.986 1.791 . . . . 15.0 110.485 166.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.62 113.96 7.39 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.54 -0.755 . . . . 15.0 111.214 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 143.77 -16.43 2.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.49 -0.777 . . . . 15.0 112.729 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 66.4 m-85 -98.36 138.74 35.16 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.626 -0.338 . . . . 15.0 110.737 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -109.33 144.3 37.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -89.85 118.55 29.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 15.0 108.796 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.7 136.36 53.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.387 0.613 . . . . 15.0 111.536 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 m -129.45 115.61 17.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.931 -1.032 . . . . 15.0 109.592 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -90.15 150.62 21.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.536 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.48 -17.34 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.31 0.576 . . . . 15.0 110.617 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -54.2 -22.7 12.13 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.012 170.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.43 16.65 48.9 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.009 -0.615 . . . . 15.0 112.78 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 16.0 mt-30 -131.47 146.81 52.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.773 0.321 . . . . 15.0 110.213 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.56 141.21 15.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.415 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.5 127.42 27.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.889 0.376 . . . . 15.0 110.098 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 25.1 m-85 -89.62 111.65 22.66 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.05 -0.523 . . . . 15.0 111.434 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.046 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.83 135.86 49.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.684 1.231 . . . . 15.0 113.619 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 37.8 t60 -148.74 107.44 3.82 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.678 -2.055 . . . . 15.0 108.292 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 11.9 m -103.42 87.58 2.89 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 116.17 -2.212 . . . . 15.0 110.625 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.413 ' HB3' ' NE2' ' A' ' 254' ' ' HIS . 43.7 tt0 -101.35 -48.19 4.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.071 -1.877 . . . . 15.0 107.253 149.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 43.6 p -125.11 25.17 7.31 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.099 -1.864 . . . . 15.0 111.201 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.27 75.38 0.23 Allowed Glycine 0 C--N 1.272 -2.983 0 CA-C-N 111.17 -2.741 . . . . 15.0 113.187 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 253' ' ' LEU . 75.3 t -89.74 119.94 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.161 0.48 . . . . 15.0 111.604 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.4 p -134.21 107.32 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 124.817 1.323 . . . . 15.0 108.932 171.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -150.13 150.36 31.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 37.7 m95 -72.83 -28.69 62.7 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.114 174.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 264' ' ' ASP . 6.0 p-80 -87.65 134.62 33.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.97 0.414 . . . . 15.0 111.132 -169.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.676 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t70 -52.73 126.97 42.27 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.444 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.447 ' HD3' ' CD1' ' A' ' 252' ' ' PHE . 80.9 Cg_endo -76.96 -14.44 17.04 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.381 2.054 . . . . 15.0 114.052 -173.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.647 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 13.3 tpt180 . . . . . 0 C--N 1.312 -1.053 0 CA-C-O 122.108 0.956 . . . . 15.0 108.465 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.662 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 32.6 t70 . . . . . 0 CA--C 1.557 1.216 0 N-CA-C 113.798 1.036 . . . . 15.0 113.798 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.046 ' HG3' HD11 ' A' ' 253' ' ' LEU . 62.8 Cg_endo -93.04 160.33 2.63 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.513 2.142 . . . . 15.0 112.127 -169.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.088 0 C-N-CA 119.639 -1.267 . . . . 15.0 110.369 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.545 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo . . . . . 0 N--CA 1.462 -0.35 0 CA-C-O 121.887 0.703 . . . . 15.0 113.262 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.633 -0.712 . . . . 15.0 109.523 175.228 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 265' ' ' PRO . 6.4 mt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.443 ' HD3' ' CD ' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.62 160.6 49.14 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 121.925 1.75 . . . . 15.0 110.543 168.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.4 119.4 13.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.548 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 137.18 -17.89 3.55 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.481 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 67.0 m-85 -103.33 132.01 49.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.596 0.198 . . . . 15.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -108.97 139.29 44.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.78 105.0 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 243' ' ' ARG . 16.4 ttt85 -105.71 138.66 41.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.261 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 m -128.37 117.2 21.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.195 -0.912 . . . . 15.0 109.824 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.784 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.3 t -90.02 150.3 22.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.945 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 t -54.53 -18.06 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.575 0.702 . . . . 15.0 110.522 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.784 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.4 tp60 -53.02 -24.62 10.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.07 -0.968 . . . . 15.0 111.774 172.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.92 -2.96 52.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.627 -0.797 . . . . 15.0 112.824 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.559 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 13.0 mp0 -113.35 143.84 43.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.133 0.492 . . . . 15.0 111.486 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.83 136.81 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 15.0 110.161 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -130.68 130.95 44.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.054 0.454 . . . . 15.0 110.529 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 38.9 m-85 -89.66 109.16 20.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.691 -0.686 . . . . 15.0 111.297 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -109.37 134.62 51.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.682 1.23 . . . . 15.0 113.716 -176.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 34.4 t60 -141.81 105.63 4.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.457 -2.156 . . . . 15.0 107.698 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.401 HG22 ' HA2' ' A' ' 258' ' ' GLY . 22.5 p -104.26 87.75 2.82 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.281 -2.168 . . . . 15.0 111.277 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -101.35 -49.1 4.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.367 -1.742 . . . . 15.0 106.89 146.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 24.9 p -126.09 30.92 5.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.006 -1.906 . . . . 15.0 111.557 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 49.02 76.01 0.17 Allowed Glycine 0 C--N 1.278 -2.685 0 CA-C-N 111.952 -2.385 . . . . 15.0 114.361 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.56 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.6 t -89.81 118.32 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.247 0.524 . . . . 15.0 110.91 171.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.0 p -132.57 107.3 8.35 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.504 1.128 . . . . 15.0 109.51 172.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.6 t -150.16 150.24 31.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.307 0.855 . . . . 15.0 113.307 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.628 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -67.76 -32.38 72.94 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.901 173.317 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -87.97 135.74 33.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.582 -0.447 . . . . 15.0 111.351 -168.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.636 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.9 t0 -56.28 128.73 73.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 171.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.599 ' HD2' HD22 ' A' ' 236' ' ' LEU . 73.3 Cg_endo -76.57 -14.91 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.834 1.69 . . . . 15.0 113.183 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.443 ' CD ' ' HD3' ' A' ' 237' ' ' PRO . 4.7 tpt180 . . . . . 0 C--N 1.31 -1.137 0 CA-C-O 121.975 0.893 . . . . 15.0 108.998 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.664 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 7.7 m-20 . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 113.855 1.057 . . . . 15.0 113.855 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 63.0 Cg_endo -95.7 160.19 1.48 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.822 2.348 . . . . 15.0 112.77 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.941 0 C-N-CA 119.973 -1.108 . . . . 15.0 111.308 174.622 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.628 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 6.5 Cg_exo . . . . . 0 CA--C 1.528 0.224 0 CA-C-O 121.486 0.536 . . . . 15.0 113.395 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.641 -0.708 . . . . 15.0 109.811 175.236 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.747 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.7 Cg_exo -69.67 161.92 44.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.418 1.412 . . . . 15.0 110.343 166.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -69.44 126.41 29.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.147 -0.933 . . . . 15.0 111.254 -170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 125.42 -14.99 7.25 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.773 -0.727 . . . . 15.0 113.671 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 63.2 m-85 -100.3 136.53 40.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.574 0.687 . . . . 15.0 110.78 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.43 146.18 29.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.716 -0.846 . . . . 15.0 108.716 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 17.4 tm0? -89.78 109.51 20.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -117.33 141.34 48.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.627 0.727 . . . . 15.0 111.096 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.9 m -139.34 117.38 11.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.879 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.7 t -89.91 150.29 22.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.06 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.33 -22.72 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.6 0.714 . . . . 15.0 111.085 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.829 ' HB3' HG23 ' A' ' 245' ' ' THR . 63.9 tp60 -49.55 -24.34 2.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.409 -1.269 . . . . 15.0 111.746 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.5 58.68 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.224 -0.513 . . . . 15.0 111.876 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.523 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 30.9 mt-30 -100.83 135.94 41.48 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.741 -0.466 . . . . 15.0 109.741 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.97 143.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.638 -0.256 . . . . 15.0 110.464 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -135.47 123.47 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 15.0 110.424 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 39.1 m-85 -89.67 110.84 21.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.426 -0.806 . . . . 15.0 110.824 -171.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.57 132.84 52.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.724 1.25 . . . . 15.0 113.66 -175.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 20.6 t60 -144.74 106.99 4.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 112.569 -2.105 . . . . 15.0 108.317 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 12.7 m -102.11 87.78 3.16 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 116.1 -2.24 . . . . 15.0 111.002 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.445 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 6.5 tt0 -101.38 -53.05 3.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.668 -1.604 . . . . 15.0 106.668 147.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 18.0 p -122.25 26.94 8.21 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 112.664 -2.062 . . . . 15.0 111.364 -174.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.29 75.97 0.2 Allowed Glycine 0 C--N 1.273 -2.931 0 CA-C-N 111.607 -2.542 . . . . 15.0 113.4 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.4 t -89.81 114.98 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 O-C-N 122.484 -0.421 . . . . 15.0 111.257 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.811 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.2 p -129.87 108.32 10.05 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.699 1.249 . . . . 15.0 108.858 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.3 t -150.14 150.23 31.36 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.935 0.717 . . . . 15.0 112.935 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.523 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 56.1 m95 -70.86 -31.85 68.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.487 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -88.51 134.68 33.79 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.006 0.432 . . . . 15.0 110.937 -170.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.626 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 13.0 t0 -58.5 123.82 68.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.72 -14.76 36.69 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 C-N-CA 122.099 1.866 . . . . 15.0 112.194 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.747 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.8 tpt180 . . . . . 0 C--N 1.314 -0.974 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.938 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.786 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 29.1 t70 . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 114.021 1.119 . . . . 15.0 114.021 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 51.7 Cg_endo -102.43 160.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 123.667 2.911 . . . . 15.0 114.236 -165.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 110.323 -1.111 . . . . 15.0 110.323 171.867 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.499 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.9 Cg_exo . . . . . 0 CA--C 1.527 0.157 0 CA-C-O 121.37 0.488 . . . . 15.0 113.076 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.791 -0.641 . . . . 15.0 109.824 171.927 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.227 0 N-CA-C 109.301 -0.629 . . . . 15.0 109.301 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.629 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.39 164.85 32.62 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.328 2.019 . . . . 15.0 110.172 165.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.49 130.52 42.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.851 -172.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 124.9 -34.59 3.38 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.809 -1.087 . . . . 15.0 113.245 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 53.6 m-85 -83.89 149.45 26.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.165 0.482 . . . . 15.0 110.744 -175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -116.49 147.27 41.91 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 166.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.494 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.46 102.49 15.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.622 ' HD3' ' CE1' ' A' ' 251' ' ' TYR . 13.6 ttt-85 -102.82 147.61 26.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.136 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.2 m -138.95 118.38 12.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.799 -1.092 . . . . 15.0 108.751 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.6 t -96.67 150.23 20.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.641 -0.254 . . . . 15.0 110.422 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.98 -21.63 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.267 0.556 . . . . 15.0 110.854 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.683 ' HB3' HG23 ' A' ' 245' ' ' THR . 48.5 tp60 -53.08 -23.71 8.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.273 -0.876 . . . . 15.0 111.523 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.25 17.58 39.45 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.154 -0.546 . . . . 15.0 112.318 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.578 ' OE1' ' HG2' ' A' ' 247' ' ' GLN . 4.7 mt-30 -125.13 147.43 49.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.01 -0.737 . . . . 15.0 109.01 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.2 130.56 50.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.162 -0.31 . . . . 15.0 110.162 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.622 ' CE1' ' HD3' ' A' ' 243' ' ' ARG . 34.9 p90 -126.99 129.13 47.5 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.531 -0.468 . . . . 15.0 110.626 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.696 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 27.5 m-85 -89.73 111.05 21.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.135 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.028 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.71 135.86 50.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.712 1.244 . . . . 15.0 113.928 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.617 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 55.5 t60 -144.35 100.76 3.59 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 112.458 -2.156 . . . . 15.0 107.819 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.679 HG22 ' HA2' ' A' ' 258' ' ' GLY . 2.8 p -102.8 87.41 2.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 116.163 -2.215 . . . . 15.0 110.833 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 34.0 tt0 -101.25 -35.73 9.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 113.316 -1.765 . . . . 15.0 108.029 146.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.5 p -139.02 30.64 2.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.916 1.341 . . . . 15.0 111.362 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.5 73.78 0.38 Allowed Glycine 0 C--N 1.279 -2.591 0 CA-C-N 111.936 -2.393 . . . . 15.0 114.603 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.674 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -92.77 115.08 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 117.274 0.537 . . . . 15.0 111.406 171.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.796 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.4 p -135.49 104.36 5.8 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.573 1.171 . . . . 15.0 109.229 172.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -150.22 150.43 31.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 15.0 112.733 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.453 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 39.0 m95 -66.98 -38.05 85.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.639 -0.71 . . . . 15.0 111.166 171.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 264' ' ' ASP . 7.0 p-80 -78.41 136.85 37.74 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.121 -0.491 . . . . 15.0 111.177 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.696 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.9 t70 -57.03 127.65 76.12 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.828 -0.805 . . . . 15.0 108.828 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 71.1 Cg_endo -75.87 -14.64 19.25 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.135 1.89 . . . . 15.0 113.039 -174.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.629 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.6 tpt180 . . . . . 0 C--N 1.315 -0.923 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 18.2 t70 . . . . . 0 CA--C 1.556 1.189 0 N-CA-C 113.322 0.86 . . . . 15.0 113.322 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.028 ' HG3' HD11 ' A' ' 253' ' ' LEU . 48.9 Cg_endo -91.88 160.25 3.37 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.529 2.153 . . . . 15.0 112.411 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.045 0 N-CA-C 110.442 -1.063 . . . . 15.0 110.442 175.409 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.453 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.401 0 CA-C-O 121.776 0.657 . . . . 15.0 112.53 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.0 179.198 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.748 0.309 . . . . 15.0 110.393 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.863 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.2 Cg_exo -69.58 157.24 61.43 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 121.945 1.763 . . . . 15.0 110.506 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.88 121.18 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.976 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 134.49 -14.33 4.5 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.741 -0.742 . . . . 15.0 113.105 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 79.4 m-85 -99.13 129.33 45.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.472 0.636 . . . . 15.0 111.048 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.79 137.13 43.05 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.91 119.32 30.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.179 -0.675 . . . . 15.0 109.179 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 243' ' ' ARG . 8.1 ttt-85 -122.39 132.81 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.559 0.695 . . . . 15.0 111.81 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -120.13 122.5 41.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.338 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -94.01 150.16 20.59 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.357 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -54.61 -19.28 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.529 0.681 . . . . 15.0 111.157 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.696 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.6 tp-100 -50.1 -24.44 2.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.415 -1.266 . . . . 15.0 111.701 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.67 -1.75 55.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.151 -0.547 . . . . 15.0 112.196 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.499 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 4.5 mt-30 -111.29 138.49 47.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.879 0.371 . . . . 15.0 110.418 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.08 136.44 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.625 -0.509 . . . . 15.0 109.625 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -131.73 126.7 35.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.18 0.514 . . . . 15.0 110.957 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.688 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.7 m-85 -89.77 113.5 25.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.357 -173.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -111.82 134.75 53.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 122.842 1.306 . . . . 15.0 114.087 -176.294 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 40.3 t60 -141.88 103.73 4.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.579 -2.1 . . . . 15.0 107.611 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.8 t -100.14 87.92 3.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 116.287 -2.165 . . . . 15.0 111.056 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.62 -54.43 2.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.311 -1.768 . . . . 15.0 106.712 147.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 38.2 p -119.88 27.23 8.81 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.397 -2.183 . . . . 15.0 111.329 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.07 75.66 0.21 Allowed Glycine 0 C--N 1.274 -2.867 0 CA-C-N 111.315 -2.675 . . . . 15.0 113.698 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.5 t -89.58 114.89 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-N 117.395 0.598 . . . . 15.0 111.028 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 9.1 p -126.44 107.61 10.43 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.965 -1.471 . . . . 15.0 108.79 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.1 p -140.21 149.43 42.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.255 0.835 . . . . 15.0 113.255 -168.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.507 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 21.3 m95 -75.05 -38.52 61.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.457 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -79.11 143.92 35.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.943 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.688 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.6 t70 -62.61 130.16 93.34 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.903 -0.777 . . . . 15.0 108.903 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.7 -14.77 24.43 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 C-N-CA 122.044 1.829 . . . . 15.0 113.775 -173.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.863 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.2 tpt180 . . . . . 0 C--N 1.31 -1.145 0 CA-C-O 122.17 0.986 . . . . 15.0 108.792 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.5 m-20 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -98.17 160.32 0.81 Allowed 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.889 2.393 . . . . 15.0 112.832 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 N-CA-C 109.776 -1.33 . . . . 15.0 109.776 173.253 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.507 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.4 Cg_exo . . . . . 0 CA--C 1.529 0.239 0 CA-C-O 121.278 0.449 . . . . 15.0 112.202 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.5 -177.382 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.94 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 15.3 Cg_exo -69.62 154.46 68.28 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.095 1.863 . . . . 15.0 110.611 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.81 131.37 44.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.902 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 127.19 -16.47 6.35 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.564 -0.827 . . . . 15.0 112.921 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.622 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 90.2 m-85 -95.22 135.01 37.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.983 0.392 . . . . 15.0 110.267 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -113.7 138.55 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.196 0.522 . . . . 15.0 109.831 170.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.422 ' OE1' HG23 ' A' ' 244' ' ' THR . 0.4 OUTLIER -89.87 107.36 19.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.715 -0.846 . . . . 15.0 108.715 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -103.55 135.79 44.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.325 0.583 . . . . 15.0 111.816 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.422 HG23 ' OE1' ' A' ' 242' ' ' GLN . 0.9 OUTLIER -117.29 115.21 24.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.596 -1.184 . . . . 15.0 110.41 177.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.713 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -89.95 150.34 22.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 15.0 109.684 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.9 t -51.5 -24.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.4 0.619 . . . . 15.0 110.071 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.713 ' HB3' HG23 ' A' ' 245' ' ' THR . 40.3 tp60 -50.2 -31.37 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.964 -1.016 . . . . 15.0 111.588 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.36 19.94 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.107 -0.568 . . . . 15.0 113.31 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.62 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.9 mt-30 -127.02 141.35 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.04 0.42 . . . . 15.0 110.26 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.9 m -92.39 127.33 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.483 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -128.51 130.35 47.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.881 0.372 . . . . 15.0 110.204 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.658 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.4 m-85 -89.9 110.48 21.42 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.488 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.13 133.21 52.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.711 1.243 . . . . 15.0 113.899 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.622 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 33.2 t60 -143.64 95.23 2.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.655 -2.066 . . . . 15.0 107.918 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.3 m -90.4 87.91 6.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 116.512 -2.075 . . . . 15.0 110.141 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -101.15 -49.62 4.04 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 112.891 -1.959 . . . . 15.0 108.212 153.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.7 t -135.28 23.67 3.49 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-N 112.736 -2.029 . . . . 15.0 108.506 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 60.92 74.32 0.39 Allowed Glycine 0 C--N 1.279 -2.585 0 CA-C-N 109.785 -3.371 . . . . 15.0 112.909 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 253' ' ' LEU . 67.4 t -89.15 115.7 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 119.51 -0.876 . . . . 15.0 111.199 168.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.837 ' HA ' HD22 ' A' ' 253' ' ' LEU . 3.7 p -131.22 104.41 7.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.533 -1.667 . . . . 15.0 109.026 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.9 t -150.24 150.33 31.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.764 0.653 . . . . 15.0 112.764 -168.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 69.8 m95 -70.92 -34.34 71.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.136 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 264' ' ' ASP . 7.6 p-80 -81.59 136.27 35.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.11 -168.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.658 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 11.5 t70 -54.35 130.5 61.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 15.0 109.443 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.94 -14.79 16.92 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 C-N-CA 122.202 1.934 . . . . 15.0 114.179 -171.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.94 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpm_? . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 122.372 1.082 . . . . 15.0 108.645 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.591 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.555 1.151 0 N-CA-C 113.269 0.84 . . . . 15.0 113.269 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 42.2 Cg_endo -90.18 160.63 4.74 Favored 'Trans proline' 0 C--N 1.369 1.605 0 C-N-CA 122.882 2.388 . . . . 15.0 111.241 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.011 0 C-N-CA 119.334 -1.413 . . . . 15.0 110.699 179.276 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 5.7 Cg_exo . . . . . 0 N--CA 1.461 -0.4 0 CA-C-O 120.998 0.332 . . . . 15.0 112.694 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 15.0 110.049 179.332 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.085 0.469 . . . . 15.0 110.242 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.698 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.6 Cg_exo -69.37 145.54 59.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.881 1.72 . . . . 15.0 108.561 161.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.54 96.44 0.92 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.128 0.966 . . . . 15.0 112.358 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 163.28 32.09 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 113.45 -1.705 . . . . 15.0 112.607 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD2' ' HG2' ' A' ' 265' ' ' PRO . 82.7 m-85 -140.99 125.69 17.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 5.9 pt-20 -97.45 134.25 40.95 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.203 0.525 . . . . 15.0 109.986 175.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -89.7 111.6 22.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -120.3 129.78 54.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.345 0.593 . . . . 15.0 111.592 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.0 m -123.04 124.44 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.619 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.1 OUTLIER -89.86 150.46 22.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.433 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.57 -24.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.46 0.648 . . . . 15.0 110.283 174.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 249' ' ' GLN . 34.8 tp60 -47.8 -35.52 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.823 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.16 31.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.039 -0.601 . . . . 15.0 112.798 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 7.8 mt-30 -107.19 149.77 27.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 15.0 110.69 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.04 136.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.323 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -131.57 126.76 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.3 m-85 -89.74 109.94 20.89 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.139 -172.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.926 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -104.96 133.16 50.22 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 122.925 1.345 . . . . 15.0 113.28 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 1.4 t-80 -142.18 96.35 2.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 112.571 -2.104 . . . . 15.0 107.833 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 t -104.11 87.73 2.84 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 115.662 -2.415 . . . . 15.0 111.18 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -100.93 -31.55 11.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 112.401 -2.181 . . . . 15.0 108.245 145.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.9 t -144.28 24.84 1.58 Allowed 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 123.655 1.693 . . . . 15.0 110.014 -166.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 50.73 70.38 0.86 Allowed Glycine 0 C--N 1.274 -2.904 0 CA-C-N 110.006 -3.27 . . . . 15.0 113.883 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 56.4 t -89.23 116.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 119.853 -0.739 . . . . 15.0 111.629 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.834 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 3.7 p -129.18 105.44 8.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.905 -1.498 . . . . 15.0 109.131 170.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 150.17 31.46 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.713 0.635 . . . . 15.0 112.713 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.519 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 55.8 m95 -69.02 -32.91 72.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 15.0 112.102 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 14.6 p-80 -88.0 139.4 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 15.0 111.708 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.569 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.6 t0 -58.55 123.25 66.04 Favored Pre-proline 0 C--O 1.215 -0.745 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.8 Cg_exo -68.54 -14.48 39.76 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 121.983 1.789 . . . . 15.0 113.598 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.698 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.3 tpt180 . . . . . 0 C--N 1.309 -1.156 0 CA-C-O 122.095 0.95 . . . . 15.0 108.752 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.754 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.1 p-10 . . . . . 0 CA--C 1.555 1.16 0 N-CA-C 113.964 1.098 . . . . 15.0 113.964 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.926 ' HG3' HD11 ' A' ' 253' ' ' LEU . 95.7 Cg_endo -97.39 160.37 0.97 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.962 2.441 . . . . 15.0 112.664 -167.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.836 0 N-CA-C 109.8 -1.32 . . . . 15.0 109.8 173.478 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.519 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo . . . . . 0 N--CA 1.463 -0.267 0 CA-C-O 121.743 0.643 . . . . 15.0 113.414 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.422 -0.808 . . . . 15.0 109.257 173.803 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.325 0 N-CA-C 109.986 -0.375 . . . . 15.0 109.986 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.667 ' HG3' HH11 ' A' ' 266' ' ' ARG . 17.4 Cg_exo -69.51 154.32 68.88 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.566 1.51 . . . . 15.0 109.413 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.76 121.54 17.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.391 0.615 . . . . 15.0 110.869 -170.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.74 -21.57 2.86 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.095 -0.957 . . . . 15.0 111.853 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 75.8 m-85 -96.69 128.82 44.0 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.64 0.257 . . . . 15.0 110.413 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -102.19 130.83 48.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 172.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.75 116.02 27.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.154 0.502 . . . . 15.0 109.924 -174.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.519 ' HD3' ' CE2' ' A' ' 251' ' ' TYR . 0.0 OUTLIER -101.07 150.02 23.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.037 -173.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.0 p -129.26 98.02 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.311 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -89.93 150.07 22.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.517 -0.765 . . . . 15.0 112.148 -168.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.09 -20.45 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 15.0 110.521 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -57.65 -22.25 44.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.633 -1.167 . . . . 15.0 111.524 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.34 23.21 48.8 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.36 -1.096 . . . . 15.0 110.36 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.3 mm100 -130.3 150.36 51.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.482 -0.859 . . . . 15.0 108.938 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -110.67 107.55 23.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.15 0.5 . . . . 15.0 110.676 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.519 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 51.3 p90 -98.67 125.52 44.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.299 0.571 . . . . 15.0 111.076 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.1 m-85 -90.01 113.12 24.75 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.634 -0.712 . . . . 15.0 111.622 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.39 134.39 52.35 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.804 1.288 . . . . 15.0 113.45 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.629 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 21.4 t60 -141.75 99.38 3.53 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.534 -2.121 . . . . 15.0 108.05 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.1 t -92.44 87.87 6.16 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.068 -2.253 . . . . 15.0 110.425 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.79 -44.99 5.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 112.654 -2.066 . . . . 15.0 108.168 151.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 12.9 t -139.8 24.44 2.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.092 1.901 . . . . 15.0 108.424 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.18 0.37 Allowed Glycine 0 C--N 1.28 -2.546 0 CA-C-N 109.858 -3.337 . . . . 15.0 112.722 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 62.9 t -89.29 115.5 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 119.757 -0.777 . . . . 15.0 111.882 169.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.838 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 10.4 p -126.36 112.02 15.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.652 -1.613 . . . . 15.0 108.014 168.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -149.93 150.43 31.86 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.646 0.98 . . . . 15.0 113.646 -167.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 4.0 m95 -75.15 -21.34 58.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.529 -1.214 . . . . 15.0 112.548 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -101.42 144.01 30.74 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.518 -0.473 . . . . 15.0 111.578 -172.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.729 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.1 t70 -60.46 123.32 73.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.455 -0.942 . . . . 15.0 108.455 170.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 8.7 Cg_exo -71.29 -14.68 31.43 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 121.863 1.709 . . . . 15.0 113.792 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.667 HH11 ' HG3' ' A' ' 237' ' ' PRO . 17.4 tpt180 . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 6.6 t70 . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 112.683 0.623 . . . . 15.0 112.683 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 39.7 Cg_endo -92.68 160.26 2.85 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.069 1.846 . . . . 15.0 112.244 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 178.852 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 215' ' ' PRO . . . . . 0.581 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 8.1 Cg_exo . . . . . 0 C--O 1.223 -0.238 0 N-CA-C 114.719 1.007 . . . . 15.0 114.719 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 114.614 -1.175 . . . . 15.0 108.764 170.414 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 236' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.186 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 237' ' ' PRO . . . . . 0.99 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 10.4 Cg_exo -69.82 163.7 37.36 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.589 2.193 . . . . 15.0 110.822 165.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -69.81 124.31 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.817 -1.083 . . . . 15.0 112.137 -172.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 122.62 -2.12 10.22 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.583 -0.818 . . . . 15.0 114.7 170.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.654 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.1 m-85 -99.41 130.43 45.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.991 0.895 . . . . 15.0 110.581 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -104.65 138.35 41.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 173.54 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 242' ' ' GLN . . . . . 0.6 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -89.92 106.18 18.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 15.0 109.501 -179.327 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 243' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 241' ' ' GLU . 27.8 ttt85 -104.06 139.87 38.56 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.458 -0.792 . . . . 15.0 111.884 -174.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 244' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 250' ' ' VAL . 5.6 p -130.6 103.12 6.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.55 -1.204 . . . . 15.0 110.078 -177.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.652 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -90.01 150.34 22.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.942 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.08 -17.69 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.344 0.593 . . . . 15.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 247' ' ' GLN . . . . . 0.652 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.2 tp-100 -55.45 -23.8 27.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.506 -0.77 . . . . 15.0 111.076 172.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.6 -0.62 65.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.044 -0.598 . . . . 15.0 112.92 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 14.4 mt-30 -115.24 149.27 38.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.054 -0.35 . . . . 15.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' THR . 31.2 m -97.49 135.0 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.786 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.424 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 47.3 p90 -131.36 125.28 32.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.104 0.478 . . . . 15.0 110.29 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.669 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.81 112.29 23.56 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.517 -0.765 . . . . 15.0 111.445 -173.482 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.979 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -109.34 134.16 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.943 1.354 . . . . 15.0 114.243 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 254' ' ' HIS . . . . . 0.654 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 52.0 t60 -137.84 97.89 3.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 112.561 -2.108 . . . . 15.0 107.578 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 255' ' ' THR . . . . . 0.564 HG22 ' HA2' ' A' ' 258' ' ' GLY . 1.2 p -97.42 87.52 4.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.074 -2.25 . . . . 15.0 110.836 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.52 -54.14 2.82 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.14 -1.8 . . . . 15.0 106.14 147.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 30.5 p -118.06 25.88 10.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.47 -2.15 . . . . 15.0 111.331 -177.172 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 258' ' ' GLY . . . . . 0.564 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.99 76.6 0.17 Allowed Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.269 -2.696 . . . . 15.0 113.736 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.582 ' O ' HD13 ' A' ' 253' ' ' LEU . 43.5 t -90.1 115.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.157 0.479 . . . . 15.0 110.995 171.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.807 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 7.4 p -124.09 103.39 8.26 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 124.59 1.181 . . . . 15.0 109.025 172.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.6 p -138.03 150.08 46.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.881 0.697 . . . . 15.0 112.881 -169.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -78.78 -29.03 44.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.307 -0.86 . . . . 15.0 110.288 173.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -88.29 141.17 28.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.671 . . . . 15.0 110.801 -173.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 264' ' ' ASP . . . . . 0.669 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.3 t70 -55.97 131.37 73.7 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.503 -0.925 . . . . 15.0 108.503 171.283 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -14.58 28.95 Favored 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.032 1.821 . . . . 15.0 113.996 -172.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 266' ' ' ARG . . . . . 0.99 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.0 tpm_? . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 122.124 0.964 . . . . 15.0 109.161 177.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 211' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 3.0 m-20 . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 113.965 1.098 . . . . 15.0 113.965 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 212' ' ' PRO . . . . . 0.979 ' HG3' HD11 ' A' ' 253' ' ' LEU . 29.4 Cg_endo -95.25 160.49 1.62 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.937 2.425 . . . . 15.0 112.218 -173.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.086 0 C-N-CA 119.925 -1.131 . . . . 15.0 110.906 179.906 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 CA--C 1.532 0.39 0 N-CA-C 113.658 0.599 . . . . 15.0 113.658 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 15.0 109.945 175.117 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.113 -0.328 . . . . 15.0 110.113 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -119.32 163.51 26.49 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 15.0 109.63 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.689 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.4 Cg_exo -69.65 150.65 69.14 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.732 1.622 . . . . 15.0 108.961 163.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.83 141.87 53.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.551 0.691 . . . . 15.0 110.905 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.78 -22.74 6.8 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.21 -0.904 . . . . 15.0 112.334 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.7 m-85 -95.85 138.53 33.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 110.049 -0.352 . . . . 15.0 110.049 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.7 145.2 32.3 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.776 -0.824 . . . . 15.0 108.776 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.67 102.65 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -112.65 135.24 53.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 15.0 111.047 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -131.1 135.13 47.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.61 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.662 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -112.4 150.1 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.272 -0.422 . . . . 15.0 110.383 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.07 -16.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.705 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.662 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -52.96 -18.91 2.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.188 -0.915 . . . . 15.0 111.232 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.63 2.47 67.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.999 -0.619 . . . . 15.0 112.169 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.516 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 33.1 mt-30 -124.07 150.03 45.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.465 -0.568 . . . . 15.0 109.465 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.22 138.07 30.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.067 -0.346 . . . . 15.0 110.067 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -126.07 123.24 37.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.145 0.498 . . . . 15.0 110.036 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.723 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 17.9 m-85 -89.57 111.8 22.83 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 115.626 -0.716 . . . . 15.0 111.188 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.95 133.36 53.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.913 1.34 . . . . 15.0 113.986 -176.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 41.9 t60 -144.49 96.87 2.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 112.474 -2.148 . . . . 15.0 107.779 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 258' ' ' GLY . 5.1 p -96.09 87.69 4.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.256 -2.177 . . . . 15.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -101.73 -53.21 3.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.151 -1.84 . . . . 15.0 106.597 150.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.1 p -120.47 26.82 8.94 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 112.322 -2.217 . . . . 15.0 111.01 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.1 74.04 0.35 Allowed Glycine 0 C--N 1.273 -2.953 0 CA-C-N 111.262 -2.699 . . . . 15.0 113.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.0 t -90.03 115.58 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 117.286 0.543 . . . . 15.0 111.655 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.84 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.7 p -128.32 105.4 8.31 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.774 1.296 . . . . 15.0 108.863 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.4 p -141.42 150.19 42.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 32.6 m95 -75.55 -32.49 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.449 -0.796 . . . . 15.0 111.009 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -85.35 140.49 30.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.171 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.921 ' HB3' HG12 ' A' ' 267' ' ' ILE . 11.2 t70 -59.51 123.79 72.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 12.2 Cg_exo -71.38 -14.47 31.07 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.965 1.777 . . . . 15.0 113.622 -172.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.689 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 12.4 tpt180 -78.68 -9.64 59.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.526 -0.916 . . . . 15.0 108.526 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.921 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.6 pt . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.22 -1.355 . . . . 15.0 110.744 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 121.468 0.652 . . . . 15.0 110.3 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.3 p -148.39 104.15 3.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.582 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.695 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.679 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.3 m-20 -102.21 -15.56 0.18 Allowed Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 114.278 1.214 . . . . 15.0 114.278 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 55.6 Cg_endo -99.44 160.57 0.58 Allowed 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.542 2.828 . . . . 15.0 112.559 -171.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.37 160.19 29.1 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.133 -1.187 . . . . 15.0 110.133 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.454 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.3 Cg_exo -89.02 147.72 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.964 3.109 . . . . 15.0 113.191 -170.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.07 10.35 34.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.004 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.523 -0.751 . . . . 15.0 110.39 -178.033 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.695 -0.484 . . . . 15.0 109.695 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.668 HD22 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mt -90.1 157.71 45.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.806 -0.442 . . . . 15.0 109.806 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.628 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 14.3 Cg_exo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.588 1.525 . . . . 15.0 109.971 166.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.7 122.28 18.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.838 0.828 . . . . 15.0 111.645 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.82 -18.47 2.98 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.039 -1.437 . . . . 15.0 111.329 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 85.0 m-85 -100.91 138.89 37.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 15.0 110.53 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -112.27 137.89 49.75 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.314 -0.625 . . . . 15.0 109.314 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 97.93 11.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.653 HH11 ' HG2' ' A' ' 243' ' ' ARG . 2.3 ttt-85 -94.53 120.49 34.84 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.527 -0.761 . . . . 15.0 111.612 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -108.25 106.41 16.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 15.0 110.118 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -90.11 150.29 22.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.952 -0.567 . . . . 15.0 109.622 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.5 t -50.9 -24.41 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.377 0.608 . . . . 15.0 110.703 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.806 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.1 tp-100 -45.72 -34.74 3.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.837 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.01 -15.31 44.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.328 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.558 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 1.7 mp0 -97.64 132.19 43.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.976 0.417 . . . . 15.0 111.021 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.26 127.77 43.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.026 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.606 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 14.9 p90 -122.02 130.41 53.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.921 0.391 . . . . 15.0 110.741 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.671 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 30.8 m-85 -89.74 107.13 18.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.461 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.959 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -109.11 133.75 52.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.866 1.317 . . . . 15.0 113.674 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 34.1 t60 -140.2 104.04 4.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 112.451 -2.158 . . . . 15.0 108.042 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.9 p -98.13 87.73 4.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.386 -2.126 . . . . 15.0 110.918 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -101.43 -53.04 3.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.529 -1.656 . . . . 15.0 106.529 147.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -121.69 25.79 9.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 112.536 -2.12 . . . . 15.0 111.369 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 51.87 75.99 0.2 Allowed Glycine 0 C--N 1.27 -3.105 0 CA-C-N 111.144 -2.753 . . . . 15.0 113.431 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 253' ' ' LEU . 59.1 t -89.71 113.97 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.315 0.558 . . . . 15.0 111.678 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.766 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 8.1 p -125.35 107.05 10.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.265 -1.334 . . . . 15.0 109.069 173.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 150.45 31.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.173 0.805 . . . . 15.0 113.173 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.558 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 3.8 m95 -75.78 -21.35 57.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.946 -1.025 . . . . 15.0 112.018 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -95.61 135.49 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.556 -0.458 . . . . 15.0 111.116 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.953 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t0 -56.73 124.19 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.563 -0.903 . . . . 15.0 108.563 170.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.668 ' HD2' HD22 ' A' ' 236' ' ' LEU . 10.3 Cg_exo -71.61 -14.78 30.51 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.363 2.042 . . . . 15.0 113.591 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.628 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 9.8 tpt180 -79.43 -10.06 59.73 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 174.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.953 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.6 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-N 114.398 -1.274 . . . . 15.0 110.305 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 111.426 0.158 . . . . 15.0 111.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.8 m -116.15 105.15 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.658 0.265 . . . . 15.0 110.373 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.872 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 56.6 m-20 -84.51 -25.24 0.36 Allowed Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 112.958 0.725 . . . . 15.0 112.958 167.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.959 ' HG3' HD11 ' A' ' 253' ' ' LEU . 19.4 Cg_endo -97.94 160.57 0.85 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.004 2.469 . . . . 15.0 111.635 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.05 28.66 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.416 -1.074 . . . . 15.0 110.416 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.464 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.484 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo -89.11 128.27 1.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.827 3.018 . . . . 15.0 113.798 -170.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -89.35 91.38 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.545 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.706 -0.664 . . . . 15.0 110.156 -179.123 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.017 0.437 . . . . 15.0 110.473 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 265' ' ' PRO . 2.1 mm? -94.16 171.73 6.56 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 15.0 109.941 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.749 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.1 Cg_exo -69.42 147.71 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.561 1.508 . . . . 15.0 109.172 161.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.51 116.07 9.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.453 0.644 . . . . 15.0 111.83 -167.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 147.87 -16.91 1.4 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.844 -1.071 . . . . 15.0 112.122 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 92.6 m-85 -94.9 132.48 39.68 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.722 -0.281 . . . . 15.0 110.567 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.68 142.87 35.62 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.509 -0.552 . . . . 15.0 109.509 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -90.0 119.59 30.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -124.77 137.21 54.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.481 0.658 . . . . 15.0 111.123 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 m -129.4 126.16 38.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.276 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -93.11 150.15 20.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.246 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.3 m -54.52 -21.21 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.559 0.695 . . . . 15.0 110.599 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.4 tp-100 -47.66 -32.61 5.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.582 -1.19 . . . . 15.0 111.488 170.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.3 19.18 21.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.036 -0.602 . . . . 15.0 112.635 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.723 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 4.6 mt-30 -127.14 147.83 50.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.43 136.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.336 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -134.51 125.71 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.67 -0.492 . . . . 15.0 109.67 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -89.65 112.63 23.92 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.58 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.014 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -107.44 133.42 51.97 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.804 1.288 . . . . 15.0 113.494 -177.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 39.7 t60 -145.35 103.17 3.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.587 -2.097 . . . . 15.0 108.424 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.9 t -99.21 87.79 3.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 116.162 -2.215 . . . . 15.0 111.005 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -101.27 -51.73 3.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.31 -1.768 . . . . 15.0 106.597 149.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 44.8 p -121.66 24.81 9.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.425 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.2 0.34 Allowed Glycine 0 C--N 1.27 -3.138 0 CA-C-N 111.278 -2.692 . . . . 15.0 113.7 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.559 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.1 t -89.97 119.54 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 117.253 0.526 . . . . 15.0 111.622 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.821 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 4.6 p -131.76 109.11 9.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.396 -1.275 . . . . 15.0 108.677 169.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.0 t -150.17 150.11 31.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.098 0.777 . . . . 15.0 113.098 -168.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -71.06 -29.64 65.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.011 -0.995 . . . . 15.0 111.917 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -90.61 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.597 -0.441 . . . . 15.0 111.271 -170.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.943 ' HB3' HG12 ' A' ' 267' ' ' ILE . 12.3 t70 -56.65 120.43 36.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.02 -1.104 . . . . 15.0 108.02 168.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 Cg_exo -69.72 -14.61 36.47 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.247 1.965 . . . . 15.0 113.72 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.749 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.0 tpt180 -78.63 -10.61 59.81 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.943 HG12 ' HB3' ' A' ' 264' ' ' ASP . 38.9 pt . . . . . 0 C--O 1.253 1.272 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.831 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 111.981 0.363 . . . . 15.0 111.981 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.6 p -137.5 116.79 12.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 110.808 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.789 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.688 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 5.7 p-10 -104.48 -14.65 0.16 Allowed Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.014 ' HG3' HD11 ' A' ' 253' ' ' LEU . 82.0 Cg_endo -94.3 160.59 2.03 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.292 2.661 . . . . 15.0 112.014 -170.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.4 160.05 28.95 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.286 -1.435 . . . . 15.0 110.052 174.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 6.1 Cg_exo -89.06 150.38 5.7 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.444 2.762 . . . . 15.0 112.817 -172.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -108.8 4.03 23.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.591 0.71 . . . . 15.0 109.385 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 115.02 -0.991 . . . . 15.0 110.193 -175.96 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.825 0.345 . . . . 15.0 110.541 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.3 OUTLIER -98.52 158.32 32.77 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.589 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.46 144.93 57.29 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.947 1.765 . . . . 15.0 110.182 172.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.6 124.75 24.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.716 0.77 . . . . 15.0 111.875 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.36 -20.19 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.477 -1.238 . . . . 15.0 111.884 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.5 m-85 -91.12 126.23 36.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.563 ' HB2' HG22 ' B' ' 208' ' ' THR . 7.8 pt-20 -97.87 129.04 44.84 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.405 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.68 103.54 16.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.502 0.668 . . . . 15.0 109.347 -175.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -105.15 139.65 39.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.915 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 m -131.23 108.91 10.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.8 t -94.78 150.25 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.418 -0.355 . . . . 15.0 110.728 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.3 -18.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.885 0.85 . . . . 15.0 111.074 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.6 tp-100 -48.67 -23.59 1.08 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.043 -1.435 . . . . 15.0 111.534 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.67 10.46 61.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.754 -0.538 . . . . 15.0 111.754 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.492 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 26.5 mt-30 -129.83 139.79 51.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.6 m -100.68 124.07 54.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.029 0.442 . . . . 15.0 110.385 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -109.58 127.52 54.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.132 0.491 . . . . 15.0 110.092 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.722 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 22.5 m-85 -89.54 107.57 19.16 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.591 -0.731 . . . . 15.0 111.116 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.052 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -106.83 133.96 50.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.734 1.254 . . . . 15.0 113.551 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 37.4 t60 -142.91 102.76 4.08 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 112.703 -2.044 . . . . 15.0 107.865 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 25.1 m -102.1 88.06 3.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 115.874 -2.331 . . . . 15.0 110.931 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -101.17 -47.78 4.62 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.415 -1.721 . . . . 15.0 107.027 146.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 36.0 p -124.83 25.11 7.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 113.521 -1.672 . . . . 15.0 111.399 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.23 74.49 0.31 Allowed Glycine 0 C--N 1.272 -2.984 0 CA-C-N 111.137 -2.756 . . . . 15.0 113.552 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 253' ' ' LEU . 56.1 t -89.83 120.25 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 117.239 0.519 . . . . 15.0 110.982 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.815 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.3 p -135.84 105.68 6.21 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 124.519 1.137 . . . . 15.0 109.244 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -150.2 150.35 31.48 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -169.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.492 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 18.6 m95 -68.81 -30.97 69.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.204 -0.907 . . . . 15.0 111.264 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.484 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 7.5 p-80 -86.15 137.11 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.992 0.425 . . . . 15.0 111.173 -170.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.917 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.7 t0 -58.41 125.3 75.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.586 -0.894 . . . . 15.0 108.586 171.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 23.1 Cg_exo -68.3 -14.72 41.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 122.543 2.162 . . . . 15.0 113.865 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.589 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpt180 -81.92 -6.64 59.27 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.917 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.9 pt . . . . . 0 C--O 1.248 1.023 0 CA-C-N 113.852 -1.522 . . . . 15.0 110.861 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 241' ' ' GLU . 28.5 p . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.973 -0.381 . . . . 15.0 109.973 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 17.7 m -127.37 105.61 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.034 0.445 . . . . 15.0 109.836 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.734 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.585 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 23.0 t70 -90.55 -20.61 0.25 Allowed Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.052 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.3 Cg_endo -97.18 160.26 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.671 2.247 . . . . 15.0 111.919 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.57 158.02 27.09 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 119.626 -1.273 . . . . 15.0 110.566 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.457 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.2 Cg_exo -89.15 147.97 5.49 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 124.012 3.141 . . . . 15.0 113.334 -173.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.86 -4.19 21.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.516 -0.765 . . . . 15.0 109.552 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.161 -0.923 . . . . 15.0 110.528 -178.31 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.168 -0.308 . . . . 15.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.2 mm? -90.0 166.99 18.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.28 0.562 . . . . 15.0 110.927 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.712 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.7 Cg_exo -69.28 159.28 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.254 1.969 . . . . 15.0 109.701 161.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -69.49 123.95 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.542 0.686 . . . . 15.0 111.547 -172.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.47 4.64 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.775 -1.102 . . . . 15.0 113.203 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.612 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 78.2 m-85 -97.4 130.77 44.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.319 0.56 . . . . 15.0 111.004 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.5 140.06 43.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.427 ' HG3' ' N ' ' A' ' 243' ' ' ARG . 2.5 tp-100 -89.66 143.76 26.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.615 -0.883 . . . . 15.0 108.615 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.427 ' N ' ' HG3' ' A' ' 242' ' ' GLN . 8.9 ttt180 -139.84 131.61 27.45 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.802 -0.636 . . . . 15.0 110.886 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 p -115.01 111.58 21.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.719 -1.128 . . . . 15.0 110.185 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.9 150.22 22.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.027 -0.533 . . . . 15.0 109.667 176.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.51 -24.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.381 0.61 . . . . 15.0 110.533 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.733 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -47.58 -38.91 15.37 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.622 -1.172 . . . . 15.0 111.931 170.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.17 5.02 35.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.752 -0.737 . . . . 15.0 113.526 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.653 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.8 mt-30 -113.58 137.71 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.196 0.498 . . . . 15.0 111.037 -175.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 10.3 m -90.05 121.26 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.579 177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -121.16 130.1 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.882 -0.327 . . . . 15.0 110.605 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 23.6 m-85 -89.82 110.18 21.13 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.505 -174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.013 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -108.97 132.58 53.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.776 1.274 . . . . 15.0 114.086 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 40.1 t60 -140.75 101.24 4.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.702 -2.044 . . . . 15.0 107.884 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.4 t -99.07 87.54 3.71 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 116.087 -2.245 . . . . 15.0 110.667 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -101.28 -50.66 3.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.142 -1.844 . . . . 15.0 106.753 149.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 32.0 p -124.19 25.19 7.89 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 112.794 -2.003 . . . . 15.0 111.142 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.78 75.15 0.25 Allowed Glycine 0 C--N 1.273 -2.942 0 CA-C-N 111.014 -2.812 . . . . 15.0 113.554 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 253' ' ' LEU . 41.1 t -89.72 117.26 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-N 117.287 0.543 . . . . 15.0 111.23 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.793 ' HA ' HD22 ' A' ' 253' ' ' LEU . 7.6 p -127.72 108.82 11.08 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 124.326 1.016 . . . . 15.0 109.061 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.5 t -150.16 150.33 31.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.596 0.591 . . . . 15.0 112.596 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.409 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 77.1 m95 -76.52 -25.68 54.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.578 -0.737 . . . . 15.0 111.054 174.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -90.49 132.21 35.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 15.0 111.072 -171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.879 ' HB3' HG12 ' A' ' 267' ' ' ILE . 8.9 t70 -53.26 122.12 28.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 169.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.608 ' HD2' HD12 ' A' ' 236' ' ' LEU . 10.1 Cg_exo -71.65 -14.52 30.26 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 122.113 1.875 . . . . 15.0 113.924 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.712 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.7 tpt180 -80.0 -7.33 58.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.77 0.795 . . . . 15.0 109.105 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.879 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.248 0.994 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.115 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.228 0.537 . . . . 15.0 110.262 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 m -136.68 115.37 12.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 15.0 110.772 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.652 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 28.2 m-20 -84.87 -18.04 0.24 Allowed Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 114.117 1.154 . . . . 15.0 114.117 172.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.013 ' HG3' HD11 ' A' ' 253' ' ' LEU . 35.6 Cg_endo -96.89 160.85 1.08 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 123.091 2.527 . . . . 15.0 111.9 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.37 29.13 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.434 -1.466 . . . . 15.0 109.434 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.472 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.6 Cg_exo -89.13 160.17 5.77 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 124.111 3.207 . . . . 15.0 112.85 -170.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -112.13 -2.39 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.332 0.587 . . . . 15.0 110.185 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.827 -176.686 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.43 -0.211 . . . . 15.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -121.67 173.74 3.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 1.057 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 22.5 Cg_exo -69.56 159.15 54.64 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.062 1.841 . . . . 15.0 110.702 165.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.98 123.87 22.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.904 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.49 -14.46 6.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.548 -0.834 . . . . 15.0 112.837 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.673 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.8 m-85 -94.67 131.16 40.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.911 0.355 . . . . 15.0 110.334 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 131.35 44.12 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.43 -0.952 . . . . 15.0 108.43 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -89.72 99.11 12.18 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -106.97 119.32 39.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.004 -0.998 . . . . 15.0 111.379 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.9 m -115.77 111.04 19.94 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 15.0 109.337 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.8 150.06 22.42 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.42 -21.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.388 0.613 . . . . 15.0 111.561 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.814 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 4.1 tp-100 -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.499 -1.228 . . . . 15.0 111.58 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.4 -8.84 28.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.896 -0.669 . . . . 15.0 112.561 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 58.2 mt-30 -112.41 143.52 43.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.86 0.362 . . . . 15.0 110.483 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.51 135.03 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -126.66 125.29 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.971 0.415 . . . . 15.0 109.902 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 21.4 m-85 -89.78 109.92 20.88 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.111 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.38 131.07 54.02 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.727 1.251 . . . . 15.0 114.053 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.673 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 53.2 t60 -141.38 93.72 2.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 112.768 -2.014 . . . . 15.0 107.7 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 29.9 m -93.85 87.78 5.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 115.99 -2.284 . . . . 15.0 110.09 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -101.38 -52.91 3.13 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.117 -1.856 . . . . 15.0 106.233 150.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 45.2 p -118.01 24.75 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.437 -2.165 . . . . 15.0 110.904 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.19 73.19 0.44 Allowed Glycine 0 C--N 1.27 -3.096 0 CA-C-N 110.965 -2.834 . . . . 15.0 113.836 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.63 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -90.01 115.01 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 117.309 0.554 . . . . 15.0 112.037 175.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.801 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.8 p -127.46 107.87 10.33 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.37 1.043 . . . . 15.0 109.08 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -150.28 150.28 31.3 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.644 0.609 . . . . 15.0 112.644 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.575 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 79.6 m95 -75.11 -25.46 58.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.282 175.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 264' ' ' ASP . 7.0 p-80 -87.63 142.09 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.065 0.459 . . . . 15.0 111.03 -170.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.701 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.3 t70 -65.92 131.33 94.56 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.175 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.72 -14.57 8.88 Favored 'Trans proline' 0 CA--C 1.509 -0.737 0 C-N-CA 122.541 2.161 . . . . 15.0 113.855 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 1.057 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.1 tpm_? -82.33 -4.31 57.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.076 0.941 . . . . 15.0 108.858 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.701 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.8 mm . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 113.326 -1.761 . . . . 15.0 110.67 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.291 0.567 . . . . 15.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 18.8 m -105.26 121.33 43.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.121 -0.49 . . . . 15.0 109.734 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.483 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.8 m-20 -73.83 -24.41 0.59 Allowed Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 113.631 0.975 . . . . 15.0 113.631 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HG3' HD11 ' A' ' 253' ' ' LEU . 16.4 Cg_endo -97.03 160.39 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.549 2.166 . . . . 15.0 112.303 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.23 161.04 29.92 Favored Glycine 0 C--N 1.312 -0.772 0 N-CA-C 110.387 -1.085 . . . . 15.0 110.387 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.814 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 2.9 Cg_exo -88.99 148.54 5.67 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 124.303 3.335 . . . . 15.0 113.602 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.66 8.75 31.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.503 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.625 -178.245 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.408 -0.589 . . . . 15.0 109.408 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.942 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.0 OUTLIER -95.06 151.38 38.79 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 121.529 0.68 . . . . 15.0 111.119 -168.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.514 ' HD2' ' CE1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.46 158.98 55.37 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 122.831 2.354 . . . . 15.0 109.617 165.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.62 117.31 11.07 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.405 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.14 -2.1 2.87 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.759 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 237' ' ' PRO . 69.6 m-85 -116.74 136.98 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.22 134.14 51.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.601 -0.518 . . . . 15.0 109.601 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' A' ' 252' ' ' PHE . 21.4 tt0 -89.72 97.98 11.51 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.546 -0.538 . . . . 15.0 109.546 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -95.49 119.47 34.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.767 -0.651 . . . . 15.0 110.598 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.604 ' HB ' HG12 ' A' ' 250' ' ' VAL . 5.0 t -104.0 150.07 24.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.286 -0.87 . . . . 15.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.786 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -135.31 150.46 50.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.972 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.93 -17.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.336 0.589 . . . . 15.0 110.983 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.786 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.3 tp-100 -54.36 -20.43 7.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.446 -0.797 . . . . 15.0 111.245 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.38 69.01 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.363 -0.446 . . . . 15.0 112.51 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.465 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 28.0 mt-30 -125.74 136.0 52.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.033 -0.358 . . . . 15.0 110.033 -175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 244' ' ' THR . 20.8 m -89.99 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.716 0.293 . . . . 15.0 110.334 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -122.86 130.68 53.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 15.0 110.153 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 28.9 m-85 -89.76 108.51 19.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.871 -0.604 . . . . 15.0 111.698 -171.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.33 132.13 53.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.858 1.313 . . . . 15.0 113.558 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 0.3 OUTLIER -140.4 99.47 3.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 112.601 -2.091 . . . . 15.0 107.514 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.7 t -108.37 87.47 2.5 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 115.242 -2.583 . . . . 15.0 111.395 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.424 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 39.8 tt0 -101.47 -48.22 4.42 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.256 -2.247 . . . . 15.0 106.649 142.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -118.32 24.78 10.74 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 113.539 -1.664 . . . . 15.0 111.757 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.53 72.79 0.43 Allowed Glycine 0 C--N 1.271 -3.069 0 CA-C-N 110.961 -2.836 . . . . 15.0 114.495 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 253' ' ' LEU . 13.1 t -92.42 116.33 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 117.449 0.624 . . . . 15.0 111.631 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.799 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.1 p -126.63 110.08 12.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.167 0.917 . . . . 15.0 108.659 167.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -149.93 150.31 31.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.923 0.712 . . . . 15.0 112.923 -167.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.465 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 22.1 m95 -75.65 -29.65 59.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.353 -0.839 . . . . 15.0 111.479 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -93.53 140.16 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.624 -0.43 . . . . 15.0 111.27 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.912 ' HB3' HG12 ' A' ' 267' ' ' ILE . 16.2 t0 -50.61 126.22 22.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 N-CA-C 108.672 -0.862 . . . . 15.0 108.672 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.942 ' HD2' HD12 ' A' ' 236' ' ' LEU . 56.3 Cg_endo -70.55 -14.53 33.66 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 C-N-CA 122.471 2.114 . . . . 15.0 113.608 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.24 -9.58 59.28 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.898 0.856 . . . . 15.0 108.963 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.912 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.3 mm . . . . . 0 C--O 1.247 0.967 0 CA-C-N 114.186 -1.37 . . . . 15.0 110.328 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 121.364 0.602 . . . . 15.0 109.834 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 24.2 m -135.33 115.03 12.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.208 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.901 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 10.3 m-20 -81.44 -30.01 0.53 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.095 0.776 . . . . 15.0 113.095 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.4 Cg_endo -96.78 160.38 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.99 2.46 . . . . 15.0 112.759 -166.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.23 160.42 29.44 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 3.8 Cg_exo -89.08 136.66 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.312 2.674 . . . . 15.0 113.383 -169.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -98.03 1.04 47.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.815 -1.084 . . . . 15.0 109.875 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.457 ' HG3' ' HE1' ' A' ' 262' ' ' TRP . 25.6 pt20 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.559 -0.734 . . . . 15.0 110.353 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.151 -0.315 . . . . 15.0 110.151 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -115.44 177.82 1.11 Allowed Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.414 ' HG3' HH11 ' A' ' 266' ' ' ARG . 13.4 Cg_exo -69.52 160.31 50.26 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 121.524 1.482 . . . . 15.0 110.579 168.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.89 120.16 15.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.281 -171.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 135.11 -27.16 3.18 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.597 -0.729 . . . . 15.0 113.068 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 45.1 m-85 -92.39 136.69 32.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.884 0.342 . . . . 15.0 110.62 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.82 141.4 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 167.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -89.82 99.37 12.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.458 ' HD3' ' OG ' ' B' ' 210' ' ' SEP . 2.4 ttt-85 -93.47 130.22 39.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.81 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -119.76 110.41 16.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.312 -0.858 . . . . 15.0 110.142 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.656 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.06 150.26 22.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.789 -0.448 . . . . 15.0 109.789 176.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 42.6 t -55.13 -18.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.65 0.738 . . . . 15.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.823 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 3.3 tp-100 -49.94 -29.21 7.95 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.817 -1.083 . . . . 15.0 111.429 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.36 -23.92 17.05 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.046 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.505 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.5 mp0 -89.88 148.39 23.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.253 0.549 . . . . 15.0 111.322 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 123.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.713 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -114.15 128.61 56.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.439 -0.505 . . . . 15.0 110.592 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.3 m-85 -89.69 110.34 21.24 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.419 -172.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.48 134.43 52.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.739 1.257 . . . . 15.0 113.852 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 64.1 t60 -146.89 102.27 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 112.563 -2.108 . . . . 15.0 108.309 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.4 t -102.91 88.01 3.07 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 116.058 -2.257 . . . . 15.0 111.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -101.15 -50.69 3.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.164 -1.835 . . . . 15.0 106.237 147.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.9 p -116.91 27.23 9.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.142 -1.845 . . . . 15.0 111.293 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.04 72.18 0.55 Allowed Glycine 0 C--N 1.277 -2.747 0 CA-C-N 111.133 -2.758 . . . . 15.0 113.974 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.8 t -90.05 115.16 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-N 117.379 0.59 . . . . 15.0 111.807 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.839 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.1 p -127.89 100.09 5.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.956 170.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.5 p -141.25 150.27 42.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.223 0.823 . . . . 15.0 113.223 -167.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.624 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 1.7 m95 -70.87 -42.56 69.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.475 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -76.19 139.33 41.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.66 -0.7 . . . . 15.0 111.676 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.001 ' HB3' HG12 ' A' ' 267' ' ' ILE . 49.3 t0 -54.19 127.74 56.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 168.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.416 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 65.1 Cg_endo -74.13 -14.79 23.32 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 121.651 1.567 . . . . 15.0 112.916 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 13.6 tpt180 -81.92 -5.93 58.68 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.683 -0.858 . . . . 15.0 108.683 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.001 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.5 mm . . . . . 0 C--O 1.25 1.128 0 CA-C-N 113.911 -1.495 . . . . 15.0 110.141 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.44 0.162 . . . . 15.0 111.257 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 27.4 m -121.86 117.84 27.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.652 0.263 . . . . 15.0 110.474 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.885 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.696 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.8 p-10 -120.08 -17.21 0.08 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 253' ' ' LEU . 56.3 Cg_endo -90.8 160.44 4.13 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.306 2.004 . . . . 15.0 111.629 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.32 160.44 29.35 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.214 -1.154 . . . . 15.0 110.214 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.823 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.624 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo -88.64 127.44 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.72 2.947 . . . . 15.0 113.832 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -94.25 5.8 50.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.121 -0.945 . . . . 15.0 110.236 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.724 -0.655 . . . . 15.0 109.607 178.411 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.04 0.447 . . . . 15.0 110.518 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.85 -179.79 0.88 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.922 -0.77 . . . . 15.0 108.922 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.791 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.6 Cg_exo -69.62 161.97 43.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.497 1.465 . . . . 15.0 110.332 167.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.53 124.37 23.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.112 -0.949 . . . . 15.0 111.256 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.98 -13.93 8.0 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.521 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.9 m-85 -94.29 131.89 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.365 0.583 . . . . 15.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.99 140.58 38.76 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 170.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.492 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.8 OUTLIER -89.85 102.09 14.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -109.02 145.95 34.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.24 -0.891 . . . . 15.0 111.413 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 m -136.47 124.77 23.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.019 -0.991 . . . . 15.0 109.664 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.591 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.1 t -89.86 150.43 22.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.923 -0.399 . . . . 15.0 109.923 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.3 m -51.5 -24.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.316 0.579 . . . . 15.0 110.979 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.591 ' HB3' HG23 ' A' ' 245' ' ' THR . 10.4 tp60 -52.05 -33.29 38.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.037 -0.983 . . . . 15.0 111.703 172.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.8 12.16 28.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.995 -0.622 . . . . 15.0 112.512 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.4 mm-40 -99.1 142.32 30.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.241 -0.652 . . . . 15.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 m -102.78 106.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.013 0.435 . . . . 15.0 109.897 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -109.56 127.0 54.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.552 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.0 m-85 -89.54 108.4 19.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.593 -172.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.992 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.21 133.44 52.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.885 1.326 . . . . 15.0 113.503 -175.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.617 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 24.1 t60 -143.93 104.73 4.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.427 -2.17 . . . . 15.0 107.866 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -104.36 87.81 2.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 115.768 -2.373 . . . . 15.0 111.125 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 34.4 tt0 -101.32 -49.32 4.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.137 -1.847 . . . . 15.0 106.798 148.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -124.84 27.34 6.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.272 -1.785 . . . . 15.0 111.623 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.26 73.97 0.35 Allowed Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.457 -2.611 . . . . 15.0 114.292 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.565 ' O ' HD13 ' A' ' 253' ' ' LEU . 38.0 t -89.91 120.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.09 0.445 . . . . 15.0 111.517 173.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.805 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.6 p -131.25 112.23 12.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.053 -0.976 . . . . 15.0 109.166 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 p -144.33 150.12 37.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.244 0.831 . . . . 15.0 113.244 -167.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.78 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.1 OUTLIER -73.26 -36.28 66.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.975 -1.011 . . . . 15.0 110.496 171.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -86.02 142.35 28.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.237 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.909 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.6 t70 -58.96 131.52 86.8 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.744 -0.836 . . . . 15.0 108.744 171.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.99 -14.8 16.81 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 C-N-CA 122.189 1.926 . . . . 15.0 113.619 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.791 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.4 tpt180 -80.56 -7.43 59.23 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.909 HG12 ' HB3' ' A' ' 264' ' ' ASP . 44.4 mm . . . . . 0 C--O 1.25 1.125 0 CA-C-N 113.803 -1.544 . . . . 15.0 109.917 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.581 0.229 . . . . 15.0 111.397 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.2 p -123.86 106.32 10.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 15.0 110.883 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.811 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 19.8 t70 -99.39 -14.35 0.18 Allowed Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.735 1.013 . . . . 15.0 113.735 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.992 ' HG3' HD11 ' A' ' 253' ' ' LEU . 61.4 Cg_endo -101.41 160.31 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.742 2.961 . . . . 15.0 114.081 -162.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.63 160.37 28.92 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 109.669 -1.372 . . . . 15.0 109.669 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.58 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.78 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.2 Cg_exo -88.86 139.1 3.73 Favored 'Trans proline' 0 C--N 1.333 -0.279 0 C-N-CA 123.582 2.855 . . . . 15.0 113.439 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -95.41 9.59 39.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 15.0 109.764 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.308 -0.853 . . . . 15.0 110.571 -179.345 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER -92.01 154.96 43.47 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.404 0.621 . . . . 15.0 111.31 -169.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.569 ' HG3' HH11 ' A' ' 266' ' ' ARG . 19.6 Cg_exo -69.41 167.21 24.62 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 122.977 2.451 . . . . 15.0 110.82 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.54 114.6 7.91 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.676 -1.147 . . . . 15.0 111.516 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.55 -18.78 2.43 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 114.821 -1.082 . . . . 15.0 113.112 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 43.5 m-85 -101.77 131.68 47.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.053 0.427 . . . . 15.0 111.107 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -101.59 138.66 38.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.98 110.08 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.407 ' HD3' ' OG ' ' B' ' 210' ' ' SEP . 4.3 ttt-85 -112.09 128.78 56.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.235 0.54 . . . . 15.0 111.311 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -113.53 125.49 54.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.843 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -107.72 150.52 26.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.125 -0.488 . . . . 15.0 110.65 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -48.84 -20.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.314 0.646 . . . . 15.0 112.171 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.764 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.1 tp-100 -51.21 -21.76 2.25 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.336 -0.847 . . . . 15.0 111.666 171.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.14 60.92 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 15.0 111.916 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.525 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 32.7 mt-30 -130.72 149.73 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.662 -0.495 . . . . 15.0 109.662 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.73 138.66 26.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 15.0 109.975 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -125.25 128.16 47.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.351 0.596 . . . . 15.0 110.476 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 14.8 m-85 -89.73 109.66 20.62 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.028 -0.987 . . . . 15.0 111.453 -172.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.081 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.37 132.96 53.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.836 1.303 . . . . 15.0 114.039 -175.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.623 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 18.7 t60 -140.38 97.09 3.15 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.535 -2.121 . . . . 15.0 107.447 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.2 p -90.51 88.22 7.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.439 -2.104 . . . . 15.0 110.424 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -101.29 -44.73 5.56 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.032 -1.895 . . . . 15.0 108.704 152.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 5.6 t -146.05 26.09 1.24 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 124.062 1.887 . . . . 15.0 108.775 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 59.45 75.96 0.25 Allowed Glycine 0 C--N 1.28 -2.581 0 CA-C-N 110.307 -3.133 . . . . 15.0 113.356 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 79.6 t -89.27 115.8 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 118.833 -1.147 . . . . 15.0 110.841 164.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.822 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.9 p -129.31 106.15 8.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.481 -1.69 . . . . 15.0 108.571 173.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.994 0.739 . . . . 15.0 112.994 -167.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.525 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 43.3 m95 -77.84 -36.6 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 15.0 109.94 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -79.95 141.12 36.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.089 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.945 ' HB3' HG12 ' A' ' 267' ' ' ILE . 25.3 t0 -59.81 125.43 80.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.053 -1.091 . . . . 15.0 108.053 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.776 ' HD2' HD12 ' A' ' 236' ' ' LEU . 11.9 Cg_exo -70.55 -14.8 33.9 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.192 1.928 . . . . 15.0 112.897 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 237' ' ' PRO . 18.7 tpt180 -75.05 -10.26 59.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.677 0.751 . . . . 15.0 109.078 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.945 HG12 ' HB3' ' A' ' 264' ' ' ASP . 47.6 mm . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.448 -1.251 . . . . 15.0 109.739 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.411 0.148 . . . . 15.0 110.976 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.2 p -150.09 114.94 5.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.709 0.29 . . . . 15.0 110.364 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.734 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.797 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 47.4 p-10 -120.19 -14.47 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 114.059 1.133 . . . . 15.0 114.059 173.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.081 ' HG3' HD11 ' A' ' 253' ' ' LEU . 57.4 Cg_endo -96.72 160.68 1.14 Allowed 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.057 2.505 . . . . 15.0 111.928 -175.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.27 160.21 29.23 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 119.865 -1.16 . . . . 15.0 110.455 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.467 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.3 Cg_exo -89.1 151.14 5.69 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 123.722 2.948 . . . . 15.0 113.146 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -115.11 63.99 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.015 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.061 -0.971 . . . . 15.0 110.822 -176.93 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER -89.73 156.55 47.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 15.0 110.551 -173.022 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.665 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.7 Cg_exo -69.34 155.94 65.86 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.3 2.0 . . . . 15.0 109.76 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.72 117.73 11.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.219 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 146.12 -13.55 1.67 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.38 -0.827 . . . . 15.0 112.949 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.9 m-85 -104.84 138.43 41.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.276 0.538 . . . . 15.0 110.848 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 170.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.92 104.59 17.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -109.05 130.71 55.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.49 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 125.71 53.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.789 . . . . 15.0 110.213 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -106.25 150.72 25.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.082 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.0 t -45.87 -23.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.611 0.569 . . . . 15.0 111.57 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.756 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.7 tp60 -50.94 -23.08 2.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.457 0.703 . . . . 15.0 111.53 173.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.15 65.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.248 -0.501 . . . . 15.0 112.275 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 34.5 mt-30 -106.73 142.47 36.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.835 0.35 . . . . 15.0 110.587 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.03 137.23 22.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.433 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.467 ' OH ' ' O2P' ' B' ' 210' ' ' SEP . 28.1 p90 -127.79 128.25 44.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.048 0.451 . . . . 15.0 110.081 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.2 m-85 -89.7 111.33 22.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.619 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.47 133.95 51.92 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.806 1.289 . . . . 15.0 113.985 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 43.4 t60 -140.49 97.54 3.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 112.475 -2.148 . . . . 15.0 107.307 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.533 HG22 ' HA2' ' A' ' 258' ' ' GLY . 8.8 p -97.21 87.74 4.26 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 116.295 -2.162 . . . . 15.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -101.29 -52.73 3.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.278 -1.783 . . . . 15.0 106.818 147.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 35.8 p -119.4 27.66 8.66 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 112.417 -2.174 . . . . 15.0 111.116 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.36 74.94 0.24 Allowed Glycine 0 C--N 1.274 -2.883 0 CA-C-N 111.464 -2.607 . . . . 15.0 113.692 -175.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.7 t -89.59 111.11 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-N 117.452 0.626 . . . . 15.0 111.066 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.813 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.6 p -124.66 101.97 7.37 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.171 -1.377 . . . . 15.0 108.885 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -150.22 150.39 31.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -169.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 74.4 m95 -72.66 -38.32 67.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.012 174.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -74.86 136.32 41.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.165 -0.47 . . . . 15.0 111.563 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.829 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t0 -57.26 124.66 67.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.271 -0.877 . . . . 15.0 108.917 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 9.1 Cg_exo -73.38 -14.62 25.27 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.5 2.134 . . . . 15.0 113.879 -176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.665 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 26.2 tpt180 -76.66 -9.62 58.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.76 -0.83 . . . . 15.0 108.76 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.829 HG12 ' HB3' ' A' ' 264' ' ' ASP . 51.3 mm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 113.906 -1.497 . . . . 15.0 109.591 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.037 0.446 . . . . 15.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -131.82 129.53 40.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.882 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.558 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 29.5 m-20 -95.65 -19.39 0.22 Allowed Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 113.394 0.887 . . . . 15.0 113.394 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -92.04 160.19 3.26 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.191 1.927 . . . . 15.0 111.098 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.24 160.24 29.3 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.904 -1.141 . . . . 15.0 110.295 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.486 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.6 Cg_exo -88.99 137.7 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.341 2.694 . . . . 15.0 113.952 -169.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.15 7.36 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.026 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.025 -0.989 . . . . 15.0 110.014 -177.532 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 5.3 mm-40 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.578 0.228 . . . . 15.0 110.439 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.86 171.83 5.08 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.835 -0.431 . . . . 15.0 109.835 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.925 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.57 165.61 30.17 Favored 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.062 1.841 . . . . 15.0 110.92 166.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -69.48 126.93 31.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.304 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 121.52 -13.65 9.38 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 15.0 113.647 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.628 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 91.0 m-85 -95.06 128.58 41.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.471 0.636 . . . . 15.0 110.718 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -106.78 135.99 47.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 15.0 109.655 172.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.547 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -89.79 111.61 22.67 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.358 -0.979 . . . . 15.0 108.358 -178.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.708 HH11 ' HG2' ' A' ' 243' ' ' ARG . 6.1 ttt-85 -107.51 127.36 53.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.654 -0.703 . . . . 15.0 111.909 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.4 p -113.83 124.38 52.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.455 -1.248 . . . . 15.0 109.821 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -107.91 150.0 27.61 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.927 -0.397 . . . . 15.0 109.927 175.126 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.47 -18.67 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.516 0.674 . . . . 15.0 110.312 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.875 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 3.8 tp-100 -47.33 -40.99 18.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.877 -1.056 . . . . 15.0 111.198 171.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.91 21.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.779 -0.724 . . . . 15.0 112.881 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.534 ' HB2' ' O2P' ' B' ' 214' ' ' SEP . 2.5 mp0 -104.48 150.11 24.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.1 0.476 . . . . 15.0 111.662 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.12 124.17 55.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.301 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 37.8 p90 -125.82 129.23 48.99 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.013 -0.675 . . . . 15.0 111.784 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.645 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 36.7 m-85 -90.06 111.28 22.34 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.678 -174.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.953 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -110.54 134.17 52.63 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.707 1.241 . . . . 15.0 113.211 176.103 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 42.2 t60 -140.72 100.32 3.82 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.005 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.3 t -101.81 87.89 3.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 115.905 -2.318 . . . . 15.0 110.885 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.452 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 46.7 tt0 -101.08 -46.67 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.023 -1.899 . . . . 15.0 106.773 148.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.3 p -124.97 27.05 6.84 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.412 -1.722 . . . . 15.0 111.109 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.91 73.11 0.43 Allowed Glycine 0 C--N 1.278 -2.666 0 CA-C-N 111.281 -2.69 . . . . 15.0 114.212 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.644 ' O ' HD13 ' A' ' 253' ' ' LEU . 50.9 t -89.95 114.0 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 117.349 0.574 . . . . 15.0 112.066 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.776 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.7 p -121.63 106.86 11.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.786 -1.097 . . . . 15.0 108.596 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.3 p -142.41 150.13 40.22 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.257 0.836 . . . . 15.0 113.257 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 1.5 m95 -77.67 -34.81 52.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.652 172.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -82.79 137.81 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.003 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.86 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t70 -57.14 133.41 80.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 171.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.405 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 87.8 Cg_endo -81.21 -14.64 10.63 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.293 1.995 . . . . 15.0 113.986 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.925 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.3 tpt180 -83.81 -3.47 57.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.376 1.084 . . . . 15.0 108.396 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.86 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.1 mm . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 113.177 -1.829 . . . . 15.0 109.776 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.807 0.337 . . . . 15.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.2 p -109.36 107.78 18.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 15.0 110.158 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.967 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.553 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 5.3 p-10 -95.24 -24.12 0.25 Allowed Pre-proline 0 CA--C 1.549 0.911 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.244 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.967 ' HD2' ' HB3' ' B' ' 210' ' ' SEP . 13.1 Cg_endo -96.42 160.37 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.941 2.427 . . . . 15.0 111.691 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.29 160.31 29.29 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.036 -0.825 . . . . 15.0 111.036 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.875 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.508 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo -89.14 132.14 2.24 Favored 'Trans proline' 0 C--O 1.223 -0.226 0 C-N-CA 124.132 3.221 . . . . 15.0 113.895 -174.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -88.12 -2.1 58.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.663 -0.698 . . . . 15.0 109.54 172.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.102 -0.952 . . . . 15.0 110.682 -176.815 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.73 0.3 . . . . 15.0 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -122.87 172.69 5.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 15.0 109.594 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.647 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.45 159.39 53.82 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.986 1.791 . . . . 15.0 110.485 166.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.62 113.96 7.39 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.54 -0.755 . . . . 15.0 111.214 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 143.77 -16.43 2.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.49 -0.777 . . . . 15.0 112.729 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 66.4 m-85 -98.36 138.74 35.16 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.626 -0.338 . . . . 15.0 110.737 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -109.33 144.3 37.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -89.85 118.55 29.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 15.0 108.796 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.7 136.36 53.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.387 0.613 . . . . 15.0 111.536 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 m -129.45 115.61 17.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.931 -1.032 . . . . 15.0 109.592 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -90.15 150.62 21.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.536 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.48 -17.34 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.31 0.576 . . . . 15.0 110.617 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -54.2 -22.7 12.13 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.012 170.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.43 16.65 48.9 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.009 -0.615 . . . . 15.0 112.78 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 16.0 mt-30 -131.47 146.81 52.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.773 0.321 . . . . 15.0 110.213 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.56 141.21 15.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.415 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.5 127.42 27.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.889 0.376 . . . . 15.0 110.098 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 25.1 m-85 -89.62 111.65 22.66 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.05 -0.523 . . . . 15.0 111.434 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.046 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.83 135.86 49.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.684 1.231 . . . . 15.0 113.619 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 37.8 t60 -148.74 107.44 3.82 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.678 -2.055 . . . . 15.0 108.292 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 11.9 m -103.42 87.58 2.89 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 116.17 -2.212 . . . . 15.0 110.625 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.413 ' HB3' ' NE2' ' A' ' 254' ' ' HIS . 43.7 tt0 -101.35 -48.19 4.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.071 -1.877 . . . . 15.0 107.253 149.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 43.6 p -125.11 25.17 7.31 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.099 -1.864 . . . . 15.0 111.201 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.27 75.38 0.23 Allowed Glycine 0 C--N 1.272 -2.983 0 CA-C-N 111.17 -2.741 . . . . 15.0 113.187 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 253' ' ' LEU . 75.3 t -89.74 119.94 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.161 0.48 . . . . 15.0 111.604 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.4 p -134.21 107.32 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 124.817 1.323 . . . . 15.0 108.932 171.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -150.13 150.36 31.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 37.7 m95 -72.83 -28.69 62.7 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.114 174.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 264' ' ' ASP . 6.0 p-80 -87.65 134.62 33.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.97 0.414 . . . . 15.0 111.132 -169.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.771 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t70 -52.73 126.97 42.27 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.444 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.447 ' HD3' ' CD1' ' A' ' 252' ' ' PHE . 80.9 Cg_endo -76.96 -14.44 17.04 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.381 2.054 . . . . 15.0 114.052 -173.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.647 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 13.3 tpt180 -79.5 -8.1 58.91 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.108 0.956 . . . . 15.0 108.465 174.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.771 HG12 ' HB3' ' A' ' 264' ' ' ASP . 50.3 mm . . . . . 0 C--O 1.246 0.911 0 CA-C-N 113.613 -1.631 . . . . 15.0 109.797 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.466 0.174 . . . . 15.0 111.028 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.8 p -140.61 104.54 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.436 . . . . 15.0 110.938 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.667 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.671 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 32.6 t70 -109.1 -15.23 0.12 Allowed Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.798 1.036 . . . . 15.0 113.798 172.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.046 ' HG3' HD11 ' A' ' 253' ' ' LEU . 62.8 Cg_endo -93.04 160.33 2.63 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.513 2.142 . . . . 15.0 112.127 -169.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.54 159.52 28.38 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.639 -1.267 . . . . 15.0 110.369 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.477 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.545 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo -89.05 126.1 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.515 2.81 . . . . 15.0 113.262 -173.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -87.16 88.44 7.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.633 -0.712 . . . . 15.0 109.523 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.432 -0.794 . . . . 15.0 109.875 -176.392 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 265' ' ' PRO . 6.4 mt -100.5 166.23 12.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 -176.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.443 ' HD3' ' CD ' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.62 160.6 49.14 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 121.925 1.75 . . . . 15.0 110.543 168.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.4 119.4 13.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.548 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 137.18 -17.89 3.55 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.481 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 67.0 m-85 -103.33 132.01 49.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.596 0.198 . . . . 15.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -108.97 139.29 44.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.78 105.0 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 243' ' ' ARG . 16.4 ttt85 -105.71 138.66 41.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.261 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 m -128.37 117.2 21.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.195 -0.912 . . . . 15.0 109.824 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.784 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.3 t -90.02 150.3 22.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.945 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 t -54.53 -18.06 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.575 0.702 . . . . 15.0 110.522 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.784 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.4 tp60 -53.02 -24.62 10.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.07 -0.968 . . . . 15.0 111.774 172.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.92 -2.96 52.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.627 -0.797 . . . . 15.0 112.824 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.559 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 13.0 mp0 -113.35 143.84 43.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.133 0.492 . . . . 15.0 111.486 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.83 136.81 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 15.0 110.161 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -130.68 130.95 44.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.054 0.454 . . . . 15.0 110.529 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 38.9 m-85 -89.66 109.16 20.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.691 -0.686 . . . . 15.0 111.297 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -109.37 134.62 51.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.682 1.23 . . . . 15.0 113.716 -176.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 34.4 t60 -141.81 105.63 4.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.457 -2.156 . . . . 15.0 107.698 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.401 HG22 ' HA2' ' A' ' 258' ' ' GLY . 22.5 p -104.26 87.75 2.82 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.281 -2.168 . . . . 15.0 111.277 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -101.35 -49.1 4.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.367 -1.742 . . . . 15.0 106.89 146.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 24.9 p -126.09 30.92 5.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.006 -1.906 . . . . 15.0 111.557 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 49.02 76.01 0.17 Allowed Glycine 0 C--N 1.278 -2.685 0 CA-C-N 111.952 -2.385 . . . . 15.0 114.361 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.56 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.6 t -89.81 118.32 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.247 0.524 . . . . 15.0 110.91 171.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.0 p -132.57 107.3 8.35 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.504 1.128 . . . . 15.0 109.51 172.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.6 t -150.16 150.24 31.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.307 0.855 . . . . 15.0 113.307 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.628 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -67.76 -32.38 72.94 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.901 173.317 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -87.97 135.74 33.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.582 -0.447 . . . . 15.0 111.351 -168.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.903 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.28 128.73 73.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 171.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.599 ' HD2' HD22 ' A' ' 236' ' ' LEU . 73.3 Cg_endo -76.57 -14.91 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.834 1.69 . . . . 15.0 113.183 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.443 ' CD ' ' HD3' ' A' ' 237' ' ' PRO . 4.7 tpt180 -80.66 -6.2 58.03 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.975 0.893 . . . . 15.0 108.998 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.903 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.1 mm . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 114.044 -1.435 . . . . 15.0 109.885 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.241 0.543 . . . . 15.0 110.434 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 20.3 m -150.07 110.45 4.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.042 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.775 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.664 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 7.7 m-20 -103.62 -14.95 0.17 Allowed Pre-proline 0 CA--C 1.555 1.163 0 N-CA-C 113.855 1.057 . . . . 15.0 113.855 170.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 63.0 Cg_endo -95.7 160.19 1.48 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.822 2.348 . . . . 15.0 112.77 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.76 158.63 27.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.973 -1.108 . . . . 15.0 111.308 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.449 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.628 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 6.5 Cg_exo -88.88 146.88 5.67 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 123.558 2.839 . . . . 15.0 113.395 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -98.2 -1.14 42.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.641 -0.708 . . . . 15.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.15 -172.818 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.983 0.42 . . . . 15.0 110.411 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER -119.5 179.52 0.86 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 -176.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.747 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.7 Cg_exo -69.67 161.92 44.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.418 1.412 . . . . 15.0 110.343 166.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -69.44 126.41 29.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.147 -0.933 . . . . 15.0 111.254 -170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 125.42 -14.99 7.25 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.773 -0.727 . . . . 15.0 113.671 176.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 63.2 m-85 -100.3 136.53 40.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.574 0.687 . . . . 15.0 110.78 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.439 ' OE2' ' HB ' ' B' ' 208' ' ' THR . 9.9 pt-20 -105.43 146.18 29.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.716 -0.846 . . . . 15.0 108.716 168.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 17.4 tm0? -89.78 109.51 20.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -117.33 141.34 48.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.627 0.727 . . . . 15.0 111.096 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.9 m -139.34 117.38 11.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.879 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.7 t -89.91 150.29 22.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.06 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.33 -22.72 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.6 0.714 . . . . 15.0 111.085 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.829 ' HB3' HG23 ' A' ' 245' ' ' THR . 8.1 tp-100 -49.55 -24.34 2.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.409 -1.269 . . . . 15.0 111.746 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.5 58.68 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.224 -0.513 . . . . 15.0 111.876 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.523 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 30.9 mt-30 -100.83 135.94 41.48 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.741 -0.466 . . . . 15.0 109.741 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.97 143.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.638 -0.256 . . . . 15.0 110.464 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -135.47 123.47 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 15.0 110.424 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 39.1 m-85 -89.67 110.84 21.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.426 -0.806 . . . . 15.0 110.824 -171.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.57 132.84 52.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.724 1.25 . . . . 15.0 113.66 -175.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 20.6 t60 -144.74 106.99 4.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 112.569 -2.105 . . . . 15.0 108.317 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 12.7 m -102.11 87.78 3.16 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 116.1 -2.24 . . . . 15.0 111.002 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.445 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 6.5 tt0 -101.38 -53.05 3.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.668 -1.604 . . . . 15.0 106.668 147.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 18.0 p -122.25 26.94 8.21 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 112.664 -2.062 . . . . 15.0 111.364 -174.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.29 75.97 0.2 Allowed Glycine 0 C--N 1.273 -2.931 0 CA-C-N 111.607 -2.542 . . . . 15.0 113.4 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.4 t -89.81 114.98 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 O-C-N 122.484 -0.421 . . . . 15.0 111.257 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.811 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.2 p -129.87 108.32 10.05 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.699 1.249 . . . . 15.0 108.858 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.3 t -150.14 150.23 31.36 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.935 0.717 . . . . 15.0 112.935 -169.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.523 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 56.1 m95 -70.86 -31.85 68.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.487 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.403 ' HD2' ' OXT' ' A' ' 267' ' ' ILE . 10.2 p-80 -88.51 134.68 33.79 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.006 0.432 . . . . 15.0 110.937 -170.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 1.008 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.0 t0 -58.5 123.82 68.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.72 -14.76 36.69 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 C-N-CA 122.099 1.866 . . . . 15.0 112.194 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.747 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.8 tpt180 -76.14 -10.66 59.59 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.938 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 264' ' ' ASP . 39.1 pt . . . . . 0 C--O 1.25 1.112 0 CA-C-N 114.731 -1.122 . . . . 15.0 111.458 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.439 ' HB ' ' OE2' ' A' ' 241' ' ' GLU . 56.6 m . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.435 -0.209 . . . . 15.0 110.435 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 12.0 t -131.44 99.96 5.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.393 0.616 . . . . 15.0 109.736 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.472 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.786 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 29.1 t70 -98.92 -14.99 0.19 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 114.021 1.119 . . . . 15.0 114.021 175.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 51.7 Cg_endo -102.43 160.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 123.667 2.911 . . . . 15.0 114.236 -165.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.52 160.53 29.18 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.323 -1.111 . . . . 15.0 110.323 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.45 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.499 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.9 Cg_exo -89.29 160.19 5.61 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 124.145 3.23 . . . . 15.0 113.076 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -120.94 1.51 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.791 -0.641 . . . . 15.0 109.824 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.252 -0.88 . . . . 15.0 110.73 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.779 0.323 . . . . 15.0 110.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -113.96 168.11 8.44 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.301 -0.629 . . . . 15.0 109.301 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.629 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.39 164.85 32.62 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.328 2.019 . . . . 15.0 110.172 165.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.49 130.52 42.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.851 -172.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 124.9 -34.59 3.38 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.809 -1.087 . . . . 15.0 113.245 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 53.6 m-85 -83.89 149.45 26.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.165 0.482 . . . . 15.0 110.744 -175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.657 ' OE2' ' HA ' ' B' ' 208' ' ' THR . 5.1 pt-20 -116.49 147.27 41.91 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.494 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.46 102.49 15.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.622 ' HD3' ' CE1' ' A' ' 251' ' ' TYR . 13.6 ttt-85 -102.82 147.61 26.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.136 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.2 m -138.95 118.38 12.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.799 -1.092 . . . . 15.0 108.751 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.6 t -96.67 150.23 20.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.641 -0.254 . . . . 15.0 110.422 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.98 -21.63 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.267 0.556 . . . . 15.0 110.854 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.683 ' HB3' HG23 ' A' ' 245' ' ' THR . 48.5 tp60 -53.08 -23.71 8.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.273 -0.876 . . . . 15.0 111.523 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.25 17.58 39.45 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.154 -0.546 . . . . 15.0 112.318 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.578 ' OE1' ' HG2' ' A' ' 247' ' ' GLN . 4.7 mt-30 -125.13 147.43 49.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.01 -0.737 . . . . 15.0 109.01 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.2 130.56 50.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.162 -0.31 . . . . 15.0 110.162 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.622 ' CE1' ' HD3' ' A' ' 243' ' ' ARG . 34.9 p90 -126.99 129.13 47.5 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.531 -0.468 . . . . 15.0 110.626 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.696 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 27.5 m-85 -89.73 111.05 21.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.135 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.028 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.71 135.86 50.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.712 1.244 . . . . 15.0 113.928 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.617 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 55.5 t60 -144.35 100.76 3.59 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 112.458 -2.156 . . . . 15.0 107.819 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.679 HG22 ' HA2' ' A' ' 258' ' ' GLY . 2.8 p -102.8 87.41 2.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 116.163 -2.215 . . . . 15.0 110.833 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.502 ' HB3' ' HE2' ' A' ' 254' ' ' HIS . 34.0 tt0 -101.25 -35.73 9.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 113.316 -1.765 . . . . 15.0 108.029 146.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.5 p -139.02 30.64 2.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.916 1.341 . . . . 15.0 111.362 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.5 73.78 0.38 Allowed Glycine 0 C--N 1.279 -2.591 0 CA-C-N 111.936 -2.393 . . . . 15.0 114.603 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.674 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -92.77 115.08 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 117.274 0.537 . . . . 15.0 111.406 171.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.796 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.4 p -135.49 104.36 5.8 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.573 1.171 . . . . 15.0 109.229 172.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 9.0 t -150.22 150.43 31.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 15.0 112.733 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.453 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 39.0 m95 -66.98 -38.05 85.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.639 -0.71 . . . . 15.0 111.166 171.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.412 ' CD2' ' O ' ' A' ' 264' ' ' ASP . 7.0 p-80 -78.41 136.85 37.74 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.121 -0.491 . . . . 15.0 111.177 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.908 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t70 -57.03 127.65 76.12 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.828 -0.805 . . . . 15.0 108.828 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 71.1 Cg_endo -75.87 -14.64 19.25 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.135 1.89 . . . . 15.0 113.039 -174.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.629 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.6 tpt180 -76.05 -9.77 58.88 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.908 HG12 ' HB3' ' A' ' 264' ' ' ASP . 47.1 mm . . . . . 0 C--O 1.244 0.774 0 CA-C-N 114.051 -1.431 . . . . 15.0 109.765 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.657 ' HA ' ' OE2' ' A' ' 241' ' ' GLU . 6.3 m . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.566 0.698 . . . . 15.0 110.23 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 62.4 m -150.19 121.91 8.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.579 -0.737 . . . . 15.0 109.566 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.888 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.686 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 18.2 t70 -111.51 -19.82 0.12 Allowed Pre-proline 0 CA--C 1.556 1.189 0 N-CA-C 113.322 0.86 . . . . 15.0 113.322 173.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.028 ' HG3' HD11 ' A' ' 253' ' ' LEU . 48.9 Cg_endo -91.88 160.25 3.37 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.529 2.153 . . . . 15.0 112.411 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.55 160.27 28.94 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.442 -1.063 . . . . 15.0 110.442 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.453 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.8 Cg_exo -88.79 126.77 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.852 2.368 . . . . 15.0 112.53 -175.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -98.03 114.39 26.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.0 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.71 -0.662 . . . . 15.0 110.022 -178.158 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.749 -0.463 . . . . 15.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -102.45 169.68 7.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.748 0.309 . . . . 15.0 110.393 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.863 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.2 Cg_exo -69.58 157.24 61.43 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 121.945 1.763 . . . . 15.0 110.506 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.88 121.18 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.976 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 134.49 -14.33 4.5 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.741 -0.742 . . . . 15.0 113.105 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 79.4 m-85 -99.13 129.33 45.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.472 0.636 . . . . 15.0 111.048 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.79 137.13 43.05 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.91 119.32 30.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.179 -0.675 . . . . 15.0 109.179 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 243' ' ' ARG . 8.1 ttt-85 -122.39 132.81 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.559 0.695 . . . . 15.0 111.81 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -120.13 122.5 41.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.338 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -94.01 150.16 20.59 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.357 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -54.61 -19.28 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.529 0.681 . . . . 15.0 111.157 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.696 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.6 tp-100 -50.1 -24.44 2.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.415 -1.266 . . . . 15.0 111.701 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.67 -1.75 55.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.151 -0.547 . . . . 15.0 112.196 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.499 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 4.5 mt-30 -111.29 138.49 47.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.879 0.371 . . . . 15.0 110.418 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.08 136.44 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.625 -0.509 . . . . 15.0 109.625 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -131.73 126.7 35.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.18 0.514 . . . . 15.0 110.957 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.688 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.7 m-85 -89.77 113.5 25.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.357 -173.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -111.82 134.75 53.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 122.842 1.306 . . . . 15.0 114.087 -176.294 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 40.3 t60 -141.88 103.73 4.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.579 -2.1 . . . . 15.0 107.611 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.8 t -100.14 87.92 3.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 116.287 -2.165 . . . . 15.0 111.056 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.62 -54.43 2.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.311 -1.768 . . . . 15.0 106.712 147.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 38.2 p -119.88 27.23 8.81 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.397 -2.183 . . . . 15.0 111.329 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.07 75.66 0.21 Allowed Glycine 0 C--N 1.274 -2.867 0 CA-C-N 111.315 -2.675 . . . . 15.0 113.698 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.5 t -89.58 114.89 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-N 117.395 0.598 . . . . 15.0 111.028 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 9.1 p -126.44 107.61 10.43 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.965 -1.471 . . . . 15.0 108.79 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.1 p -140.21 149.43 42.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.255 0.835 . . . . 15.0 113.255 -168.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.507 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 21.3 m95 -75.05 -38.52 61.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.457 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -79.11 143.92 35.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.943 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.787 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.6 t70 -62.61 130.16 93.34 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.903 -0.777 . . . . 15.0 108.903 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.7 -14.77 24.43 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 C-N-CA 122.044 1.829 . . . . 15.0 113.775 -173.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.863 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.2 tpt180 -80.73 -5.55 57.25 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.17 0.986 . . . . 15.0 108.792 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.787 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.9 mm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 113.484 -1.689 . . . . 15.0 109.728 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.259 0.552 . . . . 15.0 110.104 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 20.9 m -150.1 100.8 2.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.928 -0.578 . . . . 15.0 109.654 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.476 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.5 m-20 -81.1 -18.04 0.26 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 172.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -98.17 160.32 0.81 Allowed 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.889 2.393 . . . . 15.0 112.832 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.4 160.32 29.16 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.776 -1.33 . . . . 15.0 109.776 173.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.466 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.507 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.4 Cg_exo -88.96 153.66 5.86 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.932 3.088 . . . . 15.0 112.202 -174.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -116.02 -2.15 12.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.5 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.562 -0.732 . . . . 15.0 110.116 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.792 0.329 . . . . 15.0 110.284 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.588 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -91.57 169.98 10.35 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -176.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.94 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 15.3 Cg_exo -69.62 154.46 68.28 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.095 1.863 . . . . 15.0 110.611 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.81 131.37 44.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.902 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 127.19 -16.47 6.35 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.564 -0.827 . . . . 15.0 112.921 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.622 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 90.2 m-85 -95.22 135.01 37.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.983 0.392 . . . . 15.0 110.267 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -113.7 138.55 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.196 0.522 . . . . 15.0 109.831 170.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.422 ' OE1' HG23 ' A' ' 244' ' ' THR . 0.4 OUTLIER -89.87 107.36 19.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.715 -0.846 . . . . 15.0 108.715 177.447 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -103.55 135.79 44.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.325 0.583 . . . . 15.0 111.816 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.422 HG23 ' OE1' ' A' ' 242' ' ' GLN . 0.9 OUTLIER -117.29 115.21 24.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.596 -1.184 . . . . 15.0 110.41 177.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.713 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -89.95 150.34 22.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 15.0 109.684 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.9 t -51.5 -24.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.4 0.619 . . . . 15.0 110.071 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.713 ' HB3' HG23 ' A' ' 245' ' ' THR . 40.3 tp60 -50.2 -31.37 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.964 -1.016 . . . . 15.0 111.588 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.36 19.94 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.107 -0.568 . . . . 15.0 113.31 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.62 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.9 mt-30 -127.02 141.35 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.04 0.42 . . . . 15.0 110.26 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.9 m -92.39 127.33 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.483 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -128.51 130.35 47.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.881 0.372 . . . . 15.0 110.204 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.658 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.4 m-85 -89.9 110.48 21.42 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.488 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.13 133.21 52.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.711 1.243 . . . . 15.0 113.899 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.622 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 33.2 t60 -143.64 95.23 2.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.655 -2.066 . . . . 15.0 107.918 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.3 m -90.4 87.91 6.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 116.512 -2.075 . . . . 15.0 110.141 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -101.15 -49.62 4.04 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 112.891 -1.959 . . . . 15.0 108.212 153.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.7 t -135.28 23.67 3.49 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-N 112.736 -2.029 . . . . 15.0 108.506 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 60.92 74.32 0.39 Allowed Glycine 0 C--N 1.279 -2.585 0 CA-C-N 109.785 -3.371 . . . . 15.0 112.909 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 253' ' ' LEU . 67.4 t -89.15 115.7 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 119.51 -0.876 . . . . 15.0 111.199 168.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.837 ' HA ' HD22 ' A' ' 253' ' ' LEU . 3.7 p -131.22 104.41 7.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.533 -1.667 . . . . 15.0 109.026 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.9 t -150.24 150.33 31.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.764 0.653 . . . . 15.0 112.764 -168.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.4 ' CZ2' ' HB2' ' B' ' 215' ' ' PRO . 69.8 m95 -70.92 -34.34 71.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.136 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 264' ' ' ASP . 7.6 p-80 -81.59 136.27 35.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.11 -168.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.869 ' HB3' HG12 ' A' ' 267' ' ' ILE . 11.5 t70 -54.35 130.5 61.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 15.0 109.443 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.94 -14.79 16.92 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 C-N-CA 122.202 1.934 . . . . 15.0 114.179 -171.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.94 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpm_? -85.45 -2.76 58.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.372 1.082 . . . . 15.0 108.645 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.869 HG12 ' HB3' ' A' ' 264' ' ' ASP . 39.7 mm . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 112.96 -1.927 . . . . 15.0 109.827 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.927 0.394 . . . . 15.0 110.823 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.5 p -132.82 110.12 10.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.408 -0.36 . . . . 15.0 110.59 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.897 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.591 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -108.02 -14.86 0.13 Allowed Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 113.269 0.84 . . . . 15.0 113.269 168.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 42.2 Cg_endo -90.18 160.63 4.74 Favored 'Trans proline' 0 C--N 1.369 1.605 0 C-N-CA 122.882 2.388 . . . . 15.0 111.241 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.46 159.57 28.5 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.334 -1.413 . . . . 15.0 110.699 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.471 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.7 Cg_exo -88.99 160.09 5.91 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.623 2.882 . . . . 15.0 112.694 -173.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -119.6 16.98 12.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 15.0 110.049 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.471 -0.776 . . . . 15.0 110.416 -177.571 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 2.0 mp0 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.758 -0.46 . . . . 15.0 109.758 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.8 OUTLIER -93.25 159.45 35.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.085 0.469 . . . . 15.0 110.242 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.698 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.6 Cg_exo -69.37 145.54 59.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.881 1.72 . . . . 15.0 108.561 161.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.54 96.44 0.92 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.128 0.966 . . . . 15.0 112.358 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 163.28 32.09 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 113.45 -1.705 . . . . 15.0 112.607 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD2' ' HG2' ' A' ' 265' ' ' PRO . 82.7 m-85 -140.99 125.69 17.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 5.9 pt-20 -97.45 134.25 40.95 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.203 0.525 . . . . 15.0 109.986 175.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -89.7 111.6 22.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -120.3 129.78 54.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.345 0.593 . . . . 15.0 111.592 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.0 m -123.04 124.44 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.619 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.1 OUTLIER -89.86 150.46 22.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.433 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.57 -24.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.46 0.648 . . . . 15.0 110.283 174.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 249' ' ' GLN . 34.8 tp60 -47.8 -35.52 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.823 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.16 31.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.039 -0.601 . . . . 15.0 112.798 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 7.8 mt-30 -107.19 149.77 27.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 15.0 110.69 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.04 136.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.323 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -131.57 126.76 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.3 m-85 -89.74 109.94 20.89 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.139 -172.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.926 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -104.96 133.16 50.22 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 122.925 1.345 . . . . 15.0 113.28 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 1.4 t-80 -142.18 96.35 2.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 112.571 -2.104 . . . . 15.0 107.833 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 t -104.11 87.73 2.84 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 115.662 -2.415 . . . . 15.0 111.18 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -100.93 -31.55 11.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 112.401 -2.181 . . . . 15.0 108.245 145.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.9 t -144.28 24.84 1.58 Allowed 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 123.655 1.693 . . . . 15.0 110.014 -166.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 50.73 70.38 0.86 Allowed Glycine 0 C--N 1.274 -2.904 0 CA-C-N 110.006 -3.27 . . . . 15.0 113.883 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 56.4 t -89.23 116.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 119.853 -0.739 . . . . 15.0 111.629 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.834 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 3.7 p -129.18 105.44 8.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.905 -1.498 . . . . 15.0 109.131 170.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 150.17 31.46 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.713 0.635 . . . . 15.0 112.713 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.519 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 55.8 m95 -69.02 -32.91 72.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 15.0 112.102 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -88.0 139.4 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 15.0 111.708 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.99 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.6 t0 -58.55 123.25 66.04 Favored Pre-proline 0 C--O 1.215 -0.745 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.8 Cg_exo -68.54 -14.48 39.76 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 121.983 1.789 . . . . 15.0 113.598 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.698 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.3 tpt180 -80.7 -7.27 59.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.095 0.95 . . . . 15.0 108.752 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.99 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.3 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.742 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' THR . . . . . 0.404 ' HA ' ' OE1' ' A' ' 241' ' ' GLU . 12.5 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.985 0.421 . . . . 15.0 110.119 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 44.3 m -150.07 108.93 3.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.991 0.424 . . . . 15.0 110.398 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.564 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.754 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.1 p-10 -93.15 -15.47 0.21 Allowed Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 113.964 1.098 . . . . 15.0 113.964 174.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.926 ' HG3' HD11 ' A' ' 253' ' ' LEU . 95.7 Cg_endo -97.39 160.37 0.97 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.962 2.441 . . . . 15.0 112.664 -167.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.67 160.22 28.75 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.8 -1.32 . . . . 15.0 109.8 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.483 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.519 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo -89.2 153.61 5.62 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.805 3.004 . . . . 15.0 113.414 -169.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -117.61 -4.3 11.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.422 -0.808 . . . . 15.0 109.257 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.216 -0.897 . . . . 15.0 110.658 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.856 0.36 . . . . 15.0 110.214 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.0 OUTLIER -109.04 172.39 3.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.213 -0.449 . . . . 15.0 109.986 -177.307 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.667 ' HG3' HH11 ' A' ' 266' ' ' ARG . 17.4 Cg_exo -69.51 154.32 68.88 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.566 1.51 . . . . 15.0 109.413 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.76 121.54 17.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.391 0.615 . . . . 15.0 110.869 -170.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.74 -21.57 2.86 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.095 -0.957 . . . . 15.0 111.853 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 75.8 m-85 -96.69 128.82 44.0 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.64 0.257 . . . . 15.0 110.413 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -102.19 130.83 48.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 172.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.75 116.02 27.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.154 0.502 . . . . 15.0 109.924 -174.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.519 ' HD3' ' CE2' ' A' ' 251' ' ' TYR . 0.0 OUTLIER -101.07 150.02 23.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.037 -173.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.0 p -129.26 98.02 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.311 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -89.93 150.07 22.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.517 -0.765 . . . . 15.0 112.148 -168.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.09 -20.45 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 15.0 110.521 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -57.65 -22.25 44.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.633 -1.167 . . . . 15.0 111.524 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.34 23.21 48.8 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.36 -1.096 . . . . 15.0 110.36 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.479 ' HB2' ' O3P' ' B' ' 214' ' ' SEP . 2.3 mm100 -130.3 150.36 51.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.482 -0.859 . . . . 15.0 108.938 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -110.67 107.55 23.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.15 0.5 . . . . 15.0 110.676 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.519 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 51.3 p90 -98.67 125.52 44.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.299 0.571 . . . . 15.0 111.076 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.1 m-85 -90.01 113.12 24.75 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.634 -0.712 . . . . 15.0 111.622 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.39 134.39 52.35 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.804 1.288 . . . . 15.0 113.45 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.629 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 21.4 t60 -141.75 99.38 3.53 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.534 -2.121 . . . . 15.0 108.05 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.1 t -92.44 87.87 6.16 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.068 -2.253 . . . . 15.0 110.425 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.79 -44.99 5.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 112.654 -2.066 . . . . 15.0 108.168 151.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 12.9 t -139.8 24.44 2.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.092 1.901 . . . . 15.0 108.424 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.18 0.37 Allowed Glycine 0 C--N 1.28 -2.546 0 CA-C-N 109.858 -3.337 . . . . 15.0 112.722 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 62.9 t -89.29 115.5 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 119.757 -0.777 . . . . 15.0 111.882 169.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.838 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 10.4 p -126.36 112.02 15.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.652 -1.613 . . . . 15.0 108.014 168.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -149.93 150.43 31.86 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.646 0.98 . . . . 15.0 113.646 -167.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 4.0 m95 -75.15 -21.34 58.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.529 -1.214 . . . . 15.0 112.548 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.545 ' HD2' ' O ' ' A' ' 267' ' ' ILE . 18.0 p-80 -101.42 144.01 30.74 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.518 -0.473 . . . . 15.0 111.578 -172.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.969 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t70 -60.46 123.32 73.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.455 -0.942 . . . . 15.0 108.455 170.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 8.7 Cg_exo -71.29 -14.68 31.43 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 121.863 1.709 . . . . 15.0 113.792 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.667 HH11 ' HG3' ' A' ' 237' ' ' PRO . 17.4 tpt180 -79.95 -8.51 59.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 264' ' ' ASP . 35.5 pt . . . . . 0 C--O 1.251 1.146 0 CA-C-N 113.947 -1.478 . . . . 15.0 111.158 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.068 0.461 . . . . 15.0 110.497 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.41 ' HA ' ' NH2' ' A' ' 243' ' ' ARG . 63.4 m -124.19 150.54 45.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.747 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 6.6 t70 -99.49 -24.78 0.23 Allowed Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.383 -0.826 . . . . 15.0 112.683 172.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 39.7 Cg_endo -92.68 160.26 2.85 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.069 1.846 . . . . 15.0 112.244 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.65 160.49 28.98 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.532 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.581 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 8.1 Cg_exo -89.04 136.4 2.95 Favored 'Trans proline' 0 C--O 1.223 -0.238 0 C-N-CA 124.039 3.159 . . . . 15.0 114.719 -170.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.94 10.62 38.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.614 -1.175 . . . . 15.0 108.764 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.842 -1.072 . . . . 15.0 110.438 -176.899 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 10.0 mm-40 . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.665 0.269 . . . . 15.0 110.506 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.7 OUTLIER -114.79 167.64 9.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -177.915 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.99 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 10.4 Cg_exo -69.82 163.7 37.36 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.589 2.193 . . . . 15.0 110.822 165.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -69.81 124.31 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.817 -1.083 . . . . 15.0 112.137 -172.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 122.62 -2.12 10.22 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.583 -0.818 . . . . 15.0 114.7 170.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.654 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.1 m-85 -99.41 130.43 45.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.991 0.895 . . . . 15.0 110.581 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -104.65 138.35 41.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 173.54 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 242' ' ' GLN . . . . . 0.6 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -89.92 106.18 18.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 15.0 109.501 -179.327 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 243' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 241' ' ' GLU . 27.8 ttt85 -104.06 139.87 38.56 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.458 -0.792 . . . . 15.0 111.884 -174.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 250' ' ' VAL . 5.6 p -130.6 103.12 6.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.55 -1.204 . . . . 15.0 110.078 -177.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.652 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -90.01 150.34 22.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.942 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.08 -17.69 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.344 0.593 . . . . 15.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' GLN . . . . . 0.652 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.2 tp-100 -55.45 -23.8 27.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.506 -0.77 . . . . 15.0 111.076 172.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.6 -0.62 65.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.044 -0.598 . . . . 15.0 112.92 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 14.4 mt-30 -115.24 149.27 38.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.054 -0.35 . . . . 15.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' THR . 31.2 m -97.49 135.0 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.786 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.424 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 47.3 p90 -131.36 125.28 32.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.104 0.478 . . . . 15.0 110.29 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.669 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.81 112.29 23.56 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.517 -0.765 . . . . 15.0 111.445 -173.482 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.979 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -109.34 134.16 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.943 1.354 . . . . 15.0 114.243 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 254' ' ' HIS . . . . . 0.654 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 52.0 t60 -137.84 97.89 3.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 112.561 -2.108 . . . . 15.0 107.578 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' THR . . . . . 0.564 HG22 ' HA2' ' A' ' 258' ' ' GLY . 1.2 p -97.42 87.52 4.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.074 -2.25 . . . . 15.0 110.836 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -101.52 -54.14 2.82 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.14 -1.8 . . . . 15.0 106.14 147.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 30.5 p -118.06 25.88 10.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.47 -2.15 . . . . 15.0 111.331 -177.172 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' GLY . . . . . 0.564 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.99 76.6 0.17 Allowed Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.269 -2.696 . . . . 15.0 113.736 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.582 ' O ' HD13 ' A' ' 253' ' ' LEU . 43.5 t -90.1 115.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.157 0.479 . . . . 15.0 110.995 171.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.807 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 7.4 p -124.09 103.39 8.26 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 124.59 1.181 . . . . 15.0 109.025 172.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.6 p -138.03 150.08 46.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.881 0.697 . . . . 15.0 112.881 -169.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -78.78 -29.03 44.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.307 -0.86 . . . . 15.0 110.288 173.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -88.29 141.17 28.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.671 . . . . 15.0 110.801 -173.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 264' ' ' ASP . . . . . 0.889 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.3 t70 -55.97 131.37 73.7 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.503 -0.925 . . . . 15.0 108.503 171.283 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -14.58 28.95 Favored 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.032 1.821 . . . . 15.0 113.996 -172.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 266' ' ' ARG . . . . . 0.99 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.0 tpm_? -85.93 -3.36 58.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.124 0.964 . . . . 15.0 109.161 177.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 267' ' ' ILE . . . . . 0.889 HG12 ' HB3' ' A' ' 264' ' ' ASP . 44.5 mm . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 113.357 -1.747 . . . . 15.0 109.916 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.247 0.546 . . . . 15.0 110.678 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 24.7 p -145.21 103.88 3.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.562 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 210' ' ' SEP . . . . . 0.617 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 211' ' ' ASP . . . . . 0.639 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -107.97 -19.12 0.15 Allowed Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.965 1.098 . . . . 15.0 113.965 171.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 212' ' ' PRO . . . . . 0.979 ' HG3' HD11 ' A' ' 253' ' ' LEU . 29.4 Cg_endo -95.25 160.49 1.62 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.937 2.425 . . . . 15.0 112.218 -173.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.27 157.94 27.34 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.925 -1.131 . . . . 15.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 214' ' ' SEP . . . . . 0.448 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 215' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 2.7 Cg_exo -89.15 150.12 5.61 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.827 3.018 . . . . 15.0 113.658 -171.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 216' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' B' ' 217' ' ' GLN . 92.0 m-85 -98.48 -9.18 25.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 15.0 109.945 175.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 217' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 216' ' ' PHE . 94.1 mt-30 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 117.789 -1.101 . . . . 15.0 110.521 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 109.63 -0.508 . . . . 15.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.689 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.4 Cg_exo -69.65 150.65 69.14 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.732 1.622 . . . . 15.0 108.961 163.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.83 141.87 53.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.551 0.691 . . . . 15.0 110.905 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.78 -22.74 6.8 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.21 -0.904 . . . . 15.0 112.334 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.7 m-85 -95.85 138.53 33.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 110.049 -0.352 . . . . 15.0 110.049 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.7 145.2 32.3 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.776 -0.824 . . . . 15.0 108.776 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.67 102.65 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -112.65 135.24 53.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 15.0 111.047 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -131.1 135.13 47.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.61 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.662 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -112.4 150.1 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.272 -0.422 . . . . 15.0 110.383 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.07 -16.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.705 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.662 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -52.96 -18.91 2.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.188 -0.915 . . . . 15.0 111.232 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.63 2.47 67.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.999 -0.619 . . . . 15.0 112.169 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.516 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 33.3 mt-30 -124.07 150.03 45.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.465 -0.568 . . . . 15.0 109.465 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.22 138.07 30.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.067 -0.346 . . . . 15.0 110.067 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -126.07 123.24 37.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.145 0.498 . . . . 15.0 110.036 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.723 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 17.9 m-85 -89.57 111.8 22.83 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 115.626 -0.716 . . . . 15.0 111.188 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.95 133.36 53.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.913 1.34 . . . . 15.0 113.986 -176.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.0 t-80 -144.49 96.87 2.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 112.474 -2.148 . . . . 15.0 107.779 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 258' ' ' GLY . 5.1 p -96.09 87.69 4.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.256 -2.177 . . . . 15.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.572 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 45.4 tt0 -101.73 -53.21 3.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.151 -1.84 . . . . 15.0 106.597 150.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.1 p -120.47 26.82 8.94 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 112.322 -2.217 . . . . 15.0 111.01 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.1 74.04 0.35 Allowed Glycine 0 C--N 1.273 -2.953 0 CA-C-N 111.262 -2.699 . . . . 15.0 113.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.0 t -90.03 115.58 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 117.286 0.543 . . . . 15.0 111.655 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.84 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.7 p -128.32 105.4 8.31 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.774 1.296 . . . . 15.0 108.863 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.4 p -141.42 150.19 42.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 32.6 m95 -75.55 -32.49 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.449 -0.796 . . . . 15.0 111.009 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -85.35 140.49 30.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.171 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.723 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 11.2 t70 -59.51 123.79 72.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 12.2 Cg_exo -71.38 -14.47 31.07 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.965 1.777 . . . . 15.0 113.622 -172.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.689 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 12.4 tpt180 . . . . . 0 C--N 1.312 -1.041 0 N-CA-C 108.526 -0.916 . . . . 15.0 108.526 173.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.679 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.3 m-20 . . . . . 0 CA--C 1.556 1.184 0 N-CA-C 114.278 1.214 . . . . 15.0 114.278 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 55.6 Cg_endo -99.44 160.57 0.58 Allowed 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.542 2.828 . . . . 15.0 112.559 -171.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.776 0 N-CA-C 110.133 -1.187 . . . . 15.0 110.133 175.408 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.402 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.3 Cg_exo . . . . . 0 N--CA 1.463 -0.319 0 CA-C-O 121.562 0.567 . . . . 15.0 113.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.004 179.398 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.668 HD22 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mt . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.806 -0.442 . . . . 15.0 109.806 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.628 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 14.3 Cg_exo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.588 1.525 . . . . 15.0 109.971 166.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.7 122.28 18.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.838 0.828 . . . . 15.0 111.645 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.82 -18.47 2.98 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.039 -1.437 . . . . 15.0 111.329 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 85.0 m-85 -100.91 138.89 37.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 15.0 110.53 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -112.27 137.89 49.75 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.314 -0.625 . . . . 15.0 109.314 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 97.93 11.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.653 HH11 ' HG2' ' A' ' 243' ' ' ARG . 2.3 ttt-85 -94.53 120.49 34.84 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.527 -0.761 . . . . 15.0 111.612 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -108.25 106.41 16.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 15.0 110.118 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -90.11 150.29 22.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.952 -0.567 . . . . 15.0 109.622 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.5 t -50.9 -24.41 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.377 0.608 . . . . 15.0 110.703 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.806 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.1 tp-100 -45.72 -34.74 3.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.837 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.01 -15.31 44.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.328 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.558 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 1.3 mp0 -97.64 132.19 43.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.976 0.417 . . . . 15.0 111.021 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.26 127.77 43.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.026 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.606 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 14.9 p90 -122.02 130.41 53.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.921 0.391 . . . . 15.0 110.741 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.671 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 30.8 m-85 -89.74 107.13 18.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.461 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.959 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -109.11 133.75 52.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.866 1.317 . . . . 15.0 113.674 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -140.2 104.04 4.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 112.451 -2.158 . . . . 15.0 108.042 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.9 p -98.13 87.73 4.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.386 -2.126 . . . . 15.0 110.918 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.4 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 41.4 tt0 -101.43 -53.04 3.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.529 -1.656 . . . . 15.0 106.529 147.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -121.69 25.79 9.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 112.536 -2.12 . . . . 15.0 111.369 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 51.87 75.99 0.2 Allowed Glycine 0 C--N 1.27 -3.105 0 CA-C-N 111.144 -2.753 . . . . 15.0 113.431 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 253' ' ' LEU . 59.1 t -89.71 113.97 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.315 0.558 . . . . 15.0 111.678 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.766 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 8.1 p -125.35 107.05 10.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.265 -1.334 . . . . 15.0 109.069 173.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 150.45 31.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.173 0.805 . . . . 15.0 113.173 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.558 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 3.8 m95 -75.78 -21.35 57.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.946 -1.025 . . . . 15.0 112.018 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -95.61 135.49 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.556 -0.458 . . . . 15.0 111.116 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.671 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t0 -56.73 124.19 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.563 -0.903 . . . . 15.0 108.563 170.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.668 ' HD2' HD22 ' A' ' 236' ' ' LEU . 10.3 Cg_exo -71.61 -14.78 30.51 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.363 2.042 . . . . 15.0 113.591 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.628 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 9.8 tpt180 . . . . . 0 C--N 1.309 -1.155 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 56.6 m-20 . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 112.958 0.725 . . . . 15.0 112.958 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.959 ' HG3' HD11 ' A' ' 253' ' ' LEU . 19.4 Cg_endo -97.94 160.57 0.85 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.004 2.469 . . . . 15.0 111.635 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.908 0 N-CA-C 110.416 -1.074 . . . . 15.0 110.416 177.745 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.484 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.463 -0.28 0 N-CA-C 113.798 0.653 . . . . 15.0 113.798 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.545 173.742 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 265' ' ' PRO . 2.1 mm? . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 109.941 -0.392 . . . . 15.0 109.941 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.749 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.1 Cg_exo -69.42 147.71 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.561 1.508 . . . . 15.0 109.172 161.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.51 116.07 9.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.453 0.644 . . . . 15.0 111.83 -167.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 147.87 -16.91 1.4 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.844 -1.071 . . . . 15.0 112.122 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 92.6 m-85 -94.9 132.48 39.68 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.722 -0.281 . . . . 15.0 110.567 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.68 142.87 35.62 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.509 -0.552 . . . . 15.0 109.509 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -90.0 119.59 30.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -124.77 137.21 54.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.481 0.658 . . . . 15.0 111.123 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 m -129.4 126.16 38.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.276 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -93.11 150.15 20.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.246 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.3 m -54.52 -21.21 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.559 0.695 . . . . 15.0 110.599 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.4 tp-100 -47.66 -32.61 5.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.582 -1.19 . . . . 15.0 111.488 170.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.3 19.18 21.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.036 -0.602 . . . . 15.0 112.635 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.723 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.2 mt-30 -127.14 147.83 50.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.43 136.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.336 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -134.51 125.71 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.67 -0.492 . . . . 15.0 109.67 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -89.65 112.63 23.92 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.58 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.014 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -107.44 133.42 51.97 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.804 1.288 . . . . 15.0 113.494 -177.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -145.35 103.17 3.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.587 -2.097 . . . . 15.0 108.424 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.9 t -99.21 87.79 3.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 116.162 -2.215 . . . . 15.0 111.005 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 59.4 tt0 -101.27 -51.73 3.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.31 -1.768 . . . . 15.0 106.597 149.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 44.8 p -121.66 24.81 9.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.425 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.2 0.34 Allowed Glycine 0 C--N 1.27 -3.138 0 CA-C-N 111.278 -2.692 . . . . 15.0 113.7 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.559 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.1 t -89.97 119.54 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 117.253 0.526 . . . . 15.0 111.622 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.821 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 4.6 p -131.76 109.11 9.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.396 -1.275 . . . . 15.0 108.677 169.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.0 t -150.17 150.11 31.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.098 0.777 . . . . 15.0 113.098 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.474 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 33.8 m95 -71.06 -29.64 65.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.011 -0.995 . . . . 15.0 111.917 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 265' ' ' PRO . 4.3 p80 -90.61 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.597 -0.441 . . . . 15.0 111.271 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.678 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 12.3 t70 -56.65 120.43 36.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.02 -1.104 . . . . 15.0 108.02 168.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 Cg_exo -69.72 -14.61 36.47 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.247 1.965 . . . . 15.0 113.72 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.749 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.0 tpt180 . . . . . 0 C--N 1.311 -1.098 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.688 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 5.7 p-10 . . . . . 0 CA--C 1.558 1.288 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.014 ' HG3' HD11 ' A' ' 253' ' ' LEU . 82.0 Cg_endo -94.3 160.59 2.03 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.292 2.661 . . . . 15.0 112.014 -170.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.978 0 C-N-CA 119.286 -1.435 . . . . 15.0 110.052 174.154 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 N--CA 1.46 -0.484 0 CA-C-O 121.6 0.583 . . . . 15.0 112.817 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 . . . . . 0 C--N 1.322 -0.626 0 CA-C-O 121.591 0.71 . . . . 15.0 109.385 175.372 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.47 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.516 -0.363 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.589 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.46 144.93 57.29 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.947 1.765 . . . . 15.0 110.182 172.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.6 124.75 24.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.716 0.77 . . . . 15.0 111.875 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.36 -20.19 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.477 -1.238 . . . . 15.0 111.884 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.5 m-85 -91.12 126.23 36.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 7.8 pt-20 -97.87 129.04 44.84 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.405 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.68 103.54 16.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.502 0.668 . . . . 15.0 109.347 -175.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -105.15 139.65 39.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.915 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 m -131.23 108.91 10.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.8 t -94.78 150.25 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.418 -0.355 . . . . 15.0 110.728 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.3 -18.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.885 0.85 . . . . 15.0 111.074 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.6 tp-100 -48.67 -23.59 1.08 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.043 -1.435 . . . . 15.0 111.534 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.67 10.46 61.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.754 -0.538 . . . . 15.0 111.754 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.545 HE21 ' HG3' ' A' ' 247' ' ' GLN . 28.1 mt-30 -129.83 139.79 51.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.6 m -100.68 124.07 54.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.029 0.442 . . . . 15.0 110.385 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -109.58 127.52 54.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.132 0.491 . . . . 15.0 110.092 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.722 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 22.5 m-85 -89.54 107.57 19.16 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.591 -0.731 . . . . 15.0 111.116 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.052 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -106.83 133.96 50.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.734 1.254 . . . . 15.0 113.551 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 11.1 t-80 -142.91 102.76 4.08 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 112.703 -2.044 . . . . 15.0 107.865 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 25.1 m -102.1 88.06 3.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 115.874 -2.331 . . . . 15.0 110.931 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.582 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.8 tt0 -101.17 -47.78 4.62 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.415 -1.721 . . . . 15.0 107.027 146.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 36.0 p -124.83 25.11 7.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 113.521 -1.672 . . . . 15.0 111.399 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.23 74.49 0.31 Allowed Glycine 0 C--N 1.272 -2.984 0 CA-C-N 111.137 -2.756 . . . . 15.0 113.552 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 253' ' ' LEU . 56.1 t -89.83 120.25 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 117.239 0.519 . . . . 15.0 110.982 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.815 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.3 p -135.84 105.68 6.21 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 124.519 1.137 . . . . 15.0 109.244 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.2 150.35 31.48 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.492 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 18.6 m95 -68.81 -30.97 69.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.204 -0.907 . . . . 15.0 111.264 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.458 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.6 p80 -86.15 137.11 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.992 0.425 . . . . 15.0 111.173 -170.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.722 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 10.7 t0 -58.41 125.3 75.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.586 -0.894 . . . . 15.0 108.586 171.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 23.1 Cg_exo -68.3 -14.72 41.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 122.543 2.162 . . . . 15.0 113.865 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.589 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpt180 . . . . . 0 N--CA 1.431 -1.387 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.585 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 23.0 t70 . . . . . 0 CA--C 1.554 1.108 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.052 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.3 Cg_endo -97.18 160.26 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.671 2.247 . . . . 15.0 111.919 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.881 0 C-N-CA 119.626 -1.273 . . . . 15.0 110.566 176.038 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.412 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.2 Cg_exo . . . . . 0 CA--C 1.531 0.332 0 CA-C-O 121.628 0.595 . . . . 15.0 113.334 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.516 -0.765 . . . . 15.0 109.552 174.697 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.2 mm? . . . . . 0 C--O 1.234 0.256 0 CA-C-O 121.28 0.562 . . . . 15.0 110.927 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.712 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.7 Cg_exo -69.28 159.28 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.254 1.969 . . . . 15.0 109.701 161.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -69.49 123.95 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.542 0.686 . . . . 15.0 111.547 -172.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.47 4.64 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.775 -1.102 . . . . 15.0 113.203 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.612 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 78.2 m-85 -97.4 130.77 44.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.319 0.56 . . . . 15.0 111.004 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.5 140.06 43.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.538 ' NE2' ' HB ' ' A' ' 250' ' ' VAL . 8.9 tp60 -89.66 143.76 26.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.615 -0.883 . . . . 15.0 108.615 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.479 ' H ' HE21 ' A' ' 242' ' ' GLN . 8.9 ttt180 -139.84 131.61 27.45 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.802 -0.636 . . . . 15.0 110.886 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 p -115.01 111.58 21.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.719 -1.128 . . . . 15.0 110.185 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.9 150.22 22.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.027 -0.533 . . . . 15.0 109.667 176.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.51 -24.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.381 0.61 . . . . 15.0 110.533 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.733 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -47.58 -38.91 15.37 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.622 -1.172 . . . . 15.0 111.931 170.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.17 5.02 35.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.752 -0.737 . . . . 15.0 113.526 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.729 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.5 mt-30 -113.58 137.71 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.196 0.498 . . . . 15.0 111.037 -175.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.538 ' HB ' ' NE2' ' A' ' 242' ' ' GLN . 10.3 m -90.05 121.26 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.579 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -121.16 130.1 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.882 -0.327 . . . . 15.0 110.605 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 23.6 m-85 -89.82 110.18 21.13 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.505 -174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.013 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -108.97 132.58 53.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.776 1.274 . . . . 15.0 114.086 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -140.75 101.24 4.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.702 -2.044 . . . . 15.0 107.884 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.4 t -99.07 87.54 3.71 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 116.087 -2.245 . . . . 15.0 110.667 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 47.5 tt0 -101.28 -50.66 3.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.142 -1.844 . . . . 15.0 106.753 149.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 32.0 p -124.19 25.19 7.89 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 112.794 -2.003 . . . . 15.0 111.142 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.78 75.15 0.25 Allowed Glycine 0 C--N 1.273 -2.942 0 CA-C-N 111.014 -2.812 . . . . 15.0 113.554 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 253' ' ' LEU . 41.1 t -89.72 117.26 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-N 117.287 0.543 . . . . 15.0 111.23 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.793 ' HA ' HD22 ' A' ' 253' ' ' LEU . 7.6 p -127.72 108.82 11.08 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 124.326 1.016 . . . . 15.0 109.061 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.5 t -150.16 150.33 31.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.596 0.591 . . . . 15.0 112.596 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.41 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 77.1 m95 -76.52 -25.68 54.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.578 -0.737 . . . . 15.0 111.054 174.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -90.49 132.21 35.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 15.0 111.072 -171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.551 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 8.9 t70 -53.26 122.12 28.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 169.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.608 ' HD2' HD12 ' A' ' 236' ' ' LEU . 10.1 Cg_exo -71.65 -14.52 30.26 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 122.113 1.875 . . . . 15.0 113.924 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.712 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.7 tpt180 . . . . . 0 C--N 1.31 -1.114 0 CA-C-O 121.77 0.795 . . . . 15.0 109.105 175.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 28.2 m-20 . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 114.117 1.154 . . . . 15.0 114.117 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.013 ' HG3' HD11 ' A' ' 253' ' ' LEU . 35.6 Cg_endo -96.89 160.85 1.08 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 123.091 2.527 . . . . 15.0 111.9 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.982 0 N-CA-C 109.434 -1.466 . . . . 15.0 109.434 173.114 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.401 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.6 Cg_exo . . . . . 0 N--CA 1.463 -0.293 0 CA-C-O 121.021 0.342 . . . . 15.0 112.85 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.332 0.587 . . . . 15.0 110.185 176.711 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 1.057 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 22.5 Cg_exo -69.56 159.15 54.64 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.062 1.841 . . . . 15.0 110.702 165.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.98 123.87 22.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.904 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.49 -14.46 6.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.548 -0.834 . . . . 15.0 112.837 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.673 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.8 m-85 -94.67 131.16 40.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.911 0.355 . . . . 15.0 110.334 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 131.35 44.12 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.43 -0.952 . . . . 15.0 108.43 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -89.72 99.11 12.18 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -106.97 119.32 39.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.004 -0.998 . . . . 15.0 111.379 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.9 m -115.77 111.04 19.94 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 15.0 109.337 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.8 150.06 22.42 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.42 -21.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.388 0.613 . . . . 15.0 111.561 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.743 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.499 -1.228 . . . . 15.0 111.58 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.4 -8.84 28.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.896 -0.669 . . . . 15.0 112.561 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 9.2 mt-30 -112.41 143.52 43.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.86 0.362 . . . . 15.0 110.483 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.51 135.03 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -126.66 125.29 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.971 0.415 . . . . 15.0 109.902 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 21.4 m-85 -89.78 109.92 20.88 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.111 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.38 131.07 54.02 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.727 1.251 . . . . 15.0 114.053 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.673 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 15.8 t-80 -141.38 93.72 2.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 112.768 -2.014 . . . . 15.0 107.7 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 29.9 m -93.85 87.78 5.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 115.99 -2.284 . . . . 15.0 110.09 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -101.38 -52.91 3.13 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.117 -1.856 . . . . 15.0 106.233 150.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 45.2 p -118.01 24.75 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.437 -2.165 . . . . 15.0 110.904 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.19 73.19 0.44 Allowed Glycine 0 C--N 1.27 -3.096 0 CA-C-N 110.965 -2.834 . . . . 15.0 113.836 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.63 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -90.01 115.01 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 117.309 0.554 . . . . 15.0 112.037 175.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.801 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.8 p -127.46 107.87 10.33 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.37 1.043 . . . . 15.0 109.08 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -150.28 150.28 31.3 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.644 0.609 . . . . 15.0 112.644 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.575 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 79.6 m95 -75.11 -25.46 58.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.282 175.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -87.63 142.09 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.065 0.459 . . . . 15.0 111.03 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.634 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.3 t70 -65.92 131.33 94.56 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.175 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.72 -14.57 8.88 Favored 'Trans proline' 0 CA--C 1.509 -0.737 0 C-N-CA 122.541 2.161 . . . . 15.0 113.855 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 1.057 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.1 tpm_? . . . . . 0 C--N 1.306 -1.308 0 CA-C-O 122.076 0.941 . . . . 15.0 108.858 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.8 m-20 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 113.631 0.975 . . . . 15.0 113.631 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HG3' HD11 ' A' ' 253' ' ' LEU . 16.4 Cg_endo -97.03 160.39 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.549 2.166 . . . . 15.0 112.303 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -0.772 0 N-CA-C 110.387 -1.085 . . . . 15.0 110.387 176.509 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.46 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo . . . . . 0 N--CA 1.464 -0.221 0 CA-C-O 121.91 0.713 . . . . 15.0 113.602 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.503 177.442 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.942 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.343 0 CA-C-O 121.529 0.68 . . . . 15.0 111.119 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.514 ' HD2' ' CE1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.46 158.98 55.37 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 122.831 2.354 . . . . 15.0 109.617 165.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.62 117.31 11.07 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.405 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.14 -2.1 2.87 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.759 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 237' ' ' PRO . 69.6 m-85 -116.74 136.98 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.22 134.14 51.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.601 -0.518 . . . . 15.0 109.601 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' A' ' 252' ' ' PHE . 21.4 tt0 -89.72 97.98 11.51 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.546 -0.538 . . . . 15.0 109.546 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -95.49 119.47 34.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.767 -0.651 . . . . 15.0 110.598 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.604 ' HB ' HG12 ' A' ' 250' ' ' VAL . 5.0 t -104.0 150.07 24.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.286 -0.87 . . . . 15.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.786 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -135.31 150.46 50.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.972 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.93 -17.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.336 0.589 . . . . 15.0 110.983 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.786 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.3 tp-100 -54.36 -20.43 7.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.446 -0.797 . . . . 15.0 111.245 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.38 69.01 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.363 -0.446 . . . . 15.0 112.51 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.512 HE21 ' HG3' ' A' ' 247' ' ' GLN . 29.7 mt-30 -125.74 136.0 52.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.033 -0.358 . . . . 15.0 110.033 -175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 244' ' ' THR . 20.8 m -89.99 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.716 0.293 . . . . 15.0 110.334 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -122.86 130.68 53.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 15.0 110.153 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 28.9 m-85 -89.76 108.51 19.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.871 -0.604 . . . . 15.0 111.698 -171.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.33 132.13 53.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.858 1.313 . . . . 15.0 113.558 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.1 OUTLIER -140.4 99.47 3.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 112.601 -2.091 . . . . 15.0 107.514 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.7 t -108.37 87.47 2.5 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 115.242 -2.583 . . . . 15.0 111.395 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 39.8 tt0 -101.47 -48.22 4.42 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.256 -2.247 . . . . 15.0 106.649 142.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -118.32 24.78 10.74 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 113.539 -1.664 . . . . 15.0 111.757 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.53 72.79 0.43 Allowed Glycine 0 C--N 1.271 -3.069 0 CA-C-N 110.961 -2.836 . . . . 15.0 114.495 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 253' ' ' LEU . 13.1 t -92.42 116.33 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 117.449 0.624 . . . . 15.0 111.631 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.799 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.1 p -126.63 110.08 12.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.167 0.917 . . . . 15.0 108.659 167.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -149.93 150.31 31.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.923 0.712 . . . . 15.0 112.923 -167.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.465 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 22.1 m95 -75.65 -29.65 59.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.353 -0.839 . . . . 15.0 111.479 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -93.53 140.16 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.624 -0.43 . . . . 15.0 111.27 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.566 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 16.2 t0 -50.61 126.22 22.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 N-CA-C 108.672 -0.862 . . . . 15.0 108.672 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.942 ' HD2' HD12 ' A' ' 236' ' ' LEU . 56.3 Cg_endo -70.55 -14.53 33.66 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 C-N-CA 122.471 2.114 . . . . 15.0 113.608 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 . . . . . 0 C--N 1.314 -0.974 0 CA-C-O 121.898 0.856 . . . . 15.0 108.963 174.567 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 10.3 m-20 . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 113.095 0.776 . . . . 15.0 113.095 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.4 Cg_endo -96.78 160.38 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.99 2.46 . . . . 15.0 112.759 -166.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.015 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 174.343 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo . . . . . 0 N--CA 1.46 -0.453 0 CA-C-O 121.839 0.683 . . . . 15.0 113.383 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 C--N 1.325 -0.494 0 CA-C-N 114.815 -1.084 . . . . 15.0 109.875 -179.522 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.233 0.218 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.414 ' HG3' HH11 ' A' ' 266' ' ' ARG . 13.4 Cg_exo -69.52 160.31 50.26 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 121.524 1.482 . . . . 15.0 110.579 168.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.89 120.16 15.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.281 -171.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 135.11 -27.16 3.18 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.597 -0.729 . . . . 15.0 113.068 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 45.1 m-85 -92.39 136.69 32.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.884 0.342 . . . . 15.0 110.62 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.82 141.4 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 167.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -89.82 99.37 12.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -93.47 130.22 39.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.81 -175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -119.76 110.41 16.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.312 -0.858 . . . . 15.0 110.142 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.656 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.06 150.26 22.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.789 -0.448 . . . . 15.0 109.789 176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 42.6 t -55.13 -18.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.65 0.738 . . . . 15.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.656 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.3 tp-100 -49.94 -29.21 7.95 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.817 -1.083 . . . . 15.0 111.429 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.36 -23.92 17.05 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.046 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.505 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.0 mp0 -89.88 148.39 23.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.253 0.549 . . . . 15.0 111.322 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 123.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.713 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -114.15 128.61 56.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.439 -0.505 . . . . 15.0 110.592 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.3 m-85 -89.69 110.34 21.24 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.419 -172.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.48 134.43 52.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.739 1.257 . . . . 15.0 113.852 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 20.4 t-80 -146.89 102.27 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 112.563 -2.108 . . . . 15.0 108.309 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.4 t -102.91 88.01 3.07 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 116.058 -2.257 . . . . 15.0 111.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 7.9 tt0 -101.15 -50.69 3.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.164 -1.835 . . . . 15.0 106.237 147.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.9 p -116.91 27.23 9.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.142 -1.845 . . . . 15.0 111.293 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.04 72.18 0.55 Allowed Glycine 0 C--N 1.277 -2.747 0 CA-C-N 111.133 -2.758 . . . . 15.0 113.974 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.8 t -90.05 115.16 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-N 117.379 0.59 . . . . 15.0 111.807 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.839 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.1 p -127.89 100.09 5.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.956 170.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.5 p -141.25 150.27 42.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.223 0.823 . . . . 15.0 113.223 -167.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.624 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 1.7 m95 -70.87 -42.56 69.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.475 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -76.19 139.33 41.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.66 -0.7 . . . . 15.0 111.676 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.57 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 49.3 t0 -54.19 127.74 56.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 168.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.416 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 65.1 Cg_endo -74.13 -14.79 23.32 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 121.651 1.567 . . . . 15.0 112.916 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 13.6 tpt180 . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 108.683 -0.858 . . . . 15.0 108.683 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 3.8 p-10 . . . . . 0 CA--C 1.554 1.101 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 253' ' ' LEU . 56.3 Cg_endo -90.8 160.44 4.13 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.306 2.004 . . . . 15.0 111.629 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.158 0 N-CA-C 110.214 -1.154 . . . . 15.0 110.214 179.74 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.624 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.463 -0.289 0 CA-C-O 122.007 0.753 . . . . 15.0 113.832 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 C--N 1.324 -0.534 0 CA-C-N 115.121 -0.945 . . . . 15.0 110.236 178.025 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 108.922 -0.77 . . . . 15.0 108.922 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.791 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.6 Cg_exo -69.62 161.97 43.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.497 1.465 . . . . 15.0 110.332 167.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.53 124.37 23.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.112 -0.949 . . . . 15.0 111.256 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.98 -13.93 8.0 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.521 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.9 m-85 -94.29 131.89 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.365 0.583 . . . . 15.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.99 140.58 38.76 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 170.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.492 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.8 OUTLIER -89.85 102.09 14.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -109.02 145.95 34.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.24 -0.891 . . . . 15.0 111.413 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 m -136.47 124.77 23.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.019 -0.991 . . . . 15.0 109.664 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.591 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.1 t -89.86 150.43 22.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.923 -0.399 . . . . 15.0 109.923 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.3 m -51.5 -24.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.316 0.579 . . . . 15.0 110.979 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.591 ' HB3' HG23 ' A' ' 245' ' ' THR . 2.2 tp-100 -52.05 -33.29 38.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.037 -0.983 . . . . 15.0 111.703 172.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.8 12.16 28.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.995 -0.622 . . . . 15.0 112.512 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.4 mm-40 -99.1 142.32 30.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.241 -0.652 . . . . 15.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 m -102.78 106.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.013 0.435 . . . . 15.0 109.897 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -109.56 127.0 54.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.552 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.0 m-85 -89.54 108.4 19.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.593 -172.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.992 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.21 133.44 52.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.885 1.326 . . . . 15.0 113.503 -175.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.618 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 6.7 t-80 -143.93 104.73 4.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.427 -2.17 . . . . 15.0 107.866 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -104.36 87.81 2.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 115.768 -2.373 . . . . 15.0 111.125 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.618 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.4 tt0 -101.32 -49.32 4.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.137 -1.847 . . . . 15.0 106.798 148.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -124.84 27.34 6.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.272 -1.785 . . . . 15.0 111.623 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.26 73.97 0.35 Allowed Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.457 -2.611 . . . . 15.0 114.292 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.565 ' O ' HD13 ' A' ' 253' ' ' LEU . 38.0 t -89.91 120.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.09 0.445 . . . . 15.0 111.517 173.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.805 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.6 p -131.25 112.23 12.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.053 -0.976 . . . . 15.0 109.166 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 p -144.33 150.12 37.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.244 0.831 . . . . 15.0 113.244 -167.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.78 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.1 OUTLIER -73.26 -36.28 66.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.975 -1.011 . . . . 15.0 110.496 171.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -86.02 142.35 28.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.237 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.661 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 10.6 t70 -58.96 131.52 86.8 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.744 -0.836 . . . . 15.0 108.744 171.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.99 -14.8 16.81 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 C-N-CA 122.189 1.926 . . . . 15.0 113.619 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.791 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.4 tpt180 . . . . . 0 C--N 1.31 -1.146 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.811 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 19.8 t70 . . . . . 0 CA--C 1.56 1.337 0 N-CA-C 113.735 1.013 . . . . 15.0 113.735 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.992 ' HG3' HD11 ' A' ' 253' ' ' LEU . 61.4 Cg_endo -101.41 160.31 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.742 2.961 . . . . 15.0 114.081 -162.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 N-CA-C 109.669 -1.372 . . . . 15.0 109.669 169.609 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.78 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.2 Cg_exo . . . . . 0 C--O 1.223 -0.247 0 CA-C-O 121.744 0.643 . . . . 15.0 113.439 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 15.0 109.764 174.755 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER . . . . . 0 CA--C 1.517 -0.327 0 CA-C-O 121.404 0.621 . . . . 15.0 111.31 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.569 ' HG3' HH11 ' A' ' 266' ' ' ARG . 19.6 Cg_exo -69.41 167.21 24.62 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 122.977 2.451 . . . . 15.0 110.82 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.54 114.6 7.91 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.676 -1.147 . . . . 15.0 111.516 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.55 -18.78 2.43 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 114.821 -1.082 . . . . 15.0 113.112 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 43.5 m-85 -101.77 131.68 47.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.053 0.427 . . . . 15.0 111.107 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -101.59 138.66 38.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.98 110.08 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 4.3 ttt-85 -112.09 128.78 56.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.235 0.54 . . . . 15.0 111.311 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -113.53 125.49 54.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.843 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -107.72 150.52 26.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.125 -0.488 . . . . 15.0 110.65 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -48.84 -20.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.314 0.646 . . . . 15.0 112.171 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.764 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.1 tp-100 -51.21 -21.76 2.25 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.336 -0.847 . . . . 15.0 111.666 171.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.14 60.92 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 15.0 111.916 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.525 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 34.1 mt-30 -130.72 149.73 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.662 -0.495 . . . . 15.0 109.662 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.73 138.66 26.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 15.0 109.975 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -125.25 128.16 47.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.351 0.596 . . . . 15.0 110.476 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 14.8 m-85 -89.73 109.66 20.62 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.028 -0.987 . . . . 15.0 111.453 -172.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.081 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.37 132.96 53.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.836 1.303 . . . . 15.0 114.039 -175.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.623 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.4 t-80 -140.38 97.09 3.15 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.535 -2.121 . . . . 15.0 107.447 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.2 p -90.51 88.22 7.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.439 -2.104 . . . . 15.0 110.424 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -101.29 -44.73 5.56 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.032 -1.895 . . . . 15.0 108.704 152.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 5.6 t -146.05 26.09 1.24 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 124.062 1.887 . . . . 15.0 108.775 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 59.45 75.96 0.25 Allowed Glycine 0 C--N 1.28 -2.581 0 CA-C-N 110.307 -3.133 . . . . 15.0 113.356 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 79.6 t -89.27 115.8 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 118.833 -1.147 . . . . 15.0 110.841 164.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.822 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.9 p -129.31 106.15 8.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.481 -1.69 . . . . 15.0 108.571 173.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.994 0.739 . . . . 15.0 112.994 -167.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.525 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 43.3 m95 -77.84 -36.6 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 15.0 109.94 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -79.95 141.12 36.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.089 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.516 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 25.3 t0 -59.81 125.43 80.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.053 -1.091 . . . . 15.0 108.053 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.776 ' HD2' HD12 ' A' ' 236' ' ' LEU . 11.9 Cg_exo -70.55 -14.8 33.9 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.192 1.928 . . . . 15.0 112.897 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 237' ' ' PRO . 18.7 tpt180 . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 121.677 0.751 . . . . 15.0 109.078 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.588 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 47.4 p-10 . . . . . 0 CA--C 1.556 1.185 0 N-CA-C 114.059 1.133 . . . . 15.0 114.059 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.081 ' HG3' HD11 ' A' ' 253' ' ' LEU . 57.4 Cg_endo -96.72 160.68 1.14 Allowed 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.057 2.505 . . . . 15.0 111.928 -175.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.969 0 C-N-CA 119.865 -1.16 . . . . 15.0 110.455 176.776 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.427 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.3 Cg_exo . . . . . 0 CA--C 1.53 0.301 0 CA-C-O 121.584 0.577 . . . . 15.0 113.146 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.015 -179.009 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.498 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.518 -0.253 0 CA-C-O 120.982 0.42 . . . . 15.0 110.551 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.665 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.7 Cg_exo -69.34 155.94 65.86 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.3 2.0 . . . . 15.0 109.76 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.72 117.73 11.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.219 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 146.12 -13.55 1.67 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.38 -0.827 . . . . 15.0 112.949 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.9 m-85 -104.84 138.43 41.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.276 0.538 . . . . 15.0 110.848 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 170.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.92 104.59 17.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -109.05 130.71 55.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.49 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 125.71 53.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.789 . . . . 15.0 110.213 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -106.25 150.72 25.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.082 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.0 t -45.87 -23.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.611 0.569 . . . . 15.0 111.57 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.756 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.7 tp60 -50.94 -23.08 2.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.457 0.703 . . . . 15.0 111.53 173.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.15 65.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.248 -0.501 . . . . 15.0 112.275 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 35.5 mt-30 -106.73 142.47 36.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.835 0.35 . . . . 15.0 110.587 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.03 137.23 22.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.433 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -127.79 128.25 44.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.048 0.451 . . . . 15.0 110.081 177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.2 m-85 -89.7 111.33 22.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.619 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.47 133.95 51.92 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.806 1.289 . . . . 15.0 113.985 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 t-80 -140.49 97.54 3.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 112.475 -2.148 . . . . 15.0 107.307 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.533 HG22 ' HA2' ' A' ' 258' ' ' GLY . 8.8 p -97.21 87.74 4.26 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 116.295 -2.162 . . . . 15.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 40.8 tt0 -101.29 -52.73 3.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.278 -1.783 . . . . 15.0 106.818 147.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 35.8 p -119.4 27.66 8.66 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 112.417 -2.174 . . . . 15.0 111.116 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.36 74.94 0.24 Allowed Glycine 0 C--N 1.274 -2.883 0 CA-C-N 111.464 -2.607 . . . . 15.0 113.692 -175.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.7 t -89.59 111.11 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-N 117.452 0.626 . . . . 15.0 111.066 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.813 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.6 p -124.66 101.97 7.37 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.171 -1.377 . . . . 15.0 108.885 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -150.22 150.39 31.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -169.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 74.4 m95 -72.66 -38.32 67.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.012 174.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -74.86 136.32 41.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.165 -0.47 . . . . 15.0 111.563 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.614 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t0 -57.26 124.66 67.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.271 -0.877 . . . . 15.0 108.917 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 9.1 Cg_exo -73.38 -14.62 25.27 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.5 2.134 . . . . 15.0 113.879 -176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.665 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 26.2 tpt180 . . . . . 0 C--N 1.313 -1.016 0 N-CA-C 108.76 -0.83 . . . . 15.0 108.76 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.558 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 29.5 m-20 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 113.394 0.887 . . . . 15.0 113.394 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -92.04 160.19 3.26 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.191 1.927 . . . . 15.0 111.098 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.936 0 C-N-CA 119.904 -1.141 . . . . 15.0 110.295 -179.51 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.461 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 CA-C-O 122.082 0.784 . . . . 15.0 113.952 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.026 172.351 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 C--O 1.234 0.239 0 N-CA-C 109.835 -0.431 . . . . 15.0 109.835 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.925 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.57 165.61 30.17 Favored 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.062 1.841 . . . . 15.0 110.92 166.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -69.48 126.93 31.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.304 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 121.52 -13.65 9.38 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 15.0 113.647 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.628 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 91.0 m-85 -95.06 128.58 41.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.471 0.636 . . . . 15.0 110.718 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -106.78 135.99 47.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 15.0 109.655 172.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.547 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -89.79 111.61 22.67 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.358 -0.979 . . . . 15.0 108.358 -178.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.708 HH11 ' HG2' ' A' ' 243' ' ' ARG . 6.1 ttt-85 -107.51 127.36 53.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.654 -0.703 . . . . 15.0 111.909 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.4 p -113.83 124.38 52.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.455 -1.248 . . . . 15.0 109.821 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -107.91 150.0 27.61 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.927 -0.397 . . . . 15.0 109.927 175.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.47 -18.67 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.516 0.674 . . . . 15.0 110.312 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.724 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.8 tp-100 -47.33 -40.99 18.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.877 -1.056 . . . . 15.0 111.198 171.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.91 21.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.779 -0.724 . . . . 15.0 112.881 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -104.48 150.11 24.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.1 0.476 . . . . 15.0 111.662 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.12 124.17 55.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.301 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 37.8 p90 -125.82 129.23 48.99 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.013 -0.675 . . . . 15.0 111.784 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.645 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 36.7 m-85 -90.06 111.28 22.34 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.678 -174.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.953 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -110.54 134.17 52.63 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.707 1.241 . . . . 15.0 113.211 176.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.9 t-80 -140.72 100.32 3.82 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.005 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.3 t -101.81 87.89 3.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 115.905 -2.318 . . . . 15.0 110.885 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.609 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 46.7 tt0 -101.08 -46.67 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.023 -1.899 . . . . 15.0 106.773 148.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.3 p -124.97 27.05 6.84 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.412 -1.722 . . . . 15.0 111.109 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.91 73.11 0.43 Allowed Glycine 0 C--N 1.278 -2.666 0 CA-C-N 111.281 -2.69 . . . . 15.0 114.212 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.644 ' O ' HD13 ' A' ' 253' ' ' LEU . 50.9 t -89.95 114.0 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 117.349 0.574 . . . . 15.0 112.066 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.776 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.7 p -121.63 106.86 11.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.786 -1.097 . . . . 15.0 108.596 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.3 p -142.41 150.13 40.22 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.257 0.836 . . . . 15.0 113.257 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 1.5 m95 -77.67 -34.81 52.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.652 172.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -82.79 137.81 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.003 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.645 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.9 t70 -57.14 133.41 80.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 171.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.405 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 87.8 Cg_endo -81.21 -14.64 10.63 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.293 1.995 . . . . 15.0 113.986 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.925 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.3 tpt180 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 122.376 1.084 . . . . 15.0 108.396 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.553 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 5.3 p-10 . . . . . 0 CA--C 1.549 0.911 0 CA-C-O 118.987 -0.53 . . . . 15.0 112.244 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.953 ' HG3' HD11 ' A' ' 253' ' ' LEU . 13.1 Cg_endo -96.42 160.37 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.941 2.427 . . . . 15.0 111.691 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 111.036 -0.825 . . . . 15.0 111.036 178.242 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.508 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo . . . . . 0 C--O 1.223 -0.226 0 N-CA-C 113.895 0.69 . . . . 15.0 113.895 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 115.663 -0.698 . . . . 15.0 109.54 172.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.594 -0.521 . . . . 15.0 109.594 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.647 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.45 159.39 53.82 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.986 1.791 . . . . 15.0 110.485 166.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.62 113.96 7.39 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.54 -0.755 . . . . 15.0 111.214 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 143.77 -16.43 2.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.49 -0.777 . . . . 15.0 112.729 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 66.4 m-85 -98.36 138.74 35.16 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.626 -0.338 . . . . 15.0 110.737 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -109.33 144.3 37.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -89.85 118.55 29.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 15.0 108.796 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.7 136.36 53.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.387 0.613 . . . . 15.0 111.536 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 m -129.45 115.61 17.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.931 -1.032 . . . . 15.0 109.592 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -90.15 150.62 21.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.536 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.48 -17.34 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.31 0.576 . . . . 15.0 110.617 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -54.2 -22.7 12.13 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.012 170.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.43 16.65 48.9 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.009 -0.615 . . . . 15.0 112.78 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 18.1 mt-30 -131.47 146.81 52.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.773 0.321 . . . . 15.0 110.213 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.56 141.21 15.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.415 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.5 127.42 27.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.889 0.376 . . . . 15.0 110.098 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 25.1 m-85 -89.62 111.65 22.66 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.05 -0.523 . . . . 15.0 111.434 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.046 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.83 135.86 49.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.684 1.231 . . . . 15.0 113.619 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -148.74 107.44 3.82 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.678 -2.055 . . . . 15.0 108.292 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 11.9 m -103.42 87.58 2.89 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 116.17 -2.212 . . . . 15.0 110.625 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.613 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 43.7 tt0 -101.35 -48.19 4.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.071 -1.877 . . . . 15.0 107.253 149.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 43.6 p -125.11 25.17 7.31 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.099 -1.864 . . . . 15.0 111.201 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.27 75.38 0.23 Allowed Glycine 0 C--N 1.272 -2.983 0 CA-C-N 111.17 -2.741 . . . . 15.0 113.187 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 253' ' ' LEU . 75.3 t -89.74 119.94 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.161 0.48 . . . . 15.0 111.604 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.4 p -134.21 107.32 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 124.817 1.323 . . . . 15.0 108.932 171.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -150.13 150.36 31.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 37.7 m95 -72.83 -28.69 62.7 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.114 174.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -87.65 134.62 33.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.97 0.414 . . . . 15.0 111.132 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.676 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.7 t70 -52.73 126.97 42.27 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.444 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.447 ' HD3' ' CD1' ' A' ' 252' ' ' PHE . 80.9 Cg_endo -76.96 -14.44 17.04 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.381 2.054 . . . . 15.0 114.052 -173.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.647 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 13.3 tpt180 . . . . . 0 C--N 1.312 -1.053 0 CA-C-O 122.108 0.956 . . . . 15.0 108.465 174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.662 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 32.6 t70 . . . . . 0 CA--C 1.557 1.216 0 N-CA-C 113.798 1.036 . . . . 15.0 113.798 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.046 ' HG3' HD11 ' A' ' 253' ' ' LEU . 62.8 Cg_endo -93.04 160.33 2.63 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.513 2.142 . . . . 15.0 112.127 -169.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.088 0 C-N-CA 119.639 -1.267 . . . . 15.0 110.369 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.545 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo . . . . . 0 N--CA 1.462 -0.35 0 CA-C-O 121.887 0.703 . . . . 15.0 113.262 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 C--N 1.326 -0.434 0 CA-C-N 115.633 -0.712 . . . . 15.0 109.523 175.228 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 265' ' ' PRO . 6.4 mt . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.443 ' HD3' ' CD ' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.62 160.6 49.14 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 121.925 1.75 . . . . 15.0 110.543 168.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.4 119.4 13.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.548 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 137.18 -17.89 3.55 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.481 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 67.0 m-85 -103.33 132.01 49.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.596 0.198 . . . . 15.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -108.97 139.29 44.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.78 105.0 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 243' ' ' ARG . 16.4 ttt85 -105.71 138.66 41.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.261 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 m -128.37 117.2 21.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.195 -0.912 . . . . 15.0 109.824 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.784 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.3 t -90.02 150.3 22.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.945 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 t -54.53 -18.06 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.575 0.702 . . . . 15.0 110.522 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.784 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.4 tp60 -53.02 -24.62 10.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.07 -0.968 . . . . 15.0 111.774 172.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.92 -2.96 52.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.627 -0.797 . . . . 15.0 112.824 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.601 ' NE2' ' HG3' ' A' ' 247' ' ' GLN . 1.2 mp0 -113.35 143.84 43.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.133 0.492 . . . . 15.0 111.486 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.83 136.81 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 15.0 110.161 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -130.68 130.95 44.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.054 0.454 . . . . 15.0 110.529 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 38.9 m-85 -89.66 109.16 20.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.691 -0.686 . . . . 15.0 111.297 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -109.37 134.62 51.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.682 1.23 . . . . 15.0 113.716 -176.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.5 t-80 -141.81 105.63 4.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.457 -2.156 . . . . 15.0 107.698 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.401 HG22 ' HA2' ' A' ' 258' ' ' GLY . 22.5 p -104.26 87.75 2.82 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.281 -2.168 . . . . 15.0 111.277 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.459 HE21 HG23 ' A' ' 257' ' ' THR . 16.5 tt0 -101.35 -49.1 4.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.367 -1.742 . . . . 15.0 106.89 146.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . 0.459 HG23 HE21 ' A' ' 256' ' ' GLN . 24.9 p -126.09 30.92 5.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.006 -1.906 . . . . 15.0 111.557 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 49.02 76.01 0.17 Allowed Glycine 0 C--N 1.278 -2.685 0 CA-C-N 111.952 -2.385 . . . . 15.0 114.361 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.56 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.6 t -89.81 118.32 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.247 0.524 . . . . 15.0 110.91 171.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.0 p -132.57 107.3 8.35 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.504 1.128 . . . . 15.0 109.51 172.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.6 t -150.16 150.24 31.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.307 0.855 . . . . 15.0 113.307 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.628 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -67.76 -32.38 72.94 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.901 173.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -87.97 135.74 33.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.582 -0.447 . . . . 15.0 111.351 -168.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.636 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.9 t0 -56.28 128.73 73.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 171.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.599 ' HD2' HD22 ' A' ' 236' ' ' LEU . 73.3 Cg_endo -76.57 -14.91 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.834 1.69 . . . . 15.0 113.183 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.443 ' CD ' ' HD3' ' A' ' 237' ' ' PRO . 4.7 tpt180 . . . . . 0 C--N 1.31 -1.137 0 CA-C-O 121.975 0.893 . . . . 15.0 108.998 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.664 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 7.7 m-20 . . . . . 0 CA--C 1.555 1.163 0 N-CA-C 113.855 1.057 . . . . 15.0 113.855 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 63.0 Cg_endo -95.7 160.19 1.48 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.822 2.348 . . . . 15.0 112.77 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.941 0 C-N-CA 119.973 -1.108 . . . . 15.0 111.308 174.622 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.628 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 6.5 Cg_exo . . . . . 0 CA--C 1.528 0.224 0 CA-C-O 121.486 0.536 . . . . 15.0 113.395 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 115.641 -0.708 . . . . 15.0 109.811 175.236 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.747 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.7 Cg_exo -69.67 161.92 44.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.418 1.412 . . . . 15.0 110.343 166.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -69.44 126.41 29.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.147 -0.933 . . . . 15.0 111.254 -170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 125.42 -14.99 7.25 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.773 -0.727 . . . . 15.0 113.671 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 63.2 m-85 -100.3 136.53 40.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.574 0.687 . . . . 15.0 110.78 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -105.43 146.18 29.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.716 -0.846 . . . . 15.0 108.716 168.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 17.4 tm0? -89.78 109.51 20.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -117.33 141.34 48.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.627 0.727 . . . . 15.0 111.096 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.9 m -139.34 117.38 11.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.879 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.7 t -89.91 150.29 22.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.06 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.33 -22.72 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.6 0.714 . . . . 15.0 111.085 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.829 ' HB3' HG23 ' A' ' 245' ' ' THR . 8.1 tp-100 -49.55 -24.34 2.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.409 -1.269 . . . . 15.0 111.746 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.5 58.68 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.224 -0.513 . . . . 15.0 111.876 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.592 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 4.5 mt-30 -100.83 135.94 41.48 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.741 -0.466 . . . . 15.0 109.741 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.97 143.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.638 -0.256 . . . . 15.0 110.464 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -135.47 123.47 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 15.0 110.424 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 39.1 m-85 -89.67 110.84 21.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.426 -0.806 . . . . 15.0 110.824 -171.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.57 132.84 52.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.724 1.25 . . . . 15.0 113.66 -175.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.653 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 4.1 t-80 -144.74 106.99 4.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 112.569 -2.105 . . . . 15.0 108.317 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 12.7 m -102.11 87.78 3.16 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 116.1 -2.24 . . . . 15.0 111.002 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.653 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.5 tt0 -101.38 -53.05 3.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.668 -1.604 . . . . 15.0 106.668 147.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 18.0 p -122.25 26.94 8.21 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 112.664 -2.062 . . . . 15.0 111.364 -174.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.29 75.97 0.2 Allowed Glycine 0 C--N 1.273 -2.931 0 CA-C-N 111.607 -2.542 . . . . 15.0 113.4 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.4 t -89.81 114.98 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 O-C-N 122.484 -0.421 . . . . 15.0 111.257 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.811 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.2 p -129.87 108.32 10.05 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.699 1.249 . . . . 15.0 108.858 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.3 t -150.14 150.23 31.36 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.935 0.717 . . . . 15.0 112.935 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.592 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 56.1 m95 -70.86 -31.85 68.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.487 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.401 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.3 p80 -88.51 134.68 33.79 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.006 0.432 . . . . 15.0 110.937 -170.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.626 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 13.0 t0 -58.5 123.82 68.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.72 -14.76 36.69 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 C-N-CA 122.099 1.866 . . . . 15.0 112.194 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.747 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.8 tpt180 . . . . . 0 C--N 1.314 -0.974 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.938 173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.786 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 29.1 t70 . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 114.021 1.119 . . . . 15.0 114.021 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 51.7 Cg_endo -102.43 160.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 123.667 2.911 . . . . 15.0 114.236 -165.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.453 0 N-CA-C 110.323 -1.111 . . . . 15.0 110.323 171.867 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.499 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.9 Cg_exo . . . . . 0 CA--C 1.527 0.157 0 CA-C-O 121.37 0.488 . . . . 15.0 113.076 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 115.791 -0.641 . . . . 15.0 109.824 171.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.227 0 N-CA-C 109.301 -0.629 . . . . 15.0 109.301 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.629 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.39 164.85 32.62 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.328 2.019 . . . . 15.0 110.172 165.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.49 130.52 42.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.851 -172.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 124.9 -34.59 3.38 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.809 -1.087 . . . . 15.0 113.245 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 53.6 m-85 -83.89 149.45 26.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.165 0.482 . . . . 15.0 110.744 -175.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -116.49 147.27 41.91 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 166.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.494 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.46 102.49 15.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.622 ' HD3' ' CE1' ' A' ' 251' ' ' TYR . 13.6 ttt-85 -102.82 147.61 26.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.136 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.2 m -138.95 118.38 12.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.799 -1.092 . . . . 15.0 108.751 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.6 t -96.67 150.23 20.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.641 -0.254 . . . . 15.0 110.422 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.98 -21.63 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.267 0.556 . . . . 15.0 110.854 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.728 ' HG2' ' NE2' ' A' ' 249' ' ' GLN . 5.9 tp-100 -53.08 -23.71 8.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.273 -0.876 . . . . 15.0 111.523 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.25 17.58 39.45 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.154 -0.546 . . . . 15.0 112.318 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.728 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 5.2 mt-30 -125.13 147.43 49.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.01 -0.737 . . . . 15.0 109.01 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.2 130.56 50.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.162 -0.31 . . . . 15.0 110.162 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.622 ' CE1' ' HD3' ' A' ' 243' ' ' ARG . 34.9 p90 -126.99 129.13 47.5 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.531 -0.468 . . . . 15.0 110.626 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.696 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 27.5 m-85 -89.73 111.05 21.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.135 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.028 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.71 135.86 50.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.712 1.244 . . . . 15.0 113.928 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.68 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 16.1 t-80 -144.35 100.76 3.59 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 112.458 -2.156 . . . . 15.0 107.819 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.679 HG22 ' HA2' ' A' ' 258' ' ' GLY . 2.8 p -102.8 87.41 2.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 116.163 -2.215 . . . . 15.0 110.833 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.68 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.0 tt0 -101.25 -35.73 9.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 113.316 -1.765 . . . . 15.0 108.029 146.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.5 p -139.02 30.64 2.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.916 1.341 . . . . 15.0 111.362 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.5 73.78 0.38 Allowed Glycine 0 C--N 1.279 -2.591 0 CA-C-N 111.936 -2.393 . . . . 15.0 114.603 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.674 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -92.77 115.08 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 117.274 0.537 . . . . 15.0 111.406 171.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.796 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.4 p -135.49 104.36 5.8 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.573 1.171 . . . . 15.0 109.229 172.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.22 150.43 31.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 15.0 112.733 -169.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.453 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 39.0 m95 -66.98 -38.05 85.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.639 -0.71 . . . . 15.0 111.166 171.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.408 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.7 p80 -78.41 136.85 37.74 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.121 -0.491 . . . . 15.0 111.177 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.696 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.9 t70 -57.03 127.65 76.12 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.828 -0.805 . . . . 15.0 108.828 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 71.1 Cg_endo -75.87 -14.64 19.25 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.135 1.89 . . . . 15.0 113.039 -174.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.629 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.6 tpt180 . . . . . 0 C--N 1.315 -0.923 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 174.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.581 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 18.2 t70 . . . . . 0 CA--C 1.556 1.189 0 N-CA-C 113.322 0.86 . . . . 15.0 113.322 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.028 ' HG3' HD11 ' A' ' 253' ' ' LEU . 48.9 Cg_endo -91.88 160.25 3.37 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.529 2.153 . . . . 15.0 112.411 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.045 0 N-CA-C 110.442 -1.063 . . . . 15.0 110.442 175.409 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.453 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.8 Cg_exo . . . . . 0 N--CA 1.461 -0.401 0 CA-C-O 121.776 0.657 . . . . 15.0 112.53 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.0 179.198 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.748 0.309 . . . . 15.0 110.393 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.863 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.2 Cg_exo -69.58 157.24 61.43 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 121.945 1.763 . . . . 15.0 110.506 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.88 121.18 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.976 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 134.49 -14.33 4.5 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.741 -0.742 . . . . 15.0 113.105 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 79.4 m-85 -99.13 129.33 45.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.472 0.636 . . . . 15.0 111.048 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.79 137.13 43.05 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.91 119.32 30.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.179 -0.675 . . . . 15.0 109.179 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 243' ' ' ARG . 8.1 ttt-85 -122.39 132.81 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.559 0.695 . . . . 15.0 111.81 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -120.13 122.5 41.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.338 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -94.01 150.16 20.59 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.357 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -54.61 -19.28 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.529 0.681 . . . . 15.0 111.157 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HG2' HE21 ' A' ' 249' ' ' GLN . 4.6 tp-100 -50.1 -24.44 2.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.415 -1.266 . . . . 15.0 111.701 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.67 -1.75 55.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.151 -0.547 . . . . 15.0 112.196 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.701 HE21 ' HG2' ' A' ' 247' ' ' GLN . 5.1 mt-30 -111.29 138.49 47.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.879 0.371 . . . . 15.0 110.418 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.08 136.44 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.625 -0.509 . . . . 15.0 109.625 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -131.73 126.7 35.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.18 0.514 . . . . 15.0 110.957 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.688 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.7 m-85 -89.77 113.5 25.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.357 -173.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -111.82 134.75 53.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 122.842 1.306 . . . . 15.0 114.087 -176.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.5 t-80 -141.88 103.73 4.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.579 -2.1 . . . . 15.0 107.611 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.8 t -100.14 87.92 3.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 116.287 -2.165 . . . . 15.0 111.056 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 33.6 tt0 -101.62 -54.43 2.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.311 -1.768 . . . . 15.0 106.712 147.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 38.2 p -119.88 27.23 8.81 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.397 -2.183 . . . . 15.0 111.329 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.07 75.66 0.21 Allowed Glycine 0 C--N 1.274 -2.867 0 CA-C-N 111.315 -2.675 . . . . 15.0 113.698 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.5 t -89.58 114.89 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-N 117.395 0.598 . . . . 15.0 111.028 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 9.1 p -126.44 107.61 10.43 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.965 -1.471 . . . . 15.0 108.79 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.1 p -140.21 149.43 42.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.255 0.835 . . . . 15.0 113.255 -168.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.507 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 21.3 m95 -75.05 -38.52 61.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.457 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -79.11 143.92 35.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.943 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.688 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.6 t70 -62.61 130.16 93.34 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.903 -0.777 . . . . 15.0 108.903 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.7 -14.77 24.43 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 C-N-CA 122.044 1.829 . . . . 15.0 113.775 -173.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.863 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.2 tpt180 . . . . . 0 C--N 1.31 -1.145 0 CA-C-O 122.17 0.986 . . . . 15.0 108.792 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.5 m-20 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -98.17 160.32 0.81 Allowed 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.889 2.393 . . . . 15.0 112.832 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 N-CA-C 109.776 -1.33 . . . . 15.0 109.776 173.253 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.507 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.4 Cg_exo . . . . . 0 CA--C 1.529 0.239 0 CA-C-O 121.278 0.449 . . . . 15.0 112.202 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.5 -177.382 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.163 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.94 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 15.3 Cg_exo -69.62 154.46 68.28 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.095 1.863 . . . . 15.0 110.611 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.81 131.37 44.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.902 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 127.19 -16.47 6.35 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.564 -0.827 . . . . 15.0 112.921 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.622 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 90.2 m-85 -95.22 135.01 37.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.983 0.392 . . . . 15.0 110.267 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -113.7 138.55 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.196 0.522 . . . . 15.0 109.831 170.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.673 HE22 HG23 ' A' ' 244' ' ' THR . 1.1 tm0? -89.87 107.36 19.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.715 -0.846 . . . . 15.0 108.715 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -103.55 135.79 44.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.325 0.583 . . . . 15.0 111.816 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.673 HG23 HE22 ' A' ' 242' ' ' GLN . 0.9 OUTLIER -117.29 115.21 24.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.596 -1.184 . . . . 15.0 110.41 177.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.713 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -89.95 150.34 22.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 15.0 109.684 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.9 t -51.5 -24.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.4 0.619 . . . . 15.0 110.071 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.713 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.4 tp-100 -50.2 -31.37 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.964 -1.016 . . . . 15.0 111.588 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.36 19.94 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.107 -0.568 . . . . 15.0 113.31 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.679 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.6 mt-30 -127.02 141.35 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.04 0.42 . . . . 15.0 110.26 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.9 m -92.39 127.33 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.483 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -128.51 130.35 47.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.881 0.372 . . . . 15.0 110.204 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.658 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.4 m-85 -89.9 110.48 21.42 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.488 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.13 133.21 52.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.711 1.243 . . . . 15.0 113.899 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.622 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.0 t-80 -143.64 95.23 2.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.655 -2.066 . . . . 15.0 107.918 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.3 m -90.4 87.91 6.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 116.512 -2.075 . . . . 15.0 110.141 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 27.0 tt0 -101.15 -49.62 4.04 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 112.891 -1.959 . . . . 15.0 108.212 153.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.7 t -135.28 23.67 3.49 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-N 112.736 -2.029 . . . . 15.0 108.506 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 60.92 74.32 0.39 Allowed Glycine 0 C--N 1.279 -2.585 0 CA-C-N 109.785 -3.371 . . . . 15.0 112.909 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 253' ' ' LEU . 67.4 t -89.15 115.7 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 119.51 -0.876 . . . . 15.0 111.199 168.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.837 ' HA ' HD22 ' A' ' 253' ' ' LEU . 3.7 p -131.22 104.41 7.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.533 -1.667 . . . . 15.0 109.026 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.9 t -150.24 150.33 31.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.764 0.653 . . . . 15.0 112.764 -168.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.407 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 69.8 m95 -70.92 -34.34 71.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.136 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -81.59 136.27 35.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.11 -168.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.658 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 11.5 t70 -54.35 130.5 61.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 15.0 109.443 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.94 -14.79 16.92 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 C-N-CA 122.202 1.934 . . . . 15.0 114.179 -171.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.94 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpm_? . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 122.372 1.082 . . . . 15.0 108.645 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.591 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.555 1.151 0 N-CA-C 113.269 0.84 . . . . 15.0 113.269 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 42.2 Cg_endo -90.18 160.63 4.74 Favored 'Trans proline' 0 C--N 1.369 1.605 0 C-N-CA 122.882 2.388 . . . . 15.0 111.241 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.011 0 C-N-CA 119.334 -1.413 . . . . 15.0 110.699 179.276 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.4 ' HB2' ' CZ2' ' A' ' 262' ' ' TRP . 5.7 Cg_exo . . . . . 0 N--CA 1.461 -0.4 0 CA-C-O 120.998 0.332 . . . . 15.0 112.694 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 15.0 110.049 179.332 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.8 OUTLIER . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.085 0.469 . . . . 15.0 110.242 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.698 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.6 Cg_exo -69.37 145.54 59.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.881 1.72 . . . . 15.0 108.561 161.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.54 96.44 0.92 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.128 0.966 . . . . 15.0 112.358 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 163.28 32.09 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 113.45 -1.705 . . . . 15.0 112.607 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD2' ' HG2' ' A' ' 265' ' ' PRO . 82.7 m-85 -140.99 125.69 17.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 5.9 pt-20 -97.45 134.25 40.95 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.203 0.525 . . . . 15.0 109.986 175.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -89.7 111.6 22.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -120.3 129.78 54.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.345 0.593 . . . . 15.0 111.592 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.0 m -123.04 124.44 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.619 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.1 OUTLIER -89.86 150.46 22.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.433 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.57 -24.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.46 0.648 . . . . 15.0 110.283 174.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 249' ' ' GLN . 3.3 tp-100 -47.8 -35.52 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.823 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.16 31.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.039 -0.601 . . . . 15.0 112.798 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 9.0 mt-30 -107.19 149.77 27.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 15.0 110.69 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.04 136.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.323 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -131.57 126.76 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.3 m-85 -89.74 109.94 20.89 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.139 -172.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.926 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -104.96 133.16 50.22 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 122.925 1.345 . . . . 15.0 113.28 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.8 OUTLIER -142.18 96.35 2.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 112.571 -2.104 . . . . 15.0 107.833 -178.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 t -104.11 87.73 2.84 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 115.662 -2.415 . . . . 15.0 111.18 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.573 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 16.4 tt0 -100.93 -31.55 11.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 112.401 -2.181 . . . . 15.0 108.245 145.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.9 t -144.28 24.84 1.58 Allowed 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 123.655 1.693 . . . . 15.0 110.014 -166.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 50.73 70.38 0.86 Allowed Glycine 0 C--N 1.274 -2.904 0 CA-C-N 110.006 -3.27 . . . . 15.0 113.883 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 56.4 t -89.23 116.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 119.853 -0.739 . . . . 15.0 111.629 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.834 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 3.7 p -129.18 105.44 8.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.905 -1.498 . . . . 15.0 109.131 170.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 150.17 31.46 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.713 0.635 . . . . 15.0 112.713 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.519 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 55.8 m95 -69.02 -32.91 72.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 15.0 112.102 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -88.0 139.4 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 15.0 111.708 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.569 ' HA ' ' CD2' ' A' ' 252' ' ' PHE . 9.6 t0 -58.55 123.25 66.04 Favored Pre-proline 0 C--O 1.215 -0.745 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.8 Cg_exo -68.54 -14.48 39.76 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 121.983 1.789 . . . . 15.0 113.598 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.698 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.3 tpt180 . . . . . 0 C--N 1.309 -1.156 0 CA-C-O 122.095 0.95 . . . . 15.0 108.752 175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.754 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.1 p-10 . . . . . 0 CA--C 1.555 1.16 0 N-CA-C 113.964 1.098 . . . . 15.0 113.964 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.926 ' HG3' HD11 ' A' ' 253' ' ' LEU . 95.7 Cg_endo -97.39 160.37 0.97 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.962 2.441 . . . . 15.0 112.664 -167.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.836 0 N-CA-C 109.8 -1.32 . . . . 15.0 109.8 173.478 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.519 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo . . . . . 0 N--CA 1.463 -0.267 0 CA-C-O 121.743 0.643 . . . . 15.0 113.414 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.422 -0.808 . . . . 15.0 109.257 173.803 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.517 -0.325 0 N-CA-C 109.986 -0.375 . . . . 15.0 109.986 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.667 ' HG3' HH11 ' A' ' 266' ' ' ARG . 17.4 Cg_exo -69.51 154.32 68.88 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.566 1.51 . . . . 15.0 109.413 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.76 121.54 17.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.391 0.615 . . . . 15.0 110.869 -170.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.74 -21.57 2.86 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.095 -0.957 . . . . 15.0 111.853 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 75.8 m-85 -96.69 128.82 44.0 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.64 0.257 . . . . 15.0 110.413 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -102.19 130.83 48.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 172.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.75 116.02 27.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.154 0.502 . . . . 15.0 109.924 -174.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.519 ' HD3' ' CE2' ' A' ' 251' ' ' TYR . 0.0 OUTLIER -101.07 150.02 23.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.037 -173.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.0 p -129.26 98.02 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.311 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -89.93 150.07 22.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.517 -0.765 . . . . 15.0 112.148 -168.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.09 -20.45 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 15.0 110.521 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.65 -22.25 44.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.633 -1.167 . . . . 15.0 111.524 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.34 23.21 48.8 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.36 -1.096 . . . . 15.0 110.36 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.436 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.3 mm100 -130.3 150.36 51.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.482 -0.859 . . . . 15.0 108.938 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -110.67 107.55 23.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.15 0.5 . . . . 15.0 110.676 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.519 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 51.3 p90 -98.67 125.52 44.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.299 0.571 . . . . 15.0 111.076 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.1 m-85 -90.01 113.12 24.75 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.634 -0.712 . . . . 15.0 111.622 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.39 134.39 52.35 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.804 1.288 . . . . 15.0 113.45 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.629 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -141.75 99.38 3.53 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.534 -2.121 . . . . 15.0 108.05 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.1 t -92.44 87.87 6.16 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.068 -2.253 . . . . 15.0 110.425 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.79 -44.99 5.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 112.654 -2.066 . . . . 15.0 108.168 151.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 12.9 t -139.8 24.44 2.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.092 1.901 . . . . 15.0 108.424 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.18 0.37 Allowed Glycine 0 C--N 1.28 -2.546 0 CA-C-N 109.858 -3.337 . . . . 15.0 112.722 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 62.9 t -89.29 115.5 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 119.757 -0.777 . . . . 15.0 111.882 169.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.838 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 10.4 p -126.36 112.02 15.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.652 -1.613 . . . . 15.0 108.014 168.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 12.8 t -149.93 150.43 31.86 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.646 0.98 . . . . 15.0 113.646 -167.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 4.0 m95 -75.15 -21.34 58.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.529 -1.214 . . . . 15.0 112.548 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.431 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.1 p80 -101.42 144.01 30.74 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.518 -0.473 . . . . 15.0 111.578 -172.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.729 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.1 t70 -60.46 123.32 73.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.455 -0.942 . . . . 15.0 108.455 170.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 8.7 Cg_exo -71.29 -14.68 31.43 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 121.863 1.709 . . . . 15.0 113.792 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.667 HH11 ' HG3' ' A' ' 237' ' ' PRO . 17.4 tpt180 . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 6.6 t70 . . . . . 0 CA--C 1.549 0.934 0 N-CA-C 112.683 0.623 . . . . 15.0 112.683 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 39.7 Cg_endo -92.68 160.26 2.85 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.069 1.846 . . . . 15.0 112.244 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 178.852 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . 0.581 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 8.1 Cg_exo . . . . . 0 C--O 1.223 -0.238 0 N-CA-C 114.719 1.007 . . . . 15.0 114.719 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 114.614 -1.175 . . . . 15.0 108.764 170.414 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.233 0.186 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . 0.99 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 10.4 Cg_exo -69.82 163.7 37.36 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.589 2.193 . . . . 15.0 110.822 165.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -69.81 124.31 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.817 -1.083 . . . . 15.0 112.137 -172.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.501 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 122.62 -2.12 10.22 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.583 -0.818 . . . . 15.0 114.7 170.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.654 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.1 m-85 -99.41 130.43 45.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.991 0.895 . . . . 15.0 110.581 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -104.65 138.35 41.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 173.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' GLN . . . . . 0.6 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -89.92 106.18 18.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 15.0 109.501 -179.327 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 241' ' ' GLU . 27.8 ttt85 -104.06 139.87 38.56 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.458 -0.792 . . . . 15.0 111.884 -174.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 250' ' ' VAL . 5.6 p -130.6 103.12 6.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.55 -1.204 . . . . 15.0 110.078 -177.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.652 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -90.01 150.34 22.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.942 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.08 -17.69 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.344 0.593 . . . . 15.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 247' ' ' GLN . . . . . 0.652 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.2 tp-100 -55.45 -23.8 27.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.506 -0.77 . . . . 15.0 111.076 172.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.6 -0.62 65.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.044 -0.598 . . . . 15.0 112.92 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 15.8 mt-30 -115.24 149.27 38.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.054 -0.35 . . . . 15.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' THR . 31.2 m -97.49 135.0 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.786 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.424 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 47.3 p90 -131.36 125.28 32.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.104 0.478 . . . . 15.0 110.29 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.669 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.81 112.29 23.56 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.517 -0.765 . . . . 15.0 111.445 -173.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.979 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -109.34 134.16 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.943 1.354 . . . . 15.0 114.243 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 254' ' ' HIS . . . . . 0.654 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 13.5 t-80 -137.84 97.89 3.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 112.561 -2.108 . . . . 15.0 107.578 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 255' ' ' THR . . . . . 0.564 HG22 ' HA2' ' A' ' 258' ' ' GLY . 1.2 p -97.42 87.52 4.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.074 -2.25 . . . . 15.0 110.836 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 35.3 tt0 -101.52 -54.14 2.82 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.14 -1.8 . . . . 15.0 106.14 147.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 30.5 p -118.06 25.88 10.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.47 -2.15 . . . . 15.0 111.331 -177.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 258' ' ' GLY . . . . . 0.564 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.99 76.6 0.17 Allowed Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.269 -2.696 . . . . 15.0 113.736 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.582 ' O ' HD13 ' A' ' 253' ' ' LEU . 43.5 t -90.1 115.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.157 0.479 . . . . 15.0 110.995 171.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.807 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 7.4 p -124.09 103.39 8.26 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 124.59 1.181 . . . . 15.0 109.025 172.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.6 p -138.03 150.08 46.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.881 0.697 . . . . 15.0 112.881 -169.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -78.78 -29.03 44.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.307 -0.86 . . . . 15.0 110.288 173.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -88.29 141.17 28.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.671 . . . . 15.0 110.801 -173.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 264' ' ' ASP . . . . . 0.669 ' HA ' ' CD1' ' A' ' 252' ' ' PHE . 9.3 t70 -55.97 131.37 73.7 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.503 -0.925 . . . . 15.0 108.503 171.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -14.58 28.95 Favored 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.032 1.821 . . . . 15.0 113.996 -172.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 266' ' ' ARG . . . . . 0.99 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.0 tpm_? . . . . . 0 C--N 1.301 -1.502 0 CA-C-O 122.124 0.964 . . . . 15.0 109.161 177.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 211' ' ' ASP . . . . . 0.563 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 3.0 m-20 . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 113.965 1.098 . . . . 15.0 113.965 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 212' ' ' PRO . . . . . 0.979 ' HG3' HD11 ' A' ' 253' ' ' LEU . 29.4 Cg_endo -95.25 160.49 1.62 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.937 2.425 . . . . 15.0 112.218 -173.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.086 0 C-N-CA 119.925 -1.131 . . . . 15.0 110.906 179.906 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 215' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 CA--C 1.532 0.39 0 N-CA-C 113.658 0.599 . . . . 15.0 113.658 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 15.0 109.945 175.117 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.113 -0.328 . . . . 15.0 110.113 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -119.32 163.51 26.49 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.63 -0.508 . . . . 15.0 109.63 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.689 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.4 Cg_exo -69.65 150.65 69.14 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.732 1.622 . . . . 15.0 108.961 163.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.83 141.87 53.21 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.551 0.691 . . . . 15.0 110.905 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.78 -22.74 6.8 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.21 -0.904 . . . . 15.0 112.334 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.7 m-85 -95.85 138.53 33.36 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 110.049 -0.352 . . . . 15.0 110.049 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.7 145.2 32.3 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.776 -0.824 . . . . 15.0 108.776 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.67 102.65 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -112.65 135.24 53.6 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.133 -0.94 . . . . 15.0 111.047 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -131.1 135.13 47.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.088 -0.96 . . . . 15.0 109.61 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.662 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -112.4 150.1 31.59 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.272 -0.422 . . . . 15.0 110.383 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 4.4 m -53.07 -16.63 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.003 -0.544 . . . . 15.0 111.705 175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.662 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -52.96 -18.91 2.22 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.188 -0.915 . . . . 15.0 111.232 171.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.63 2.47 67.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.999 -0.619 . . . . 15.0 112.169 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.516 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 33.3 mt-30 -124.07 150.03 45.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.465 -0.568 . . . . 15.0 109.465 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.22 138.07 30.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 110.067 -0.346 . . . . 15.0 110.067 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -126.07 123.24 37.95 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.145 0.498 . . . . 15.0 110.036 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.723 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 17.9 m-85 -89.57 111.8 22.83 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 115.626 -0.716 . . . . 15.0 111.188 -172.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.95 133.36 53.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.913 1.34 . . . . 15.0 113.986 -176.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.0 t-80 -144.49 96.87 2.94 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 112.474 -2.148 . . . . 15.0 107.779 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.522 HG22 ' HA2' ' A' ' 258' ' ' GLY . 5.1 p -96.09 87.69 4.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.256 -2.177 . . . . 15.0 110.872 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.572 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 45.4 tt0 -101.73 -53.21 3.02 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.151 -1.84 . . . . 15.0 106.597 150.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.1 p -120.47 26.82 8.94 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 112.322 -2.217 . . . . 15.0 111.01 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.522 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.1 74.04 0.35 Allowed Glycine 0 C--N 1.273 -2.953 0 CA-C-N 111.262 -2.699 . . . . 15.0 113.701 -176.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.556 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.0 t -90.03 115.58 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 117.286 0.543 . . . . 15.0 111.655 174.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.84 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.7 p -128.32 105.4 8.31 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.774 1.296 . . . . 15.0 108.863 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.4 p -141.42 150.19 42.02 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 112.703 0.631 . . . . 15.0 112.703 -168.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.516 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 32.6 m95 -75.55 -32.49 60.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.449 -0.796 . . . . 15.0 111.009 173.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -85.35 140.49 30.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 15.0 111.171 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.921 ' HB3' HG12 ' A' ' 267' ' ' ILE . 11.2 t70 -59.51 123.79 72.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.389 -0.967 . . . . 15.0 108.389 169.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.503 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 12.2 Cg_exo -71.38 -14.47 31.07 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.965 1.777 . . . . 15.0 113.622 -172.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.689 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 12.4 tpt180 -78.68 -9.64 59.47 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.526 -0.916 . . . . 15.0 108.526 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.921 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.6 pt . . . . . 0 C--O 1.249 1.032 0 CA-C-N 114.22 -1.355 . . . . 15.0 110.744 176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 121.468 0.652 . . . . 15.0 110.3 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 4.3 p -148.39 104.15 3.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.582 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.695 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.679 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.3 m-20 -102.21 -15.56 0.18 Allowed Pre-proline 0 CA--C 1.556 1.184 0 N-CA-C 114.278 1.214 . . . . 15.0 114.278 173.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 55.6 Cg_endo -99.44 160.57 0.58 Allowed 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 123.542 2.828 . . . . 15.0 112.559 -171.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.37 160.19 29.1 Favored Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.133 -1.187 . . . . 15.0 110.133 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.454 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.3 Cg_exo -89.02 147.72 5.59 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 123.964 3.109 . . . . 15.0 113.191 -170.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -105.07 10.35 34.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.421 -0.809 . . . . 15.0 110.004 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.523 -0.751 . . . . 15.0 110.39 -178.033 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 109.695 -0.484 . . . . 15.0 109.695 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.668 HD22 ' HD2' ' A' ' 265' ' ' PRO . 1.4 mt -90.1 157.71 45.14 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.806 -0.442 . . . . 15.0 109.806 -177.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.628 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 14.3 Cg_exo -69.33 156.43 64.5 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 121.588 1.525 . . . . 15.0 109.971 166.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -69.7 122.28 18.83 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.838 0.828 . . . . 15.0 111.645 -172.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.82 -18.47 2.98 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.039 -1.437 . . . . 15.0 111.329 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.65 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 85.0 m-85 -100.91 138.89 37.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.574 0.226 . . . . 15.0 110.53 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -112.27 137.89 49.75 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.314 -0.625 . . . . 15.0 109.314 169.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -89.93 97.93 11.47 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.507 -0.923 . . . . 15.0 108.507 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.653 HH11 ' HG2' ' A' ' 243' ' ' ARG . 2.3 ttt-85 -94.53 120.49 34.84 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.527 -0.761 . . . . 15.0 111.612 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 27.6 m -108.25 106.41 16.57 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 15.0 110.118 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.806 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -90.11 150.29 22.11 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.952 -0.567 . . . . 15.0 109.622 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.5 t -50.9 -24.41 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 121.377 0.608 . . . . 15.0 110.703 179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.806 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.1 tp-100 -45.72 -34.74 3.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 114.746 -1.116 . . . . 15.0 111.837 171.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 106.01 -15.31 44.1 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.921 -0.657 . . . . 15.0 112.328 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.558 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 1.3 mp0 -97.64 132.19 43.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.976 0.417 . . . . 15.0 111.021 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.9 m -91.26 127.77 43.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 15.0 110.026 175.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.606 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 14.9 p90 -122.02 130.41 53.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.921 0.391 . . . . 15.0 110.741 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.671 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 30.8 m-85 -89.74 107.13 18.92 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.803 -0.635 . . . . 15.0 111.461 -173.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.959 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.6 OUTLIER -109.11 133.75 52.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.866 1.317 . . . . 15.0 113.674 179.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.65 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -140.2 104.04 4.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 112.451 -2.158 . . . . 15.0 108.042 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 21.9 p -98.13 87.73 4.01 Favored 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 116.386 -2.126 . . . . 15.0 110.918 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.4 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 41.4 tt0 -101.43 -53.04 3.09 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.529 -1.656 . . . . 15.0 106.529 147.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 63.1 p -121.69 25.79 9.07 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 112.536 -2.12 . . . . 15.0 111.369 -174.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 51.87 75.99 0.2 Allowed Glycine 0 C--N 1.27 -3.105 0 CA-C-N 111.144 -2.753 . . . . 15.0 113.431 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.613 ' O ' HD13 ' A' ' 253' ' ' LEU . 59.1 t -89.71 113.97 26.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.315 0.558 . . . . 15.0 111.678 174.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.766 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 8.1 p -125.35 107.05 10.3 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.265 -1.334 . . . . 15.0 109.069 173.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.2 t -150.01 150.45 31.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 113.173 0.805 . . . . 15.0 113.173 -168.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.558 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 3.8 m95 -75.78 -21.35 57.48 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 114.946 -1.025 . . . . 15.0 112.018 174.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -95.61 135.49 37.22 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.556 -0.458 . . . . 15.0 111.116 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.953 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t0 -56.73 124.19 62.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 108.563 -0.903 . . . . 15.0 108.563 170.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.668 ' HD2' HD22 ' A' ' 236' ' ' LEU . 10.3 Cg_exo -71.61 -14.78 30.51 Favored 'Trans proline' 0 CA--C 1.507 -0.869 0 C-N-CA 122.363 2.042 . . . . 15.0 113.591 -174.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.628 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 9.8 tpt180 -79.43 -10.06 59.73 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.346 -0.983 . . . . 15.0 108.346 174.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.953 HG12 ' HB3' ' A' ' 264' ' ' ASP . 41.6 pt . . . . . 0 C--O 1.25 1.087 0 CA-C-N 114.398 -1.274 . . . . 15.0 110.305 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 111.426 0.158 . . . . 15.0 111.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.8 m -116.15 105.15 12.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.658 0.265 . . . . 15.0 110.373 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.872 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.557 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 56.6 m-20 -84.51 -25.24 0.36 Allowed Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 112.958 0.725 . . . . 15.0 112.958 167.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.959 ' HG3' HD11 ' A' ' 253' ' ' LEU . 19.4 Cg_endo -97.94 160.57 0.85 Allowed 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 123.004 2.469 . . . . 15.0 111.635 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.05 28.66 Favored Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 110.416 -1.074 . . . . 15.0 110.416 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.464 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.484 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo -89.11 128.27 1.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.28 0 C-N-CA 123.827 3.018 . . . . 15.0 113.798 -170.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -89.35 91.38 8.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.65 -0.705 . . . . 15.0 109.545 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 118.706 -0.664 . . . . 15.0 110.156 -179.123 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 121.017 0.437 . . . . 15.0 110.473 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.501 HD12 ' HD2' ' A' ' 265' ' ' PRO . 2.1 mm? -94.16 171.73 6.56 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.797 -0.638 . . . . 15.0 109.941 -177.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.749 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 19.1 Cg_exo -69.42 147.71 65.65 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 121.561 1.508 . . . . 15.0 109.172 161.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.51 116.07 9.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.453 0.644 . . . . 15.0 111.83 -167.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 147.87 -16.91 1.4 Allowed Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.844 -1.071 . . . . 15.0 112.122 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.618 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 92.6 m-85 -94.9 132.48 39.68 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 122.722 -0.281 . . . . 15.0 110.567 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -106.68 142.87 35.62 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.509 -0.552 . . . . 15.0 109.509 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -90.0 119.59 30.48 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.846 -0.798 . . . . 15.0 108.846 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -124.77 137.21 54.34 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.481 0.658 . . . . 15.0 111.123 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 7.1 m -129.4 126.16 38.18 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.839 -1.073 . . . . 15.0 109.276 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -93.11 150.15 20.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.379 -0.373 . . . . 15.0 110.246 177.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.3 m -54.52 -21.21 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 121.559 0.695 . . . . 15.0 110.599 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 3.4 tp-100 -47.66 -32.61 5.84 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.582 -1.19 . . . . 15.0 111.488 170.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.3 19.18 21.8 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.036 -0.602 . . . . 15.0 112.635 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.723 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 5.2 mt-30 -127.14 147.83 50.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.652 -0.499 . . . . 15.0 109.652 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.43 136.03 38.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.382 -0.372 . . . . 15.0 110.336 177.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 34.5 p90 -134.51 125.71 27.89 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.67 -0.492 . . . . 15.0 109.67 177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 24.3 m-85 -89.65 112.63 23.92 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 116.044 -0.525 . . . . 15.0 111.58 -171.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.014 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -107.44 133.42 51.97 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.804 1.288 . . . . 15.0 113.494 -177.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.9 t-80 -145.35 103.17 3.81 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 112.587 -2.097 . . . . 15.0 108.424 -178.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 4.9 t -99.21 87.79 3.75 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 116.162 -2.215 . . . . 15.0 111.005 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 59.4 tt0 -101.27 -51.73 3.43 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.31 -1.768 . . . . 15.0 106.597 149.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 44.8 p -121.66 24.81 9.61 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 112.799 -2.0 . . . . 15.0 111.425 -176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 55.24 74.2 0.34 Allowed Glycine 0 C--N 1.27 -3.138 0 CA-C-N 111.278 -2.692 . . . . 15.0 113.7 -175.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.559 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.1 t -89.97 119.54 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 CA-C-N 117.253 0.526 . . . . 15.0 111.622 175.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.821 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 4.6 p -131.76 109.11 9.92 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.396 -1.275 . . . . 15.0 108.677 169.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.42 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.0 t -150.17 150.11 31.16 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.098 0.777 . . . . 15.0 113.098 -168.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.474 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 33.8 m95 -71.06 -29.64 65.57 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.011 -0.995 . . . . 15.0 111.917 176.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 265' ' ' PRO . 4.3 p80 -90.61 136.45 33.06 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.597 -0.441 . . . . 15.0 111.271 -170.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.943 ' HB3' HG12 ' A' ' 267' ' ' ILE . 12.3 t70 -56.65 120.43 36.84 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 108.02 -1.104 . . . . 15.0 108.02 168.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.548 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 Cg_exo -69.72 -14.61 36.47 Favored 'Trans proline' 0 CA--C 1.51 -0.69 0 C-N-CA 122.247 1.965 . . . . 15.0 113.72 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.749 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 20.0 tpt180 -78.63 -10.61 59.81 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.518 -0.919 . . . . 15.0 108.518 173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.943 HG12 ' HB3' ' A' ' 264' ' ' ASP . 38.9 pt . . . . . 0 C--O 1.253 1.272 0 CA-C-N 114.129 -1.396 . . . . 15.0 110.831 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.48 1.068 0 N-CA-C 111.981 0.363 . . . . 15.0 111.981 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.6 p -137.5 116.79 12.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.005 0.431 . . . . 15.0 110.808 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.789 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.688 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 5.7 p-10 -104.48 -14.65 0.16 Allowed Pre-proline 0 CA--C 1.558 1.288 0 N-CA-C 113.439 0.903 . . . . 15.0 113.439 171.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.014 ' HG3' HD11 ' A' ' 253' ' ' LEU . 82.0 Cg_endo -94.3 160.59 2.03 Favored 'Trans proline' 0 C--N 1.367 1.518 0 C-N-CA 123.292 2.661 . . . . 15.0 112.014 -170.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.4 160.05 28.95 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 119.286 -1.435 . . . . 15.0 110.052 174.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 6.1 Cg_exo -89.06 150.38 5.7 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.444 2.762 . . . . 15.0 112.817 -172.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -108.8 4.03 23.18 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.591 0.71 . . . . 15.0 109.385 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 . . . . . 0 C--O 1.249 1.034 0 CA-C-N 115.02 -0.991 . . . . 15.0 110.193 -175.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.825 0.345 . . . . 15.0 110.541 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.3 OUTLIER -98.52 158.32 32.77 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 108.956 -0.757 . . . . 15.0 108.956 178.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.589 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.8 Cg_exo -69.46 144.93 57.29 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 C-N-CA 121.947 1.765 . . . . 15.0 110.182 172.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -69.6 124.75 24.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.716 0.77 . . . . 15.0 111.875 -171.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.36 -20.19 2.44 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.477 -1.238 . . . . 15.0 111.884 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.567 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.5 m-85 -91.12 126.23 36.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 110.194 -0.299 . . . . 15.0 110.194 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.563 ' HB2' HG22 ' B' ' 208' ' ' THR . 7.8 pt-20 -97.87 129.04 44.84 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.97 -0.752 . . . . 15.0 108.97 172.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.405 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.68 103.54 16.18 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.502 0.668 . . . . 15.0 109.347 -175.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 -105.15 139.65 39.49 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.029 -0.987 . . . . 15.0 110.915 -175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 10.2 m -131.23 108.91 10.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.321 -0.854 . . . . 15.0 110.221 -174.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.8 t -94.78 150.25 20.39 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.418 -0.355 . . . . 15.0 110.728 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 6.0 p -53.3 -18.66 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 121.885 0.85 . . . . 15.0 111.074 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.6 tp-100 -48.67 -23.59 1.08 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.043 -1.435 . . . . 15.0 111.534 171.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.67 10.46 61.68 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.754 -0.538 . . . . 15.0 111.754 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.545 HE21 ' HG3' ' A' ' 247' ' ' GLN . 28.1 mt-30 -129.83 139.79 51.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.879 -0.415 . . . . 15.0 109.879 -175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 28.6 m -100.68 124.07 54.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.029 0.442 . . . . 15.0 110.385 178.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.5 p90 -109.58 127.52 54.56 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.132 0.491 . . . . 15.0 110.092 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.722 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 22.5 m-85 -89.54 107.57 19.16 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.591 -0.731 . . . . 15.0 111.116 -172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.052 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -106.83 133.96 50.7 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 122.734 1.254 . . . . 15.0 113.551 -177.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 11.1 t-80 -142.91 102.76 4.08 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 112.703 -2.044 . . . . 15.0 107.865 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 25.1 m -102.1 88.06 3.23 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 115.874 -2.331 . . . . 15.0 110.931 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.582 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.8 tt0 -101.17 -47.78 4.62 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.415 -1.721 . . . . 15.0 107.027 146.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 36.0 p -124.83 25.11 7.49 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-N 113.521 -1.672 . . . . 15.0 111.399 -175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.23 74.49 0.31 Allowed Glycine 0 C--N 1.272 -2.984 0 CA-C-N 111.137 -2.756 . . . . 15.0 113.552 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.553 ' O ' HD13 ' A' ' 253' ' ' LEU . 56.1 t -89.83 120.25 38.31 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 117.239 0.519 . . . . 15.0 110.982 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.815 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.3 p -135.84 105.68 6.21 Favored 'General case' 0 C--N 1.317 -0.842 0 O-C-N 124.519 1.137 . . . . 15.0 109.244 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.458 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.2 150.35 31.48 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 113.166 0.802 . . . . 15.0 113.166 -169.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.492 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 18.6 m95 -68.81 -30.97 69.65 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.204 -0.907 . . . . 15.0 111.264 173.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.458 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.6 p80 -86.15 137.11 32.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.992 0.425 . . . . 15.0 111.173 -170.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.917 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.7 t0 -58.41 125.3 75.27 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 108.586 -0.894 . . . . 15.0 108.586 171.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.556 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 23.1 Cg_exo -68.3 -14.72 41.01 Favored 'Trans proline' 0 CA--C 1.505 -0.948 0 C-N-CA 122.543 2.162 . . . . 15.0 113.865 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.589 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpt180 -81.92 -6.64 59.27 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 108.378 -0.971 . . . . 15.0 108.378 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.917 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.9 pt . . . . . 0 C--O 1.248 1.023 0 CA-C-N 113.852 -1.522 . . . . 15.0 110.861 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.563 HG22 ' HB2' ' A' ' 241' ' ' GLU . 28.5 p . . . . . 0 N--CA 1.475 0.819 0 N-CA-C 109.973 -0.381 . . . . 15.0 109.973 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 17.7 m -127.37 105.61 8.64 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.034 0.445 . . . . 15.0 109.836 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.734 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.585 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 23.0 t70 -90.55 -20.61 0.25 Allowed Pre-proline 0 CA--C 1.554 1.108 0 N-CA-C 113.486 0.921 . . . . 15.0 113.486 172.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.052 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.3 Cg_endo -97.18 160.26 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.671 2.247 . . . . 15.0 111.919 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.57 158.02 27.09 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 119.626 -1.273 . . . . 15.0 110.566 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.457 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.2 Cg_exo -89.15 147.97 5.49 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 124.012 3.141 . . . . 15.0 113.334 -173.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -105.86 -4.19 21.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.516 -0.765 . . . . 15.0 109.552 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.161 -0.923 . . . . 15.0 110.528 -178.31 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 110.168 -0.308 . . . . 15.0 110.168 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.608 HD12 ' HD2' ' A' ' 265' ' ' PRO . 1.2 mm? -90.0 166.99 18.18 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.28 0.562 . . . . 15.0 110.927 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.712 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 18.7 Cg_exo -69.28 159.28 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.254 1.969 . . . . 15.0 109.701 161.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -69.49 123.95 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.542 0.686 . . . . 15.0 111.547 -172.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 133.65 -15.47 4.64 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.775 -1.102 . . . . 15.0 113.203 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.612 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 78.2 m-85 -97.4 130.77 44.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.319 0.56 . . . . 15.0 111.004 -178.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -109.5 140.06 43.73 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.402 -0.592 . . . . 15.0 109.402 171.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.538 ' NE2' ' HB ' ' A' ' 250' ' ' VAL . 8.9 tp60 -89.66 143.76 26.54 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.615 -0.883 . . . . 15.0 108.615 174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.479 ' H ' HE21 ' A' ' 242' ' ' GLN . 8.9 ttt180 -139.84 131.61 27.45 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.802 -0.636 . . . . 15.0 110.886 -173.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 p -115.01 111.58 21.35 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.719 -1.128 . . . . 15.0 110.185 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.733 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.9 150.22 22.29 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.027 -0.533 . . . . 15.0 109.667 176.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.51 -24.94 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.381 0.61 . . . . 15.0 110.533 176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.733 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.1 tp-100 -47.58 -38.91 15.37 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.622 -1.172 . . . . 15.0 111.931 170.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 107.17 5.02 35.32 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.752 -0.737 . . . . 15.0 113.526 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.729 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.5 mt-30 -113.58 137.71 51.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 117.196 0.498 . . . . 15.0 111.037 -175.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.538 ' HB ' ' NE2' ' A' ' 242' ' ' GLN . 10.3 m -90.05 121.26 40.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 15.0 110.579 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -121.16 130.1 53.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.882 -0.327 . . . . 15.0 110.605 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 23.6 m-85 -89.82 110.18 21.13 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 116.049 -0.523 . . . . 15.0 111.505 -174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.013 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -108.97 132.58 53.96 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.776 1.274 . . . . 15.0 114.086 -179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.612 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -140.75 101.24 4.03 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 112.702 -2.044 . . . . 15.0 107.884 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 2.4 t -99.07 87.54 3.71 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 116.087 -2.245 . . . . 15.0 110.667 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.49 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 47.5 tt0 -101.28 -50.66 3.71 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.142 -1.844 . . . . 15.0 106.753 149.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 32.0 p -124.19 25.19 7.89 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 112.794 -2.003 . . . . 15.0 111.142 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.78 75.15 0.25 Allowed Glycine 0 C--N 1.273 -2.942 0 CA-C-N 111.014 -2.812 . . . . 15.0 113.554 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.621 ' O ' HD13 ' A' ' 253' ' ' LEU . 41.1 t -89.72 117.26 32.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.644 0 CA-C-N 117.287 0.543 . . . . 15.0 111.23 174.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.793 ' HA ' HD22 ' A' ' 253' ' ' LEU . 7.6 p -127.72 108.82 11.08 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 124.326 1.016 . . . . 15.0 109.061 171.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 10.5 t -150.16 150.33 31.49 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 112.596 0.591 . . . . 15.0 112.596 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.41 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 77.1 m95 -76.52 -25.68 54.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.578 -0.737 . . . . 15.0 111.054 174.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -90.49 132.21 35.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.14 0.495 . . . . 15.0 111.072 -171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.879 ' HB3' HG12 ' A' ' 267' ' ' ILE . 8.9 t70 -53.26 122.12 28.7 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 108.699 -0.852 . . . . 15.0 108.699 169.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.608 ' HD2' HD12 ' A' ' 236' ' ' LEU . 10.1 Cg_exo -71.65 -14.52 30.26 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 C-N-CA 122.113 1.875 . . . . 15.0 113.924 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.712 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.7 tpt180 -80.0 -7.33 58.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.77 0.795 . . . . 15.0 109.105 175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.879 HG12 ' HB3' ' A' ' 264' ' ' ASP . 43.5 mm . . . . . 0 C--O 1.248 0.994 0 CA-C-N 114.115 -1.402 . . . . 15.0 110.115 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 121.228 0.537 . . . . 15.0 110.262 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.3 m -136.68 115.37 12.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.951 0.405 . . . . 15.0 110.772 -175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.652 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.565 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 28.2 m-20 -84.87 -18.04 0.24 Allowed Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 114.117 1.154 . . . . 15.0 114.117 172.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.013 ' HG3' HD11 ' A' ' 253' ' ' LEU . 35.6 Cg_endo -96.89 160.85 1.08 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 123.091 2.527 . . . . 15.0 111.9 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.46 160.37 29.13 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.434 -1.466 . . . . 15.0 109.434 173.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.472 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.6 Cg_exo -89.13 160.17 5.77 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 124.111 3.207 . . . . 15.0 112.85 -170.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -112.13 -2.39 14.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.332 0.587 . . . . 15.0 110.185 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 . . . . . 0 C--O 1.248 0.993 0 CA-C-N 115.434 -0.803 . . . . 15.0 109.827 -176.686 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.43 -0.211 . . . . 15.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.45 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -121.67 173.74 3.76 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.295 -0.631 . . . . 15.0 109.295 179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 1.057 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 22.5 Cg_exo -69.56 159.15 54.64 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 122.062 1.841 . . . . 15.0 110.702 165.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -69.98 123.87 22.62 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.279 -0.873 . . . . 15.0 110.904 -172.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 128.49 -14.46 6.13 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.548 -0.834 . . . . 15.0 112.837 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.673 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.8 m-85 -94.67 131.16 40.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.911 0.355 . . . . 15.0 110.334 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -97.36 131.35 44.12 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.43 -0.952 . . . . 15.0 108.43 168.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -89.72 99.11 12.18 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.542 -0.91 . . . . 15.0 108.542 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -106.97 119.32 39.03 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.004 -0.998 . . . . 15.0 111.379 -168.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.9 m -115.77 111.04 19.94 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.907 -1.042 . . . . 15.0 109.337 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.8 OUTLIER -89.8 150.06 22.42 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.798 -0.445 . . . . 15.0 109.798 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -51.42 -21.08 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.388 0.613 . . . . 15.0 111.561 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.814 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 4.1 tp-100 -45.84 -37.42 6.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.499 -1.228 . . . . 15.0 111.58 170.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.4 -8.84 28.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.896 -0.669 . . . . 15.0 112.561 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.575 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 9.2 mt-30 -112.41 143.52 43.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.86 0.362 . . . . 15.0 110.483 -177.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.3 m -97.51 135.03 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.074 -0.512 . . . . 15.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -126.66 125.29 41.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.971 0.415 . . . . 15.0 109.902 175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.634 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 21.4 m-85 -89.78 109.92 20.88 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.718 -0.674 . . . . 15.0 111.111 -174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.921 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -106.38 131.07 54.02 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.727 1.251 . . . . 15.0 114.053 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.673 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 15.8 t-80 -141.38 93.72 2.61 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 112.768 -2.014 . . . . 15.0 107.7 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 29.9 m -93.85 87.78 5.53 Favored 'General case' 0 N--CA 1.434 -1.238 0 C-N-CA 115.99 -2.284 . . . . 15.0 110.09 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -101.38 -52.91 3.13 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 113.117 -1.856 . . . . 15.0 106.233 150.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 45.2 p -118.01 24.75 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.437 -2.165 . . . . 15.0 110.904 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 54.19 73.19 0.44 Allowed Glycine 0 C--N 1.27 -3.096 0 CA-C-N 110.965 -2.834 . . . . 15.0 113.836 -175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.63 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -90.01 115.01 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 CA-C-N 117.309 0.554 . . . . 15.0 112.037 175.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.801 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.8 p -127.46 107.87 10.33 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.37 1.043 . . . . 15.0 109.08 171.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.7 t -150.28 150.28 31.3 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.644 0.609 . . . . 15.0 112.644 -170.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.575 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 79.6 m95 -75.11 -25.46 58.51 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.9 -0.591 . . . . 15.0 111.282 175.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -87.63 142.09 28.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.065 0.459 . . . . 15.0 111.03 -170.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.701 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.3 t70 -65.92 131.33 94.56 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.624 -0.716 . . . . 15.0 109.175 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.72 -14.57 8.88 Favored 'Trans proline' 0 CA--C 1.509 -0.737 0 C-N-CA 122.541 2.161 . . . . 15.0 113.855 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 1.057 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.1 tpm_? -82.33 -4.31 57.01 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 122.076 0.941 . . . . 15.0 108.858 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.701 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.8 mm . . . . . 0 C--N 1.31 -1.122 0 CA-C-N 113.326 -1.761 . . . . 15.0 110.67 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.291 0.567 . . . . 15.0 110.306 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 18.8 m -105.26 121.33 43.64 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.121 -0.49 . . . . 15.0 109.734 174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.483 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.8 m-20 -73.83 -24.41 0.59 Allowed Pre-proline 0 CA--C 1.545 0.764 0 N-CA-C 113.631 0.975 . . . . 15.0 113.631 173.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.921 ' HG3' HD11 ' A' ' 253' ' ' LEU . 16.4 Cg_endo -97.03 160.39 1.04 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.549 2.166 . . . . 15.0 112.303 -176.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.23 161.04 29.92 Favored Glycine 0 C--N 1.312 -0.772 0 N-CA-C 110.387 -1.085 . . . . 15.0 110.387 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.814 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 2.9 Cg_exo -88.99 148.54 5.67 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 124.303 3.335 . . . . 15.0 113.602 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -106.66 8.75 31.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.327 -0.851 . . . . 15.0 109.503 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 . . . . . 0 C--O 1.249 1.074 0 CA-C-N 115.444 -0.798 . . . . 15.0 109.625 -178.245 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 109.408 -0.589 . . . . 15.0 109.408 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.942 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.0 OUTLIER -95.06 151.38 38.79 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 121.529 0.68 . . . . 15.0 111.119 -168.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.514 ' HD2' ' CE1' ' A' ' 240' ' ' TYR . 17.0 Cg_exo -69.46 158.98 55.37 Favored 'Trans proline' 0 C--N 1.326 -0.611 0 C-N-CA 122.831 2.354 . . . . 15.0 109.617 165.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -69.62 117.31 11.07 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.997 -0.547 . . . . 15.0 110.405 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 138.14 -2.1 2.87 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.566 -0.743 . . . . 15.0 112.759 -176.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.514 ' CE1' ' HD2' ' A' ' 237' ' ' PRO . 69.6 m-85 -116.74 136.98 52.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.915 -0.402 . . . . 15.0 109.915 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -108.22 134.14 51.49 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.601 -0.518 . . . . 15.0 109.601 172.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.537 ' HG3' ' CE2' ' A' ' 252' ' ' PHE . 21.4 tt0 -89.72 97.98 11.51 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.546 -0.538 . . . . 15.0 109.546 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -95.49 119.47 34.05 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.767 -0.651 . . . . 15.0 110.598 -176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.604 ' HB ' HG12 ' A' ' 250' ' ' VAL . 5.0 t -104.0 150.07 24.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.286 -0.87 . . . . 15.0 110.083 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.786 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.7 t -135.31 150.46 50.0 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.618 -0.719 . . . . 15.0 109.972 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.2 t -51.93 -17.11 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.336 0.589 . . . . 15.0 110.983 177.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.786 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.3 tp-100 -54.36 -20.43 7.31 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.446 -0.797 . . . . 15.0 111.245 171.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.38 69.01 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.363 -0.446 . . . . 15.0 112.51 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.512 HE21 ' HG3' ' A' ' 247' ' ' GLN . 29.7 mt-30 -125.74 136.0 52.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.033 -0.358 . . . . 15.0 110.033 -175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.604 HG12 ' HB ' ' A' ' 244' ' ' THR . 20.8 m -89.99 138.01 20.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.716 0.293 . . . . 15.0 110.334 176.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -122.86 130.68 53.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.06 0.457 . . . . 15.0 110.153 177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.566 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 28.9 m-85 -89.76 108.51 19.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.871 -0.604 . . . . 15.0 111.698 -171.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.33 132.13 53.47 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 122.858 1.313 . . . . 15.0 113.558 -179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.1 OUTLIER -140.4 99.47 3.65 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 112.601 -2.091 . . . . 15.0 107.514 -179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.7 t -108.37 87.47 2.5 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 115.242 -2.583 . . . . 15.0 111.395 177.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 39.8 tt0 -101.47 -48.22 4.42 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.256 -2.247 . . . . 15.0 106.649 142.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 68.5 p -118.32 24.78 10.74 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 113.539 -1.664 . . . . 15.0 111.757 -173.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 49.53 72.79 0.43 Allowed Glycine 0 C--N 1.271 -3.069 0 CA-C-N 110.961 -2.836 . . . . 15.0 114.495 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 253' ' ' LEU . 13.1 t -92.42 116.33 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 117.449 0.624 . . . . 15.0 111.631 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.799 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.1 p -126.63 110.08 12.8 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.167 0.917 . . . . 15.0 108.659 167.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -149.93 150.31 31.69 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.923 0.712 . . . . 15.0 112.923 -167.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.465 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 22.1 m95 -75.65 -29.65 59.18 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.353 -0.839 . . . . 15.0 111.479 175.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -93.53 140.16 29.92 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.624 -0.43 . . . . 15.0 111.27 -170.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.912 ' HB3' HG12 ' A' ' 267' ' ' ILE . 16.2 t0 -50.61 126.22 22.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 N-CA-C 108.672 -0.862 . . . . 15.0 108.672 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.942 ' HD2' HD12 ' A' ' 236' ' ' LEU . 56.3 Cg_endo -70.55 -14.53 33.66 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 C-N-CA 122.471 2.114 . . . . 15.0 113.608 -174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . . . . . . . . . 4.7 tpt180 -78.24 -9.58 59.28 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.898 0.856 . . . . 15.0 108.963 174.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.912 HG12 ' HB3' ' A' ' 264' ' ' ASP . 33.3 mm . . . . . 0 C--O 1.247 0.967 0 CA-C-N 114.186 -1.37 . . . . 15.0 110.328 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.474 0.769 0 CA-C-O 121.364 0.602 . . . . 15.0 109.834 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 24.2 m -135.33 115.03 12.8 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.906 -0.588 . . . . 15.0 110.208 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.901 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.577 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 10.3 m-20 -81.44 -30.01 0.53 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.095 0.776 . . . . 15.0 113.095 168.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 40.4 Cg_endo -96.78 160.38 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 122.99 2.46 . . . . 15.0 112.759 -166.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.23 160.42 29.44 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 109.765 -1.334 . . . . 15.0 109.765 174.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.456 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 3.8 Cg_exo -89.08 136.66 2.99 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.312 2.674 . . . . 15.0 113.383 -169.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -98.03 1.04 47.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.815 -1.084 . . . . 15.0 109.875 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.457 ' HG3' ' HE1' ' A' ' 262' ' ' TRP . 3.5 pt20 . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.559 -0.734 . . . . 15.0 110.353 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.151 -0.315 . . . . 15.0 110.151 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.471 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -115.44 177.82 1.11 Allowed Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.475 -0.935 . . . . 15.0 108.475 178.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.414 ' HG3' HH11 ' A' ' 266' ' ' ARG . 13.4 Cg_exo -69.52 160.31 50.26 Favored 'Trans proline' 0 CA--C 1.517 -0.358 0 C-N-CA 121.524 1.482 . . . . 15.0 110.579 168.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -69.89 120.16 15.19 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.39 -0.823 . . . . 15.0 111.281 -171.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 135.11 -27.16 3.18 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.597 -0.729 . . . . 15.0 113.068 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.669 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 45.1 m-85 -92.39 136.69 32.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.884 0.342 . . . . 15.0 110.62 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -109.82 141.4 42.56 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.248 -0.649 . . . . 15.0 109.248 167.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -89.82 99.37 12.39 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.36 -0.607 . . . . 15.0 109.36 178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.458 ' HD3' ' OG ' ' B' ' 210' ' ' SEP . 2.4 ttt-85 -93.47 130.22 39.38 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.916 -0.584 . . . . 15.0 110.81 -175.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 15.8 m -119.76 110.41 16.76 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.312 -0.858 . . . . 15.0 110.142 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.656 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -90.06 150.26 22.16 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.789 -0.448 . . . . 15.0 109.789 176.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 42.6 t -55.13 -18.19 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.65 0.738 . . . . 15.0 110.635 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.823 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 3.3 tp-100 -49.94 -29.21 7.95 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 114.817 -1.083 . . . . 15.0 111.429 171.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 111.36 -23.92 17.05 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.901 -0.666 . . . . 15.0 112.046 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.505 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.0 mp0 -89.88 148.39 23.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.253 0.549 . . . . 15.0 111.322 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -105.13 123.1 59.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.419 -0.809 . . . . 15.0 109.713 173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -114.15 128.61 56.45 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.439 -0.505 . . . . 15.0 110.592 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.57 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.3 m-85 -89.69 110.34 21.24 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.516 -0.765 . . . . 15.0 111.419 -172.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.48 134.43 52.36 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 122.739 1.257 . . . . 15.0 113.852 -178.096 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.669 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 20.4 t-80 -146.89 102.27 3.51 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 112.563 -2.108 . . . . 15.0 108.309 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.4 t -102.91 88.01 3.07 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 116.058 -2.257 . . . . 15.0 111.294 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.433 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 7.9 tt0 -101.15 -50.69 3.71 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 113.164 -1.835 . . . . 15.0 106.237 147.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 37.9 p -116.91 27.23 9.27 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 113.142 -1.845 . . . . 15.0 111.293 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.04 72.18 0.55 Allowed Glycine 0 C--N 1.277 -2.747 0 CA-C-N 111.133 -2.758 . . . . 15.0 113.974 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.8 t -90.05 115.16 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 CA-C-N 117.379 0.59 . . . . 15.0 111.807 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.839 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.1 p -127.89 100.09 5.78 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.708 -1.133 . . . . 15.0 108.956 170.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.5 p -141.25 150.27 42.41 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.223 0.823 . . . . 15.0 113.223 -167.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.624 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 1.7 m95 -70.87 -42.56 69.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.319 -0.855 . . . . 15.0 111.475 173.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -76.19 139.33 41.17 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.66 -0.7 . . . . 15.0 111.676 -171.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.001 ' HB3' HG12 ' A' ' 267' ' ' ILE . 49.3 t0 -54.19 127.74 56.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.243 -1.021 . . . . 15.0 108.243 168.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.416 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 65.1 Cg_endo -74.13 -14.79 23.32 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 121.651 1.567 . . . . 15.0 112.916 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.467 ' HD2' ' HA ' ' A' ' 266' ' ' ARG . 13.6 tpt180 -81.92 -5.93 58.68 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.683 -0.858 . . . . 15.0 108.683 176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.001 HG12 ' HB3' ' A' ' 264' ' ' ASP . 24.5 mm . . . . . 0 C--O 1.25 1.128 0 CA-C-N 113.911 -1.495 . . . . 15.0 110.141 177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.8 p . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.44 0.162 . . . . 15.0 111.257 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 27.4 m -121.86 117.84 27.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.652 0.263 . . . . 15.0 110.474 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.885 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.696 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.8 p-10 -120.08 -17.21 0.08 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 N-CA-C 113.299 0.851 . . . . 15.0 113.299 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 253' ' ' LEU . 56.3 Cg_endo -90.8 160.44 4.13 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 122.306 2.004 . . . . 15.0 111.629 -178.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.32 160.44 29.35 Favored Glycine 0 N--CA 1.439 -1.158 0 N-CA-C 110.214 -1.154 . . . . 15.0 110.214 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.823 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.624 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.6 Cg_exo -88.64 127.44 1.94 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 123.72 2.947 . . . . 15.0 113.832 -171.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -94.25 5.8 50.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.121 -0.945 . . . . 15.0 110.236 178.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.724 -0.655 . . . . 15.0 109.607 178.411 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 121.04 0.447 . . . . 15.0 110.518 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.6 mt -100.85 -179.79 0.88 Allowed Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 108.922 -0.77 . . . . 15.0 108.922 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.791 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 13.6 Cg_exo -69.62 161.97 43.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.497 1.465 . . . . 15.0 110.332 167.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -69.53 124.37 23.74 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.112 -0.949 . . . . 15.0 111.256 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 123.98 -13.93 8.0 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.922 -0.656 . . . . 15.0 113.521 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 89.9 m-85 -94.29 131.89 39.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.365 0.583 . . . . 15.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -105.99 140.58 38.76 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.046 -0.724 . . . . 15.0 109.046 170.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.492 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.8 OUTLIER -89.85 102.09 14.79 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.406 -0.961 . . . . 15.0 108.406 179.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 38.0 ttt85 -109.02 145.95 34.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.24 -0.891 . . . . 15.0 111.413 -176.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 23.1 m -136.47 124.77 23.24 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.019 -0.991 . . . . 15.0 109.664 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.591 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.1 t -89.86 150.43 22.22 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.923 -0.399 . . . . 15.0 109.923 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.3 m -51.5 -24.16 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.316 0.579 . . . . 15.0 110.979 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.591 ' HB3' HG23 ' A' ' 245' ' ' THR . 2.2 tp-100 -52.05 -33.29 38.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.037 -0.983 . . . . 15.0 111.703 172.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 104.8 12.16 28.73 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.995 -0.622 . . . . 15.0 112.512 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.628 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 2.4 mm-40 -99.1 142.32 30.73 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.241 -0.652 . . . . 15.0 109.241 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 15.8 m -102.78 106.24 19.64 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.013 0.435 . . . . 15.0 109.897 169.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -109.56 127.0 54.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.271 -0.572 . . . . 15.0 110.552 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.661 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.0 m-85 -89.54 108.4 19.64 Favored 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.423 -0.808 . . . . 15.0 110.593 -172.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.992 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -108.21 133.44 52.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 122.885 1.326 . . . . 15.0 113.503 -175.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.618 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 6.7 t-80 -143.93 104.73 4.19 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 112.427 -2.17 . . . . 15.0 107.866 -178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 5.0 t -104.36 87.81 2.82 Favored 'General case' 0 N--CA 1.431 -1.392 0 C-N-CA 115.768 -2.373 . . . . 15.0 111.125 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.618 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.4 tt0 -101.32 -49.32 4.1 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 113.137 -1.847 . . . . 15.0 106.798 148.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 29.4 p -124.84 27.34 6.81 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 113.272 -1.785 . . . . 15.0 111.623 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.26 73.97 0.35 Allowed Glycine 0 C--N 1.276 -2.792 0 CA-C-N 111.457 -2.611 . . . . 15.0 114.292 -178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.565 ' O ' HD13 ' A' ' 253' ' ' LEU . 38.0 t -89.91 120.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 117.09 0.445 . . . . 15.0 111.517 173.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.805 ' HA ' HD22 ' A' ' 253' ' ' LEU . 5.6 p -131.25 112.23 12.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.053 -0.976 . . . . 15.0 109.166 169.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.5 p -144.33 150.12 37.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 113.244 0.831 . . . . 15.0 113.244 -167.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.78 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.1 OUTLIER -73.26 -36.28 66.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.975 -1.011 . . . . 15.0 110.496 171.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -86.02 142.35 28.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.5 -0.773 . . . . 15.0 111.237 -172.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.909 ' HB3' HG12 ' A' ' 267' ' ' ILE . 10.6 t70 -58.96 131.52 86.8 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 108.744 -0.836 . . . . 15.0 108.744 171.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.99 -14.8 16.81 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 C-N-CA 122.189 1.926 . . . . 15.0 113.619 -173.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.791 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 24.4 tpt180 -80.56 -7.43 59.23 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.619 -0.882 . . . . 15.0 108.619 175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.909 HG12 ' HB3' ' A' ' 264' ' ' ASP . 44.4 mm . . . . . 0 C--O 1.25 1.125 0 CA-C-N 113.803 -1.544 . . . . 15.0 109.917 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.581 0.229 . . . . 15.0 111.397 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.2 p -123.86 106.32 10.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.202 0.525 . . . . 15.0 110.883 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.811 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 19.8 t70 -99.39 -14.35 0.18 Allowed Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.735 1.013 . . . . 15.0 113.735 174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.992 ' HG3' HD11 ' A' ' 253' ' ' LEU . 61.4 Cg_endo -101.41 160.31 0.37 Allowed 'Trans proline' 0 C--N 1.363 1.308 0 C-N-CA 123.742 2.961 . . . . 15.0 114.081 -162.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.63 160.37 28.92 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 109.669 -1.372 . . . . 15.0 109.669 169.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.58 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.78 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.2 Cg_exo -88.86 139.1 3.73 Favored 'Trans proline' 0 C--N 1.333 -0.279 0 C-N-CA 123.582 2.855 . . . . 15.0 113.439 -174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -95.41 9.59 39.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 15.0 109.764 174.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 C--O 1.245 0.867 0 CA-C-O 118.308 -0.853 . . . . 15.0 110.571 -179.345 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.481 1.078 0 N-CA-C 109.476 -0.564 . . . . 15.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.776 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.1 OUTLIER -92.01 154.96 43.47 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 121.404 0.621 . . . . 15.0 111.31 -169.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.569 ' HG3' HH11 ' A' ' 266' ' ' ARG . 19.6 Cg_exo -69.41 167.21 24.62 Favored 'Trans proline' 0 C--N 1.33 -0.4 0 C-N-CA 122.977 2.451 . . . . 15.0 110.82 164.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -69.54 114.6 7.91 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 114.676 -1.147 . . . . 15.0 111.516 -174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 142.55 -18.78 2.43 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 114.821 -1.082 . . . . 15.0 113.112 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 43.5 m-85 -101.77 131.68 47.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.053 0.427 . . . . 15.0 111.107 -177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -101.59 138.66 38.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.328 -0.619 . . . . 15.0 109.328 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.98 110.08 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.448 -0.575 . . . . 15.0 109.448 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.407 ' HD3' ' OG ' ' B' ' 210' ' ' SEP . 4.3 ttt-85 -112.09 128.78 56.3 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.235 0.54 . . . . 15.0 111.311 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -113.53 125.49 54.26 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.375 -0.829 . . . . 15.0 109.843 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.764 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -107.72 150.52 26.85 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.125 -0.488 . . . . 15.0 110.65 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.1 m -48.84 -20.75 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.314 0.646 . . . . 15.0 112.171 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.764 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.1 tp-100 -51.21 -21.76 2.25 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.336 -0.847 . . . . 15.0 111.666 171.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 90.08 13.14 60.92 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 15.0 111.916 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.525 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 34.1 mt-30 -130.72 149.73 52.23 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.662 -0.495 . . . . 15.0 109.662 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.7 m -102.73 138.66 26.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.199 -0.455 . . . . 15.0 109.975 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -125.25 128.16 47.85 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.351 0.596 . . . . 15.0 110.476 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 14.8 m-85 -89.73 109.66 20.62 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.028 -0.987 . . . . 15.0 111.453 -172.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.081 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.37 132.96 53.72 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 122.836 1.303 . . . . 15.0 114.039 -175.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.623 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.4 t-80 -140.38 97.09 3.15 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 112.535 -2.121 . . . . 15.0 107.447 179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 17.2 p -90.51 88.22 7.07 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.439 -2.104 . . . . 15.0 110.424 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -101.29 -44.73 5.56 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 113.032 -1.895 . . . . 15.0 108.704 152.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 5.6 t -146.05 26.09 1.24 Allowed 'General case' 0 CA--C 1.494 -1.18 0 CA-C-O 124.062 1.887 . . . . 15.0 108.775 -166.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 59.45 75.96 0.25 Allowed Glycine 0 C--N 1.28 -2.581 0 CA-C-N 110.307 -3.133 . . . . 15.0 113.356 -174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 79.6 t -89.27 115.8 29.63 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 C-N-CA 118.833 -1.147 . . . . 15.0 110.841 164.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.822 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.9 p -129.31 106.15 8.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.481 -1.69 . . . . 15.0 108.571 173.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.5 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.994 0.739 . . . . 15.0 112.994 -167.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.525 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 43.3 m95 -77.84 -36.6 49.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.605 -0.725 . . . . 15.0 109.94 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -79.95 141.12 36.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.242 -0.89 . . . . 15.0 111.089 -172.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.945 ' HB3' HG12 ' A' ' 267' ' ' ILE . 25.3 t0 -59.81 125.43 80.33 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 108.053 -1.091 . . . . 15.0 108.053 170.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.776 ' HD2' HD12 ' A' ' 236' ' ' LEU . 11.9 Cg_exo -70.55 -14.8 33.9 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.192 1.928 . . . . 15.0 112.897 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.569 HH11 ' HG3' ' A' ' 237' ' ' PRO . 18.7 tpt180 -75.05 -10.26 59.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.677 0.751 . . . . 15.0 109.078 173.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.945 HG12 ' HB3' ' A' ' 264' ' ' ASP . 47.6 mm . . . . . 0 C--O 1.249 1.062 0 CA-C-N 114.448 -1.251 . . . . 15.0 109.739 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 120.411 0.148 . . . . 15.0 110.976 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 21.2 p -150.09 114.94 5.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.709 0.29 . . . . 15.0 110.364 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.734 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.797 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 47.4 p-10 -120.19 -14.47 0.08 OUTLIER Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 114.059 1.133 . . . . 15.0 114.059 173.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.081 ' HG3' HD11 ' A' ' 253' ' ' LEU . 57.4 Cg_endo -96.72 160.68 1.14 Allowed 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.057 2.505 . . . . 15.0 111.928 -175.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.27 160.21 29.23 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 119.865 -1.16 . . . . 15.0 110.455 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.467 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.3 Cg_exo -89.1 151.14 5.69 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 123.722 2.948 . . . . 15.0 113.146 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -115.11 63.99 0.68 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.66 -0.7 . . . . 15.0 110.015 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.061 -0.971 . . . . 15.0 110.822 -176.93 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 109.488 -0.56 . . . . 15.0 109.488 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.9 OUTLIER -89.73 156.55 47.35 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.982 0.42 . . . . 15.0 110.551 -173.022 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.665 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.7 Cg_exo -69.34 155.94 65.86 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.3 2.0 . . . . 15.0 109.76 166.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -69.72 117.73 11.68 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.07 -0.514 . . . . 15.0 111.219 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 146.12 -13.55 1.67 Allowed Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.38 -0.827 . . . . 15.0 112.949 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 46.9 m-85 -104.84 138.43 41.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 117.276 0.538 . . . . 15.0 110.848 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -106.01 138.0 42.95 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.517 -0.549 . . . . 15.0 109.517 170.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.92 104.59 17.14 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.379 -0.971 . . . . 15.0 108.379 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -109.05 130.71 55.48 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.814 -0.63 . . . . 15.0 111.49 -174.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 35.7 m -115.65 125.71 53.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.463 -0.789 . . . . 15.0 110.213 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -106.25 150.72 25.64 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.853 -0.612 . . . . 15.0 110.082 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 45.0 t -45.87 -23.32 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.611 0.569 . . . . 15.0 111.57 175.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.756 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.7 tp60 -50.94 -23.08 2.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.457 0.703 . . . . 15.0 111.53 173.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 96.47 -13.15 65.91 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.248 -0.501 . . . . 15.0 112.275 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.498 ' HB3' ' CZ3' ' A' ' 262' ' ' TRP . 35.5 mt-30 -106.73 142.47 36.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.835 0.35 . . . . 15.0 110.587 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.9 m -92.03 137.23 22.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.082 -0.508 . . . . 15.0 110.433 176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.467 ' OH ' ' O2P' ' B' ' 210' ' ' SEP . 28.1 p90 -127.79 128.25 44.96 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.048 0.451 . . . . 15.0 110.081 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.2 m-85 -89.7 111.33 22.27 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.68 -0.691 . . . . 15.0 111.619 -171.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.994 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.47 133.95 51.92 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.806 1.289 . . . . 15.0 113.985 179.496 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.3 t-80 -140.49 97.54 3.23 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 112.475 -2.148 . . . . 15.0 107.307 177.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.533 HG22 ' HA2' ' A' ' 258' ' ' GLY . 8.8 p -97.21 87.74 4.26 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 116.295 -2.162 . . . . 15.0 111.07 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.483 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 40.8 tt0 -101.29 -52.73 3.18 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.278 -1.783 . . . . 15.0 106.818 147.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 35.8 p -119.4 27.66 8.66 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 112.417 -2.174 . . . . 15.0 111.116 -175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.36 74.94 0.24 Allowed Glycine 0 C--N 1.274 -2.883 0 CA-C-N 111.464 -2.607 . . . . 15.0 113.692 -175.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 55.7 t -89.59 111.11 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 CA-C-N 117.452 0.626 . . . . 15.0 111.066 175.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.813 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.6 p -124.66 101.97 7.37 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.171 -1.377 . . . . 15.0 108.885 174.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.4 t -150.22 150.39 31.5 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.528 0.566 . . . . 15.0 112.528 -169.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.498 ' CZ3' ' HB3' ' A' ' 249' ' ' GLN . 74.4 m95 -72.66 -38.32 67.69 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.771 -0.65 . . . . 15.0 111.012 174.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -74.86 136.32 41.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.165 -0.47 . . . . 15.0 111.563 -170.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.829 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t0 -57.26 124.66 67.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.271 -0.877 . . . . 15.0 108.917 171.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 9.1 Cg_exo -73.38 -14.62 25.27 Favored 'Trans proline' 0 CA--C 1.514 -0.506 0 C-N-CA 122.5 2.134 . . . . 15.0 113.879 -176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.665 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 26.2 tpt180 -76.66 -9.62 58.8 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.76 -0.83 . . . . 15.0 108.76 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.829 HG12 ' HB3' ' A' ' 264' ' ' ASP . 51.3 mm . . . . . 0 C--O 1.248 1.001 0 CA-C-N 113.906 -1.497 . . . . 15.0 109.591 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.037 0.446 . . . . 15.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 15.1 m -131.82 129.53 40.59 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.92 -0.4 . . . . 15.0 109.92 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.882 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.558 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 29.5 m-20 -95.65 -19.39 0.22 Allowed Pre-proline 0 CA--C 1.546 0.827 0 N-CA-C 113.394 0.887 . . . . 15.0 113.394 170.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.994 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -92.04 160.19 3.26 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.191 1.927 . . . . 15.0 111.098 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.24 160.24 29.3 Favored Glycine 0 N--CA 1.442 -0.936 0 C-N-CA 119.904 -1.141 . . . . 15.0 110.295 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.486 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 4.6 Cg_exo -88.99 137.7 3.27 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 123.341 2.694 . . . . 15.0 113.952 -169.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -98.15 7.36 46.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.873 -1.058 . . . . 15.0 109.026 172.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 115.025 -0.989 . . . . 15.0 110.014 -177.532 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 5.3 mm-40 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.578 0.228 . . . . 15.0 110.439 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 13.4 mt -100.86 171.83 5.08 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.835 -0.431 . . . . 15.0 109.835 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.925 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.2 Cg_exo -69.57 165.61 30.17 Favored 'Trans proline' 0 CA--C 1.518 -0.286 0 C-N-CA 122.062 1.841 . . . . 15.0 110.92 166.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -69.48 126.93 31.24 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.845 -1.071 . . . . 15.0 111.304 -174.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 121.52 -13.65 9.38 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.601 -0.727 . . . . 15.0 113.647 177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.628 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 91.0 m-85 -95.06 128.58 41.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.471 0.636 . . . . 15.0 110.718 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -106.78 135.99 47.37 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.655 -0.498 . . . . 15.0 109.655 172.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.547 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -89.79 111.61 22.67 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.358 -0.979 . . . . 15.0 108.358 -178.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.708 HH11 ' HG2' ' A' ' 243' ' ' ARG . 6.1 ttt-85 -107.51 127.36 53.54 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.654 -0.703 . . . . 15.0 111.909 -174.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 1.4 p -113.83 124.38 52.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.455 -1.248 . . . . 15.0 109.821 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.724 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.9 OUTLIER -107.91 150.0 27.61 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.927 -0.397 . . . . 15.0 109.927 175.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 44.4 t -55.47 -18.67 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.516 0.674 . . . . 15.0 110.312 178.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.875 ' HG2' ' P ' ' B' ' 214' ' ' SEP . 3.8 tp-100 -47.33 -40.99 18.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.877 -1.056 . . . . 15.0 111.198 171.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 115.1 -6.91 21.51 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.779 -0.724 . . . . 15.0 112.881 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.534 ' HB2' ' O2P' ' B' ' 214' ' ' SEP . 1.7 mp0 -104.48 150.11 24.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.1 0.476 . . . . 15.0 111.662 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 16.0 m -102.12 124.17 55.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.618 -0.719 . . . . 15.0 110.301 174.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.657 ' CZ ' ' HD3' ' A' ' 243' ' ' ARG . 37.8 p90 -125.82 129.23 48.99 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.013 -0.675 . . . . 15.0 111.784 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.645 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 36.7 m-85 -90.06 111.28 22.34 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.164 -0.926 . . . . 15.0 111.678 -174.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.953 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.5 OUTLIER -110.54 134.17 52.63 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.707 1.241 . . . . 15.0 113.211 176.103 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.628 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 10.9 t-80 -140.72 100.32 3.82 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-N 112.652 -2.067 . . . . 15.0 108.005 178.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 6.3 t -101.81 87.89 3.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 115.905 -2.318 . . . . 15.0 110.885 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.609 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 46.7 tt0 -101.08 -46.67 5.0 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.023 -1.899 . . . . 15.0 106.773 148.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 23.3 p -124.97 27.05 6.84 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 113.412 -1.722 . . . . 15.0 111.109 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.91 73.11 0.43 Allowed Glycine 0 C--N 1.278 -2.666 0 CA-C-N 111.281 -2.69 . . . . 15.0 114.212 -177.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.644 ' O ' HD13 ' A' ' 253' ' ' LEU . 50.9 t -89.95 114.0 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 117.349 0.574 . . . . 15.0 112.066 175.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.776 ' HA ' HD22 ' A' ' 253' ' ' LEU . 6.7 p -121.63 106.86 11.74 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.786 -1.097 . . . . 15.0 108.596 170.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.3 p -142.41 150.13 40.22 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.257 0.836 . . . . 15.0 113.257 -169.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.508 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 1.5 m95 -77.67 -34.81 52.86 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 114.953 -1.021 . . . . 15.0 110.652 172.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -82.79 137.81 34.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.736 -0.665 . . . . 15.0 111.003 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.86 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t70 -57.14 133.41 80.68 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 15.0 108.967 171.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.405 ' HG3' ' CD2' ' A' ' 240' ' ' TYR . 87.8 Cg_endo -81.21 -14.64 10.63 Favored 'Trans proline' 0 CA--C 1.511 -0.659 0 C-N-CA 122.293 1.995 . . . . 15.0 113.986 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.925 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 7.3 tpt180 -83.81 -3.47 57.89 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.376 1.084 . . . . 15.0 108.396 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.86 HG12 ' HB3' ' A' ' 264' ' ' ASP . 46.1 mm . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 113.177 -1.829 . . . . 15.0 109.776 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.807 0.337 . . . . 15.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.2 p -109.36 107.78 18.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 15.0 110.158 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.967 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.553 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 5.3 p-10 -95.24 -24.12 0.25 Allowed Pre-proline 0 CA--C 1.549 0.911 0 CA-C-N 115.809 -0.632 . . . . 15.0 112.244 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.967 ' HD2' ' HB3' ' B' ' 210' ' ' SEP . 13.1 Cg_endo -96.42 160.37 1.24 Allowed 'Trans proline' 0 C--N 1.367 1.512 0 C-N-CA 122.941 2.427 . . . . 15.0 111.691 -179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.29 160.31 29.29 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.036 -0.825 . . . . 15.0 111.036 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.875 ' P ' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.508 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.7 Cg_exo -89.14 132.14 2.24 Favored 'Trans proline' 0 C--O 1.223 -0.226 0 C-N-CA 124.132 3.221 . . . . 15.0 113.895 -174.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -88.12 -2.1 58.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.663 -0.698 . . . . 15.0 109.54 172.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 118.102 -0.952 . . . . 15.0 110.682 -176.815 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 120.73 0.3 . . . . 15.0 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.2 mm? -122.87 172.69 5.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.594 -0.521 . . . . 15.0 109.594 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.647 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.45 159.39 53.82 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 121.986 1.791 . . . . 15.0 110.485 166.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.62 113.96 7.39 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.54 -0.755 . . . . 15.0 111.214 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 143.77 -16.43 2.2 Favored Glycine 0 N--CA 1.447 -0.569 0 CA-C-N 115.49 -0.777 . . . . 15.0 112.729 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.614 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 66.4 m-85 -98.36 138.74 35.16 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.626 -0.338 . . . . 15.0 110.737 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -109.33 144.3 37.68 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.558 -0.534 . . . . 15.0 109.558 172.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 18.8 tm0? -89.85 118.55 29.51 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.796 -0.816 . . . . 15.0 108.796 178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -125.7 136.36 53.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.387 0.613 . . . . 15.0 111.536 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.6 m -129.45 115.61 17.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.931 -1.032 . . . . 15.0 109.592 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -90.15 150.62 21.95 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.213 -0.449 . . . . 15.0 110.536 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.7 t -53.48 -17.34 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.31 0.576 . . . . 15.0 110.617 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.732 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.5 tp60 -54.2 -22.7 12.13 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.695 -0.684 . . . . 15.0 111.012 170.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 92.43 16.65 48.9 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 121.009 -0.615 . . . . 15.0 112.78 176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.468 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 18.1 mt-30 -131.47 146.81 52.42 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.773 0.321 . . . . 15.0 110.213 -178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.4 m -96.56 141.21 15.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.017 -0.538 . . . . 15.0 110.415 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.5 127.42 27.57 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.889 0.376 . . . . 15.0 110.098 176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 25.1 m-85 -89.62 111.65 22.66 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 116.05 -0.523 . . . . 15.0 111.434 -172.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.046 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -108.83 135.86 49.34 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 122.684 1.231 . . . . 15.0 113.619 -176.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.614 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -148.74 107.44 3.82 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 112.678 -2.055 . . . . 15.0 108.292 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 11.9 m -103.42 87.58 2.89 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 116.17 -2.212 . . . . 15.0 110.625 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.613 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 43.7 tt0 -101.35 -48.19 4.45 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 113.071 -1.877 . . . . 15.0 107.253 149.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 43.6 p -125.11 25.17 7.31 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 113.099 -1.864 . . . . 15.0 111.201 -176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.27 75.38 0.23 Allowed Glycine 0 C--N 1.272 -2.983 0 CA-C-N 111.17 -2.741 . . . . 15.0 113.187 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.554 ' O ' HD13 ' A' ' 253' ' ' LEU . 75.3 t -89.74 119.94 37.68 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.161 0.48 . . . . 15.0 111.604 176.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.4 p -134.21 107.32 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 O-C-N 124.817 1.323 . . . . 15.0 108.932 171.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.8 t -150.13 150.36 31.56 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 112.843 0.683 . . . . 15.0 112.843 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.545 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 37.7 m95 -72.83 -28.69 62.7 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 115.57 -0.741 . . . . 15.0 111.114 174.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -87.65 134.62 33.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.97 0.414 . . . . 15.0 111.132 -169.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.771 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.7 t70 -52.73 126.97 42.27 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.392 -0.822 . . . . 15.0 109.444 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.447 ' HD3' ' CD1' ' A' ' 252' ' ' PHE . 80.9 Cg_endo -76.96 -14.44 17.04 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.381 2.054 . . . . 15.0 114.052 -173.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.647 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 13.3 tpt180 -79.5 -8.1 58.91 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-O 122.108 0.956 . . . . 15.0 108.465 174.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.771 HG12 ' HB3' ' A' ' 264' ' ' ASP . 50.3 mm . . . . . 0 C--O 1.246 0.911 0 CA-C-N 113.613 -1.631 . . . . 15.0 109.797 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 120.466 0.174 . . . . 15.0 111.028 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 13.8 p -140.61 104.54 4.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.017 0.436 . . . . 15.0 110.938 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.667 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.671 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 32.6 t70 -109.1 -15.23 0.12 Allowed Pre-proline 0 CA--C 1.557 1.216 0 N-CA-C 113.798 1.036 . . . . 15.0 113.798 172.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.046 ' HG3' HD11 ' A' ' 253' ' ' LEU . 62.8 Cg_endo -93.04 160.33 2.63 Favored 'Trans proline' 0 C--N 1.36 1.151 0 C-N-CA 122.513 2.142 . . . . 15.0 112.127 -169.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.54 159.52 28.38 Favored Glycine 0 N--CA 1.44 -1.088 0 C-N-CA 119.639 -1.267 . . . . 15.0 110.369 175.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.477 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.545 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.9 Cg_exo -89.05 126.1 1.64 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.515 2.81 . . . . 15.0 113.262 -173.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -87.16 88.44 7.7 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.633 -0.712 . . . . 15.0 109.523 175.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.432 -0.794 . . . . 15.0 109.875 -176.392 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.786 -0.45 . . . . 15.0 109.786 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.599 HD22 ' HD2' ' A' ' 265' ' ' PRO . 6.4 mt -100.5 166.23 12.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.889 -0.412 . . . . 15.0 109.889 -176.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.443 ' HD3' ' CD ' ' A' ' 266' ' ' ARG . 20.0 Cg_exo -69.62 160.6 49.14 Favored 'Trans proline' 0 CA--C 1.517 -0.369 0 C-N-CA 121.925 1.75 . . . . 15.0 110.543 168.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -69.4 119.4 13.61 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.559 -0.746 . . . . 15.0 110.548 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 137.18 -17.89 3.55 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.462 -0.79 . . . . 15.0 112.481 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.59 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 67.0 m-85 -103.33 132.01 49.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.596 0.198 . . . . 15.0 110.502 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -108.97 139.29 44.04 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.579 -0.526 . . . . 15.0 109.579 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -89.78 105.0 17.51 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.736 -0.839 . . . . 15.0 108.736 -178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 243' ' ' ARG . 16.4 ttt85 -105.71 138.66 41.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.585 -0.734 . . . . 15.0 111.261 -176.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 16.6 m -128.37 117.2 21.01 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.195 -0.912 . . . . 15.0 109.824 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.784 HG23 ' HB3' ' A' ' 247' ' ' GLN . 2.3 t -90.02 150.3 22.16 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.228 -0.442 . . . . 15.0 109.945 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.8 t -54.53 -18.06 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.575 0.702 . . . . 15.0 110.522 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.784 ' HB3' HG23 ' A' ' 245' ' ' THR . 5.4 tp60 -53.02 -24.62 10.01 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.07 -0.968 . . . . 15.0 111.774 172.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 101.92 -2.96 52.05 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.627 -0.797 . . . . 15.0 112.824 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.601 ' NE2' ' HG3' ' A' ' 247' ' ' GLN . 1.2 mp0 -113.35 143.84 43.77 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.133 0.492 . . . . 15.0 111.486 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 35.6 m -97.83 136.81 27.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 15.0 110.161 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -130.68 130.95 44.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.054 0.454 . . . . 15.0 110.529 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.636 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 38.9 m-85 -89.66 109.16 20.15 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 115.691 -0.686 . . . . 15.0 111.297 -173.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -109.37 134.62 51.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.682 1.23 . . . . 15.0 113.716 -176.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.59 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 8.5 t-80 -141.81 105.63 4.73 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 112.457 -2.156 . . . . 15.0 107.698 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.401 HG22 ' HA2' ' A' ' 258' ' ' GLY . 22.5 p -104.26 87.75 2.82 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 116.281 -2.168 . . . . 15.0 111.277 178.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.459 HE21 HG23 ' A' ' 257' ' ' THR . 16.5 tt0 -101.35 -49.1 4.15 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 113.367 -1.742 . . . . 15.0 106.89 146.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . 0.459 HG23 HE21 ' A' ' 256' ' ' GLN . 24.9 p -126.09 30.92 5.54 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 113.006 -1.906 . . . . 15.0 111.557 -175.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 49.02 76.01 0.17 Allowed Glycine 0 C--N 1.278 -2.685 0 CA-C-N 111.952 -2.385 . . . . 15.0 114.361 -177.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.56 ' O ' HD13 ' A' ' 253' ' ' LEU . 55.6 t -89.81 118.32 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.739 0 CA-C-N 117.247 0.524 . . . . 15.0 110.91 171.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.83 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 6.0 p -132.57 107.3 8.35 Favored 'General case' 0 C--N 1.318 -0.782 0 O-C-N 124.504 1.128 . . . . 15.0 109.51 172.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 11.6 t -150.16 150.24 31.35 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 113.307 0.855 . . . . 15.0 113.307 -168.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.628 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 0.6 OUTLIER -67.76 -32.38 72.94 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 114.751 -1.113 . . . . 15.0 111.901 173.317 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -87.97 135.74 33.27 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.582 -0.447 . . . . 15.0 111.351 -168.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.903 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t0 -56.28 128.73 73.47 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 108.587 -0.894 . . . . 15.0 108.587 171.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.599 ' HD2' HD22 ' A' ' 236' ' ' LEU . 73.3 Cg_endo -76.57 -14.91 17.66 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.834 1.69 . . . . 15.0 113.183 -174.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.443 ' CD ' ' HD3' ' A' ' 237' ' ' PRO . 4.7 tpt180 -80.66 -6.2 58.03 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.975 0.893 . . . . 15.0 108.998 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.903 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.1 mm . . . . . 0 C--N 1.314 -0.962 0 CA-C-N 114.044 -1.435 . . . . 15.0 109.885 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.241 0.543 . . . . 15.0 110.434 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 20.3 m -150.07 110.45 4.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.974 -0.557 . . . . 15.0 110.042 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.775 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.664 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 7.7 m-20 -103.62 -14.95 0.17 Allowed Pre-proline 0 CA--C 1.555 1.163 0 N-CA-C 113.855 1.057 . . . . 15.0 113.855 170.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 63.0 Cg_endo -95.7 160.19 1.48 Allowed 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 122.822 2.348 . . . . 15.0 112.77 -170.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.76 158.63 27.39 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 119.973 -1.108 . . . . 15.0 111.308 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.449 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.628 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 6.5 Cg_exo -88.88 146.88 5.67 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 123.558 2.839 . . . . 15.0 113.395 -176.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -98.2 -1.14 42.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.641 -0.708 . . . . 15.0 109.811 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.388 -0.824 . . . . 15.0 111.15 -172.818 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.983 0.42 . . . . 15.0 110.411 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.522 HD12 ' HB2' ' A' ' 266' ' ' ARG . 0.9 OUTLIER -119.5 179.52 0.86 Allowed Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.9 -0.778 . . . . 15.0 108.9 -176.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.747 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.7 Cg_exo -69.67 161.92 44.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 121.418 1.412 . . . . 15.0 110.343 166.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -69.44 126.41 29.66 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.147 -0.933 . . . . 15.0 111.254 -170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 125.42 -14.99 7.25 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.773 -0.727 . . . . 15.0 113.671 176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.561 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 63.2 m-85 -100.3 136.53 40.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.574 0.687 . . . . 15.0 110.78 -178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.439 ' OE2' ' HB ' ' B' ' 208' ' ' THR . 9.9 pt-20 -105.43 146.18 29.83 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.716 -0.846 . . . . 15.0 108.716 168.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 17.4 tm0? -89.78 109.51 20.49 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.274 -1.01 . . . . 15.0 108.274 178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 32.2 ttt85 -117.33 141.34 48.43 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.627 0.727 . . . . 15.0 111.096 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.9 m -139.34 117.38 11.77 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.629 -1.168 . . . . 15.0 108.879 -176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.829 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.7 t -89.91 150.29 22.25 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.249 -0.432 . . . . 15.0 110.06 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.8 p -50.33 -22.72 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.6 0.714 . . . . 15.0 111.085 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.829 ' HB3' HG23 ' A' ' 245' ' ' THR . 8.1 tp-100 -49.55 -24.34 2.07 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.409 -1.269 . . . . 15.0 111.746 172.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.5 58.68 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 121.224 -0.513 . . . . 15.0 111.876 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.592 ' NE2' ' HH2' ' A' ' 262' ' ' TRP . 4.5 mt-30 -100.83 135.94 41.48 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.741 -0.466 . . . . 15.0 109.741 -176.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.97 143.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.638 -0.256 . . . . 15.0 110.464 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -135.47 123.47 22.77 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.204 0.526 . . . . 15.0 110.424 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.626 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 39.1 m-85 -89.67 110.84 21.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 115.426 -0.806 . . . . 15.0 110.824 -171.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.996 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.57 132.84 52.83 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.724 1.25 . . . . 15.0 113.66 -175.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.653 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 4.1 t-80 -144.74 106.99 4.34 Favored 'General case' 0 CA--C 1.501 -0.904 0 CA-C-N 112.569 -2.105 . . . . 15.0 108.317 -177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 12.7 m -102.11 87.78 3.16 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 116.1 -2.24 . . . . 15.0 111.002 179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.653 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 6.5 tt0 -101.38 -53.05 3.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.668 -1.604 . . . . 15.0 106.668 147.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 18.0 p -122.25 26.94 8.21 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 112.664 -2.062 . . . . 15.0 111.364 -174.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 53.29 75.97 0.2 Allowed Glycine 0 C--N 1.273 -2.931 0 CA-C-N 111.607 -2.542 . . . . 15.0 113.4 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 45.4 t -89.81 114.98 28.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 O-C-N 122.484 -0.421 . . . . 15.0 111.257 174.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.811 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.2 p -129.87 108.32 10.05 Favored 'General case' 0 C--N 1.316 -0.886 0 O-C-N 124.699 1.249 . . . . 15.0 108.858 169.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.401 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 15.3 t -150.14 150.23 31.36 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.935 0.717 . . . . 15.0 112.935 -169.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.592 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 56.1 m95 -70.86 -31.85 68.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.01 -0.995 . . . . 15.0 111.487 175.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.401 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 3.3 p80 -88.51 134.68 33.79 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.006 0.432 . . . . 15.0 110.937 -170.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 1.008 ' HB3' HG12 ' A' ' 267' ' ' ILE . 13.0 t0 -58.5 123.82 68.7 Favored Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.984 -0.747 . . . . 15.0 108.984 170.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 14.8 Cg_exo -69.72 -14.76 36.69 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 C-N-CA 122.099 1.866 . . . . 15.0 112.194 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.747 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.8 tpt180 -76.14 -10.66 59.59 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.934 -1.03 . . . . 15.0 108.938 173.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 1.008 HG12 ' HB3' ' A' ' 264' ' ' ASP . 39.1 pt . . . . . 0 C--O 1.25 1.112 0 CA-C-N 114.731 -1.122 . . . . 15.0 111.458 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.439 ' HB ' ' OE2' ' A' ' 241' ' ' GLU . 56.6 m . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.435 -0.209 . . . . 15.0 110.435 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 12.0 t -131.44 99.96 5.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.393 0.616 . . . . 15.0 109.736 175.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.472 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.786 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 29.1 t70 -98.92 -14.99 0.19 Allowed Pre-proline 0 CA--C 1.562 1.412 0 N-CA-C 114.021 1.119 . . . . 15.0 114.021 175.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.996 ' HG3' HD11 ' A' ' 253' ' ' LEU . 51.7 Cg_endo -102.43 160.45 0.31 Allowed 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 123.667 2.911 . . . . 15.0 114.236 -165.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.52 160.53 29.18 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.323 -1.111 . . . . 15.0 110.323 171.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.45 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.499 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 5.9 Cg_exo -89.29 160.19 5.61 Favored 'Trans proline' 0 CA--C 1.527 0.157 0 C-N-CA 124.145 3.23 . . . . 15.0 113.076 -172.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -120.94 1.51 10.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.791 -0.641 . . . . 15.0 109.824 171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.252 -0.88 . . . . 15.0 110.73 -179.779 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.779 0.323 . . . . 15.0 110.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.5 OUTLIER -113.96 168.11 8.44 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.301 -0.629 . . . . 15.0 109.301 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.629 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 17.3 Cg_exo -69.39 164.85 32.62 Favored 'Trans proline' 0 CA--C 1.515 -0.449 0 C-N-CA 122.328 2.019 . . . . 15.0 110.172 165.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -69.49 130.52 42.71 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.053 -0.976 . . . . 15.0 111.851 -172.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 124.9 -34.59 3.38 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.809 -1.087 . . . . 15.0 113.245 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.617 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 53.6 m-85 -83.89 149.45 26.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.165 0.482 . . . . 15.0 110.744 -175.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.657 ' OE2' ' HA ' ' B' ' 208' ' ' THR . 5.1 pt-20 -116.49 147.27 41.91 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.918 -0.771 . . . . 15.0 108.918 166.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.494 ' HG2' ' CE1' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -89.46 102.49 15.16 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.05 -1.093 . . . . 15.0 108.05 178.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.622 ' HD3' ' CE1' ' A' ' 251' ' ' TYR . 13.6 ttt-85 -102.82 147.61 26.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.489 -0.778 . . . . 15.0 111.136 -173.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 22.2 m -138.95 118.38 12.85 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.799 -1.092 . . . . 15.0 108.751 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.683 HG23 ' HB3' ' A' ' 247' ' ' GLN . 3.6 t -96.67 150.23 20.91 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.641 -0.254 . . . . 15.0 110.422 -178.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.4 t -53.98 -21.63 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 121.267 0.556 . . . . 15.0 110.854 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.728 ' HG2' ' NE2' ' A' ' 249' ' ' GLN . 5.9 tp-100 -53.08 -23.71 8.44 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.273 -0.876 . . . . 15.0 111.523 172.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.25 17.58 39.45 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 121.154 -0.546 . . . . 15.0 112.318 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.728 ' NE2' ' HG2' ' A' ' 247' ' ' GLN . 5.2 mt-30 -125.13 147.43 49.02 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.01 -0.737 . . . . 15.0 109.01 -178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 21.5 m -101.2 130.56 50.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 110.162 -0.31 . . . . 15.0 110.162 177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.622 ' CE1' ' HD3' ' A' ' 243' ' ' ARG . 34.9 p90 -126.99 129.13 47.5 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.531 -0.468 . . . . 15.0 110.626 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.696 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 27.5 m-85 -89.73 111.05 21.92 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-N 115.626 -0.715 . . . . 15.0 111.135 -172.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.028 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.71 135.86 50.68 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 122.712 1.244 . . . . 15.0 113.928 -176.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.68 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 16.1 t-80 -144.35 100.76 3.59 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 112.458 -2.156 . . . . 15.0 107.819 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.679 HG22 ' HA2' ' A' ' 258' ' ' GLY . 2.8 p -102.8 87.41 2.95 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 116.163 -2.215 . . . . 15.0 110.833 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.68 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 34.0 tt0 -101.25 -35.73 9.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 113.316 -1.765 . . . . 15.0 108.029 146.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 17.5 p -139.02 30.64 2.22 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.916 1.341 . . . . 15.0 111.362 -175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.679 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 54.5 73.78 0.38 Allowed Glycine 0 C--N 1.279 -2.591 0 CA-C-N 111.936 -2.393 . . . . 15.0 114.603 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.674 ' O ' HD13 ' A' ' 253' ' ' LEU . 53.4 t -92.77 115.08 30.79 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 117.274 0.537 . . . . 15.0 111.406 171.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.796 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 5.4 p -135.49 104.36 5.8 Favored 'General case' 0 C--N 1.312 -1.026 0 O-C-N 124.573 1.171 . . . . 15.0 109.229 172.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.408 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 9.0 t -150.22 150.43 31.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.735 -0.666 . . . . 15.0 112.733 -169.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.453 ' HH2' ' CD ' ' A' ' 249' ' ' GLN . 39.0 m95 -66.98 -38.05 85.35 Favored 'General case' 0 C--N 1.334 -0.089 0 CA-C-N 115.639 -0.71 . . . . 15.0 111.166 171.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.408 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 2.7 p80 -78.41 136.85 37.74 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 116.121 -0.491 . . . . 15.0 111.177 -168.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.908 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.9 t70 -57.03 127.65 76.12 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.828 -0.805 . . . . 15.0 108.828 172.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.479 ' HD2' HD12 ' A' ' 236' ' ' LEU . 71.1 Cg_endo -75.87 -14.64 19.25 Favored 'Trans proline' 0 C--N 1.327 -0.597 0 C-N-CA 122.135 1.89 . . . . 15.0 113.039 -174.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.629 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 10.6 tpt180 -76.05 -9.77 58.88 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.595 -0.891 . . . . 15.0 108.595 174.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.908 HG12 ' HB3' ' A' ' 264' ' ' ASP . 47.1 mm . . . . . 0 C--O 1.244 0.774 0 CA-C-N 114.051 -1.431 . . . . 15.0 109.765 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.657 ' HA ' ' OE2' ' A' ' 241' ' ' GLU . 6.3 m . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.566 0.698 . . . . 15.0 110.23 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 62.4 m -150.19 121.91 8.08 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.579 -0.737 . . . . 15.0 109.566 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.888 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.686 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 18.2 t70 -111.51 -19.82 0.12 Allowed Pre-proline 0 CA--C 1.556 1.189 0 N-CA-C 113.322 0.86 . . . . 15.0 113.322 173.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.028 ' HG3' HD11 ' A' ' 253' ' ' LEU . 48.9 Cg_endo -91.88 160.25 3.37 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.529 2.153 . . . . 15.0 112.411 -171.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.55 160.27 28.94 Favored Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 110.442 -1.063 . . . . 15.0 110.442 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.453 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 2.8 Cg_exo -88.79 126.77 1.81 Allowed 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.852 2.368 . . . . 15.0 112.53 -175.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -98.03 114.39 26.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.09 -0.959 . . . . 15.0 110.0 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.71 -0.662 . . . . 15.0 110.022 -178.158 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.749 -0.463 . . . . 15.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.444 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.1 mm? -102.45 169.68 7.26 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.748 0.309 . . . . 15.0 110.393 -176.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.863 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 20.2 Cg_exo -69.58 157.24 61.43 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 121.945 1.763 . . . . 15.0 110.506 166.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.88 121.18 16.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.8 -0.636 . . . . 15.0 110.976 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 134.49 -14.33 4.5 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.741 -0.742 . . . . 15.0 113.105 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.578 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 79.4 m-85 -99.13 129.33 45.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.472 0.636 . . . . 15.0 111.048 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.79 137.13 43.05 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.011 -0.737 . . . . 15.0 109.011 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -89.91 119.32 30.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.179 -0.675 . . . . 15.0 109.179 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 243' ' ' ARG . 8.1 ttt-85 -122.39 132.81 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.559 0.695 . . . . 15.0 111.81 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 19.0 m -120.13 122.5 41.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.763 -1.108 . . . . 15.0 109.338 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.696 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.2 t -94.01 150.16 20.59 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.988 -0.285 . . . . 15.0 110.357 177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 15.0 m -54.61 -19.28 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-O 121.529 0.681 . . . . 15.0 111.157 176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.701 ' HG2' HE21 ' A' ' 249' ' ' GLN . 4.6 tp-100 -50.1 -24.44 2.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.415 -1.266 . . . . 15.0 111.701 170.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 100.67 -1.75 55.66 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 121.151 -0.547 . . . . 15.0 112.196 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.701 HE21 ' HG2' ' A' ' 247' ' ' GLN . 5.1 mt-30 -111.29 138.49 47.69 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.879 0.371 . . . . 15.0 110.418 -174.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.08 136.44 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.625 -0.509 . . . . 15.0 109.625 174.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -131.73 126.7 35.14 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.18 0.514 . . . . 15.0 110.957 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.688 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 25.7 m-85 -89.77 113.5 25.05 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.41 -0.814 . . . . 15.0 111.357 -173.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -111.82 134.75 53.18 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 122.842 1.306 . . . . 15.0 114.087 -176.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.5 t-80 -141.88 103.73 4.38 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 112.579 -2.1 . . . . 15.0 107.611 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 3.8 t -100.14 87.92 3.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 116.287 -2.165 . . . . 15.0 111.056 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.555 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 33.6 tt0 -101.62 -54.43 2.75 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.311 -1.768 . . . . 15.0 106.712 147.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 38.2 p -119.88 27.23 8.81 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 112.397 -2.183 . . . . 15.0 111.329 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 52.07 75.66 0.21 Allowed Glycine 0 C--N 1.274 -2.867 0 CA-C-N 111.315 -2.675 . . . . 15.0 113.698 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.597 ' O ' ' HA ' ' A' ' 253' ' ' LEU . 53.5 t -89.58 114.89 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-N 117.395 0.598 . . . . 15.0 111.028 173.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.823 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 9.1 p -126.44 107.61 10.43 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.965 -1.471 . . . . 15.0 108.79 171.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 16.1 p -140.21 149.43 42.9 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 113.255 0.835 . . . . 15.0 113.255 -168.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.507 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 21.3 m95 -75.05 -38.52 61.38 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.037 -0.983 . . . . 15.0 110.457 171.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -79.11 143.92 35.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.443 -0.799 . . . . 15.0 110.943 -174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.787 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.6 t70 -62.61 130.16 93.34 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 108.903 -0.777 . . . . 15.0 108.903 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.7 -14.77 24.43 Favored 'Trans proline' 0 CA--C 1.516 -0.425 0 C-N-CA 122.044 1.829 . . . . 15.0 113.775 -173.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.863 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 18.2 tpt180 -80.73 -5.55 57.25 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.17 0.986 . . . . 15.0 108.792 176.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.787 HG12 ' HB3' ' A' ' 264' ' ' ASP . 48.9 mm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 113.484 -1.689 . . . . 15.0 109.728 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 121.259 0.552 . . . . 15.0 110.104 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 20.9 m -150.1 100.8 2.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.928 -0.578 . . . . 15.0 109.654 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.476 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 4.5 m-20 -81.1 -18.04 0.26 Allowed Pre-proline 0 CA--C 1.551 1.003 0 N-CA-C 114.213 1.19 . . . . 15.0 114.213 172.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 41.6 Cg_endo -98.17 160.32 0.81 Allowed 'Trans proline' 0 C--N 1.364 1.343 0 C-N-CA 122.889 2.393 . . . . 15.0 112.832 -175.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.4 160.32 29.16 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.776 -1.33 . . . . 15.0 109.776 173.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.466 ' O2P' ' HG2' ' A' ' 247' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.507 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 4.4 Cg_exo -88.96 153.66 5.86 Favored 'Trans proline' 0 CA--C 1.529 0.239 0 C-N-CA 123.932 3.088 . . . . 15.0 112.202 -174.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -116.02 -2.15 12.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.086 -0.506 . . . . 15.0 110.5 -177.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.562 -0.732 . . . . 15.0 110.116 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 120.792 0.329 . . . . 15.0 110.284 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.588 HD22 ' H ' ' A' ' 236' ' ' LEU . 0.2 OUTLIER -91.57 169.98 10.35 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.76 -0.459 . . . . 15.0 109.76 -176.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.94 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 15.3 Cg_exo -69.62 154.46 68.28 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.095 1.863 . . . . 15.0 110.611 170.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.81 131.37 44.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.126 -0.488 . . . . 15.0 110.902 -174.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 127.19 -16.47 6.35 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.564 -0.827 . . . . 15.0 112.921 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.622 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 90.2 m-85 -95.22 135.01 37.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.983 0.392 . . . . 15.0 110.267 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -113.7 138.55 50.07 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.196 0.522 . . . . 15.0 109.831 170.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.673 HE22 HG23 ' A' ' 244' ' ' THR . 1.1 tm0? -89.87 107.36 19.06 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.715 -0.846 . . . . 15.0 108.715 177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -103.55 135.79 44.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.325 0.583 . . . . 15.0 111.816 -177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.673 HG23 HE22 ' A' ' 242' ' ' GLN . 0.9 OUTLIER -117.29 115.21 24.83 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.596 -1.184 . . . . 15.0 110.41 177.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.713 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.3 t -89.95 150.34 22.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.809 -0.632 . . . . 15.0 109.684 175.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 39.9 t -51.5 -24.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.4 0.619 . . . . 15.0 110.071 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.713 ' HB3' HG23 ' A' ' 245' ' ' THR . 4.4 tp-100 -50.2 -31.37 13.66 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.964 -1.016 . . . . 15.0 111.588 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 95.21 23.36 19.94 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.107 -0.568 . . . . 15.0 113.31 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.679 HE21 ' HG2' ' A' ' 247' ' ' GLN . 6.6 mt-30 -127.02 141.35 51.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.04 0.42 . . . . 15.0 110.26 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.9 m -92.39 127.33 44.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.3 -0.409 . . . . 15.0 110.483 176.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -128.51 130.35 47.35 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.881 0.372 . . . . 15.0 110.204 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.658 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.4 m-85 -89.9 110.48 21.42 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.846 -0.615 . . . . 15.0 111.488 -173.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 1.078 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -107.13 133.21 52.07 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.711 1.243 . . . . 15.0 113.899 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.622 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 11.0 t-80 -143.64 95.23 2.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.655 -2.066 . . . . 15.0 107.918 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 24.3 m -90.4 87.91 6.98 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 116.512 -2.075 . . . . 15.0 110.141 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.41 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 27.0 tt0 -101.15 -49.62 4.04 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 112.891 -1.959 . . . . 15.0 108.212 153.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 6.7 t -135.28 23.67 3.49 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-N 112.736 -2.029 . . . . 15.0 108.506 -170.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 60.92 74.32 0.39 Allowed Glycine 0 C--N 1.279 -2.585 0 CA-C-N 109.785 -3.371 . . . . 15.0 112.909 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 253' ' ' LEU . 67.4 t -89.15 115.7 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 119.51 -0.876 . . . . 15.0 111.199 168.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.837 ' HA ' HD22 ' A' ' 253' ' ' LEU . 3.7 p -131.22 104.41 7.04 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.533 -1.667 . . . . 15.0 109.026 173.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 14.9 t -150.24 150.33 31.41 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.764 0.653 . . . . 15.0 112.764 -168.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.407 ' HH2' ' NE2' ' A' ' 249' ' ' GLN . 69.8 m95 -70.92 -34.34 71.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.602 -0.726 . . . . 15.0 111.136 174.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -81.59 136.27 35.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 15.0 111.11 -168.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.869 ' HB3' HG12 ' A' ' 267' ' ' ILE . 11.5 t70 -54.35 130.5 61.53 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 15.0 109.443 172.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.94 -14.79 16.92 Favored 'Trans proline' 0 CA--C 1.502 -1.086 0 C-N-CA 122.202 1.934 . . . . 15.0 114.179 -171.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.94 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 5.1 tpm_? -85.45 -2.76 58.46 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 122.372 1.082 . . . . 15.0 108.645 178.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.869 HG12 ' HB3' ' A' ' 264' ' ' ASP . 39.7 mm . . . . . 0 C--N 1.308 -1.233 0 CA-C-N 112.96 -1.927 . . . . 15.0 109.827 176.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.927 0.394 . . . . 15.0 110.823 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 5.5 p -132.82 110.12 10.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.408 -0.36 . . . . 15.0 110.59 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.897 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.591 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 0.8 OUTLIER -108.02 -14.86 0.13 Allowed Pre-proline 0 CA--C 1.555 1.151 0 N-CA-C 113.269 0.84 . . . . 15.0 113.269 168.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 1.078 ' HG3' HD11 ' A' ' 253' ' ' LEU . 42.2 Cg_endo -90.18 160.63 4.74 Favored 'Trans proline' 0 C--N 1.369 1.605 0 C-N-CA 122.882 2.388 . . . . 15.0 111.241 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.46 159.57 28.5 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 119.334 -1.413 . . . . 15.0 110.699 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.471 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 5.7 Cg_exo -88.99 160.09 5.91 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 123.623 2.882 . . . . 15.0 112.694 -173.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -119.6 16.98 12.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.154 0.502 . . . . 15.0 110.049 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.471 -0.776 . . . . 15.0 110.416 -177.571 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 2.0 mp0 . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.758 -0.46 . . . . 15.0 109.758 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.654 HD12 ' HD2' ' A' ' 265' ' ' PRO . 0.8 OUTLIER -93.25 159.45 35.34 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 121.085 0.469 . . . . 15.0 110.242 -178.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.698 ' HD3' ' HD3' ' A' ' 266' ' ' ARG . 16.6 Cg_exo -69.37 145.54 59.7 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 121.881 1.72 . . . . 15.0 108.561 161.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -69.54 96.44 0.92 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.128 0.966 . . . . 15.0 112.358 -169.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 163.28 32.09 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 113.45 -1.705 . . . . 15.0 112.607 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.646 ' CD2' ' HG2' ' A' ' 265' ' ' PRO . 82.7 m-85 -140.99 125.69 17.93 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.92 -0.77 . . . . 15.0 108.92 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 253' ' ' LEU . 5.9 pt-20 -97.45 134.25 40.95 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.203 0.525 . . . . 15.0 109.986 175.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -89.7 111.6 22.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.452 -0.944 . . . . 15.0 108.452 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . . . . . . . . . 9.9 ttt85 -120.3 129.78 54.17 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.345 0.593 . . . . 15.0 111.592 -175.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 14.0 m -123.04 124.44 43.13 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.995 -1.002 . . . . 15.0 109.619 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.661 HG23 ' HB3' ' A' ' 247' ' ' GLN . 0.1 OUTLIER -89.86 150.46 22.21 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.21 -0.45 . . . . 15.0 110.433 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.3 t -50.57 -24.33 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 121.46 0.648 . . . . 15.0 110.283 174.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 249' ' ' GLN . 3.3 tp-100 -47.8 -35.52 10.24 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.497 -1.229 . . . . 15.0 111.823 171.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 109.45 -4.16 31.14 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.039 -0.601 . . . . 15.0 112.798 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.757 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 9.0 mt-30 -107.19 149.77 27.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.88 0.372 . . . . 15.0 110.69 -177.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 34.7 m -102.04 136.23 35.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.921 -0.581 . . . . 15.0 110.323 176.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -131.57 126.76 35.64 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.774 -0.454 . . . . 15.0 109.774 175.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 264' ' ' ASP . 22.3 m-85 -89.74 109.94 20.89 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.867 -0.606 . . . . 15.0 111.139 -172.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.926 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -104.96 133.16 50.22 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 122.925 1.345 . . . . 15.0 113.28 -178.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 256' ' ' GLN . 0.8 OUTLIER -142.18 96.35 2.94 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 112.571 -2.104 . . . . 15.0 107.833 -178.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 10.1 t -104.11 87.73 2.84 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 115.662 -2.415 . . . . 15.0 111.18 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.573 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 16.4 tt0 -100.93 -31.55 11.07 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 112.401 -2.181 . . . . 15.0 108.245 145.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 8.9 t -144.28 24.84 1.58 Allowed 'General case' 0 CA--C 1.491 -1.319 0 CA-C-O 123.655 1.693 . . . . 15.0 110.014 -166.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 50.73 70.38 0.86 Allowed Glycine 0 C--N 1.274 -2.904 0 CA-C-N 110.006 -3.27 . . . . 15.0 113.883 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 254' ' ' HIS . 56.4 t -89.23 116.72 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 C-N-CA 119.853 -0.739 . . . . 15.0 111.629 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.834 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 3.7 p -129.18 105.44 8.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 113.905 -1.498 . . . . 15.0 109.131 170.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 12.2 t -149.96 150.17 31.46 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.713 0.635 . . . . 15.0 112.713 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.519 ' CH2' ' HD2' ' B' ' 215' ' ' PRO . 55.8 m95 -69.02 -32.91 72.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.654 -0.703 . . . . 15.0 112.102 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -88.0 139.4 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.951 0.405 . . . . 15.0 111.708 -168.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.99 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.6 t0 -58.55 123.25 66.04 Favored Pre-proline 0 C--O 1.215 -0.745 0 N-CA-C 108.155 -1.054 . . . . 15.0 108.155 169.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 236' ' ' LEU . 16.8 Cg_exo -68.54 -14.48 39.76 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 C-N-CA 121.983 1.789 . . . . 15.0 113.598 -174.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.698 ' HD3' ' HD3' ' A' ' 237' ' ' PRO . 25.3 tpt180 -80.7 -7.27 59.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 122.095 0.95 . . . . 15.0 108.752 175.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.99 HG12 ' HB3' ' A' ' 264' ' ' ASP . 45.3 pt . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.218 -1.355 . . . . 15.0 110.742 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . 0.404 ' HA ' ' OE1' ' A' ' 241' ' ' GLU . 12.5 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.985 0.421 . . . . 15.0 110.119 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 44.3 m -150.07 108.93 3.87 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.991 0.424 . . . . 15.0 110.398 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.564 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.754 ' N ' ' HD3' ' B' ' 212' ' ' PRO . 3.1 p-10 -93.15 -15.47 0.21 Allowed Pre-proline 0 CA--C 1.555 1.16 0 N-CA-C 113.964 1.098 . . . . 15.0 113.964 174.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.926 ' HG3' HD11 ' A' ' 253' ' ' LEU . 95.7 Cg_endo -97.39 160.37 0.97 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 122.962 2.441 . . . . 15.0 112.664 -167.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.67 160.22 28.75 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 109.8 -1.32 . . . . 15.0 109.8 173.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.483 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.519 ' HD2' ' CH2' ' A' ' 262' ' ' TRP . 3.3 Cg_exo -89.2 153.61 5.62 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.805 3.004 . . . . 15.0 113.414 -169.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -117.61 -4.3 11.24 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.422 -0.808 . . . . 15.0 109.257 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.216 -0.897 . . . . 15.0 110.658 -179.586 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.856 0.36 . . . . 15.0 110.214 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 236' ' ' LEU . 1.0 OUTLIER -109.04 172.39 3.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.213 -0.449 . . . . 15.0 109.986 -177.307 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.667 ' HG3' HH11 ' A' ' 266' ' ' ARG . 17.4 Cg_exo -69.51 154.32 68.88 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.566 1.51 . . . . 15.0 109.413 164.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -69.76 121.54 17.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.391 0.615 . . . . 15.0 110.869 -170.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 139.74 -21.57 2.86 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.095 -0.957 . . . . 15.0 111.853 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 75.8 m-85 -96.69 128.82 44.0 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.64 0.257 . . . . 15.0 110.413 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -102.19 130.83 48.94 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.34 -0.615 . . . . 15.0 109.34 172.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -89.75 116.02 27.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.154 0.502 . . . . 15.0 109.924 -174.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.519 ' HD3' ' CE2' ' A' ' 251' ' ' TYR . 0.0 OUTLIER -101.07 150.02 23.34 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.611 -0.722 . . . . 15.0 111.037 -173.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . . . . . . . . . 8.0 p -129.26 98.02 4.76 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.361 -0.836 . . . . 15.0 109.311 -178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 1.1 m -89.93 150.07 22.33 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.517 -0.765 . . . . 15.0 112.148 -168.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 12.4 m -61.09 -20.45 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.413 -0.812 . . . . 15.0 110.521 171.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -57.65 -22.25 44.56 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.633 -1.167 . . . . 15.0 111.524 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 85.34 23.21 48.8 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.36 -1.096 . . . . 15.0 110.36 -174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.479 ' HB2' ' O3P' ' B' ' 214' ' ' SEP . 2.3 mm100 -130.3 150.36 51.57 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.482 -0.859 . . . . 15.0 108.938 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 18.8 m -110.67 107.55 23.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.15 0.5 . . . . 15.0 110.676 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.519 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 51.3 p90 -98.67 125.52 44.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.299 0.571 . . . . 15.0 111.076 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.729 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 18.1 m-85 -90.01 113.12 24.75 Favored 'General case' 0 CA--C 1.508 -0.642 0 CA-C-N 115.634 -0.712 . . . . 15.0 111.622 -174.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.939 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.3 OUTLIER -110.39 134.39 52.35 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 122.804 1.288 . . . . 15.0 113.45 179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.629 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 t-80 -141.75 99.38 3.53 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 112.534 -2.121 . . . . 15.0 108.05 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . . . . . . . . . 7.1 t -92.44 87.87 6.16 Favored 'General case' 0 N--CA 1.431 -1.376 0 C-N-CA 116.068 -2.253 . . . . 15.0 110.425 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -100.79 -44.99 5.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 112.654 -2.066 . . . . 15.0 108.168 151.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 12.9 t -139.8 24.44 2.4 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 124.092 1.901 . . . . 15.0 108.424 -169.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . . . . . . . . . . . 57.3 74.18 0.37 Allowed Glycine 0 C--N 1.28 -2.546 0 CA-C-N 109.858 -3.337 . . . . 15.0 112.722 -175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 253' ' ' LEU . 62.9 t -89.29 115.5 29.12 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.604 0 C-N-CA 119.757 -0.777 . . . . 15.0 111.882 169.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.838 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 10.4 p -126.36 112.02 15.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 113.652 -1.613 . . . . 15.0 108.014 168.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . 0.431 ' OG1' ' HD2' ' A' ' 263' ' ' HIS . 12.8 t -149.93 150.43 31.86 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 113.646 0.98 . . . . 15.0 113.646 -167.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . 0.581 ' HZ2' ' O ' ' B' ' 215' ' ' PRO . 4.0 m95 -75.15 -21.34 58.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.529 -1.214 . . . . 15.0 112.548 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.431 ' HD2' ' OG1' ' A' ' 261' ' ' THR . 5.1 p80 -101.42 144.01 30.74 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 120.518 -0.473 . . . . 15.0 111.578 -172.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.969 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.1 t70 -60.46 123.32 73.16 Favored Pre-proline 0 C--O 1.218 -0.569 0 N-CA-C 108.455 -0.942 . . . . 15.0 108.455 170.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . 0.607 ' HG2' ' CD2' ' A' ' 240' ' ' TYR . 8.7 Cg_exo -71.29 -14.68 31.43 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 121.863 1.709 . . . . 15.0 113.792 -174.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.667 HH11 ' HG3' ' A' ' 237' ' ' PRO . 17.4 tpt180 -79.95 -8.51 59.37 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.086 -1.079 . . . . 15.0 108.086 175.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.969 HG12 ' HB3' ' A' ' 264' ' ' ASP . 35.5 pt . . . . . 0 C--O 1.251 1.146 0 CA-C-N 113.947 -1.478 . . . . 15.0 111.158 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.068 0.461 . . . . 15.0 110.497 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.41 ' HA ' ' NH2' ' A' ' 243' ' ' ARG . 63.4 m -124.19 150.54 45.09 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.267 -0.642 . . . . 15.0 109.267 176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.747 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.538 ' N ' ' CD ' ' B' ' 212' ' ' PRO . 6.6 t70 -99.49 -24.78 0.23 Allowed Pre-proline 0 CA--C 1.549 0.934 0 CA-C-N 115.383 -0.826 . . . . 15.0 112.683 172.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.939 ' HG3' HD11 ' A' ' 253' ' ' LEU . 39.7 Cg_endo -92.68 160.26 2.85 Favored 'Trans proline' 0 C--N 1.368 1.571 0 C-N-CA 122.069 1.846 . . . . 15.0 112.244 -177.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.65 160.49 28.98 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.336 -0.706 . . . . 15.0 111.336 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.532 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.581 ' O ' ' HZ2' ' A' ' 262' ' ' TRP . 8.1 Cg_exo -89.04 136.4 2.95 Favored 'Trans proline' 0 C--O 1.223 -0.238 0 C-N-CA 124.039 3.159 . . . . 15.0 114.719 -170.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.94 10.62 38.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.614 -1.175 . . . . 15.0 108.764 170.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 C--O 1.247 0.937 0 CA-C-N 114.842 -1.072 . . . . 15.0 110.438 -176.899 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 266' ' ' ARG . 10.0 mm-40 . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.665 0.269 . . . . 15.0 110.506 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 236' ' ' LEU . 0.7 OUTLIER -114.79 167.64 9.4 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 110.15 -0.315 . . . . 15.0 110.15 -177.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.99 ' HD3' ' HD2' ' A' ' 266' ' ' ARG . 10.4 Cg_exo -69.82 163.7 37.36 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.589 2.193 . . . . 15.0 110.822 165.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -69.81 124.31 23.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.817 -1.083 . . . . 15.0 112.137 -172.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.501 ' HA3' ' HD2' ' A' ' 254' ' ' HIS . . . 122.62 -2.12 10.22 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.583 -0.818 . . . . 15.0 114.7 170.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.654 ' CD2' ' HB2' ' A' ' 254' ' ' HIS . 83.1 m-85 -99.41 130.43 45.68 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.991 0.895 . . . . 15.0 110.581 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 243' ' ' ARG . 0.0 OUTLIER -104.65 138.35 41.1 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.49 -0.559 . . . . 15.0 109.49 173.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . 0.6 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.3 OUTLIER -89.92 106.18 18.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.38 0.61 . . . . 15.0 109.501 -179.327 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 241' ' ' GLU . 27.8 ttt85 -104.06 139.87 38.56 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.458 -0.792 . . . . 15.0 111.884 -174.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 250' ' ' VAL . 5.6 p -130.6 103.12 6.44 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.55 -1.204 . . . . 15.0 110.078 -177.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.652 HG23 ' HB3' ' A' ' 247' ' ' GLN . 1.5 t -90.01 150.34 22.16 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.275 -0.42 . . . . 15.0 110.942 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.3 t -54.08 -17.69 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.344 0.593 . . . . 15.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' GLN . . . . . 0.652 ' HB3' HG23 ' A' ' 245' ' ' THR . 6.2 tp-100 -55.45 -23.8 27.32 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.506 -0.77 . . . . 15.0 111.076 172.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 94.6 -0.62 65.48 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 121.044 -0.598 . . . . 15.0 112.92 176.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.424 ' HG3' ' HG3' ' A' ' 247' ' ' GLN . 15.8 mt-30 -115.24 149.27 38.02 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.054 -0.35 . . . . 15.0 110.054 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.424 HG12 HG22 ' A' ' 244' ' ' THR . 31.2 m -97.49 135.0 33.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.359 -0.382 . . . . 15.0 110.786 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.424 ' CE2' ' HD3' ' A' ' 243' ' ' ARG . 47.3 p90 -131.36 125.28 32.25 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.104 0.478 . . . . 15.0 110.29 174.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.669 ' CD1' ' HA ' ' A' ' 264' ' ' ASP . 32.0 m-85 -89.81 112.29 23.56 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-N 115.517 -0.765 . . . . 15.0 111.445 -173.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.979 HD11 ' HG3' ' B' ' 212' ' ' PRO . 0.4 OUTLIER -109.34 134.16 52.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 122.943 1.354 . . . . 15.0 114.243 -179.574 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' HIS . . . . . 0.654 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 13.5 t-80 -137.84 97.89 3.53 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 112.561 -2.108 . . . . 15.0 107.578 176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' THR . . . . . 0.564 HG22 ' HA2' ' A' ' 258' ' ' GLY . 1.2 p -97.42 87.52 4.15 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 116.074 -2.25 . . . . 15.0 110.836 178.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.436 ' HB3' ' CE1' ' A' ' 254' ' ' HIS . 35.3 tt0 -101.52 -54.14 2.82 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 106.14 -1.8 . . . . 15.0 106.14 147.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' THR . . . . . . . . . . . . . 30.5 p -118.06 25.88 10.04 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.47 -2.15 . . . . 15.0 111.331 -177.172 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' GLY . . . . . 0.564 ' HA2' HG22 ' A' ' 255' ' ' THR . . . 51.99 76.6 0.17 Allowed Glycine 0 C--N 1.273 -2.922 0 CA-C-N 111.269 -2.696 . . . . 15.0 113.736 -177.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.582 ' O ' HD13 ' A' ' 253' ' ' LEU . 43.5 t -90.1 115.3 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-N 117.157 0.479 . . . . 15.0 110.995 171.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.807 ' HA ' ' CD2' ' A' ' 253' ' ' LEU . 7.4 p -124.09 103.39 8.26 Favored 'General case' 0 C--N 1.315 -0.899 0 O-C-N 124.59 1.181 . . . . 15.0 109.025 172.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 15.6 p -138.03 150.08 46.63 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.881 0.697 . . . . 15.0 112.881 -169.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 262' ' ' TRP . . . . . . . . . . . . . 36.6 m95 -78.78 -29.03 44.8 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.307 -0.86 . . . . 15.0 110.288 173.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -88.29 141.17 28.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.723 -0.671 . . . . 15.0 110.801 -173.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . 0.889 ' HB3' HG12 ' A' ' 267' ' ' ILE . 9.3 t70 -55.97 131.37 73.7 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 108.503 -0.925 . . . . 15.0 108.503 171.283 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 265' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.1 -14.58 28.95 Favored 'Trans proline' 0 CA--C 1.504 -0.988 0 C-N-CA 122.032 1.821 . . . . 15.0 113.996 -172.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 266' ' ' ARG . . . . . 0.99 ' HD2' ' HD3' ' A' ' 237' ' ' PRO . 3.0 tpm_? -85.93 -3.36 58.91 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 122.124 0.964 . . . . 15.0 109.161 177.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . 0.889 HG12 ' HB3' ' A' ' 264' ' ' ASP . 44.5 mm . . . . . 0 C--N 1.306 -1.313 0 CA-C-N 113.357 -1.747 . . . . 15.0 109.916 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 208' ' ' THR . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.247 0.546 . . . . 15.0 110.678 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 24.7 p -145.21 103.88 3.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.35 -0.386 . . . . 15.0 110.562 -178.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 210' ' ' SEP . . . . . 0.617 ' HB3' ' HD2' ' B' ' 212' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 211' ' ' ASP . . . . . 0.639 ' H ' ' HD3' ' B' ' 212' ' ' PRO . 3.0 m-20 -107.97 -19.12 0.15 Allowed Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.965 1.098 . . . . 15.0 113.965 171.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 212' ' ' PRO . . . . . 0.979 ' HG3' HD11 ' A' ' 253' ' ' LEU . 29.4 Cg_endo -95.25 160.49 1.62 Allowed 'Trans proline' 0 C--N 1.363 1.314 0 C-N-CA 122.937 2.425 . . . . 15.0 112.218 -173.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -89.27 157.94 27.34 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 119.925 -1.131 . . . . 15.0 110.906 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 214' ' ' SEP . . . . . 0.448 ' HA ' ' HD3' ' B' ' 215' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 215' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' B' ' 214' ' ' SEP . 2.7 Cg_exo -89.15 150.12 5.61 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 123.827 3.018 . . . . 15.0 113.658 -171.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 216' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' B' ' 217' ' ' GLN . 92.0 m-85 -98.48 -9.18 25.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.69 -0.686 . . . . 15.0 109.945 175.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 217' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' B' ' 216' ' ' PHE . 19.0 mt-30 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 117.789 -1.101 . . . . 15.0 110.521 -177.359 . . . . . . . . 1 1 . 1 stop_ save_